Viimeisin päivitys :
26/03/2024
Suodattimet  
Tekijät : Tyyppi :
Otsikko :
Julkaisu : Année :  
Tutkimus Joukkueet :
Farmakologinen luokka :
Galeeniset muodot :
Viitteet   Viitteet  
1 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1939-1943.
Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection.
Yuan LC, Samuels GJ, Visor GC.
1996
2 Lehti
Am J Hosp Pharm 1994 ; 51: 88-90.
Stability of foscarnet in 0.9% sodium chloride injection.
Woods K, Steinmann W, Bruns L, Neels JT.
1994
3 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1995
4 Lehti
Act Pharm Biol Clin 1995 ; 8: 525-528.
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Zazempa V, Morgenszejn J, Paul M, Astier A.
1995
5 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1583-1588.
Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes.
Stiles ML, Allen LV Jr, Prince SJ.
1996
6 Lehti
Am J Hosp Pharm 1994 ; 51: 2138-2142.
Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C.
Trissel LA, Xu QA, Martinez JF, Fox JL.
1994
8 Lehti
Am J Hosp Pharm 1988 ; 45: 368-371.
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER.
1988
9 Lehti
Can J Hosp Pharm 1992 ; 45: 187-192.
Compatibility and stability of hyaluronidase and hydromorphone.
Walker SE, Lau DWC.
1992
10 Lehti
Am J Health-Syst Pharm 1997 ; 54: 412-421.
Stability of meropenem in intravenous solutions.
Patel PR, Cook SE.
1997
11 Lehti
Am J Health-Syst Pharm 1997 ; 54: 424-427.
Stability of ceftriaxone sodium and metronidazole hydrochloride.
Bailey LC, Orosz ST.
1997
12 Lehti
Am J Health-Syst Pharm 1997 ; 54: 683-686.
Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion.
Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD.
1997
13 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Stiles ML, Allen LV.
1997
14 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1193-1195.
Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
Gilbert DL, Trissel LA, Martinez JF.
1997
16 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1554-1556.
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA.
1995
18 Lehti
Am J Hosp Pharm 1994 ; 51: 391-394.
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
Pompilio FM, Fox JL, Inagaki K, Burm JP, Jhee S, Gill MA.
1994
19 Lehti
Am J Hosp Pharm 1986 ; 43: 1444-1453.
Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin.
Bell RG, Lipford LC, Massanari MJ, Riley CM.
1986
20 Lehti
Am J Hosp Pharm 1986 ; 43: 2732,2738.
Stability of erythromycin in intravenous admixtures.
Pluta PL, Morgan PK.
1986
21 Lehti
Am J Hosp Pharm 1986 ; 43: 2803-2809.
Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
Bigley FP, Forsyth RJ, Henley MW.
1986
22 Lehti
Int J Pharm 1991 ; 72: 57-63.
The chemical and physical stability of three intravenous infusions subjected to frozen storage and microwave thawing.
Sewell GJ, Palmer AJ.
1991
23 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1065-1068.
Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride and in 5% dextrose injection.
Evrard B, Ceccato A, Gaspard O, Delattre L, Delporte JP.
1997
24 Lehti
Am J Hosp Pharm 1994 ; 51: 514-517.
Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
Stiles ML, Allen LV Jr, Prince SJ, Holland JS.
1994
25 Lehti
Am J Hosp Pharm 1993 ; 50: 1410-1414.
Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR, Narducci WA, Fox JL.
1993
26 Lehti
Am J Health-Syst Pharm 1997 ; 54: 915-920.
Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Stewart JT, Warren FW, King DT, Venkateshwaran TG, Ponder GW, Fox JL.
1997
27 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1174-1176.
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA.
1996
28 Lehti
PDA J Pharm Sci Technol 1996 ; 50: 261-267.
Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DWC, Law S, Walker SE, Iazzetta J.
1996
29 Lehti
J Pharm Sci 1995 ; 84: 267-268.
Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions.
Pinguet F, Rouanet P, Martel P, Fabbro M, Salabert D, Astre C.
1995
30 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1431-1435.
Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days.
Hagan RL, Mallett MS, Fox JL.
1996
31 Lehti
Hosp Pharm 1996 ; 31: 965-970.
Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution.
Zhang Y, Xu QA, Trissel LA, Gilbert DL.
1996
32 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1171-1173.
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK, Johansson SG, Seiving BE.
1996
33 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1457-1458.
Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs.
Baud-Camus F, Crauste-Manciet S, Klein E, Richard L, Brossard D.
1996
35 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2128-2130.
Long term stability of interferon alfa-2b diluted to 2 million units/mL.
Schepart BS, Burns BA, Evans S, Poleon G.
1995
36 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
1995
38 Lehti
Int J Pharm 1996 ; 127: 65-71.
The extraction of diethylhexylphtalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection.
Allwood MC, Martin HJ.
1996
39 Lehti
J Pharm Clin 1997 ; 16: 45-48.
Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil.
Farhang-Asnafi S, Callaert S, Barre J, Tillement JP, Thebault A.
1997
40 Lehti
Pharm Sci Communications 1994 ; 4: 97-101.
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J, Cazin M, Cazin JC.
1994
41 Lehti
Am J Health-Syst Pharm 1997 ; 54: 913-915.
Stability of midazolam hydrochloride in syringes and IV fluids.
Pramar YV, Loucas VA, El-Rachidi A.
1997
42 Lehti
Am J Health-Syst Pharm 1997 ; 54: 422-423.
Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE.
1997
43 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1106-1108.
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Fraser BD, Berod T, Whitney HAK.
1997
44 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1701-1705.
Stability of nicardipine hydrochloride in intravenous solutions.
Baaske DM, DeMay JF, Latona CA, Mirmira S, Sigvardson KW.
1996
45 Lehti
Am J Hosp Pharm 1991 ; 48: 501-506.
Stability of succinylcholine chloride injection.
Schmutz CW, Mühlbach SF.
1991
46 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1588-1590.
Stability of ranitidine hydrochloride in water for injection in glass vials and plastic syringes.
Nahata MC, Morosco RS, Fox JL.
1996
47 Lehti
Am J Hosp Pharm 1994 ; 51: 1201-1204.
Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Burm JP, Jhee SS, Chin A, Moon YSK.
1994
48 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2744-2746.
Stability of granisetron hydrochloride in polypropylene syringes.
Quercia RA, Zhang J, Fau C, Chow MSS.
1996
49 Lehti
Am J Health-Syst Pharm 1995 ; 52: 208.
Compatibility of granisetron hydrochloride with selected alkaline drugs.
Trissel LA, Martinez JF.
1995
50 Lehti
Am J Health-Syst Pharm 1995 ; 52: 514-516.
Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
Fleming RA, Olsen DJ, Savage PD, Fox JL.
1995
51 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1541-1543.
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA.
1995
52 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1557-1558.
Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
Kirkham JC, Rutherford ET, Cumingham GN, Daneshmand KA, Falls AL.
1995
53 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2570-2573.
Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD.
1995
54 Lehti
J Pharm Clin 1995 ; 14: 26-30.
Compatibility PVC-psychotropic drugs during an infusion.
Bureau A, Lahet JJ, D?Athis P, Vailleau JL, Cosmidis V, Martin L.
1995
55 Lehti
J Clin Hosp Pharm 1982 ; 7: 181-186.
The compatibility of diazepam with infusion fluids and their containers.
Smith A, Bird G.
1982
57 Lehti
Am J Health-Syst Pharm 1996 ; 53: 294-304.
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Mayron D, Gennaro AR.
1996
58 Lehti
Can J Hosp Pharm 1985 ; 38: 160-161.
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Parker WA.
1985
59 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Kim MC.
1997
60 Lehti
Am J Hosp Pharm 1990 ; 47: 2037-2040.
Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs.
Tu YH, Stiles ML, Allen LV Jr.
1990
62 Lehti
Am J Hosp Pharm 1991 ; 48: 123-125.
Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
Pugh CB, Pabis DJ, Rodriguez C.
1991
63 Lehti
Am J Hosp Pharm 1994 ; 51: 811-812.
Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection.
Marquardt Ed, Lam SSY.
1994
64 Lehti
Am J Hosp Pharm 1992 ; 49: 1672.
Additional data on visual compatibility of foscarnet sodium with morphine sulfate.
DiStefano JE, Outman WR.
1992
65 Lehti
Am J Hosp Pharm 1990 ; 47: 143-146.
Stability of morphine sulfate in infusion devices and containers for intravenous administration.
Duafala ME, Kleinberg ML, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
1990
66 Lehti
Can J Hosp Pharm 1996 ; 49: 140-145.
Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin.
Avelar MA, Walker SE.
1996
67 Lehti
Am J Hosp Pharm 1991 ; 48: 1538-1539.
Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection.
Outman WR, Mitrano FP, Baptista RJ.
1991
68 Lehti
J Clin Pharm Ther 1989 ; 14: 451-456.
Stability of acyclovir sodium in dextrose and sodium chloride injections.
Das Gupta V, Pramar Y, Bethea C.
1989
69 Lehti
Am J Hosp Pharm 1986 ; 43: 2810-2812.
Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections.
Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA.
1986
70 Lehti
Am J Hosp Pharm 1991 ; 48: 2641-2643.
Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days.
Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.
1991
71 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2204-2206.
Stability of cidofovir in 0.9% sodium chloride injection for five days.
Ennis RD, Dahl TC.
1997
72 Lehti
Am J Hosp Pharm 1994 ; 51: 503-508.
Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Johnson CE, Jacobson PA, Chan E.
1994
73 Lehti
Am J Hosp Pharm 1990 ; 47: 157-159.
Visual compatibility of foscarnet with other injectable drugs.
Lor E, Takagi J.
1990
74 Lehti
Am J Hosp Pharm 1994 ; 51: 1348-1349.
Stability of ganciclovir sodium in an infusion-pump syringe.
Mulye NV, Turco SJ, Speaker TJ.
1994
75 Lehti
J Clin Pharm Ther 1994 ; 19: 35-36.
Stability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injections.
Mathew M, Das Gupta V, Bethea C.
1994
76 Lehti
Am J Hosp Pharm 1992 ; 49: 116-118.
Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA.
1992
77 Lehti
Am J Hosp Pharm 1990 ; 47: 2073-2074.
Stability of famotidine frozen in polypropylene syringes.
Shea BF, Souney PF.
1990
78 Lehti
Am J Hosp Pharm 1990 ; 47: 2043-2046.
Stability of ranitidine in intravenous admixtures stored frozen, refrigerated, and at room temperature.
Stewart JT, Warren FW, Johnson SM, Galante LJ.
1990
79 Lehti
Am J Hosp Pharm 1991 ; 48: 111-113.
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.
Lee DKT, Wang DP, Lee A.
1991
80 Lehti
Am J Hosp Pharm 1993 ; 50: 2559-2561.
Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1993
81 Lehti
Am J Hosp Pharm 1994 ; 51: 672-678.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF.
1994
84 Lehti
Am J Hosp Pharm 1994 ; 51: 495-499.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF.
1994
85 Lehti
Am J Hosp Pharm 1992 ; 49: 1716-1719.
Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
Trissel LA, Bready BB.
1992
86 Lehti
Am J Hosp Pharm 1994 ; 51: 2812-2815.
Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA.
1994
87 Lehti
Am J Hosp Pharm 1991 ; 48: 108-110.
Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection.
Lee DKT, Lee A, Wang DP.
1991
88 Lehti
J Acquired Immune Defic Syndr 1992 ; 5: 354-358.
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
Mole L, Oliva C, O?Hanley P.
1992
89 Lehti
Am J Hosp Pharm 1993 ; 50: 2521-2522.
Incompatibility of labetalol hydrochloride and furosemide.
Zeisler J, Alagna C.
1993
90 Lehti
Am J Hosp Pharm 1993 ; 50: 2561-2563.
Stability of nitroglycerin concentrate for injection stored in plastic syringes.
Driver PS, Jarvi EJ, Gratzer PL.
1993
91 Lehti
Am J Hosp Pharm 1993 ; 50: 1208-1210.
Visual compatibility of gallium nitrate with selected drugs during Y-site injection.
Lober CA, Dollard PA.
1993
92 Lehti
Am J Hosp Pharm 1990 ; 47: 606-608.
Visual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugs.
Lee CY, Mauro VF, Alexander KS.
1990
93 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2185-2188.
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Hutchings SR, Rusho WJ, Tyler LS.
1996
94 Lehti
Am J Hosp Pharm 1990 ; 47: 1970.
Aztreonam-vancomycin incompatibility.
Chandler SW, Folstad J, Trissel LA.
1990
95 Lehti
Am J Hosp Pharm 1991 ; 48: 77.
Incompatibility of ceftriaxone with vancomycin.
Pritts D, Hancock D.
1991
96 Lehti
Am J Hosp Pharm 1994 ; 51: 809-811.
Stability of cefuroxime sodium and aminophylline or theophylline.
Stewart JT, Warren FW, Johnson SM.
1994
99 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1995
100 Lehti
Am J Health-Syst Pharm 1996 ; 43: 2320-2323.
Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°C.
Plumridge RJ, Rieck AM, Annus TP, Langton SR.
1996
103 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1347.
Incompatibility of cefotetan disodium and promethazine hydrochloride.
Erickson SH, Ulici D.
1995
104 Lehti
Am J Health-Syst Pharm 1997 ; 54: 185-189.
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Hall PD, Yui D, Lyons S, Bosso JA.
1997
106 Lehti
Am J Hosp Pharm 1990 ; 47: 519.
Incompatibility of cefoperazone and promethazine.
Scott SM.
1990
107 Lehti
J Pharm Biomed Anal 2001 ; 25: 861-869.
Stability of stored methacholine solutions: study of hydrolysis kinetic by IP-LC.
Acar V, Houri JJ, Le Hoang MD, Pradeau D, Guyon F.
2001
108 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2309-2313.
Stability of levofloxacin in intravenous solutions in polyvinyl chloride bags.
Williams NA, Bornstein M, Johnson K.
1996
110 Lehti
Int J Pharm 1989 ; 54: 181-189.
Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers.
Vincke BJ, Verstraeten AE, El Eini DID, Mc Carthy TM.
1989
111 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1608,1610.
Stability of cefazolin sodium and meperidine hydrochloride.
Lee DKT, Wong CY, Wang DP.
1996
113 Lehti
Am J Hosp Pharm 1993 ; 50: 1918-1920.
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C.
Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA.
1993
115 Lehti
Am J Hosp Pharm 1992 ; 49: 2785-2786.
Stability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1992
116 Lehti
Am J Hosp Pharm 1989 ; 46: 1404-1407.
Stability of morphine sulfate in portable pump reservoirs during storage and simulated administration.
Stiles ML, Tu YH, Allen LV Jr.
1989
117 Lehti
Can J Hosp Pharm 1988 ; 41: 5-9.
The stability of morphine intravenous infusion solutions.
Vecchio M, Walker SE, Iazzetta J, Hardy BG.
1988
119 Lehti
J Clin Pharm Ther 1994 ; 19: 361-369.
Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices.
Strong ML, Schaaf LJ, Pankaskie MC, Robinson DH.
1994
120 Lehti
Can J Hosp Pharm 1988 ; 41: 177-182.
Hydromorphone and morphine stability in portable infusion pump cassettes and minibags.
Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B.
1988
121 Lehti
Can J Hosp Pharm 1989 ; 42: 195-200.
Stability of sulfite free high potency morphine sulfate solutions in portable infusion pump cassettes.
Walker SE, Iazzetta J, Lau DWC.
1989
122 Lehti
Int J Pharm Pract 1993 ; 2: 39-43.
Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes.
Grassby PF, Hutchings L.
1993
124 Lehti
Int Pharm J 1993 ; 7: 14-19.
An in vitro interaction between promethazine hydrochloride and chloroquine phosphate.
Abubakar AA, Mustapha A, Wambebe OC.
1993
125 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C.
Chernin EL, Stewart JT, Smiler B.
1996
126 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
Physicochemical compatibility of propofol with thiopental sodium.
Prankerd RJ, Jones RD.
1996
127 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1910-1911.
Stability of octreotide acetate in polypropylene syringes at 5 and -20°C.
Ripley RG, Ritchie DJ, Holstad SG.
1995
129 Lehti
Am J Hosp Pharm 1991 ; 48: 125-126.
Visual compatibility of insulin with secondary intravenous drugs in admixtures.
Smythe M, Malouf E.
1991
132 Lehti
Am J Health-Syst Pharm 1997 ; 54: 181-184.
Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
Najari Z, Rusho WJ.
1997
138 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1845-1848.
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint.
Corbrion V, Crauste-Manciet S, Allain P, Brossard D.
1997
140 Lehti
Am J Hosp Pharm 1993 ; 50: 1405-1409.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Pearson SD, Trissel LA.
1993
141 Lehti
Hosp Pharm 1989 ; 24: 929-934.
Stability of gallium nitrate and mitoguazone dihydrochloride in commonly used intravenous fluids.
Kleinberg ML, Oberdier J, Muller RJ, Duafala M, Boylan JC.
1989
142 Lehti
Am J Hosp Pharm 1992 ; 49: 619-623.
Stability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinylacetate portable infusion-pump reservoirs.
Rochard EB, Barthes DMC, Courtois PY.
1992
144 Lehti
Int J Pharm 1991 ; 77: 279-285.
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.
1991
145 Lehti
J Pharm Clin 1992 ; 11: 285-295.
Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers.
Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR.
1992
146 Lehti
Clin Ther 1992 ; 14: 821-824.
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.
1992
147 Lehti
Pharm World Sci 1993 ; 15: 34-36.
Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material.
Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV.
1993
148 Lehti
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
1992
149 Lehti
J Clin Pharm Ther 1992 ; 17: 315-318.
Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs.
Rochard E, Barthes D, Courtois P.
1992
150 Lehti
J Pharm Clin 1993 ; 12: 31-35.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
Aujoulat P, Coze C, Braguer D, Raybaud C.
1993
151 Lehti
Am J Hosp Pharm 1994 ; 51: 2704-2706.
Stability of paclitaxel and fluconazole during simulated Y-site administration.
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA.
1994
152 Lehti
Pharm Acta Helv 1995 ; 70: 141-148.
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J.
1995
153 Lehti
Am J Health-Syst Pharm 1995 ; 52: 98-99.
Stability of fluorouracil-metoclopramide hydrochloride admixture.
Wang DP, Chang LC, Lee DK.
1995
154 Lehti
Pharm Res 1990 ; 7: 452-460.
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ.
1990
155 Lehti
Am J Health-Syst Pharm 1995 ; 52: 710-715.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Trissel LA, Martinez JF, Xu QA.
1995
156 Lehti
Anticancer Drugs 1995 ; 6: 163-164.
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions.
Barberi-Hayob M, Merlin JL, Vigneron M, Conroy T.
1995
157 Lehti
Am J Hosp Pharm 1994 ; 51: 3058-3060.
Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C.
Xu QA, Trissel LA, Martinez JF.
1994
158 Lehti
Am J Hosp Pharm 1994 ; 51: 2804-2810.
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
Trissel LA, Xu QA, Kwan J, Martinez JF.
1994
160 Lehti
Am J Hosp Pharm 1994 ; 51: 2701-2704.
Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.
Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C.
1994
161 Lehti
Am J Hosp Pharm 1994 ; 51: 2706-2709.
Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY.
1994
162 Lehti
Int J Pharm 1994 ; 105: 83-87.
Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures.
Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC.
1994
163 Lehti
J Clin Pharm Ther 1994 ; 19: 127-133.
Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.
Sewell GJ, Allsopp M, Collinson MP, Tyrrell C, Prentice AJ, Copplestone JA.
1994
164 Lehti
J Clin Pharm Ther 1994 ; 19: 95-100.
Stability and compatibility of cisplatin and carboplatin with PVC infusion bags.
Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC.
1994
165 Lehti
Int J Pharm 1994 ; 105: 89-93.
Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution.
Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC.
1994
166 Lehti
Int J Pharm 1994 ; 101: 257-262.
Stability and compatibility study of carboplatin with three portable infusion pump reservoirs.
Rochard E, Barthes D, Courtois P.
1994
167 Lehti
Int J Pharm 1994 ; 103: 87-92.
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Francomb MM, Ford JL, Lee MG.
1994
168 Lehti
J Pharm Pharmacol 1993 ; 45: 6-9.
The long term stability of mechlorethamine hydrochloride (Nitrogen Mustard) ointment measured by HPLC.
Cummings J, Maclellan A, Langdon SJ, Smyth JF.
1993
169 Lehti
Am J Hosp Pharm 1993 ; 50: 2359-2363.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1993
170 Lehti
Am J Hosp Pharm 1975 ; 62: 44-45.
Effect of briefly heating cyclophosphamide solutions.
Brooke D, Scott JA, Bequette RJ.
1975
172 Lehti
J Parenter Sci Technol 1992 ; 46: 111-116.
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM.
1992
173 Lehti
J Infus Chemother 1994 ; 4: 140-142.
Precipitation of paclitaxel from continuous infusion fluids.
Williams DA, Naik A.
1994
174 Lehti
Am J Hosp Pharm 1990 ; 47: 1567-1571.
Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride.
Schaaf LJ, Robinson DH, Vogel GJ, Wulf BG, Drda KD, Moses JO.
1990
175 Lehti
Am J Hosp Pharm 1994 ; 51: 368-372.
Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags.
Trissel LA, Pearson SD.
1994
176 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2567-2568.
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
Mantong ML, Marquardt ED.
1995
177 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2213-2216.
Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers.
Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR.
1995
179 Lehti
Am J Hosp Pharm 1992 ; 49: 1471-1473.
Stability of ondansetron hydrochloride in portable infusion-pump reservoirs.
Stiles ML, Allen LV Jr, Fox JL.
1992
180 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1300-1302.
Stability of metoclopramide hydrochloride in plastic syringes.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL.
1996
181 Lehti
Med Sci Monit 2015 ; 21:1138-1145.
Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration: A Long-Term Stability Study.
Fuchao Chen, Hui Xiong, Jinguo Yang, Baoxia Fang, Jun Zhu, Benhong Zhou.
2015
182 Lehti
Am J Health-Syst Pharm 1997 ; 54: 56-60.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
183 Lehti
Am J Hosp Pharm 1992 ; 49: 2223-2225.
Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25°C.
Bosso JA, Prince RA, Fox JL.
1992
184 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1297-1300.
Stability of ondansetron hydrochloride and five antineoplasic medications.
Stewart JT, Warren FW, King DT, Fox JL.
1996
185 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2018-2020.
Stability of midazolam hydrochloride in polyvinyl chloride bags under fluorescent light.
McMullin ST, Burns Schaiff RA, Dietzen DJ.
1995
186 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Swart EL, Mooren RAG, Van Loenen AC.
1995
187 Lehti
Am J Hosp Pharm 1993 ; 50: 1907-1912.
Stability of flumazenil with selected drugs in 5% dextrose injection.
Olsen KM, Gurley BJ, Davis GA, Christensen R, Monaghan MS.
1993
188 Lehti
Am J Hosp Pharm 1994 ; 51: 2709-2710.
Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes.
Gibler B, Kim MS, Raleigh F.
1994
190 Lehti
Am J Hosp Pharm 1986 ; 43: 1945-1950.
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Lee MG.
1986
191 Lehti
Am J Hosp Pharm 1988 ; 45: 2079-2091.
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
Riley CM.
1988
192 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1417-1419.
Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injection.
Peddicord TE, Olsen KM, ZumBrunnen TL, Warner DJ, Webb L.
1997
193 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1293-1295.
Stability of propafenone hydrochloride in IV solutions.
Dupuis LL, Wong B, Trope A.
1997
194 Lehti
Am J Hosp Pharm 1990 ; 47: 1559-1562.
Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set.
Loucas SP, Maager P, Mehl B, Loucas ER.
1990
196 Lehti
J Clin Pharm Ther 1991 ; 16: 203-207.
Stabilities of dobutamine, dopamine, nitroglycerin and sodium nitroprusside in disposable plastic syringes.
Pramar Y, Das Gupta V, Neal Gardner S, Yau B.
1991
197 Lehti
J Clin Pharm Ther 1991 ; 16: 337-340.
The stability of four catecholamines in 5% glucose infusions.
Allwood MC.
1991
198 Lehti
Am J Health-Syst Pharm 1995 ; 52: 516-520.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Gayed AA, Kheshary PR, Hinkle RL.
1995
199 Lehti
Am J Hosp Pharm 1994 ; 51: 2143-2145.
Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
Hassan E, Leslie J, Martir-Herrero ML.
1994
200 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2340.
Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
Korth-Bradley JM, Ludwig S, Callaghan C.
1995
201 Lehti
Am J Hosp Pharm 1990 ; 47: 2530-2531.
Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection.
Thompson DF, Allen LV, Stiles ML.
1990
204 Lehti
Am J Hosp Pharm 1994 ; 51: 2693-2696.
Stability of esmolol hydrochloride in intravenous solutions.
Baaske DM, Dyskstra SD, Wagenknecht DM, Karnatz NN.
1994
205 Lehti
Am J Health-Syst Pharm 1996 ; 53: 184.
Incompatibility of amiodarone hydrochloride and evacuated glass bottles.
Strozyk WR, Williamson R, Thompson D.
1996
206 Lehti
Am J Health-Syst Pharm 1996 ; 53: 186.
Stability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration sets.
Sautou-Miranda V, Gremeau I, Chamard I, Cassagnes J, Chopineau J.
1996
207 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2024-2025.
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Ku YM, Min DI, Kumar V, Noormohamed SE.
1995
208 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1304-1306.
Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
Nolan PE, Hoyer GL, Ledoux JH, Fox JL.
1997
209 Lehti
Am J Hosp Pharm 1990 ; 47: 1574-1579.
In vitro evaluation of the stability of raniditine hydrochloride in total parenteral nutrient mixtures.
Williams MF, Hak LJ, Dukes G.
1990
210 Lehti
Am J Hosp Pharm 1994 ; 51: 1802-1807.
Stability of ranitidine hydrochloride and seven medications.
Stewart JT, Warren FW, King AD.
1994
211 Lehti
Am J Hosp Pharm 1991 ; 48: 1237-1241.
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
Strom JG, Miller SW.
1991
212 Lehti
Am J Hosp Pharm 1994 ; 51: 2157-2159.
Stability of diluted methylprednisolone sodium succinate injection at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1994
213 Lehti
Am J Hosp Pharm 1990 ; 47: 1580-1584.
Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
Galante LJ, Stewart JT, Warren FW, Johnson SM, Duncan R.
1990
214 Lehti
Am J Hosp Pharm 1990 ; 47: 1606-1610.
Stability of ranitidine hydrochloride with eight medications in intravenous admixtures.
Galante LJ, Stewart JT, Warren FW, Edgar JW, Huff AJ.
1990
215 Lehti
Ann Pharmacotherapy 1993 ; 27: 422-426.
Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs.
Keyi X, Gagnon N, Bisson C, Desmarais M, LeBel M.
1993
216 Lehti
Am J Hosp Pharm 1994 ; 51: 2963.
Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
Huang E, Anderson RP.
1994
217 Lehti
Am J Hosp Pharm 1993 ; 50: 714-715.
Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs.
Allen LV, Stiles ML, Wang DP, Tu YH.
1993
218 Lehti
Am J Hosp Pharm 1993 ; 50: 2311.
Compatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injection.
Vogt C, Ruggaber S.
1993
219 Lehti
J Clin Pharm Ther 1997 ; 22: 283-290.
Study protocol : stability of morphine injected without preservative, delivered with a disposable infusion device.
Oustric-Mendes AC, Huart B, Le Hoang MD, Perrin-Rosset M, Pailler FM, Darbord JC, Prognon, Gard C, Pradeau D.
1997
220 Lehti
Am J Health-Syst Pharm 1997 ; 54: 61-64.
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M.
1997
221 Lehti
Am J Hosp Pharm 1992 ; 49: 2149.
Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate.
Neels JT.
1992
222 Lehti
Am J Hosp Pharm 1990 ; 47: 1572-1574.
Stability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumps.
Allen LV, Stiles ML, Tu YH.
1990
223 Lehti
Am J Hosp Pharm 1990 ; 47: 1584-1587.
Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system.
Kowalski SR, Gourlay GK.
1990
224 Lehti
Am J Hosp Pharm 1991 ; 48: 515-517.
Stability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containers.
Denson DD, Crews JC, Grummich KW, Stirm EJ, Sue CA.
1991
225 Lehti
Am J Health-Syst Pharm 1995 ; 52: 511-513.
Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration.
Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M.
1995
226 Lehti
Can J Hosp Pharm 1991 ; 44: 289-295.
Stability and compatibility of combinations of hydromorphone and a second drug.
Walker SE, DeAngelis C, Iazzetta J.
1991
227 Lehti
Am J Hosp Pharm 1994 ; 51: 2292.
Compatibility of cyclizine lactate and haloperidol lactate.
Fawcett JP, Woods DJ, Munasiri B, Becket G.
1994
228 Lehti
Am J Hosp Pharm 1994 ; 51: 2964.
Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate.
Mendenhall A, Hoyt DB.
1994
229 Lehti
Am J Hosp Pharm 1994 ; 51: 2962-2963.
Compatibility of haloperidol lactate with benztropine mesylate.
Jackson CW, Cunningham K.
1994
230 Lehti
Am J Hosp Pharm 1994 ; 51: 905-906.
Visual compatibility of haloperidol lactate with injectable solutions.
Fraser GL, Riker RR.
1994
231 Lehti
Am J Hosp Pharm 1993 ; 50: 2379-2381.
Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days.
Hagan RL, Jacobs III LF, Pimsler M, Merritt GJ.
1993
232 Lehti
Am J Hosp Pharm 1993 ; 50: 285-288.
Stability of midazolam hydrochloride in parenteral nutrient solutions.
Bhatt-Mehta V, Rosen DA, King RS, Marsym CJ.
1993
233 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1850.
Precipitation of lorazepam during infusion by volumetric pump.
Grillo JA, Barie PS.
1996
234 Lehti
J Clin Pharm Ther 1997 ; 22: 257-260.
Stability of refrigerated and frozen solutions of tropisetron in either polyvinylchloride or polyolefin infusion bags.
Georget S, Vigneron J, Blaise N, Perrin A, Hoffman MA, Hoffman M.
1997
235 Lehti
Am J Hosp Pharm 1994 ; 51: 2273-2276.
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA.
1994
237 Lehti
Am J Health-Syst Pharm 1996 ; 53: 432.
Stability of cefmetazole and famotidine.
Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH.
1996
238 Lehti
Am J Hosp Pharm 1993 ; 50: 950-952.
Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection.
Belliveau PP, Shea BF, Scavone JM.
1993
239 Lehti
Am J Health-Syst Pharm 1996 ; 53: 655-658.
Loss of quinidine gluconate injection in a polyvinyl chloride infusion system.
Darbar D, Dell'Orto S, Wilkinson GR, Roden DM.
1996
240 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1904-1909.
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR.
1995
241 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2639.
Incompatibility between ceftriaxone sodium and labetolol hydrochloride.
Leader WG, Jones JM.
1996
242 Lehti
Am J Hosp Pharm 1986 ; 43: 917-921.
Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M.
1986
244 Lehti
Am J Hosp Pharm 1994 ; 51: 1907-1913.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1994
245 Lehti
J Pharm Belg 1992 ; 47: 494-498.
Stability of ganciclovir sodium (Cymevan*) after dilution in PVC infusions and polypropylene syringes.
Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman M.
1992
246 Lehti
Aust J Hosp Pharm 1996 ; 26: 560-561.
The stability of foscarnet in the presence of potassium.
McDonald C, Boddy M, Garas G.
1996
248 Lehti
Am J Hosp Pharm 1993 ; 50: 300-304.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Trissel LA, Martinez JF.
1993
249 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1996
250 Lehti
Am J Health-Syst Pharm 1997 ; 54: 566-569.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
1997
251 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
252 Lehti
Am J Hosp Pharm 1990 ; 47: 2528-2529.
Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers.
Koberda M, Zieske PA, Raghavan NV, Payton RJ.
1990
253 Lehti
Am J Hosp Pharm 1990 ; 47: 2525-2528.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Trissel LA, Chandler SW, Folstad JT.
1990
255 Lehti
Am J Hosp Pharm 1994 ; 51: 2290,2292.
Visual compatibility of fluconazole with drugs given by continuous infusion.
Ishisaka DY.
1994
256 Lehti
Am J Hosp Pharm 1993 ; 50: 1206-1208.
Stability of fluconazole in commonly used intravenous antibiotic solutions.
Inagaki K, Takagi J, Lor E, Lee KJ, Nii L, Gill MA.
1993
257 Lehti
Am J Hosp Pharm 1993 ; 50: 1186-1187.
Stability of fluconazole in injectable solutions.
Hunt-Fugate AK, Hennessey CK, Kazarian CM.
1993
258 Lehti
Am J Hosp Pharm 1994 ; 51: 901-904.
Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
Belliveau PP, Nightingale CH, Quintiliani R.
1994
259 Lehti
Am J Hosp Pharm 1993 ; 50: 2092-2094.
Stability of ceftriaxone sodium in infusion-pump syringes.
Bailey LC, Tang KT, Medwick T.
1993
260 Lehti
Am J Hosp Pharm 1993 ; 50: 2054, 2057.
Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration.
Szof C, Walker PC.
1993
261 Lehti
Am J Hosp Pharm 1993 ; 50: 715-716.
Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
Percy LA, Rho JP.
1993
262 Lehti
Am J Hosp Pharm 1993 ; 50: 703-706.
Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL.
1993
263 Lehti
Am J Hosp Pharm 1993 ; 50: 698-702.
Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures.
Pearson SD, Trissel LA.
1993
264 Lehti
Pharm Hosp Fr 1997 ; 121: 124.
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Leboucher G, Charpiat B.
1997
265 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1463-1464.
Amphotericin B does not mix with fat emulsion.
Trissel LA.
1995
266 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2853-2855.
Compatibility of meropenem with commonly used injectable drugs.
Patel PR.
1996
267 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1046-1048.
Stability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25°C.
Nahata MC, Edmonds JJ, Morosco RS.
1996
268 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1850-1851.
Ciprofloxacin and sodium phosphate not compatible during actual Y-site injection.
Benjamin BE.
1996
269 Lehti
Am J Health-Syst Pharm 1996 ; 53: 84-85.
Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate.
Trissel LA.
1996
270 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1449.
Precipitation of amphotericin B from IV fat emulsion.
Heide PE.
1997
273 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1302-1305.
Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir.
Van Doorne V, Bernaards J, DeJonge P.
1996
274 Lehti
Am J Health-Syst Pharm 1995 ; 52: 999-1001.
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
Moon YSK, Chung KC, Chin A, Gill MA.
1995
275 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
Cephalosporin-pentamidine isethionate incompatibilities.
Lewis JD, El-Gendy A.
1996
276 Lehti
Am J Hosp Pharm 1994 ; 51: 92-94.
Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures.
Parrish MA, Bailey LC, Medwick T.
1994
278 Lehti
Am J Health-Syst Pharm 1995 ; 52: 521-523.
Stability of nafcillin sodium in the presence of lidocaine hydrochloride.
Hagan RL, Carr-Lopez S, Strickland JS.
1995
279 Lehti
Am J Hosp Pharm 1994 ; 51: 2159-2161.
Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes.
Bailey LC, Cappel KM, Orosz ST.
1994
280 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2427-2433.
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Allen LV, Stiles ML, Prince SJ, Sylvestri MF.
1995
281 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1561-1563.
Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags.
Belliveau PP, Nightingale CH, Quintiliani R.
1995
282 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2568-2570.
Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags.
Rivers TE, Webster AA.
1995
283 Lehti
Am J Hosp Pharm 1994 ; 51: 394-396.
Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours.
Lee MD, Hess MM, Boucher BA, Apple AM.
1994
284 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2560-2564.
Compatibility and stability of aztreonam and vancomycin hydrochloride.
Trissel LA, Xu QA, Martinez JF.
1995
285 Lehti
Clin Ther 1996 ; 18: 246-255.
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.
1996
286 Lehti
Am J Hosp Pharm 1992 ; 49: 1459-1462.
Stability of fluconazole and amino acids in parenteral nutrient solutions.
Couch P, Jacobson P, Johnson CE.
1992
287 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1912-1914.
Stability of ceftazidime (with arginine) in an elastomeric infusion device.
Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH.
1995
288 Lehti
Hosp Pharm 1992 ; 27: 957-958,961-962.
Visual compatibility of injectable ciprofloxacin lactate with selected injectable drugs during simulated Y-site administration.
Cervenka P, Dejong DJ, Butler BL, Monzingo MD.
1992
289 Lehti
Ann Pharmacotherapy 1993 ; 27: 704-707.
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Jim LK.
1993
291 Lehti
Am J Hosp Pharm 1993 ; 50: 470-472.
Stability of cyclosporine with magnesium sulfate in 5% dextrose injection.
Nieforth KA, Shea BF, Souney PF, Scavone JM.
1993
293 Lehti
Am J Hosp Pharm 1993 ; 50: 2364-2365.
Stability of bupivacaine hydrochloride in polypropylene syringes.
Jones JW, Davis AT.
1993
294 Lehti
Am J Hosp Pharm 1993 ; 50: 2356-2358.
Stability of octreotide acetate in polypropylene syringes.
Stiles ML, Allen LV, Resztak KE, Prince SJ.
1993
295 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1048-1051.
Compatibility of selected critical care drugs during Y-site administration.
Yamashita SK, Walker SE, Choudhury T, Iazzetta J.
1996
298 Lehti
Am J Health-Syst Pharm 1995 ; 52: 320-321.
Compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Smith WR, Vissing RS.
1995
299 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF, Gilbert DL.
1997
300 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1997
301 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
1997
302 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2588-2591.
Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection.
Murray KM, Erkkila D, Gombotz WR, Pankey S.
1997
303 Lehti
Am J Health-Syst Pharm 1998 ; 55: 154-158.
Stability of reconstituted indomethacin sodium trihydrate in original vials and polypropylene syringes.
Walker SE, Gray S, Schmidt B.
1998
304 Lehti
Am J Hosp Pharm 1992 ; 49: 1455-1458.
Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacterostatic diluent.
Corbo DC, Suddith RL, Sharma B, Naso RB.
1992
305 Lehti
Am J Hosp Pharm 1992 ; 49: 1463-1466.
Stability and sorption of calcitriol in plastic tuberculin syringes.
Pecosky DA, Parasrampuria J, Li LC, Stelmach A.
1992
306 Lehti
Am J Health-Syst Pharm 1996 ; 53: 170-173.
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR.
1996
307 Lehti
Am J Hosp Pharm 1994 ; 51: 1792-1799.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF.
1994
309 Lehti
Am J Health-Syst Pharm 1995 ; 52: 192-196.
Stability of propofol with parenteral nutrient solutions during simulated Y-site injection.
Bhatt-Mehta V, Paglia RE, Rosen DA.
1995
310 Lehti
Am J Hosp Pharm 1991 ; 48: 510-514.
Compatibility and pH variability of four injectable phenytoin sodium products.
Markowsky SJ, Kohls PR, Ehresman D, Leppik I.
1991
311 Lehti
Am J Health-Syst Pharm 1996 ; 53: 167-169.
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Newborn AL, Kessler JM, Joyner KA.
1996
312 Lehti
Am J Health-Syst Pharm 1997 ; 54: 570-571.
Compatibility of iron dextran with neonatal parenteral nutrient solutions.
Mayhew SL, Quick MW.
1997
313 Lehti
Am J Hosp Pharm 1992 ; 49: 2233-2235.
Compatibility of iron dextran with total nutrient admixtures.
Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR.
1992
314 Lehti
Am J Health-Syst Pharm 1997 ; 54: 64-65.
Visual compatibility of injectable drugs used in the intensive care unit.
Chiu MF, Schwartz ML.
1997
315 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2599-2600.
Visual compatibility of warfarin sodium injection with selected medications and solutions.
Bahal SM, Lee TJ, McGinnes M, Dobler GL.
1997
316 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2611-2613.
Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs.
Veltri M, Lee CKK.
1996
317 Lehti
Am J Hosp Pharm 1993 ; 50: 1360-1362.
Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration.
Kershaw BP, Monnier HL, Mason JH.
1993
318 Lehti
Am J Hosp Pharm 1994 ; 51: 512-514.
Stability of citrated caffeine injectable solution in glass vials.
Donnelly RF, Tirona RG.
1994
319 Lehti
Am J Health-Syst Pharm 1995 ; 52: 997-999.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Hadzija BW, Lubarsky DA.
1995
321 Lehti
Am J Health-Syst Pharm 1997 ; 54: 205.
Compatibility of ketamine hydrochloride and meperidine hydrochloride.
Ambados F.
1997
322 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2639.
More on compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Hill LJ.
1996
331 Lehti
Am J Hosp Pharm 1988 ; 45: 2127.
Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents.
Marquardt ED.
1988
332 Lehti
Ann Pharmacotherapy 1995 ; 29: 1106-1109.
Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
Xu QA, Trissel LA, Fox JL.
1995
333 Lehti
Ann Pharmacotherapy 1992 ; 26: 768-771.
Stability of ondansetron in large-volume parenteral solutions.
Graham CL, Dukes GE, Kao CF, Bertch JM, Hak LJ.
1992
334 Lehti
Am J Hosp Pharm 1991 ; 48: 988-992.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Trissel LA, Tramonte SM, Grilley BJ.
1991
335 Lehti
Am J Hosp Pharm 1992 ; 49: 402-406.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Trissel LA, Bready BB, Kwan JW, Santiago NM.
1992
336 Lehti
Am J Hosp Pharm 1987 ; 44: 1408-1409.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Forman JK, Lachs JR, Souney PF.
1987
337 Lehti
Am J Hosp Pharm 1988 ; 45: 2532-2533.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Bashaw ED, Amantea MA, Minor JR, Galleli JF.
1988
338 Lehti
Am J Hosp Pharm 1991 ; 48: 280-282.
Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
Lam NP, Kennedy PE, Jarosinski PF, Galleli JF.
1991
339 Lehti
Am J Hosp Pharm 1990 ; 47: 377-381.
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
1990
340 Lehti
Am J Hosp Pharm 1985 ; 42: 1087-1094.
Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation.
Macias JM, Martin WJ, Lloyd CW.
1985
341 Lehti
Am J Hosp Pharm 1985 ; 42: 1352-1355.
Compatibility of heparin sodium and morphine sulfate.
Baker DE, Yost GS, Craig VL, Campbell RK.
1985
342 Lehti
Am J Hosp Pharm 1985 ; 42: 339-342.
Stability of an analgesic-sedative combination in glass and plastic single-dose syringes.
Conklin CA, Kerege JF, Christensen JM.
1985
345 Lehti
Can J Hosp Pharm 1996 ; 49: 290-298.
Stability and compatibility of reconstituted sterile hydromorphone with midazolam.
Walker SE, Meinders A, Tailor H.
1996
346 Lehti
J Pain Symptom Manage 1994 ; 9: 308-311.
The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes.
Wulf H, Gleim M, Mignat C.
1994
347 Lehti
Am J Hosp Pharm 1991 ; 48: 2627-2630.
Effect of syringe filter and IV administration set on delivery of propofol emulsion.
Bailey LC, Tang KT, Rogozinski BA.
1991
348 Lehti
Am J Hosp Pharm 1985 ; 42: 335-339.
Effect of a polyethylene-lined administration set on the avaibility of diazepam injection.
Hancock BG, Black CD.
1985
349 Lehti
Am J Hosp Pharm 1986 ; 43: 384-385.
Stability of phenobarbital sodium diluted in 0.9% sodium chloride injection.
Nahata MC, Hipple TF, Strausbaugh SD.
1986
350 Lehti
Am J Hosp Pharm 1990 ; 47: 369-373.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Martens HJ, De Goede PN, Van Loenen AC.
1990
351 Lehti
Am J Hosp Pharm 1986 ; 43: 2795-2799.
Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems.
Yliruusi JK, Uotila JA, Kristoffersson ER.
1986
352 Lehti
Am J Hosp Pharm 1986 ; 43: 2789-2794.
Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets.
Yliruusi JK, Uotilo JA, Kristoffersson ER.
1986
353 Lehti
Am J Hosp Pharm 1987 ; 44: 2519-2524.
Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid.
Lunn G, Sansone EB.
1987
354 Lehti
Am J Hosp Pharm 1989 ; 46: 2329-2332.
Stability of famotidine 20 and 40 mg/L in total nutrient admixtures.
Montoro JB, Pou L, Salvador P, Pastor C, Cano SM.
1989
355 Lehti
Am J Hosp Pharm 1989 ; 46: 2326-2329.
Stability of famotidine 20 and 50 mg/L in total nutrient admixtures.
Bullock L, Fitzgerald JF, Glick MR.
1989
356 Lehti
Am J Hosp Pharm 1989 ; 46: 2321-2325.
Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions.
Bullock LS, Fitzgerald JF, Glick MR, Parks RB, Schnabel JG, Hancock BG.
1989
357 Lehti
Am J Hosp Pharm 1988 ; 45: 1100-1102.
Stability of ranitidine hydrochloride in total nutrient admixtures.
Cano SM, Montoro JB, Pastor C, Pou L, Sabin P.
1988
358 Lehti
Am J Hosp Pharm 1986 ; 43: 921-925.
Stability of ranitidine admixtures frozen and refrigerated in minibags.
Lampasona V, Mullins RE, Parks RB.
1986
359 Lehti
Am J Hosp Pharm 1985 ; 42: 2683-2687.
Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
Bullock LS, Parks RB, Lampasona V, Mullins RE.
1985
360 Lehti
Am J Hosp Pharm 1992 ; 49: 2769-2772.
Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J.
1992
361 Lehti
Am J Hosp Pharm 1991 ; 48: 1507-1510.
Stability of nizatidine in total nutrient admixtures.
Hatton J, Holstad SG, Rosenbloom AD, Westrich T, Hirsch J.
1991
362 Lehti
Am J Hosp Pharm 1985 ; 42: 2208-2210.
Stability of cimetidine hydrochloride in a total nutrient admixture.
Baptista RJ, Palombo JD, Tahan SR, Valicenti AJ, Bistrian BR, Arkin CF, Blackburn GL.
1985
363 Lehti
Am J Hosp Pharm 1989 ; 46: 101-104.
Stability of esmolol hydrochloride and sodium nitroprussiate in intravenous admixtures.
Karnatz NN, Wong J, Baaske DM, Johnson JH, Speicher ER, Herbranson DE.
1989
364 Lehti
Am J Hosp Pharm 1989 ; 46: 97-100.
Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ.
1989
365 Lehti
Med Sci Monit 2015 ; 21:2528-2534.
Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery.
Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia.
2015
366 Lehti
Am J Hosp Pharm 1986 ; 43: 2218-2220.
Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
Wilson TD, Forde MD, Crain AVR, Dombrowski LJ, Joyce MA.
1986
367 Lehti
Am J Hosp Pharm 1985 ; 42: 116-119.
Compatibility of furosemide with aminoglycoside admixtures.
Thompson DF, Allen LV, Desai SR, Rao PS.
1985
370 Lehti
Am J Hosp Pharm 1988 ; 45: 2513-2517.
Stability of procainamide hydrochloride in neutralized 5% dextrose injection.
Raymond GG, Reed MT, Teagarden JR, Story K, Geberbauer CW.
1988
371 Lehti
Am J Hosp Pharm 1988 ; 45: 142-145.
Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
Thompson DF, Stiles ML, Allen LV, Tu YH.
1988
372 Lehti
Am J Hosp Pharm 1988 ; 45: 609-612.
Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL.
1988
375 Lehti
Am J Hosp Pharm 1991 ; 48: 1511-1514.
Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
Patel JP, Tran LT, Sinai WJ, Carr LJ.
1991
377 Lehti
Am J Hosp Pharm 1988 ; 45: 1350-1352.
Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry.
Pereira-Rosario R, Utamura T, Perrin JH.
1988
379 Lehti
Am J Hosp Pharm 1985 ; 42: 2679-2683.
Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets.
Weir SJ, Szucs Myers VA, Bengtson KD, Ueda CT.
1985
380 Lehti
Crit Care Med 1995 ; 23: 1061-1066.
Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B.
1995
381 Lehti
J Parenter Sci Technol 1993 ; 47: 166-171.
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R.
1993
384 Lehti
Am J Hosp Pharm 1988 ; 45: 630-632.
Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
Colucci RD, Cobuzzi LE, Halpern NA.
1988
385 Lehti
Am J Hosp Pharm 1988 ; 45: 1117-1118.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Benedict MK, Roche VF, Banakar UV, Hilleman DE.
1988
386 Lehti
Am J Hosp Pharm 1988 ; 45: 1357-1358.
Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
Colucci RD, Cobuzzi LE, Halpern NA.
1988
388 Lehti
Am J Hosp Pharm 1988 ; 45: 1523-1529.
Stability of nizatidine in commonly used intravenous fluids and containers.
Raineri DL, Cwik MJ, Rodvold KA, Deyo KL, Scaros LP, Fischer JH.
1988
389 Lehti
Am J Hosp Pharm 1991 ; 48: 2161-2166.
Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
Walker SE, DeAngelis C, Iazzetta J, Eppel JG.
1991
390 Lehti
Am J Hosp Pharm 1986 ; 43: 1482-1485.
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Craft DA, Lizer MH.
1986
391 Lehti
Am J Hosp Pharm 1987 ; 44: 1620-1624.
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE.
1987
394 Lehti
Am J Hosp Pharm 1989 ; 46: 2333-2335.
Long-term stability of famotidine 20 mg/L in a total parenteral nutrient solution.
DiStefano JE, Mitrano FP, Baptista RJ, Der MM, Silvestri Ap, Palombo JD, Bistrian BR.
1989
396 Lehti
Am J Hosp Pharm 1989 ; 46: 2057-2058.
Visual compatibility of ranitidine hydrochloride with commonly used critical-care medications.
Chilvers MR, Lysne JM.
1989
397 Lehti
Am J Hosp Pharm 1989 ; 46: 125-126.
Visual compatibility of intravenous famotidine with selected drugs.
Fong PA, Ward J.
1989
398 Lehti
Am J Hosp Pharm 1988 ; 45: 1556-1557.
Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
Jay GT, Fanikos J, Souney PF.
1988
399 Lehti
Aust J Hosp Pharm 1993 ; 23: 260-262.
Stability of midazolam in sodium chloride infusion packs.
Bleasel MD, Peterson GM, Jestrimski KW.
1993
401 Lehti
Aust J Hosp Pharm 1991 ; 21: 115-118.
A preliminary study of the stability of midazolam in polypropylene syringes.
Peterson GM, Khoo BHC, Galloway JG, Paterson J.
1991
402 Lehti
Am J Hosp Pharm 1990 ; 47: 820-821.
Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
Savitsky ME.
1990
403 Lehti
Am J Hosp Pharm 1991 ; 48: 1539-1541.
Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
Outman WR, Monolakis J.
1991
404 Lehti
Am J Hosp Pharm 1987 ; 44: 2298-2299.
Visual compatibility of midazolam hydrochloride with common preoperative injectable medications.
Forman JK, Souney PF.
1987
405 Lehti
Am J Hosp Pharm 1985 ; 42: 1108-1109.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Nieves-Cordero AL, Luciw HM, Souney PF.
1985
406 Lehti
Am J Hosp Pharm 1990 ; 47: 819-820.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Smythe MA, Patel MA, Gasloli RA.
1990
407 Lehti
Am J Hosp Pharm 1985 ; 42: 1750-1754.
Stability of mitomycin admixtures.
Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR.
1985
408 Lehti
Am J Hosp Pharm 1986 ; 43: 3022-3027.
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM.
1986
409 Lehti
Am J Hosp Pharm 1987 ; 44: 124-130.
Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP.
1987
410 Lehti
Am J Hosp Pharm 1991 ; 48: 1500-1506.
Characterization of cisplatin degradation as affected by pH and light.
Zieske PA, Koberda M, Hines JL, Knight CC, Sriram R, Raghavan NV, Rabinow BE.
1991
411 Lehti
Am J Hosp Pharm 1991 ; 48: 2158-2160.
Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
Woloschuk DMM, Wermeling JR, Pruemer JM.
1991
412 Lehti
Am J Hosp Pharm 1991 ; 48: 1520-1524.
Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
Waugh WN, Trissel LA, Stella VJ.
1991
413 Lehti
Am J Hosp Pharm 1990 ; 47: 1373-1377.
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
Stewart CF, Fleming RA.
1990
414 Lehti
Am J Hosp Pharm 1989 ; 46: 2500-2505.
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Den Hartigh J, Brandenburg HCR, Vermeij P.
1989
415 Lehti
Am J Hosp Pharm 1989 ; 46: 2036-2040.
Stability of fluorouracil administered through four portable infusion pumps.
Stiles ML, Allen LV, Tu YH.
1989
417 Lehti
Am J Hosp Pharm 1989 ; 46: 1400-1404.
Stability of cisplatin and etoposide in intravenous admixtures.
Stewart CF, Hampton EM.
1989
418 Lehti
Am J Hosp Pharm 1985 ; 42: 2211-2214.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Bosso JA, Townsend RJ.
1985
419 Lehti
Am J Hosp Pharm 1985 ; 42: 1984-1986.
Stability of intravenous admixtures of aztreonam and clindamycin phosphate.
James MJ, Riley CM.
1985
420 Lehti
Am J Hosp Pharm 1985 ; 42: 1980-1983.
Stability of cefonicid sodium in infusion fluids.
Wong WW, Maderich AB, Polli GP, Ravin LJ.
1985
421 Lehti
Am J Hosp Pharm 1985 ; 42: 839-843.
Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures.
Foley PT, Bosso JA, Bair JN, Townsend RJ.
1985
422 Lehti
Am J Hosp Pharm 1985 ; 42: 1095-1100.
Stability of intravenous admixtures of aztreonam and ampicillin.
James MJ, Riley CM.
1985
423 Lehti
Am J Hosp Pharm 1985 ; 42: 332-335.
Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ.
1985
424 Lehti
Am J Hosp Pharm 1986 ; 43: 1486-1488.
Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
De NC, Alam AS, Kapoor JN.
1986
426 Lehti
Am J Hosp Pharm 1986 ; 43: 925-927.
Stability of intravenous admixtures containing aztreonam and cefazolin.
Riley CM, James MJ.
1986
427 Lehti
Am J Hosp Pharm 1986 ; 43: 3027-3030.
Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states.
Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB.
1986
428 Lehti
Am J Hosp Pharm 1987 ; 44: 802-804.
Stability of vancomycin hydrochloride in various concentrations of dextrose injection.
Nahata MC, Miller MA, Durrell DE.
1987
430 Lehti
Am J Hosp Pharm 1986 ; 43: 1729-1731.
Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Stewart KR, Nohria S.
1986
431 Lehti
Am J Hosp Pharm 1975 ; 33: 1010-1013.
Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures.
McRae MP, King JC.
1975
432 Lehti
Am J Hosp Pharm 1986 ; 43: 1732-1736.
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Marble DA, Bosso JA, Townsend RJ.
1986
433 Lehti
Am J Hosp Pharm 1986 ; 43: 2221-2224.
Interaction of aztreonam with nafcillin in intravenous admixtures.
Riley CM, Lipford LC.
1986
434 Lehti
Am J Hosp Pharm 1991 ; 48: 2166-2171.
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Goodwin SD, Nix DE, Heyd A, Wilton JH.
1991
435 Lehti
Am J Hosp Pharm 1991 ; 48: 2430-2433.
Stability of amphotericin B in four concentrations of dextrose injection.
Wiest DB, Maish WA, Garner SS, El-Chaar GM.
1991
436 Lehti
Am J Hosp Pharm 1991 ; 48: 2635-2637.
Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days.
Mitrano FP, Outman WR, Baptista RJ, Palombo JD.
1991
439 Lehti
Am J Hosp Pharm 1991 ; 48: 283-285.
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
Kintzel PE, Kennedy PE.
1991
440 Lehti
Am J Hosp Pharm 1989 ; 46: 1408-1412.
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Stiles ML, Tu YH, Allen LV.
1989
442 Lehti
Am J Hosp Pharm 1989 ; 46: 732-737.
Stability of a concentrated trimethoprim-sulfamethoxazole admixtures.
Jarosinski PF, Kennedy PE, Gallelli JF.
1989
443 Lehti
Am J Hosp Pharm 1992 ; 49: 2761-2764.
Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
Stiles ML, Allen LV, Fox JL.
1992
444 Lehti
Am J Hosp Pharm 1992 ; 49: 2756-2760.
Stability of an ofloxacin injection in various infusion fluids.
Bornstein M, Kao SH, Mercorelli M, Verma S.
1992
445 Lehti
Am J Hosp Pharm 1992 ; 49: 2765-2768.
Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.
Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J.
1992
446 Lehti
Am J Hosp Pharm 1992 ; 49: 2782-2783.
Stability of undiluted trimethoprim-sulfamethoxazole for injection in plastic syringes.
Kaufman MB, Scavone JM, Foley JJ.
1992
448 Lehti
Am J Hosp Pharm 1986 ; 43: 1760-1762.
Stability of terbutaline sulfate admixtures stored in polyvinyl chloride bags.
Mehta J, Searcy CJ, Jung DT.
1986
449 Lehti
Am J Hosp Pharm 1987 ; 44: 2291-2293.
Stability of terbutaline sulfate repackaged in disposable plastic syringes.
Glascock JC, DiPiro JT, Cadwallader DE, Perri M.
1987
451 Lehti
Int J Pharm Compound 1997 ; 1: 206-207.
Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections.
Das Gupta V, Maswoswe J, Bailey RE.
1997
453 Lehti
Am J Hosp Pharm 1986 ; 43: 692-694.
Stability and availability of cyclosporine stored in plastic syringes.
Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R.
1986
454 Lehti
Am J Hosp Pharm 1986 ; 43: 94-97.
Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
Ptachcinski RJ, Logue LW, Burckart GJ, Venkataramanan R.
1986
455 Lehti
Am J Hosp Pharm 1986 ; 43: 2800-2802.
Leaching of diethylhexyl phtalate from polyvinyl chloride bags into intravenous cyclosporine solution.
Venkataramanan R, Burckart GJ, Ptachcinski RJ, Blaha R, Logue LW, Bahnson A, Giam CS, Brady JE.
1986
456 Lehti
Am J Hosp Pharm 1987 ; 44: 2524-2527.
Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures.
Tu YH, Allen LV, Wang DP.
1987
460 Lehti
Am J Hosp Pharm 1987 ; 44: 358-360.
Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection.
Parasrampuria J, Das Gupta V, Stewart KR.
1987
464 Lehti
Am J Hosp Pharm 1986 ; 43: 2209-2213.
Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system.
Furberg H, Kruse Jensen A, Salbu B.
1986
465 Lehti
Am J Hosp Pharm 1990 ; 47: 297-298.
More information on the visual compatibility of hetastarch with injectable critical-care drugs.
Wohlford JG, Wright JC, Wilson MR.
1990
466 Lehti
Am J Hosp Pharm 1991 ; 48: 2172-2175.
Activity of octreotide acetate in a total nutrient admixture.
Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM.
1991
467 Lehti
Am J Hosp Pharm 1991 ; 48: 2442-2443.
Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion.
Ishisaka DY, van Vleet J, Marquardt E.
1991
468 Lehti
Am J Hosp Pharm 1991 ; 48: 2631-2634.
Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days.
Tarr BD, Campbell RK, Workman TM.
1991
469 Lehti
Am J Hosp Pharm 1990 ; 47: 1097-1100.
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Floy BJ, Royko CJ, Fleitman JS.
1990
471 Lehti
Am J Hosp Pharm 1989 ; 46: 2053-2055.
Stability of cyclosporine in 5% dextrose injection.
Shea BF, Ptachcinski RJ, O'Neill S, Cersosimo RJ, Sesin GP, Souney PF.
1989
472 Lehti
Am J Hosp Pharm 1989 ; 46: 995-996.
Visual compatibility of hetastarch with injectable critical-care drugs.
Wohlford JG, Fowler MD.
1989
475 Lehti
Am J Hosp Pharm 1992 ; 49: 119-122.
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.
1992
476 Lehti
Am J Hosp Pharm 1992 ; 49: 2960-2962.
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS.
1992
477 Lehti
Am J Hosp Pharm 1992 ; 49: 2954-2956.
Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
Nahata MC, Morosco RS, Fox JL.
1992
478 Lehti
Am J Hosp Pharm 1992 ; 49: 2962-2963.
Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures.
Nahata MC, Morosco RS, Hipple TF.
1992
479 Lehti
Am J Hosp Pharm 1992 ; 49: 2964-2966.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Min DI, Brown T, HWang GC.
1992
481 Lehti
J Parenter Sci Technol 1989 ; 43: 84-87.
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
Beijnen JH, Vendrig DEMM, Underberg WJM.
1989
482 Lehti
J Parenter Sci Technol 1991 ; 45: 108-112.
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM.
1991
484 Lehti
J Clin Pharm Ther 1991 ; 16: 123-129.
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions.
Northcott M, Allsopp MA, Powell H, Sewell GJ.
1991
485 Lehti
J Oncol Pharm Practice 1995 ; 1: 19-24.
Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids.
Dorr RT, Liddil JD.
1995
486 Lehti
Am J Health-Syst Pharm 1998 ; 55: 602, 604.
Stability of carboplatin in polyvinyl chloride bags.
Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A.
1998
489 Lehti
Am J Hosp Pharm 1992 ; 49: 1137-1139.
Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable IV pump cassette.
Munoz M, Girona V, Pujol M, Duran S, Vicente P, Solé LA.
1992
491 Lehti
Am J Hosp Pharm 1991 ; 48: 2181-2184.
Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
Turowski RC, Durthaler JM.
1991
492 Lehti
Am J Hosp Pharm 1991 ; 48: 2186-2189.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Trissel LA, Parks NPT, Santiago NM.
1991
494 Lehti
Am J Hosp Pharm 1992 ; 49: 836,838.
Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate.
Thompson DF, Heflin NR.
1992
496 Lehti
Am J Hosp Pharm 1991 ; 48: 744-746.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Lor E, Sheybani T, Takagi J.
1991
497 Lehti
Am J Hosp Pharm 1991 ; 48: 1681.
Stability of amphotericin B in 5% dextrose injection at 25°C.
Kintzel PE, Kennedy PE.
1991
499 Lehti
Hosp Pharm 1991 ; 26: 634-635.
Intramuscular antibiotic preparation and administration using a 1% lidocaine diluent: policies for the pediatric patient.
Rockwell K, Burch K.
1991
500 Lehti
Am J Hosp Pharm 1988 ; 45: 1910-1911.
Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
Tucker DR, Sieradzan R.
1988
501 Lehti
Am J Hosp Pharm 1985 ; 42: 129-130.
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Senholzi CS, Kerns MP.
1985
503 Lehti
Am J Hosp Pharm 1985 ; 45: 1987-1988.
Stability of tobramycin sulfate in admixtures with calcium gluconate.
Nahata MC, Durrell DE.
1985
504 Lehti
Sci Tech Pharm 1987 ; 3: 33-40.
Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26).
Hamon M, Plas-Remoissenet D, Kubab-Alajati S.
1987
506 Lehti
J Pharm Pharmacol 1989 ; 41: 275-277.
Diamorphine stability in aqueous solution for subcutaneous infusion.
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.
1989
507 Lehti
Br J Anaesth 1992 ; 68: 414-417.
Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion.
Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH.
1992
509 Lehti
Pharm World Sci 1993 ; 15: 139-144.
Effect of pH absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditions.
Roos PJ, Glerum JH, Meilink JW, Zwang L.
1993
510 Lehti
Pharm World Sci 1993 ; 15: 269-275.
Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter.
Roos PJ, Glerum JH, Schroeders MJH.
1993
512 Lehti
Pharm World Sci 1995 ; 17: 87-92.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Barnes AR, Nash S.
1995
513 Lehti
Ann Pharmacotherapy 1996 ; 30: 756-761.
Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
Xu QA, Trissel LA, Martinez JF.
1996
514 Lehti
Ann Pharmacotherapy 1997 ; 31: 297-302.
Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers.
Xu QA, Trissel LA, Martinez JF.
1997
515 Lehti
J Pharm Clin 1998 ; 17: 35-39.
Stability of morphine hydrochloride solutions in portable single-use PCA systems. Additives leaching into the morphine solutions.
Le Hoang MD, Sarbach C, Prognon P, Delvordre P, Mignot A, Pradeau D.
1998
517 Lehti
Am J Hosp Pharm 1992 ; 49: 838-839.
Visual compatibility of magnesium sulfate with narcotic analgesics.
Letourneau M.
1992
518 Lehti
Am J Hosp Pharm 1988 ; 45: 1278.
Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride.
Jimenez MD.
1988
519 Lehti
Aust J Hosp Pharm 1991 ; 21: 316.
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Poggi GL.
1991
522 Lehti
Can J Hosp Pharm 1989 ; 42: 97-103.
Famotidine stability in total parenteral nutrient solutions.
Walker SE, Iazetta J, Lau DWC, Madorin PL.
1989
523 Lehti
Am J Hosp Pharm 1987 ; 44: 2740.
Visual compatibility of esmolol hydrochloride and furosemide in 5% dextrose or 0.9% sodium chloride injections.
Thompson DF, Thompson GD.
1987
524 Lehti
Am J Hosp Pharm 1992 ; 49: 1911.
Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
Farquhar Zanetti LA.
1992
525 Lehti
Int J Pharm 1990 ; 65: 49-56.
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
De Vroe C, De Muynck C, Remon JP, Samsom M.
1990
527 Lehti
J Clin Pharm Ther 1987 ; 12: 339-342.
Chemical stability of thiopental sodium injection in disposable plastic syringes.
Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.
1987
529 Lehti
Pharm Weekbl [Sci] 1991 ; 13: 254-256.
Compatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesia.
Van Asten P, Glerum JH, Spaanderman ER, Van Niekerk J, Van Dijk A.
1991
531 Lehti
J Oral Maxillofac Surg 1994 ; 52: 393-396.
Stability of reconstituted methohexital sodium.
Beeman CS, Dembo J, Bogardus A.
1994
532 Lehti
Ann Pharmacotherapy 1996 ; 30: 343-346.
Lorazepam stability in parenteral solutions for continuous intravenous administration.
Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP.
1996
533 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1037-1041.
Stability of cisatracurium besylate in vials, syringes and infusion admixtures.
Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL.
1998
539 Lehti
Drug Intell Clin Pharm 1988 ; 22: 592-593.
Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection.
Baptista RJ, Mitrano FP.
1988
546 Lehti
Ann Pharmacotherapy 1994 ; 28: 1018-1019.
Stability of diluted dexamethasone sodium phosphate injection at two temperatures.
Lugo RA, Nahata MC.
1994
549 Lehti
Int J Pharm Compound 1997 ; 1: 121-122.
Compatibility of common respiratory therapy drug combinations.
Owsley HD, Rusho WJ.
1997
550 Lehti
Int J Pharm Compound 1997 ; 1: 132-134.
Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Zhang YP, Trissel LA.
1997
552 Lehti
Int J Pharm Compound 1997 ; 1: 356-358.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Martinez JF, Trissel LA, Gilbert DL.
1997
553 Lehti
Ann Pharmacotherapy 1989 ; 23: 132-135.
Stability of famotidine in minibags refrigerated and/or frozen.
Bullock LS, Fitzgerald JF, Glick MR.
1989
554 Lehti
J Parenter Sci Technol 1991 ; 45: 212-217.
A study of the interaction of selected drugs and plastic syringes.
Speaker TJ, Turco SJ, Nardone DA, Miripol JE.
1991
558 Lehti
Br J Parent Ther 1986 ; july/august : 86-92.
Stability of reconstituted mustine injection BP during storage.
Kirk B.
1986
561 Lehti
Current Ther Res 1976 ; 20: 359-368.
Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II.
Nunning BC, Granatek AP.
1976
563 Lehti
Am J Hosp Pharm 1978 ; 35: 1386-1387.
Stability of frozen solutions of doxycycline hyclate for injection.
Petrick RJ, Wolleben JE, Vargas TA.
1978
565 Lehti
Drug Intell Clin Pharm 1986 ; 20: 960-963.
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
Marble DA, Bosso JA, Townsend RJ.
1986
566 Lehti
Am J Hosp Pharm 1983 ; 40: 91-94.
Compatibility and stability of clindamycin phosphate with intravenous fluids.
Porter WR, Johnson CA, Cohon MS, Gillespie W.
1983
567 Lehti
Can J Hosp Pharm 1989 ; 42: 109-112.
Stability of clindamycin phophate in dextrose and saline solutions.
Das Gupta V, Parasrampuria J, Bethea C, Wright W.
1989
573 Lehti
Drug Intell Clin Pharm 1977 ; 11: 542-548.
Stability of antibiotic admixtures frozen in minibags.
Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL.
1977
574 Lehti
Am J Hosp Pharm 1980 ; 37: 1087-1088.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
1980
575 Lehti
Am J Hosp Pharm 1982 ; 39: 104-108.
Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags.
Holmes CJ, Ausman RK, Kundsin RB, Walter CW.
1982
576 Lehti
Drug Intell Clin Pharm 1980 ; 14: 353-357.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
1980
580 Lehti
Am J Hosp Pharm 1972 ; 29: 687-689.
Stability of frozen solutions of sodium cephalothin and cephaloridine.
Boylan JC, Simmons JL, Winely CL.
1972
581 Lehti
Am J Hosp Pharm 1976 ; 33: 639-641.
Stability of frozen solutions of cefazolin sodium.
Carone SM, Bornstein M, Coleman DL, Thomas PN, Boylan JC.
1976
582 Lehti
Am J Hosp Pharm 1980 ; 37: 211-215.
Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation.
Tomecko GW, Kleinberg ML, Latiolais CL, Proior RB, Pesko LJ, Jones BC.
1980
585 Lehti
J Clin Pharm Ther 1988 ; 13: 199-205.
Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Bethea C, Dela Torre M.
1988
587 Lehti
Am J Hosp Pharm 1983 ; 40: 1024-1025.
Effect of storage temperature and time stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
Smith BR.
1983
589 Lehti
J Pharm Sci 1989 ; 78: 73-77.
Stability of parenteral ceftriaxone disodium solutions in frozen and liquid states: effect of freezing and microwave thawing.
Kedzierewicz F, Finance C, Nicolas A, Dixneuf P, Hoffman M.
1989
591 Lehti
Can J Hosp Pharm 1993 ; 46: 13-16.
Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride.
Knoppert DC, Freeman D, Webb D.
1993
592 Lehti
J Pharm Clin 1989 ; 8: 101-106.
Effects of storage temperature and pH on the stability of cefotaxime in PVC bags.
Barthes D, Fauconneau B, Martin JP, Courtois P.
1989
593 Lehti
J Pharm Sci 1984 ; 73: 565-567.
Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography.
Das Gupta V.
1984
598 Lehti
J Clin Pharm Ther 1989 ; 14: 45-52.
The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states.
Mc Donald C, Sunderland VB, Lau H, Shija R.
1989
600 Lehti
Am J IV Ther Clin Nut 1984 ; 11: 14-15, 18-19.
Stability of piperacillin sodium in dextrose 5% and sodium chloride 0.9% injections.
Das Gupta V, Davis DD, Stewart KR.
1984
604 Laboratorio
Baxter 1998
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
1998
605 Lehti
Am J Hosp Pharm 1982 ; 39: 292-294.
Stability of haloperidol in 5% dextrose injection.
Das Gupta V, Stewart KR.
1982
612 Lehti
Am J Hosp Pharm 1982 ; 39: 622-627.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Frable RA, Klink PR, Engel GL, Mundell EE.
1982
616 Lehti
Am J Hosp Pharm 1982 ; 39: 841-843.
Compatibility of nalbuphine hydrochloride with other preoperative medications.
Jump WG, Plaza VM, Poremba A.
1982
617 Lehti
Am J Hosp Pharm 1982 ; 39: 843-844.
Compatibility of haloperidol lactate and heparin sodium.
Solomon DA, Nasinnyk KK.
1982
618 Lehti
Am J Hosp Pharm 1982 ; 39: 844-846.
Stability of digoxin in common large-volume injections.
Shank WA, Coupal JJ.
1982
619 Lehti
Am J Hosp Pharm 1982 ; 39: 1013-1015.
Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives.
Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ.
1982
621 Lehti
Am J Hosp Pharm 1982 ; 39: 1018-1021.
Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers.
Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER.
1982
626 Lehti
Am J Hosp Pharm 1982 ; 39: 1495-1498.
Moxalactam disodium compatibility with intramuscular and intravenous diluents.
Bornstein M, Lo AY, Thomas PN, Wilham WL.
1982
628 Lehti
Am J Hosp Pharm 1982 ; 39: 1923-1925.
Stability of dobutamine hydrochloride in selected large-volume parenterals.
Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ.
1982
630 Lehti
J Clin Hosp Pharm 1985 ; 10: 67-72.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
Das Gupta V, Stewart KR.
1985
631 Lehti
J Parenter Sci Technol 1985 ; 39: 145-148.
Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
Das Gupta V, Stewart KR.
1985
632 Lehti
J Parenter Sci Technol 1985 ; 39: 220-222.
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM.
1985
633 Lehti
J Clin Hosp Pharm 1985 ; 10: 351-360.
The stability of sodium nitroprusside infusion during administration by motorized syringe-pump.
Sewell GJ, Forbes DR, Munton TJ.
1985
636 Lehti
J Clin Hosp Pharm 1986 ; 11: 47-54.
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
Das Gupta V, Stewart KR.
1986
639 Lehti
Drug Intell Clin Pharm 1987 ; 21: 806-810.
Compatibility and stability of clindamycin phosphate - aminoglycoside combinations within polypropylene syringes.
Zbrozek AS, Marble DA, Bosso JA, Bair JN, Townsend RJ.
1987
640 Lehti
Can J Hosp Pharm 1987 ; 40: 161-166.
Stability of reconstituted ceftriaxone in dextrose and saline solutions.
Walker SE, Dranitsaris G.
1987
642 Lehti
Hosp Pharm 1988 ; 23: 44,49, 59.
Norepinephrine stability in saline solutions.
Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
1988
643 Lehti
Cancer Treat Rep 1987 ; 71: 1189-1192.
In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.
1987
644 Lehti
Drug Intell Clin Pharm 1988 ; 22: 54-57.
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Marble DA, Bosso JA, Townsend RJ.
1988
645 Lehti
J Clin Pharm Ther 1987 ; 12: 427-432.
The stability of carboplatin in ambulatory continuous infusion regimes.
Sewell GJ, Riley CM, Rowland CG.
1987
646 Lehti
J Clin Pharm Ther 1999 ; 24: 365-368.
Stability of methacholine chloride in isotonic sodium chloride using a capillary electrophoresis assay.
Henn S, Monfort P, Vigneron JH, Hoffman MA, Hoffman M.
1999
647 Lehti
Int J Pharm Compound 1997 ; 1: 347-348.
Chemical stability of amiodarone hydrochloride in intravenous fluids.
Pramar YV.
1997
648 Lehti
Int J Pharm Compound 1997 ; 1: 282-283.
Stability of mitomycin aqueous solution when stored in tuberculin syringes.
Das Gupta V.
1997
649 Lehti
Int J Pharm Compound 1997 ; 1: 280-281.
Stability of ceftriaxone sodium when mixed with metronidazole injection.
Das Gupta V.
1997
650 Lehti
Int J Pharm Compound 1997 ; 1: 274-277.
Development of clonidine hydrochloride injections for epidural and intrathecal administration.
Trissel LA, Hassenbusch SJ.
1997
652 Lehti
Int J Pharm Compound 1997 ; 1: 208-209.
Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey R.E, County H.
1997
653 Lehti
Int J Pharm Compound 1997 ; 1: 125-127.
Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture.
Das Gupta V.
1997
654 Lehti
Int J Pharm Compound 1997 ; 1: 123-124.
Stability of vancomycin hydrochloride in Medication Cassette* reservoirs.
Allen LV.
1997
656 Lehti
J Clin Pharm Ther 1996 ; 21: 185-189.
Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.
1996
657 Lehti
J Clin Pharm Ther 1996 ; 21: 173-175.
Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes.
Pramar YV, Loucas VA, Word D.
1996
658 Lehti
J Oncol Pharm Practice 1996 ; 2: 101-105.
Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Xu QA, Zhang YP, Trissel LA, Martinez JF.
1996
659 Lehti
Can J Hosp Pharm 1996 ; 49: 62-65.
Epinephrine stability in plastic syringes and glass vials.
Donnely RF, Yen M.
1996
660 Lehti
Ann Pharmacotherapy 1996 ; 30: 228-232.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Michaels MR, Stauffer GL, Haas DP.
1996
665 Lehti
Int J Pharm Compound 2005 ; 9, 4: 323-326.
Stability of Nebulizer Admixtures.
Blondino, FE, Baker M.
2005
666 Lehti
J Clin Pharm Ther 1994 ; 19: 261-262.
Stability of ciprofloxacin in 5% dextrose and normal saline injections.
Mathew M, Das Gupta V, Zerai T.
1994
667 Lehti
J Clin Pharm Ther 1994 ; 19: 195-198.
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
Pramar YV, Moniz D, Hobbs D.
1994
668 Lehti
Medicine 2015 ; 94(6):e432.
Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use.
Chen, Fu-Chao; Shi, Xiao-Ya; Li, Peng; Yang, Jin-Guo; Zhou, Ben-Hong.
2015
669 Lehti
Ann Pharmacotherapy 1994 ; 28: 35-36.
Paclitaxel stability and compatibility in polyolefin containers.
Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS.
1994
671 Lehti
J Parenter Sci Technol 1993 ; 47: 135-137.
Stability of cefazolin sodium and metronidazole at 8°C for use as an IV admixture.
Rivers TE, McBride HA, Trang JM.
1993
673 Lehti
JPEN 1989 ; 13: 505-509.
The stability of amikacin, gentamicin, and tobramycin in total nutrient admixtures.
Bullock L, Clark JH, Fitzgerald JF, Glick MR, Hancock BG, Baenziger JC, Black CD.
1989
674 Lehti
Can J Hosp Pharm 1992 ; 45: 237-242.
Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions.
Walker SE, Paton TW, Oreopoulos DG.
1992
675 Lehti
Pharm Weekbl [Sci] 1992 ; 14: 196-200.
Stability of sufentanil citrate in a portable pump reservoir, a glass container and a polyethylene container.
Roos PJ, Glerum JH, Meilink JW.
1992
677 Lehti
Can J Hosp Pharm 2015 ; 68, 4 : 346-348.
Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2015
679 Lehti
Pharm Weekbl [Sci] 1992 ; 14: 23-26.
Stability of morphine hydrochloride in a portable pump reservoir.
Roos PJ, Glerum JH, Meilink JW.
1992
681 Lehti
Can J Hosp Pharm 1991 ; 44: 71-78.
Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker S, Lau D, DeAngelis C, Iazetta J, Coons C.
1991
682 Lehti
Ann Pharmacotherapy 1991 ; 25: 123-126.
Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection.
Raymond GG, Davis RL.
1991
683 Lehti
Can J Hosp Pharm 1990 ; 43: 265-272.
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
1990
684 Lehti
Ann Pharmacotherapy 1990 ; 24: 1056-1058.
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM.
1990
686 Lehti
J Clin Pharm Ther 1990 ; 15: 279-289.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
Wood MJ, Irwin WJ, Scott DK.
1990
687 Lehti
Ann Pharmacotherapy 1990 ; 24: 232-235.
Stability of famotidine in a 3-in-1 total nutrient admixture.
Shea BF, Souney PF.
1990
689 Lehti
Can J Hosp Pharm 1988 ; 41: 105-108.
Stability of ranitidine hydrochloride admixtures refrigerated in polyvinyl chloride minibags.
Walker SE, Kirby K.
1988
690 Lehti
Ann Pharmacotherapy 1989 ; 23: 588-590.
Stability of intravenous famotidine stored in polyvinyl chloride syringes.
Bullock LS, Fitzgerald JF, Mazur HI.
1989
691 Lehti
J Clin Pharm Ther 1989 ; 14: 53-55.
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE.
1989
693 Lehti
J Clin Pharm Ther 1988 ; 13: 329-334.
Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures.
Das Gupta V, Parasrampuria J, Bethea C.
1988
694 Lehti
Can J Hosp Pharm 1988 ; 41: 233-238, 242.
Stability of intravenous vancomycin.
Walker SE, Birkhans B.
1988
695 Lehti
Drug Intell Clin Pharm 1988 ; 22: 873-875.
Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions.
Zbrozek AS, Marble DA, Bosso JA.
1988
697 Lehti
Can J Hosp Pharm 1988 ; 41: 65-71.
Ceftazidime stability in normal saline and dextrose in water.
Walker SE, Dratnitsaris G.
1988
698 Lehti
Ann Pharmacotherapy 1989 ; 23: 466-467.
Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE.
1989
702 Lehti
J Pharm Clin 1998 ; 17: 145-148.
Stability of vancomycin in polyolefine or PVC bags and glass vials.
Biellmann-Berlaud V, Willemin JC.
1998
703 Lehti
Am J Hosp Pharm 1980 ; 37: 935-941.
Effect of inline filtration on the potency of low-dose drugs.
Butler LD, Munson JM, DeLuca PP.
1980
705 Lehti
Am J Hosp Pharm 1981 ; 38: 183-187.
Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin.
Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE.
1981
706 Lehti
Am J Hosp Pharm 1981 ; 38: 231.
Compatibility of verapamil hydrochloride with other additives.
Cutie MR.
1981
707 Lehti
Am J Hosp Pharm 1980 ; 37: 95-98.
Solubility and stability of phenytoin sodium when mixed with intravenous solutions.
Carmichael RR, Mahoney CD, Jeffrey LP.
1980
708 Lehti
Am J Hosp Pharm 1980 ; 37: 201-205.
Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets.
Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG.
1980
709 Lehti
Am J Hosp Pharm 1980 ; 37: 1614-1615.
Stability of tobramycin sulfate in plastic syringes.
Seitz DJ, Archambault JR, Brinck-Johnsen T.
1980
711 Lehti
Am J Hosp Pharm 1980 ; 37: 492-496.
Avaibility of diazepam from plastic containers.
Cloyd JC, Vezeau C, Miller KW.
1980
712 Lehti
Am J Hosp Pharm 1980 ; 37: 496-500.
Compatibility of diazepam with intravenous fluid containers and administration sets.
Parker WA, MacCara ME.
1980
715 Lehti
Am J Hosp Pharm 1980 ; 37: 677-678.
Stability of carmustine in the presence of sodium bicarbonate.
Colvin M, Hartner J, Summerfield M.
1980
729 Lehti
Am J Hosp Pharm 1977 ; 34: 1071-1074.
Effect of inline filtration on the potency of drugs administered intravenously.
Rusmin S, Welton S, DeLuca P, DeLuca PP.
1977
730 Lehti
Am J Hosp Pharm 1977 ; 34: 939-943.
Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets.
Allen LV, Saul Levinson R, Phisutsinthop D.
1977
731 Lehti
Am J Hosp Pharm 1978 ; 35: 669-672.
Compatibility and stability of diazepam injection following dilution with intravenous fluids.
Morris ME.
1978
732 Lehti
Am J Hosp Pharm 1975 ; 32: 575-578.
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids.
Gardella LA, Zaroslinski JF, Possley LH.
1975
738 Lehti
Am J Hosp Pharm 1978 ; 35: 581-584.
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives.
Gardella LA, Kesler H, Amann A, Carter JE.
1978
739 Lehti
Am J Hosp Pharm 1978 ; 35: 402-406.
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
Cradock JC, Kleinmann LM, Rahman A.
1978
740 Lehti
Am J Hosp Pharm 1979 ; 36: 1536-1538.
Stability of refrigerated and frozen solutions of doxorubicin hydrochloride.
Hoffman DM, Grossano DD, Damin LA, Woodcock TM.
1979
742 Lehti
Am J Hosp Pharm 1979 ; 36: 38-43.
Stability of cisplatin in aqueous solution.
Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF.
1979
743 Lehti
Am J Hosp Pharm 1980 ; 37: 803-808.
Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM.
1980
747 Lehti
Am J Hosp Pharm 1980 ; 37: 390-392.
Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
Rosenberg HA, Dougherty JT, Mayron D, Baldinus JG.
1980
753 Laboratorio
Hospira 2016
Topotecan (Topotecan Hospira®) - Summary of Product Characteristics
2016
754 Laboratorio
Merck Sharp & Dohme 2019
Infliximab (Remicade®) – Summary of Product Characteristics
2019
755 Laboratorio
MSD France 2016
Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
2016
761 Lehti
EJHP 2015 ;22:89-93
Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use.
Zerbit J, Bordenave J, Benoit G.
2015
763 Lehti
Cancer Treat Rep 1985 ; 69: 1325-1326.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
1985
765 Lehti
Am J Health-Syst Pharm 1998 ; 55: 2013-2015.
Stability of lorazepam 1 and 2 mg/ml in glass bottles and polypropylene syringes.
Share MJ, Harrison RD, Folstad J, Fleming RA.
1998
767 Lehti
Ann Pharmacotherapy 1997 ; 31: 789-790.
Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion.
Trinkle R.
1997
779 Lehti
J Pharm Pharmacol 1986 ; 38: 51P.
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
Collins AJ, Abethell JA, Holmes SG, Rain R.
1986
780 Lehti
Ann Pharmacotherapy 1996 ; 30: 1037-1038.
Precipitation of lorazepam infusion.
Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R.
1996
788 Lehti
Lancet 1989 ; 2 (8670): 1044-1045.
Subcutaneous drug compatibility in palliative care.
Regnard CFB, Mannix K.
1989
789 Lehti
Am J Hosp Pharm 1990 ; 47: 604-606.
Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
Garner SS, Wiest DB.
1990
791 Lehti
JPEN 1996 ; 20: 219-220.
Stability of heparin anticoagulant activity over time in parenteral nutrition solutions.
Hensrud DD, Buritt MF, Hall LG.
1996
793 Lehti
J Antimicrob Chemother 1996 ; 37: 1165-1169.
Amphotericin B intralipid formulation: stability and particule size.
Ranch?re JY, Latour JF, Fuhrmann C, Lagallarde C, Loreuil F.
1996
794 Lehti
Anaesthesia 1996 ; 51: 815-818.
The effect of the addition of lignocaine on propofol emulsion stability.
Lilley EMM, Isert PR, Carasso ML, Kennedy RA.
1996
795 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2338-2339.
21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette.
Henderson F.
1996
796 Lehti
PDA J Pharm Sci Technol 1996 ; 50: 158-162.
Photodegradation of furosemide solutions.
Asker AF, Ferdous AJ.
1996
798 Lehti
Ann Pharmacotherapy 1996 ; 30: 1501-1502.
Epoetin alfa loss with NaCl 0.9% dilution.
Widness JA, Schmidt R.
1996
800 Lehti
Ann Pharmacotherapy 1997 ; 31: 553-559.
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
Fischer JH, Cwik MJ, Luer MS, Sibley CB, Deyo KL.
1997
803 Lehti
Diabetes Care 1997 ; 20: 1061-1065.
Stability of insulin lispro in insulin infusion systems.
Lougheed WD, Weymouth AB, Zinman B, Bernstein EA, Strack TR, Korbas AM, Janis LJ, Frank BH.
1997
805 Lehti
Hosp Pharm 1997 ; 32: 1013-1020.
An automated process for determining the physical compatibility of drugs.
Oskroba DM, Leissing NC, Trissel LA.
1997
811 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Charland SL, Davis DD, Tillman DJ.
1998
813 Lehti
Am J Health-Syst Pharm 1999 ; 56: 63-68.
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions.
Akkermann SR, Zhang H, Mullins RE, Yaughn K.
1999
814 Lehti
Am J Health-Syst Pharm 1999 ; 56: 164-169.
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.
1999
815 Lehti
Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
Stability of ondansetron hydrochloride and 12 medications in plastic syringes.
Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL.
1998
816 Lehti
Am J Health-Syst Pharm 1998 ; 55: 466-470.
Stability of undiluted and diluted adenosine at three temperatures in syringes and bags.
Kektar VA, Kolling WM, Nardviriyakul N, VanDer Kamp K, Wurster DE.
1998
817 Lehti
Am J Health-Syst Pharm 1998 ; 55: 683-685.
Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.
Stendal TL, Klem W, Tonnesen HH, Kjonniksen I.
1998
818 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1042-1043.
Stability of torsemide in 5% dextrose injection.
Montgomery PA, Cornish LA, Johnson CE, Fitzpatrick KA.
1998
820 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1161-1164.
Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution.
Naud C, Marti B, Fernandez C, Astier A, Paul M.
1998
821 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1194,1197.
Visual compatibility of fentanyl citrate with parenteral nutrient solutions.
Moshfeghi M, Ciuffo JD.
1998
822 Lehti
Am J Health-Syst Pharm 1998 ; 55: 574-577.
Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL.
1998
823 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Patel K, Craig SB, McBride MG, Palepu NR.
1998
824 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1602-1605.
Stability of albumin-free interferon alfa-2b for 42 days.
Appenheimer MM, Schepart BS, Poleon GP, Evans SS.
1998
827 Lehti
Drug Intell Clin Pharm 1988 ; 22: 634-636.
Stability of vinblastine sulfate when exposed to light.
Black J, Buechter DD, Thurston DE.
1988
828 Lehti
J Pharm Clin 1990 ; 9: 159-165.
Stability of mitoxantrone (Novantrone*) after dilution in PVC infusions.
Lecompte D, Bousselet M, Magnam J.
1990
829 Lehti
Int J Pharm 1988 ; 42: 41-46.
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Cartwright-Shamoon JM, McElnay JC, D'Arcy PF.
1988
835 Lehti
Int J Pharm 1979 ; 4: 21-26.
Determination of the stability of mitomycin C by high performance liquid chromatography.
Edwards D, Selkirk AB, Taylor RB.
1979
837 Lehti
Acta Pharm Suec 1986 ; 23: 115-124.
Stability of carmustine - kinetics and compatibility during administration.
Fredriksson K, Lundgren P, Landersjo L.
1986
840 Lehti
Can J Hosp Pharm 1986 ; 39: 60-66.
Stability of 5-fluorouracil and flucytosine in parenteral solutions.
Biondi L, Nairn JG.
1986
842 Lehti
J Pharm Clin 1990 ; 9: 155-158.
Stability of 5-fluorouracil to heat and light.
Pinguet F, Favre G, Canal P, Pujol A, Soula G.
1990
844 Lehti
J Pharm Clin 1989 ; 9: 31-35.
Stability of fluorouracil and cytarabine in ethylvinylacetate containers.
Rochard E, Chapelle G, Bouquet S, Barthes D, Courtois PH.
1989
847 Lehti
J Pharm Pharmacol 1980 ; 32: 860-862.
Photolytic degradation of adriamycin.
Tavoloni N, Guarino AM, Berck PD.
1980
850 Lehti
Drug Intell Clin Pharm 1982 ; 16: 765-767.
Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes.
Munson J, Kubiak EJ, Cohon MS.
1982
854 Lehti
J Pharm Pharmacol 1979 ; 31: 853-854.
The stability of melphalan in the presence of chloride ion.
Chang SY, Evans TL, Alberts DS.
1979
855 Lehti
Cancer Chemother Pharmacol 1992 ; 29: 252-255.
Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump.
Hrubisko M, Mc Gown AT, Prendiville JA, Radford JA, Thatcher N, Fox BW.
1992
857 Lehti
Am J Hosp Pharm 1983 ; 40: 1323-1328.
Binding of selected drugs to a “treated” inline filter.
Kanke M, Eubanks JL, DeLuca PP.
1983
859 Lehti
Nor Pharm Acta 1983 ; 45: 61-67.
Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment.
Karlsen J, Thonnesen HH, Olsen IR, Sollien AH, Skobba TJ.
1983
860 Lehti
Am J Hosp Pharm 1987 ; 44: 2028.
Visual incompatibility of dacarbazine and heparin.
Nelson RW, Young R, Lamnin M.
1987
865 Lehti
Int J Pharm Compound 1998 ; 2: 79-81.
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Bhatt-Mehta V, Hirata S.
1998
871 Lehti
Anesth Analg 1998 ; 86: 208-213.
The chemical stability and sterility of sodium thiopental after preparation.
Haws JL, Herman N, Clark Y, Bjoraker R, Jones D.
1998
872 Lehti
Ann Pharmacotherapy 1997 ; 31: 1465-1470.
Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.
1997
873 Lehti
Int J Pharm Compound 1997 ; 1: 435-436.
Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey RE.
1997
874 Lehti
Int J Pharm Compound 1997 ; 1: 433-434.
Stability of two concentrations of heparin sodium prefilled in CADD-Micro pump syringes.
Stiles ML, Allen LV, Mc Laury HJ.
1997
887 Lehti
Ann Pharmacotherapy 1997 ; 31: 992-995.
Stability study of epirubicin in NaCl 0.9% injection.
Pujol M, Munoz M, Prat J, Giona V, De Bolos J.
1997
889 Lehti
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
1991
891 Lehti
Hosp Pharm 1992 ; 27: 200, 202, 209.
Visual compatibility of sargramostim (GM-CSF) during simulated Y-site administration with selected agents.
Matsuura G.
1992
892 Lehti
Am J Hosp Pharm 1992 ; 49: 1156-1164.
Practical guidelines for preparing and administering amphotericin B.
Kintzel PE, Smith GH.
1992
895 Lehti
JPEN 1992 ; 16: 268-274.
Vancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infections.
Yao JDC, Arkin CF, Karchmer AW.
1992
896 Lehti
J Clin Pharm Ther 1992 ; 17: 223-227.
Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers.
Bianchi C, Airaudo CB, Gayte-Sorbier A.
1992
898 Lehti
JPEN 1990 ; 14: 306-309.
Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
Zaccardelli DS, Sanders Kromarik C, Wolk R, Khalidi N.
1990
900 Lehti
Ann Pharmacotherapy 1992 ; 26: 1221-1226.
Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
Pleasants RA, Vaughan LM, Williams DM, Fox JL.
1992
903 Lehti
J Parenter Sci Technol 1993 ; 47: 35-39.
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J.
1993
905 Lehti
Hosp Pharm 1994 ; 29: 1010-1017.
Screening teniposide for Y-site physical incompatibilities.
Trissel LA, Martinez JF.
1994
907 Lehti
J Pharm Technol 1996 ; 12: 58-61.
Stability of tacrolimus injection in total parenteral nutrition solution.
Ku YM, Min DI, Kumar V, Noormohamed SA.
1996
909 Lehti
J Informed Pharmacother 2003 ; 13: 100-110.
Stability of hydrocortisone in extemporaneously compounded suspensions.
Chong G, Decarie D, Ensom M.H.H.
2003
913 Lehti
J Clin Pharm Ther 1995 ; 20: 319-325.
Stability of vancomycin in plastic syringes measured by high-performance liquid chromatography.
Wood MJ, Lund R, Beavan M.
1995
915 Lehti
Ann Pharmacotherapy 1994 ; 28: 712-714.
Stability of ondansetron stored in polypropylene syringes.
Casto DT.
1994
916 Lehti
J Clin Pharm Ther 1993 ; 18: 343-345.
Stability of quinine dihydrochloride in commonly used intravenous solutions.
Lerkiatbundit S.
1993
917 Lehti
EJHP 1994 ; 4: 12-13.
Stability of refrigerated and frozen solutions of ondansetron hydrochloride.
Blaise N, Vigneron J, Perrin A, Noirez V, Hoffman MA, Hoffman M.
1994
918 Lehti
EJHP 1994 ; 4: 17-19.
Stability of ornidazole in PVC bags under various storage conditions.
Rodriguez-Sasiain JM, Prieto M, Errecalde F, Jaio N, Martinez-Bengoechea MJ.
1994
919 Lehti
Anesth Analg 1998 ; 86: 422-426.
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.
1998
920 Lehti
Aust J Hosp Pharm 1997 ; 27: 452-454.
Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes.
Targett PL, Keefe PA, Merridew CG.
1997
921 Lehti
Hosp Pharm 1998 ; 33: 284-292.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1998
922 Lehti
Int J Pharm Compound 1998 ; 2: 168-169.
Stability of milrinone lactate 200 microg /mL in 5% dextrose injection and 0.9% sodium chloride injection.
Wong F, Gill MA.
1998
923 Lehti
Int J Pharm Compound 1998 ; 2: 170-171.
Stability of indomethacin in 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J.
1998
924 Lehti
J Pharm Pharmacol 1998 ; 50: 407-411.
Compatibility of tropisetron with glass and plastics. Stability under different storage conditions.
Brigas F, Sautou-Miranda V, Normand B, Geneve S, Chopineau J.
1998
925 Lehti
Can J Hosp Pharm 1998 ; 51: 55-57.
Compatibility and stability of propafenone hydrochloride with five critical-care medications.
Dupuis LL, Trope A, Giesbrecht E, Wong B.
1998
928 Lehti
Int J Pharm Compound 1998 ; 2: 246-248.
Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL.
Nguyen D, Gill MA, Wong F.
1998
929 Lehti
J Pain Symptom Manage 1998 ; 16: 52-58.
Stability of midazolam and fentanyl in infusion solutions.
Wilson KM, Schneider JJ, Ravenscroft PJ.
1998
930 Lehti
J Clin Pharm Ther 1997 ; 22: 339-345.
Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E.
1997
931 Lehti
J Clin Pharm Ther 1997 ; 22: 353-356.
Long-term stability of vancomycin hydrochloride in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.
1997
932 Lehti
J Clin Pharm Ther 1997 ; 22: 405-410.
Stability of morphine sulphate in saline under simulated patient administration conditions.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E, Ho PC.
1997
934 Lehti
Int J Pharm Compound 1998 ; 2: 318-321.
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.
1998
935 Lehti
Int J Pharm Compound 1998 ; 2: 322-324.
Stability of lorazepam in 5% dextrose injection.
Das Gupta V, Pramar Y.
1998
939 Lehti
Aust J Hosp Pharm 1994 ; 24: 167-170.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Gilbar PJ, Groves CF.
1994
948 Lehti
J Pharm Sci 1994 ; 83: 463-467.
Photodegradation of some quinolones used as antimicrobial therapeutics.
Tiefenbacher EM, Haen E, Przybilla B, Kurz H.
1994
951 Lehti
PDA J Pharm Sci Technol 1998 ; 52: 129-133.
Influence of DL methionine and sodium metasulphite on the photostability of vitamin K1.
Ho PC, Wong VK.
1998
957 Lehti
J Parenter Sci Technol 1990 ; 44: 30-34.
Stability studies of hydralazine in aqueous solutions.
Halasi S, Nairn JG.
1990
958 Lehti
Ann Pharmacotherapy 1990 ; 24: 440-442.
Netilmicin sulfate stability in combinaison with metronidazole or ranitidine hydrochloride in NaCl 0.9% infusion.
Vervloet E, Lammers J, Tan LSL, Van Mourik CH, Rots M.
1990
960 Lehti
Can J Hosp Pharm 1990 ; 43: 57-60.
Stability of aqueous solutions of deferoxamine.
Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N.
1990
961 Lehti
J Clin Pharm Ther 1990 ; 15: 187-196.
Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion.
Barnes AR.
1990
963 Lehti
J Clin Pharm Ther 1990 ; 15: 371-376.
Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Schaaf LJ, Tremel LC, Wulf BG, Vernon KK.
1990
966 Lehti
JPEN 1991 ; 15: 536-539.
In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation.
Martins AM, McDougal A, Hamilton D, Igwemezie L, McErlane K.
1991
969 Lehti
N Engl J Med 1991 ; 325: 1315-1316.
Precipitation of ondansetron in alkaline solutions.
Jarosinski PF, Hirschfeld S.
1991
978 Lehti
Can J Hosp Pharm 1994 ; 47: 147.
Methotrexate and cytarabine for intrathecal administration.
Dick DM, Woloschuk DMM.
1994
979 Lehti
Int Pharm J 1995 ; 9: 57.
In vitro compatibility of granisetron with selected alkaline drugs.
D'Arcy PF.
1995
980 Lehti
Aust J Hosp Pharm 1995 ; 25: 352.
Compatibility of morphine and ketamine for subcutaneous infusion.
Ambados F.
1995
982 Lehti
Ann Pharmacotherapy 1995 ; 29: 1168.
Compatibility of haloperidol and diphenhydramine in a hypodermic syringes.
Ukhun IA.
1995
984 Lehti
Ann Pharmacotherapy 1996 ; 30: 298.
Amphotericin B is incompatible with lipid emulsions.
Ericsson O, Hallmen AC, Wikstrom I.
1996
985 Lehti
Ann Pharmacotherapy 1996 ; 30: 549.
Haloperidol and diphenhydramine compatibility.
Raleigh FR, Gibler BS.
1996
990 Lehti
Ann Pharmacotherapy 1989 ; 23: 1035.
Stability of caffeine injection stored in plastic and glass syringes.
Nahata MC, Zingarelli JR, Hipple TF.
1989
992 Lehti
Ann Pharmacotherapy 1991 ; 25: 869.
Visual compatibility of ondansetron and dexamethasone.
Beijnen JH, Koks CHW.
1991
999 Lehti
JPEN 1985 ; 9: 220-224.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
Watson D.
1985
1009 Lehti
J Pharm Sci 1988 ; 77: 630-634.
Studies on the stability of vinblastine sulfate in aqueous solution.
Black J, Buechter DD, Chinn JW, Gard J, Thurston DE.
1988
1014 Lehti
Clin Pharmacol Ther 1988 ; 43: 183.
Lack of photodegradation but significant adsorption of nifedipine in administration systems.
Larsen JS, Uden DL, Zaske DE.
1988
1020 Lehti
Am J Hosp Pharm 1987 ; 44: 67.
Compatibility of morphine sulfate injection and prochlorperazine injection.
Zuber DEL.
1987
1021 Lehti
J Clin Hosp Pharm 1986 ; 11: 343-348.
Methotrexate in solutions - A stability test for the hospital pharmacy.
Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J.
1986
1022 Lehti
Drug Intell Clin Pharm 1986 ; 20: 886.
Heparin and aminoglycosides instability.
Hutchinson SMW.
1986
1026 Lehti
Am J Health-Syst Pharm 1999 ; 56: 875-881.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Mayron D, Gennaro AR.
1999
1027 Lehti
Am J Hosp Pharm 1984 ; 41: 1807-1811.
Stability of nitroglycerin solutions in polyolefin and glass containers.
Wagenknecht DM, Baaske DM, Alam AS, Carter JE, Shah J.
1984
1028 Lehti
Am J Hosp Pharm 1984 ; 41: 1802-1806.
Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW, Vishnuvajjala BR, Flora KP.
1984
1029 Lehti
Am J Health-Syst Pharm 1999 ; 56: 983-985.
Stability of sumatriptan succinate in polypropylene syringes.
Nii LJ, Chin A, Cao TM, Gill MA.
1999
1033 Lehti
Am J Health-Syst Pharm 1999 ; 56: 985-989.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.
1999
1035 Lehti
J Parenter Sci Technol 1983 ; 37: 129-132.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
Bisaillon S, Sarrazin R.
1983
1036 Lehti
Am J Hosp Pharm 1984 ; 41: 1379-1380.
Visual compatibility of amiodarone hydrochloride injection with other injectable drugs.
Hasegawa GR, Eder JF.
1984
1037 Lehti
J Pharm Sci 1984 ; 73: 838-839.
In vitro stability of sodium nitroprusside solutions for intravenous administration.
Mahony C, Brown JE, Stargel WW, Verghese CP, Bjornsson TD.
1984
1039 Lehti
Am J Hosp Pharm 1984 ; 41: 1156-1159.
Stability of azacitidine in infusion fluids.
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.
1984
1040 Lehti
Am J Hosp Pharm 1984 ; 41: 1153-1156.
Stability of fluorouracil in plastic containers used for continuous infusion at home.
Quebbeman EJ, Hamid AAR, Hoffman NE, Ausman RK.
1984
1041 Lehti
Am J Hosp Pharm 1984 ; 41: 949-951.
Visual compatibility of dobutamine hydrochloride with other injectable drugs.
Hasegawa GR, Eder JF.
1984
1045 Lehti
Am J Hosp Pharm 1984 ; 41: 686-689.
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections.
Das Gupta V, Stewart KR.
1984
1046 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1134.
Stability of cefepime hydrochloride in polypropylene syringes.
Stewart JT, Maddox FC, Warren FW.
1999
1047 Lehti
Am J Hosp Pharm 1984 ; 41: 323-324.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Souney PF, Colucci RD, Mariani G, Campbell D.
1984
1049 Lehti
Am J Hosp Pharm 1984 ; 41: 303-305.
Stability of nitroglycerin in intravenous admixtures.
Klamerus KJ, Ueda CT, Newton DW.
1984
1050 Lehti
Am J Hosp Pharm 1984 ; 41: 300-302.
Shelf life of unrefrigerated succinylcholine chloride injection.
Boehm JJ, Dutton DM, Poust RI.
1984
1055 Lehti
Can J Hosp Pharm 1983 ; 36: 43-52.
Compatibility of antibiotics and other drugs in total parenteral nutrition solutions.
Faragos S.
1983
1057 Lehti
Am J Hosp Pharm 1983 ; 40: 1205-1207.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Cutie MR.
1983
1058 Lehti
Am J Hosp Pharm 1983 ; 40: 1690-1691.
Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ.
1983
1061 Lehti
Am J Health-Syst Pharm 1999 ; 56: 2047-2051.
Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage.
Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM.
1999
1062 Lehti
Int J Pharm 1997 ; 146: 213-223.
The stability of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containers.
Vermeire A, Remon JP.
1997
1064 Lehti
Pharm World Sci 1996 ; 18: 74-77.
Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatement (HIVAT).
Vinks AATMM, Touw DJ, van Rossen RCJM, Heijeiman HGM, Bakker W.
1996
1067 Lehti
EJHP 1999 ; 5: 106-110.
Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers.
Zeidler C, Dettmering D, Schrammel W, Spieteller M.
1999
1068 Lehti
Am J Health-Syst Pharm 1999 ; 56: 457-459.
Stability of cefepime hydrochloride in polypropylene syringes at -20°C, 4°C and 22-24°C.
Stewart JT, Warren FW, Maddox FC.
1999
1069 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1835-1838.
Stability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combination.
Peek BT, Webster KD, Da Camara CC.
1999
1070 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1891.
Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium.
Balthasar JP.
1999
1071 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1627-1629.
Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets.
Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA.
1999
1072 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
1999
1075 Lehti
J Pharm Biomed Anal 1997 ; 16: 199-205.
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
Craig SB, Bhatt UH, Patel K.
1997
1079 Lehti
Am J Hosp Pharm 1985 ; 42: 2651.
Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes.
Stevenson JG, Patriarca C.
1985
1080 Lehti
Am J Hosp Pharm 1985 ; 42: 2652.
Stability of cisplatin admixtures in polyvinyl chloride bags.
La Folette JM, Arbus MH, Lauper RD.
1985
1084 Lehti
Lancet 1988 ; 1(8587): 700.
Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies.
Raupp P, von Kriek R, Schmidt E, Pfahl HG, G?nther O.
1988
1085 Lehti
Radiology 1989 ; 173: 91-92.
Incompatibility of contrast agents with intravascular medications.
Irving HD, Burbridge BE.
1989
1088 Lehti
JAMA 1984 ; 252: 2392.
Drug trapping in intravenous infusion side arms.
Johnston A, McKenzie MA, Krasnow SH, Hood MA, Cohen MH.
1984
1091 Lehti
Anesthesiology 1974 ; 40: 400-404.
Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing.
Petty C, Cunningham NL.
1974
1093 Lehti
Anesthesiology 1984 ; 61: 347-348.
Stability of atracurium administered by infusion.
Fisher DM, Canfell, Miller RD.
1984
1098 Lehti
Ann Intern Med 1983 ; 98: 672.
Verapamil precipitation.
Cutie MR.
1983
1099 Lehti
Ann Intern Med 1984 ; 101: 880.
Precipitation of verapamil in an intravenous line.
Tucker R, Gentile JF.
1984
1100 Lehti
Ann Intern Med 1982 ; 97: 619.
Precipitation of verapamil.
Bar-Or D, Kulig K, Marx JA, Rosen P.
1982
1102 Lehti
Eur J Clin Pharmacol 1981 ; 19: 181-185.
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Cossum PA, Roberts MS.
1981
1103 Lehti
J Pediatr 1988 ; 112: 813-817.
Antibiotic stability in a pediatric parenteral alimentation solution.
Fox AS, Boyer KM, Sweeney HM.
1988
1108 Lehti
Crit Care Med 1983 ; 11: 50-52.
Loss of nitroglycerin to cardiopulmonay bypass apparatus.
Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB.
1983
1109 Lehti
Crit Care Med 1990 ; 18: 858-861.
Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
Horrow JC, Digregorio J, Barbieri EJ, Rupp E.
1990
1113 Lehti
Am J Hosp Pharm 1989 ; 46: 2031-2035.
Nitroglycerin delivery through a polyethylene-lined intravenous administration set.
Tracy TS, Bowman L, Black CD.
1989
1115 Lehti
Am J Hosp Pharm 1980 ; 37: 1050-1052.
Stability of procainamide hydrochloride in dextrose solutions.
Baaske DM, Malick AW, Carter JE.
1980
1116 Lehti
Am J Hosp Pharm 1982 ; 39: 471-474.
Stability of thiamine hydrochloride repackaged in disposable syringes.
Nolly RJ, Stach PE, Latiolais CJ, Sokoloski TD, Nahata MC.
1982
1120 Lehti
Am J Hosp Pharm 1974 ; 31: 72-78.
Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs.
Moorhatch P, Chiou WL.
1974
1121 Lehti
Am J Hosp Pharm 1973 ; 30: 236-239.
Stability of prostaglandins.
Roseman TJ, Sims B, Stehle RG.
1973
1126 Lehti
Am J Hosp Pharm 1983 ; 40: 97-101.
Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags.
Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G.
1983
1135 Lehti
Am J Hosp Pharm 1990 ; 47: 2075-2077.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Baltz JK, Kennedy P, Minor JR, Gallelli J.
1990
1137 Lehti
Am J Hosp Pharm 1990 ; 47: 1745-1746.
Incompatibility of iron dextran and a total nutrient admixture.
Vaughan LM, Small C, Plunkett V.
1990
1147 Lehti
J Pharm Pharmacol 1991 ; 43: 601-604.
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
De Muynck C, Colardyn F, Remon JP.
1991
1148 Lehti
J Pharm Pharmacol 1988 ; 40: 601-604.
The sorption of isosorbide dinitrate to intravenous delivery systems.
De Muynck C, Remon JP, Colardyn F.
1988
1151 Lehti
J Chromatogr 1981 ; 212: 339-346.
High-performance liquid chromatographic determination of sodium nitroprusside.
Baaske DM, Smith MD, Karnatz N, Carter JE.
1981
1153 Lehti
Int J Pharm 1992 ; 80: R7-R9.
The influence of buffering on the stability of erythromycin injection in small-volume infusions.
Allwood MC.
1992
1154 Lehti
Int J Pharm 1990 ; 62: R1-R3.
The stability of erythromycin injection in small-volume infusions.
Allwood MC.
1990
1155 Lehti
Int J Pharm 1988 ; 45: 237-244.
Stability of methotrexate injection in prefilled plastic disposable syringes.
Wright MP, Newton JM.
1988
1157 Lehti
Int J Pharm 1988 ; 43: 131-138.
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.
1988
1158 Lehti
Int J Pharm 1988 ; 47: 239-247.
Stability of methotrexate and vinblastine in burette administration sets.
McElnay JC, Elliott DS, Cartwright-Shamoon J, D?Arcy PF.
1988
1160 Lehti
Int J Pharm 1986 ; 32: 123-131.
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM.
1986
1161 Lehti
Int J Pharm 1987 ; 39: 183-188.
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Allwood MC.
1987
1165 Lehti
Int J Pharm 1980 ; 4: 263-265.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
1980
1166 Lehti
Int J Pharm 1980 ; 6: 63-76.
Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic.
Sokoloski TD, Wu CC, Burkman AM.
1980
1167 Lehti
Antimicrob Agents Chemother 1987 ; 31: 610-611.
Instability of vancomycin in infusaid drug pump model 100.
Grennberg RN, Saeed AM, Kennedy DJ, McMillian R.
1987
1168 Lehti
Antimicrob Agents Chemother 1983 ; 23: 653-657.
Tobramycin inactivation by carbenicillin, ticarcillin and piperacillin.
Konishi H, Goto M, Nakamoto Y, Yamamoto I, Yamashina H.
1983
1169 Lehti
Am J Hosp Pharm 1981 ; 38: 358-362.
Phenytoin sodium solubility in three intravenous solutions.
Pfeifle CE, Adler DS, Gannaway WL.
1981
1172 Lehti
Am J Hosp Pharm 1981 ; 38: 377-378.
Compatibility of amphotericin B with certain large-volume parenterals.
Jurgens RW, DeLuca PP, Papadimitriou D.
1981
1173 Lehti
Am J Hosp Pharm 1981 ; 38: 1308-1314.
Interactions between drugs and polyvinyl chloride infusion bags.
Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.
1981
1175 Lehti
Am J Hosp Pharm 1981 ; 38: 995-997.
Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets.
Hirsch JI, Wood JH, Thomas RB.
1981
1178 Lehti
Am J Hosp Pharm 1981 ; 38: 1914-1918.
Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.
1981
1182 Lehti
Am J Hosp Pharm 1981 ; 38: 1449-1454.
Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL.
1981
1183 Lehti
Am J Hosp Pharm 1981 ; 38: 1001-1004.
Stability of diluted heparin sodium stored in plastic syringes.
Tunbridge LJ, Lloyd JV, Penhall RK, Wise AL, Maloney T.
1981
1187 Lehti
Am J Hosp Pharm 1983 ; 40: 94-97.
Droperidol stability in intravenous admixtures.
Ray JB, Newton DW, Nye MT, Leet WA.
1983
1188 Lehti
Am J Hosp Pharm 1983 ; 40: 428-432.
Stability of aminophylline injection in three parenteral nutrient solutions.
Niemiec PW, Venderveen TW, Hohenwarter MW, Gadsden RH.
1983
1189 Lehti
Am J Hosp Pharm 1983 ; 40: 1692-1693.
Uptake of clonazepam by plastic intravenous infusion bags and administration sets.
Nation RL, Hackett LP, Dusci LJ.
1983
1193 Lehti
Am J Hosp Pharm 1983 ; 40: 1010-1012.
Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
Perentesis GP, Plitz GW, Kirschenbaum HL, Navalakha P, Aronoff W, Cutie AJ.
1983
1194 Lehti
Am J Hosp Pharm 1983 ; 40: 1007-1009.
Compatibility and stability of labetolol hydrochloride in commonly used intravenous solutions.
Yuen PHC, Taddei CR, Wyka BE, Chaudry IA.
1983
1197 Lehti
Am J Hosp Pharm 1982 ; 39: 1681-1684.
Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.
Deans KW, Lang JR, Smith DE.
1982
1198 Lehti
Am J Hosp Pharm 1982 ; 39: 1685-1687.
Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
Cummings DS, Park MK, Howard B.
1982
1199 Lehti
Am J Hosp Pharm 1982 ; 1687-1690.
Stability of diazepam injection repackaged in glass unit-dose syringes.
Smith FM, Nuessle NO.
1982
1200 Lehti
Am J Hosp Pharm 1981 ; 38: 1737-1742.
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.
1981
1201 Lehti
Am J Hosp Pharm 1981 ; 38: 1919-1922.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
1981
1202 Lehti
Am J Hosp Pharm 1981 ; 38: 1745-1747.
Stability of lidocaine hydrochloride in 5% dextrose injection in plastic bags.
Smith FM, Nuessle NO.
1981
1203 Lehti
Am J Hosp Pharm 1981 ; 38: 1173-1174.
Cimetidine hydrochloride compatibility with preoperative medications.
Yuhas EM, Lofton FT, Baldinus JG, Mayron D.
1981
1206 Lehti
Am J Hosp Pharm 1983 ; 40: 564.
Cefoperazone-aminoglycoside incompatibility.
Frear RS.
1983
1221 Lehti
Am J Hosp Pharm 1980 ; 37: 460,464.
Visual compatibility of dobutamine with seven parenteral drug products.
Dahlin PA, Paredes SM.
1980
1223 Lehti
Am J Hosp Pharm 1980 ; 37: 618.
Plastic IV container for nitroglycerin.
Amann AH, Baaske DM, Wagenknecht DM.
1980
1228 Lehti
Am J Hosp Pharm 1981 ; 38: 380-381.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Allen LV, Stiles ML.
1981
1229 Lehti
Br J Pharm Pract 1990 ; 12: 53-54, 60.
Chemical stability of cytarabine and vinblastine injections.
Weir PJ, Ireland DS.
1990
1230 Lehti
Br J Pharm Pract 1986 ; 8: 218-220.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Regnard C, Pashley S, Westrope F.
1986
1232 Lehti
Br J Pharm Pract 1987 ; 9: 223-226, 236.
A physical compatibility study of furosemide & flucloxacillin injections.
Beatson C, Taylor A.
1987
1233 Lehti
Br J Pharm Pract 1990 ; 12: 328, 330, 334.
The stability of reconstituted aztreonam.
McLaughlin JP, Simpson C.
1990
1234 Lehti
Br J Pharm Pract 1989 ; 11: 34-36.
Stability of low-dosage heparin in pre-filled syringes.
Parkinson R, Wilson JV, Ross M, Denyer SP.
1989
1235 Lehti
Br J Pharm Pract 1988 ; 10: 22-23.
Pentamidine infusion stability.
Leigh PH, Buddle GC.
1988
1236 Lehti
Am J Hosp Pharm 1986 ; 43: 1241-1242.
Stability of netilmicin sulfate in admixtures with calcium gluconate and aminophylline.
Kuhn RJ, Nahata MC.
1986
1237 Lehti
Pharm Weekbl [Sci] 1986 ; 8: 194-197.
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation.
Keusters L, Stolk LML, Umans R, Van Asten P.
1986
1239 Lehti
Pharm Weekbl [Sci] 1986 ; 8: 286-288.
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans .
1986
1241 Lehti
Can J Hosp Pharm 1985 ; 38: 162-163.
The stability of penicillin G sodium in 5% dextrose in water minibags after freezing.
Rayani S, Jamali F.
1985
1242 Lehti
Pharm Weekbl [Sci] 1988 ; 10: 213-216.
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH.
1988
1243 Lehti
Can J Hosp Pharm 1989 ; 42: 143-146.
The use of stability-indicating assays to determine the in vitro compatibility and stability of metronidazole / gentamicin admixtures.
Rovers JP, Meneilly G, Souny PF, Rekhi GS, Drum D.
1989
1245 Lehti
JPEN 1989 ; 13: 539-543.
Insulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusion.
Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Sofo L, Migliore A, Manna R, Crucitti F.
1989
1246 Lehti
Pharm Weekbl [Sci] 1990 ; 12: 188-189.
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Hooymans PM, Janknegt R, Lohman JJHM.
1990
1248 Lehti
Am J Hosp Pharm 1985 ; 42: 590-592.
Stability of ranitidine hydrochloride in total parenteral nutrient solution.
Walker SE, Bayliff CD.
1985
1249 Lehti
Am J Hosp Pharm 1985 ; 42: 595-597.
Stability of dopamine hydrochloride exposed to blue-light phototherapy.
Dandurand KR, Stennett DJ.
1985
1258 Lehti
Am J Hosp Pharm 1981 ; 38: 537-540.
Effect of gentamicin on heparin activity.
Tyler LS, Rehder TL, Davis RB.
1981
1259 Lehti
Am J Hosp Pharm 1981 ; 38: 900-901.
Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection.
Jhunjhunwala VP, Bhalla HL.
1981
1260 Lehti
Am J Hosp Pharm 1981 ; 38: 871-875.
Compatibility of azathioprime sodium with intravenous fluids.
Johnson CA, Porter WA.
1981
1263 Lehti
Int J Pharm Pract 1992 ; 1: 242-244.
The effect of buffering on the stability of reconstituted benzylpenicillin injection.
Allwood MC, Brown PW.
1992
1264 Lehti
Ann Pharm Fr 1997 ; 55: 216-223.
Study of Lavoisier morphine chlorhydrate in different active perfusion systems after reconstitution in different solvents.
Truelle-Hugon B, Tourette G, Couineaux B, Gache-Charrette C.
1997
1265 Lehti
J Clin Pharm Ther 1990 ; 15: 291-300.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
Wood MJ, Irwin WJ, Scott DK.
1990
1269 Lehti
J Clin Pharm Ther 1988 ; 13: 335-340.
Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units.
DeMuynck C, De Vroe C, Remon JP, Colardyn F.
1988
1270 Lehti
J Pharm Belg 1980 ; 35: 389-393.
IV infusion of glyceryl trinitrate. Study of the sorption on various plastic containers.
Mathot F, Bonnard J, Han P, Bosly J.
1980
1271 Lehti
J Pharm Belg 1982 ; 37: 153-156.
Reliable continuous IV perfusion system for diazepam.
Mathot F, Bonnard J, Paris P, Bosly J.
1982
1274 Lehti
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J.
1997
1275 Lehti
Can J Hosp Pharm 1998 ; 51: 156-168.
Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride.
Walker SE, Varrin S, Yannicelli D, Law S.
1998
1276 Lehti
Can J Hosp Pharm 1998 ; 51: 110-116.
Stability and compatibility of morphine with bupivacaine.
Shiffman E, Walker SE, Yoon T, Yeung M.
1998
1277 Lehti
Can J Hosp Pharm 1999 ; 52: 150-155.
Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes.
Donnelly RF.
1999
1278 Lehti
Can J Hosp Pharm 1998 ; 51: 13-19.
Concentration and solution dependent stability of cloxacillin intravenous solutions.
Walker SE, Dufour A, Iazetta J.
1998
1284 Lehti
Photochem Photobiol 1981 ; 34: 131-134.
Photoinactivation of anthracyclines.
Williams BA, Tritton TR.
1981
1286 Lehti
Ann Pharmacotherapy 1998 ; 32: 1013-1016.
Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA, Xu QA, Gilbert DL.
1998
1287 Lehti
Pharm Ind 1991 ; 53: 90-94.
Stability study of reconstituted and diluted solutions of calcium folinate.
Lecompte D, Bousselet M, Gayrard D, Poitou P.
1991
1288 Lehti
Int J Pharm Pract 1994 ; 3: 57-59.
Stability of injections containing diamorphine and midazolam in plastic syringes.
Allwood MC, Brown PW, Lee M.
1994
1289 Lehti
Pharmakon 1998 ; 116: 145-148.
Etude de stabilité visuelle du chlorhydrate de chlorpromazine, du chlorure de potassium, de la furosémide et de l’héparine sodique en perfusion continue.
Hecq JD, Evrard JM, Gillet P, Grosdent N.
1998
1290 Lehti
Ann Pharmacotherapy 1999 ; 33: 906-909.
Stability of cefepime in peritoneal dialysis solution.
Williamson JC, Volles DF, Lynch PLM, Rogers PD, Haverstick DM.
1999
1291 Lehti
Int J Pharm Pract 1995 ; 3: 253-255.
Long term stability of heparin in dextrose-saline intravenous fluids.
Wright A, Hecker J.
1995
1292 Lehti
Int J Pharm Pract 1995 ; 3: 174-177.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Grassby PF, Roberts DE.
1995
1300 Lehti
Hosp Pharm Pract 1992 ; 2: 285-289.
The stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime and ceftazidime.
Ahmed ST, Parkinson R.
1992
1301 Lehti
Hosp Pharm Pract 1992 ; 2: 59-62.
The stability of reconstituted diethanolamine fusidate in a 5% dextrose infusion.
McLaughlin JP, Simpson C.
1992
1302 Lehti
Drug Intell Clin Pharm 1988 ; 22: 173-174.
Cyclosporine binding to components in medication administration sets.
Parr MD, Barton SD, Haver VM, Porter WH.
1988
1315 Lehti
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297.
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
Halpern NA, Colucci RD, Alicea M, Greenstein R.
1989
1316 Lehti
Pharm J 1987 ; 239: 599-601.
Sodium nitroprusside stability in light-protective administration sets.
Davidson SW, Lyall D.
1987
1317 Lehti
Pharm J 1987 ; 238: 476-478.
Pharmaceutical aspects of home infusion therapy for cancer patients.
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.
1987
1318 Lehti
Pharm J 1987 ; 238: 116-118.
Stability and administration of intravenous Augmentin.
Ashwin J, Lynn B, Taskis CB.
1987
1322 Lehti
JPEN 1983 ; 7: 156-158.
In vitro study of inline filtration of medications commonly administered to pediatric cancer patients.
Ennis CE, Merritt RJ, Neff DN.
1983
1325 Lehti
JPEN 1982 ; 6: 163-165.
Compatibility of 5-fluorouracil and total nutrition solutions.
Hardin TC, Clibon U, Page CP, Cruz AB.
1982
1326 Lehti
Am J Roentgenol 1986 ; 146: 1300-1301.
Incompatibility of Hexabrix and papaverine.
Pilla TJ, Beshany SE, Shields JB.
1986
1329 Lehti
Br J Parent Ther 1986 ; march/april: 42-44.
Freeze-thaw stability of antibiotics used in an IV additive service.
Brown AF, Harvey DA, Hoddinott DJ, Britton.
1986
1331 Lehti
J Clin Hosp Pharm 1986 ; 11 : 449-452.
Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.
Das Gupta V, Steward KR.
1986
1332 Lehti
J Clin Hosp Pharm 1981 ; 6: 209-211.
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
Lee MG, Fenton-May V.
1981
1333 Lehti
J Clin Hosp Pharm 1982 ; 7: 245-250.
The stability of amoxycillin sodium in intravenous infusion fluids.
Cook B, Hill SA, Lynn B.
1982
1338 Lehti
Am J Hosp Pharm 1985 ; 42: 777-778.
Compatibility of total nutrient admixtures and secondary cardiovascular medications.
Baptista RJ, Dumas GJ, Bistrian BR, Condella F, Blackburn GL.
1985
1341 Lehti
Pharm J 1983 ; 230: 495-497.
Stability of an intrathecal morphine injection formulation.
Deeks T, Davis S, Nash S.
1983
1346 Lehti
Am J Hosp Pharm 1981 ; 38: 881-883.
Stability and sterility of cimetidine admixtures frozen in minibags.
Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE.
1981
1349 Lehti
Aust J Hosp Pharm 1987 ; 17: 31-34.
Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags.
Sanburg AL, LyndonRC, Sunderland B.
1987
1351 Lehti
Am J Hosp Pharm 1984 ; 41: 2588.
Precipitation of verapamil with nafcillin.
Tucker R, Gentle JF.
1984
1352 Lehti
Am J Hosp Pharm 1984 ; 41: 2588-2589.
Dobutamine-heparin mixture inadvisable.
Hasegawa GR, Eder JF.
1984
1353 Lehti
Am J Hosp Pharm 1984 ; 41: 1835-1837.
Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
Nix DE, Tharpe WN, Francisco GE.
1984
1357 Lehti
Ann Pharmacotherapy 1989 ; 23: 91-92.
Quinolones and penicillins incompatibility.
Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.
1989
1359 Lehti
Am J Hosp Pharm 1985 ; 42: 2420-2421.
Interaction between vancomycin and ticarcillin.
Perest M, Allison J.
1985
1366 Lehti
Am J Hosp Pharm 1981 ; 38: 462,464.
Nafcillin sodium incompatibility with acidic solutions.
Jeglum EL, Winter E, Kotos M.
1981
1371 Lehti
Am J Hosp Pharm 1985 ; 42: 2436.
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Bornstein M, Templeton RJ.
1985
1372 Lehti
Int J Pharm Compound 2007 ; 11, 1: 79-81.
Chemical Stability of Desonide in Ear Drops.
Gupta,VD.
2007
1379 Lehti
Aust J Hosp Pharm 1986 ; 16: 55-56.
Stability and light sensitivity of sodium nitroprusside infusions.
Saunders A.
1986
1380 Lehti
Am J Hosp Pharm 1984 ; 41: 74.
Identification of labetolol precipitate.
Alam AS.
1984
1383 Lehti
J Pharm Pharmacol 1978 ; 30: 47P.
Photodegradation of solutions of the antitumour drug DTIC.
Stevens MFG, Peatey L.
1978
1385 Lehti
Pharm J 1985 ; 235: 171.
Diamorphine injection BP incompatibility.
Kirk B, Hain WR.
1985
1386 Lehti
Pharm J 1983 ; 231- 233.
Antibiotic interactions.
Gove L.
1983
1388 Lehti
Pharm J 1982 ; 228: 238-239.
Diamorphine hydrochloride compatibility with saline.
Page J, Hudson S.
1982
1391 Lehti
Can J Hosp Pharm 1998 ; 51: 271-272.
Is heparin always compatible with TPN and fat emulsion admixtures?
Vanstone GL.
1998
1392 Lehti
Can J Hosp Pharm 1999 ; 52: 90.
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donnelly RF.
1999
1393 Lehti
Pharm J 1987 ; 238: 290.
Ciprofloxacin lactate infusion.
Lyall D, Blythe J.
1987
1394 Lehti
Thromb Haemost 1981 ; 45: 296.
Urokinase therapy: dose reduction by administration in plastic material.
Zimmermann R, Sch?ffel G, Harenberg J.
1981
1395 Lehti
Thromb Haemost 1980 ; 43: 67.
Glass adsorption of highly purified urokinase.
Toki N, Sumi H.
1980
1396 Lehti
J Clin Oncol 1993 ; 11: 197.
Ondansetron compatible with sodium acetate.
Hauser AR, Trissel LA, Martinez JF.
1993
1397 Lehti
Pharm J 1990 ; 244: 218.
Dopamine dilutions.
Garner ST, Murdoch JM.
1990
1399 Lehti
Pharm J 1987 ; 238: 577.
Incompatibility of ceftazidime and vancomycin.
Cairns CJ, Robertson J.
1987
1405 Lehti
J Clin Pharm Ther 1998 ; 23: 67-72.
Compatibility and stability of fentanyl admixtures in polypropylene syringes.
Peterson GM, Miller KA, Galloway JG, Dunne PF.
1998
1407 Lehti
Hosp Pharm 1998 ; 33: 1203-1207.
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Xu QA, Trissel LA, Gilbert DL.
1998
1408 Lehti
J Oncol Pharm Practice 1998 ; 4: 143-149.
Stability of three cytotoxic drugs infusions in the Graseby 9000 ambulatory infusion pump.
Priston MJ, Sewell GJ.
1998
1410 Lehti
J Am Pharm Assoc 1999 ; 39: 141-145.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Simmons M.
1999
1411 Lehti
J Am Pharm Assoc 1999 ; 39: 146-150.
Physical and chemical stability of etoposide phosphate solutions.
Zhang Y, Trissel LA.
1999
1412 Lehti
Int J Pharm Compound 1999 ; 3: 64-66.
Y-site stability of fosphenytoin and sodium phenobarbital.
Brett A, Riggs RM, Webster AA, Benner KW.
1999
1413 Lehti
Int J Pharm Compound 1999 ; 3: 67-68.
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA.
1999
1414 Lehti
J Pharm Technol 1999 ; 15: 13-17.
Stability of low-dose vancomycin hydrochloride in heparin sodium 100 UI / ml.
Mayer JLR, Pascale VJ, Clyne LP, Malkus H, Santos FS, van Hoff J.
1999
1415 Lehti
JPEN 1999 ; 23: 67-74.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
1999
1416 Lehti
Am J Health-Syst Pharm 1999 ; 56: 246-248.
Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
Stamatakis MK, Leader G, Tracy TS.
1999
1419 Lehti
Int J Pharm Compound 1999 ; 3: 235-238.
Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride.
Riggs RM, English BA, Webster AA, McGuire JM, Riordan JM.
1999
1420 Lehti
J Clin Pharm Ther 1999 ; 24: 125-132.
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.
1999
1421 Lehti
J Am Pharm Assoc 1999 ; 39: 505-509.
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM.
1999
1422 Lehti
J Am Pharm Assoc 1999 ; 39: 509-513.
Physical and chemical stability of gemcitabine hydrochloride solutions.
Xu QA, Zhang Y, Trissel LA.
1999
1423 Lehti
J Am Pharm Assoc 1999 ; 39: 514-518.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Gilbert DL.
1999
1424 Lehti
Am J Emerg Med 1999 ; 17: 333-337.
Prehospital stability of diazepam and lorazepam.
Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK.
1999
1425 Lehti
J Oncol Pharm Practice 1999 ; 5: 75-82.
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices.
Krämer I, Thiesen J.
1999
1438 Lehti
Am J Hosp Pharm 1984 ; 41: 1840-1841.
Visual compatibility of cimetidine hydrochloride wih common preoperative injectable medications.
Souney PF, Solomon MA, Stancher D.
1984
1452 Lehti
Eur Hosp Pharm 2000 ; 6: 17-23.
Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*.
Muller HJ, Howe K, Frank C, Haker I.
2000
1454 Lehti
Am J Health-Syst Pharm 2000 ; 57: 992-995.
Stability of meropenem in a portable infusion device in a cold pouch.
Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R.
2000
1455 Lehti
J Pharm Clin 1995 ; 14: 178-179.
Etude de la stabilité de deux benzamides antiémétiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une période de 5 mois.
Demoré B, Raffy F, Commun N, Vigneron J, Hoffman MA, Hoffman M.
1995
1461 Lehti
J Pharm Pharmacol 1994 ; 46: 951-955.
Chemical incompatibility between procainamide hydrochloride and glucose following intravenous admixture.
Sianipar A, Parkin JE, Sunderland VB.
1994
1462 Lehti
J Pharm Pharmacol 1989 ; 41: 273-275.
The availability of diltiazem: a study on the sorption by intravenous delivery systems and on the stability of the drug.
De Vroe C, de Muynck C, Remon JP, Scheldewaert R, Colardyn F.
1989
1467 Lehti
Int J Pharm 1995 ; 118: 181-189.
Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Courage P, Sitaram M, Chapman CB.
1995
1468 Lehti
Int J Pharm 1994 ; 107: 111-119.
Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin.
Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.
1994
1469 Lehti
Int J Pharm 1996 ; 128: 283-286.
Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F.
1996
1472 Lehti
Int J Pharm 1994 ; 110: 197-201.
Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags).
Salomies HEM, Heinonen RM, Toppila MAI.
1994
1475 Lehti
J Pharm Biomed Anal 1996 ; 14: 395-399.
Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M.
1996
1477 Lehti
J Pharm Biomed Anal 1996 ; 15: 221-226.
Stability of revex, nalmefene hydrochloride injection, in injectable solutions.
Murthy SS, Brittain HG.
1996
1479 Lehti
Krankenhauspharmazie 1995 ; 1: 9-12.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Digel S.
1995
1481 Lehti
Krankenhauspharmazie 1994 ; 9: 337-340.
Kompatibilität von ofloxacin mit ampicillin.
Messerschmidt W.
1994
1482 Lehti
Krankenhauspharmazie 1992 ; 3: 98-100.
Pharmazeutische kompatibilität der kombination cefotiam und ampicillin.
Messerschmidt W.
1992
1486 Lehti
Hosp Pharm 1987 ; 22: 1131-1132.
Stability of gentamicin diluted in 0.9% sodium chloride injection in glass syringes.
Nahata MC, Hipple TF, Strausbaugh SD.
1987
1490 Lehti
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254.
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Halpern NA, Colucci RD, Alicea M, Greenstein R.
1989
1491 Lehti
Eur Hosp Pharm 1995 ; 1: 12-14.
Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs.
Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP.
1995
1492 Lehti
Can J Hosp Pharm 1995 ; 48: 155-160.
Compatibility of morphine and midazolam or haloperidol in parenteral admixtures.
LeBelle MJ, Savard C, Gagnon A.
1995
1494 Lehti
Hosp Pharm Pract 1993 ; 3: 553-556.
When is flucloxacillin stable ?
McLaughlin JP, Simpson C.
1993
1495 Lehti
Pharm J 1995 ; 254: 153-155.
The stability of morphine sulphate and metoclopramide hydrochloride in various delivery presentations.
Nixon AR, O'Hare MCB, Chisakuta AM.
1995
1496 Lehti
Hosp Pharm 1996 ; 31: 1425-1428.
Screening cladribine for Y-site physical compatibility with selected drugs.
Trissel LA, Martinez JF, Gilbert DL.
1996
1497 Lehti
Can J Hosp Pharm 1993 ; 46: 61-65.
Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine.
Walker SE, Iazetta J, DeAngelis C, Lau DWC.
1993
1498 Lehti
Ann Pharmacotherapy 1996 ; 30: 409-412.
Amphotericin B formulated in a lipid emulsion.
Cleary JD.
1996
1500 Lehti
Ann Pharmacotherapy 1996 ; 30: 87.
Ciprofloxacin-ampicillin sulbactam incompatibility.
Melonakos TK.
1996
1501 Lehti
Int J Pharm 1999 ; 185: 113-121.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
1999
1503 Lehti
Am J Hosp Pharm 1983 ; 40: 1002-1006.
Stability of cimetidine hydrochloride in admixtures after microwave thawing
Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL.
1983
1505 Lehti
Eur Hosp Pharm 1997 3,4: 154-6
Stability of cladribine in either polyethylene containers or polyvinylchloride bags.
Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
1997
1506 Lehti
EJHP 2015 ;22:107-112.
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.
2015
1508 Lehti
EJHP 2015 ;22:123-124.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
2015
1509 Laboratorio
Norgine 2014
Dantrolene sodium (Dantrium®) - Summary of Product Characteristics
2014
1510 Kirja
AHFS Formulary service 2000 Bethesda - 3546 p

2000
1512 Laboratorio
Beacon Pharmaceuticals Ltd 2015
Tirofiban (Aggrastat®) - Summary of Product Characteristics
2015
1513 Laboratorio
Monarch Pharmaceuticals Ireland 2006
Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit
2006
1514 Laboratorio
Novartis Pharmaceuticals UK Ltd 2015
Verteporfin (Visudyne®) – Summary of Product Characteristics
2015
1516 Laboratorio
Mercury Pharmaceuticals Limited 2012
Ropivacaine (Naropeine®) - Summary of Product Characteristics
2012
1517 Laboratorio
Sanofi-Aventis 2015
Rasburicase (Fasturtec®) - Summary of Product Characteristics
2015
1518 Laboratorio
Hospira UK Ltd 2013
Raltitrexed (Tomudex®) - Summary of Product Characteristics
2013
1519 Laboratorio
Merck Sharp Dohme 2015
Caspofungine (Cancidas®) - Summary of Product Characteristics
2015
1520 Laboratorio
B Braun 2001
Etude de stabilité des médicaments en Ecoflac®
2001
1522 Laboratorio
Maco Pharma 2001
Macoflex N®
2001
1600 Lehti
Am J Health-Syst Pharm 2001 ; 58: 1850-1851.
Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days.
Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I.
2001
1601 Lehti
Hosp Pharm 2001 ; 36: 950-954.
Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration.
Godwin DA, Kim NH, Zuniga R.
2001
1602 Lehti
Hosp Pharm 2001 ; 36: 740-745.
The stablity of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injection.
Trissel LA, Zhang Y, Cohen MR.
2001
1603 Lehti
Am J Health-Syst Pharm 2001 ; 58: 1218-1223.
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Bergquist PA, Manas D, Hunke WA, Reed RA.
2001
1604 Lehti
Eur Hosp Pharm 2001 ; 7: 11-14.
Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate.
Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S.
2001
1605 Lehti
Hosp Pharm 2000 ; 35: 1057-1064.
Stability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22-24°C.
Stewart JT, Maddox FC, Warren FW.
2000
1606 Lehti
Am J Health-Syst Pharm 2001 ; 58: 594-598.
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.
2001
1607 Lehti
Hosp Pharm 2000 ; 35: 1192-1196.
Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection.
Trissel LA, Zhang Y, Xu QA.
2000
1608 Lehti
Int J Pharm Compound 2001 ; 5: 397-400.
Assessment of the stability of teicoplanin in intravenous infusions.
Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.
2001
1611 Lehti
Am J Health-Syst Pharm 2001 ; 58: 504-506.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Chalmers JR, Bobek MB, Militello MA.
2001
1613 Lehti
Can J Hosp Pharm 2000 ; 53: 338-345.
Stability and compatibility of etoposide in normal saline.
Lepage R, Walker SE, Godin J.
2000
1614 Lehti
Hosp Pharm 2001 ; 36: 1170-1173.
Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS.
2001
1617 Lehti
Am J Health-Syst Pharm 2002 ; 59: 539-544.
Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT.
2002
1618 Lehti
Am J Health-Syst Pharm 2002 ; 59: 846-848.
Stability of fenoldopam in two infusion solutions.
Trissel LA, Zhang Y, Baker MB.
2002
1620 Lehti
Am J Health-Syst Pharm 2001 ; 58: 1753-1756.
Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration.
Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM.
2001
1622 Lehti
Am J Health-Syst Pharm 2001 ; 58: 238-241.
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.
2001
1624 Lehti
Am J Health-Syst Pharm 2000 ; 57: 760-762.
Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA.
2000
1625 Lehti
Int J Pharm Compound 2001 ; 5: 314-321.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Trissel LA, Saenz C, Williams YW, Ingram D.
2001
1626 Lehti
Int J Pharm Compound 2001 ; 5: 151-152.
Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
1627 Lehti
Int J Pharm Compound 2001 ; 5: 148-150.
Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Das Gupta V.
2001
1628 Lehti
Int J Pharm Compound 2001 ; 5: 482-484.
Stability of pentobarbital sodium after reconstitution in 0.9% sodium chloride injection and repackaging in glass and polypropylene syringes.
Das Gupta V.
2001
1631 Lehti
Int J Pharm Compound 2008 ; 12, 4: 372-374.
Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms
Gupta VD.
2008
1633 Lehti
Can J Hosp Pharm 2002 ; 55: 27-38.
Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions.
Walker SE, Law S.
2002
1634 Lehti
Can J Hosp Pharm 2000 ; 53: 263-269.
Stability of ketorolac tromethamine in IV solutions and waste reduction.
Shi A, Walker SE, Law S.
2000
1635 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1351-1356.
Stability of dacarbazine in amber glass vials and polyvinyl chloride bags.
El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F.
2002
1637 Lehti
Can J Hosp Pharm 2000 ; 53: 24-31.
Concentration-dependant compatibility and stability of dexamethasone and midazolam.
Wong AH, Law S, Walker SE, Bowles SK.
2000
1638 Lehti
Eur Hosp Pharm 1996 ; 2: 47-48.
Stability of reconstituted ceftriaxone solution in polypropylene syringes.
O'Connell C, Sabra K, Scott K.
1996
1639 Lehti
Eur Hosp Pharm 1997 ; 3: 168-171.
Stability of meropenem in elastomeric portable infusion devices.
Krämer I.
1997
1643 Lehti
Hosp Pharm 1994 ; 29: 76.
Haldol-benztropine incompatibility.
Raleigh F, Gibler B.
1994
1645 Lehti
EJHP 2010 ; 16: 42-47.
Evaluation of a diltiazem hydrochloride gel for the treatment of anal fissure.
Pinto JF, Salgado AC, Alves ML, Alves S, Neves C, Falcao F.
2010
1646 Lehti
Anaesthesia 2001 ; 56: 920.
Incompatibility of prochlorperazine and ketoprofen.
Kannan S.
2001
1647 Lehti
Anaesthesia 2001 ; 56: 294.
Physical incompatibility between atracurium and intravenous diclofenac.
Ackland G.
2001
1648 Lehti
Int J Pharm Compound 2002 ; 6: 391-394.
Effect of freezing, long-term storage, and microwave thawing on the stability of cefepime in 5% dextrose infusion polyvinyl chloride bags.
Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti LM.
2002
1649 Lehti
Aust J Hosp Pharm 1997 ; 27: 470.
Ticarcillin-potassium clavulanate and vancomycin incompatibility.
Gilbar P, McAllan Z.
1997
1651 Lehti
J Clin Pharm Ther 2002 ; 27: 205-209.
Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions.
Ars?ne M, Favetta P, Favier B, Bureau J.
2002
1655 Lehti
Pharmacotherapy 1999 ; 19: 484.
Stability of intravenous citalopram hydrochloride in either polyvinyl chloride bags or glass containers for infusion therapy, and compatibility with dipotassium clorazepate admixed.
Gury C, Dolizy I, Aymard N, Sellali Y.
1999
1656 Lehti
Pharmazie 1994 ; 49: 425-427.
Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
Faouzi A, Dine T, Luyckx M, Gressier B, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Cazin JC.
1994
1658 Lehti
J Am Pharm Assoc 2000 ; 40: 520-524.
Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
Zhang Y, Xu QA, Trissel LA, Willimas KY.
2000
1659 Lehti
J Am Pharm Assoc 2000 ; 40: 509-514.
Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA, Trissel LA, Williams KY.
2000
1660 Lehti
Pharm World Sci 1999 ; 21: 137-141.
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Thiesen J, Krämer I.
1999
1661 Lehti
J Oncol Pharm Practice 2002 ; 8: 27-32.
Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use.
Trissel LA, King KM, Zhang Y, Wood AM.
2002
1662 Lehti
J Oncol Pharm Practice 2002 ; 8: 33-37.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
2002
1663 Lehti
EJHP 2002 ; 1: 23-25.
The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection.
Ponton JL, Munoz C, Rey M, Val M.
2002
1664 Lehti
J Clin Pharm Ther 1994 ; 19: 317-325.
Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections.
King AD, Stewart JT, Warren FW.
1994
1665 Lehti
J Clin Pharm Ther 2002 ; 21: 39-45.
Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.
Öster Svedberg K, McKenzie J, Larrivee-Elkins C.
2002
1667 Lehti
Int J Pharm 1996 ; 138: 125-128.
Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion.
Valière C, Arnaud P, Caroff E, Dauphin JF, Clément G, Brion F.
1996
1668 Lehti
Ann Pharmacotherapy 2000 ; 34: 996-1001.
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Zhang Y, Xu QA, Trissel LA, Williams KY.
2000
1669 Lehti
Can J Hosp Pharm 1994 ; 47: 9-14.
The pharmaceutical stability of deferoxamine mesylate.
Hayes DM, Reilly RM, Lee MMC.
1994
1670 Lehti
Pharmazie 1998 ; 53: 112-116.
Compatibility of cefpirome and cephalotin with PVC bags during simulated infusion and storage.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC.
1998
1671 Lehti
Int J Pharm 1996 ; 139: 243-247.
Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC.
1996
1672 Lehti
Anesthesiology 1998 ; 89: 1609.
Incompatibility of propofol emulsion with anesthesic drugs.
Lamontagne C, Brouillette D, Hardy JF.
1998
1673 Lehti
Int J Pharm 1997 ; 154: 185-190.
Stability study of cefepime in different infusion solutions.
Rabouan-Guyon M, Guet AF, Courtois PY, Barthes DMC.
1997
1674 Lehti
Hosp Pharm 1998 ; 33: 1515-1522.
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF.
1998
1675 Lehti
Int J Pharm Compound 2002 ; 6, 2: 155-157.
Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules
Trissel LA, Zhang Y, Xu QA.
2002
1676 Lehti
Int J Pharm 1997 ; 154: 95-102.
Compatibility of granisetron towards glass and plastics and its stability under various storage conditions.
Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J.
1997
1678 Lehti
Int J Pharm 1997 ; 153: 13-24.
Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Sitaram M.
1997
1679 Lehti
Int J Pharm 2001 ; 212: 93-99.
Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F.
2001
1680 Lehti
Int J Pharm Compound 2002 ; 6: 468-470.
Chemical stability of furosemide in minibags and polypropylene syringes.
Donnelly RF.
2002
1682 Lehti
Int J Pharm Compound 2002 ; 6: 475-477.
Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes.
Storms M, Stewart JT, Warren FW.
2002
1685 Lehti
Krankenhauspharmazie 1998 ; 19: 229-234.
Stabilitätsstudie zu metamizol-natrium im PVC-infusionbeutel.
Müller H-J, Berg J.
1998
1688 Lehti
Krankenhauspharmazie 1999 ; 20: 55-58.
Stabilitätsstudie zu alizaprid im PVC-infusionbeutel.
Müller H-J, Frank C.
1999
1690 Lehti
Krankenhauspharmazie 1997 ; 18: 75-79.
Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel.
Müller H-J, Berg J.
1997
1692 Lehti
Krankenhauspharmazie 1998 ; 19: 226-228.
Pharmazeutische kompatibilität von piperacillin mit metronidazol.
Messerschmidt W.
1998
1694 Lehti
Krankenhauspharmazie 1998 ; 19: 553-557.
Stabilitätsstudie zu fosfomycin-dinatrium (Fosfocin° p.i. 5.0) in applikationsfertigen perfusorspritzen.
Stahlmann SA, Frey OR, Kovar K-A.
1998
1696 Lehti
J Pharm Biomed Anal 1999 ; 21: 851-857.
Photodegradation studies on Atenolol by liquid chromatography.
Andrisano V, Gotti R, Leoni A, Cavrini V.
1999
1697 Lehti
Krankenhauspharmazie 2000 ; 21: 615-617.
Stabilitätsuntersuchung von Dipidolor°-zubereitungen.
Witt C, Wolkewitz B, Lorenz C.
2000
1698 Lehti
Krankenhauspharmazie 1997 ; 18: 474-478.
Stabilität von dopaminhydrochlorid (Dopamine Solvay°) in mischungen mit infusionlösungen.
Körner A, Bonnacker I.
1997
1699 Lehti
Krankenhauspharmazie 2000 ; 21: 107-109.
Mischbarkeit von serotonin-antagonisten mit dexamethason und heparin.
Plaas S, Heck C, Kubrich M.
2000
1701 Lehti
Int J Pharm Compound 2002 ; 6: 395-397.
Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Gupta VD.
2002
1703 Lehti
Krankenhauspharmazie 1995 ; 16: 101-103.
Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln.
Schuster F, Bernard R.
1995
1704 Lehti
Int J Pharm Compound 2002 ; 6: 152-154.
Stability of gentamicin sulfate and tobramycin sulfate in autodose infusion system bags.
Xu QA, Trissel LA, Saenz A.
2002
1705 Lehti
Int J Pharm Compound 2002 ; 6: 226-229.
Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Zhang Y, Trissel LA.
2002
1706 Lehti
Int J Pharm Compound 2002 ; 6: 74-76.
Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA.
2002
1707 Lehti
Int J Pharm Compound 2002 ; 6: 70-73.
Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.
Trissel LA, Xu QA, Pham L.
2002
1708 Lehti
Int J Pharm Compound 2002 ; 6: 66-69.
Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.
Xu QA, Trissel LA, Pham L.
2002
1709 Lehti
Int J Pharm Compound 2002 ; 6: 62-65.
Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA.
2002
1711 Lehti
Int J Pharm Compound 2002 ; 6: 234-236.
Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V.
2002
1712 Lehti
Int J Pharm Compound 2002 ; 6: 230-233.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA.
2002
1713 Lehti
Int J Pharm Compound 2002 ; 6: 311-315.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA.
2002
1714 Lehti
Int J Pharm Compound 2002 ; 6: 316-317.
Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-ml tuberculin polypropylene syringes for pediatric use.
Gupta VD.
2002
1715 Lehti
Int J Pharm Compound 2002 ; 6: 388-390.
Stability of lidocaine hydrochloride injection at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW.
2002
1716 Lehti
Int J Pharm Compound 2001 ; 5: 73-75.
Stability of ethacrynate sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
1717 Lehti
Int J Pharm Compound 2001 ; 5: 75-77.
Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2001
1718 Lehti
Int J Pharm Compound 2001 ; 5: 230-231.
Stability of piperacillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V, Ling J.
2001
1720 Lehti
Int J Pharm Compound 2001 ; 5: 394-396.
Stability of ephedrine sulfate at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW.
2001
1721 Lehti
Int J Pharm Compound 2001 ; 5: 69-72.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Trissel LA, Williams KY, Baker MB.
2001
1722 Lehti
EJHP 2002 ; 2: 33-40.
Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions.
Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J.
2002
1723 Lehti
Pharmazie 1998 ; 53: 386-391.
Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Sattler A, Jage J, Krämer I.
1998
1724 Lehti
Can J Hosp Pharm 2001 ; 54: 102-105.
Visual compatibility of various injectable neuroleptic agents with benztropine and lorazepam in polypropylene syringes.
Elbe D, Condé C.
2001
1725 Lehti
Can J Hosp Pharm 2001 ; 54: 112-113.
Compatibility of oxytocin, zidovudine, and penicillin G.
Oliver C, Law S.
2001
1726 Lehti
Can J Hosp Pharm 2002 ; 55: 272-277.
Stability of oxycodone hydrochloride for injection in dextrose and saline solutions.
Turnbull K, Bielech M, Walker SE, Law S.
2002
1727 Lehti
Pharmazie 1999 ; 54: 625-626.
Stability of vinblastine sulphate containing infusions.
Mittner A, Vincze Z, Jemnitz K.
1999
1728 Lehti
Pharmazie 1999 ; 54: 224-225.
Stability of cyclophosphamide containing infusions.
Mittner A, Vincze Z, Jemnitz.
1999
1729 Lehti
Pharmazie 1998 ; 53: 490-492.
Stability of cisplatin containing infusion.
Mittner A, Vincze Z, Jemnitz K.
1998
1730 Lehti
Act Pharm Nord 1991 ; 3: 251.
Chemical compatibility of mitoxantrone and etoposide (VP-16).
Björkman S, Roth B.
1991
1733 Lehti
Pharmazie 1999 ; 54: 542-544.
HPTLC-based stability assay for determination of amiodarone in intravenous admixtures.
Kopelent-Frank H, Schimper A.
1999
1734 Lehti
J Pharm Biomed Anal 1993 ; 11: 723-727.
The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump : an HPLC-dynamic FAB study.
Hadfield JA, McGown AT, Dawson MJ, Thatcher N, Fox BW.
1993
1735 Lehti
J Pharm Biomed Anal 1999 ; 21: 577-583.
Stability of mepiridine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standard.
Harvey SC, Toussaint CP, Coe SE, Watson EE, O?Neil MG, Patrick KS.
1999
1736 Lehti
J Clin Pharm Ther 1999 ; 24: 145-150.
Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
Liu J, Chan Y, Ho PC.
1999
1739 Lehti
Am J Health-Syst Pharm 1990 ; 47: 519.
Incompatibility of cefperazone and promethazine.
Scott SM.
1990
1740 Lehti
Int J Pharm Compound 1998 ; 2, 4: 314-317.
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V.
1998
1741 Lehti
Am J Hosp Pharm 1993 ; 50: 2518-2521.
Precipitation of paclitaxel during infusion by pump.
Pfeifer RW, Hale KN, Cronquist SE, Daniels M.
1993
1744 Lehti
Am J Health-Syst Pharm 1999 ; 56: 384.
Incompatibility of ceftriaxone sodium with lactated Ringer’s injection.
Burkiewicz JS.
1999
1745 Lehti
Am J Health-Syst Pharm 1992 ; 49: 836-838.
Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate.
Thompson DF, Heflin NR.
1992
1746 Lehti
EJHP 2010 ; 16, 30-37.
Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags.
Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C.
2010
1748 Lehti
Int J Pharm Compound 1997 ; 1: 354-355.
Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection.
Wang DP, Wang MT, Wong CY, Lee DKT.
1997
1750 Lehti
Int J Pharm Compound 1998 ; 2: 463-465.
Chemical stability of meperidine hydrochloride in polypropylene syringes.
Donelly RF, Bushfield TL.
1998
1752 Lehti
Int J Pharm Compound 1998 ; 2: 466-468.
Stability of sufentanil in a syringe pump under simulated epidural infusion.
Jäppinen AL, Hokki H, Rasi AS, Naaranlathi TJ.
1998
1753 Lehti
Int J Pharm Compound 1999 ; 3: 412-414.
Stability of dobutamine hydrochloride 4 mg/ml in 5% dextrose injection at 5 and 23°C.
Webster AA, English BA, McGuire JM, Riggs RM, Lander V, Buckle T.
1999
1754 Lehti
Int J Pharm Compound 1999 ; 3: 241-244.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Wolkin AC.
1999
1755 Lehti
Int J Pharm Compound 2003 ; 7: 68-70.
Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW.
2003
1756 Lehti
Int J Pharm Compound 2003 ; 7: 65-67.
Stability of glycopyrrolate injection at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Flynn WW.
2003
1757 Lehti
J Clin Pharm Ther 1998 ; 23: 311-314.
Determination of compatibility and stability of drugs used in palliative care.
Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P.
1998
1758 Lehti
Can J Hosp Pharm 1999 ; 52: 90.
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donelly RF.
1999
1759 Lehti
Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Servais H, Tulkens PM.
2001
1762 Lehti
J Pharm Biomed Anal 1998 ; 18: 373-381.
Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assay.
Dine T, Khalfi F, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC.
1998
1800 Lehti
Am J Health-Syst Pharm 2002 ; 59: 853-855.
Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery.
Voytilla KL, Tyler LS, Rusho WJ.
2002
1801 Lehti
Am J Health-Syst Pharm 2003 ; 60: 1271-1272.
Physical compatibility of vasopressin with medications commonly used in cardiac arrest.
Feddema S, Rusho WJ, Tyler LS, Barker B.
2003
1802 Lehti
Am J Health-Syst Pharm 2003 ; 60: 193-194.
Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
Bell MS, Nolt DH.
2003
1803 Lehti
Am J Health-Syst Pharm 2003 ; 60: 80-85.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
2003
1804 Lehti
Am J Health-Syst Pharm 2003 ; 60: 464-468.
Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks.
Naughton CA, Duppong LM, Forbes KD, Sehgal I.
2003
1805 Lehti
Am J Health-Syst Pharm 2002 ; 59: 2362-2364.
Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution.
Lin YF, Wu CC, Lin SH, Wang DP, Wang CN.
2002
1806 Lehti
Can J Hosp Pharm 2002 ; 55, 5: 307-312.
Chemical stability of dimenhydrinate in minibags and polypropylene syringes.
Donnely RF.
2002
1807 Lehti
Can J Hosp Pharm 2003 ; 56, 2: 87-92.
Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water.
Chan J, Walker SE, Law S.
2003
1809 Lehti
EJHP 2003 ; 3: 34-42.
Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study.
Arrault XL, Rieutord A, Hassan M, Brion F.
2003
1810 Lehti
EJHP 2003 ; 1:1-3.
Stability of morphine sulphate in P.C.A.s.
Lee G, Sabra K, Doyle N, Malley GO.
2003
1811 Lehti
Hosp Pharm 2003 ; 38: 130-134.
Stability of imipenem-cilastatin sodium in autodose infusion system bags.
Trissel LA, Xu QA.
2003
1812 Lehti
Int J Pharm Compound 2000 ; 4, 4: 320-323.
Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution.
Fuhrman LC, Godwin DA, Davis RA.
2000
1813 Lehti
Int J Pharm Compound 2003 ; 7, 4: 310-312.
Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Gupta VD.
2003
1814 Lehti
Int J Pharm Compound 2003 ; 7, 2: 152-154.
Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Gupta VD.
2003
1815 Lehti
Int J Pharm Compound 2003 ; 7, 2: 149-151.
Stability of clindamycin phosphate in autodose infusion system bags.
Xu QA, Trissel LA.
2003
1816 Lehti
Int J Pharm Compound 2003 ; 7, 3: 230-232.
Stability of amikacin sulfate in autodose infusion system bags.
Zhang Y, Trissel LA.
2003
1817 Lehti
J Oncol Pharm Practice 2003 ; 9: 109-112.
Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump®.
Roberts S, Sewell GJ.
2003
1819 Lehti
J Clin Pharm Ther 2002 ; 27: 139-142.
Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution.
Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M.
2002
1820 Lehti
J Clin Pharm Ther 2003 ; 28: 471-474.
Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes.
Braenden JU, Stendal TL, Fagernaes CB.
2003
1822 Lehti
Am J Health-Syst Pharm 2003 ; 60: 1650-1652.
Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate.
Trissel LA, Seanz C.
2003
1823 Lehti
J Clin Pharm Ther 2003 ; 28: 349-353.
Stability of intravesical epirubicin infusion: a sequential temperature study.
Sewell GJ, Rigby-Jones AE, Priston MJ.
2003
1824 Lehti
J Clin Pharm Ther 2003 ; 28: 363-369.
Stability of reconstituted parecoxib for injection with commonly used diluents.
Crane IM, Mulhern MG, Nema S.
2003
1826 Lehti
Ann Pharmacotherapy 2001 ; 35: 1360-1363.
Stability of piperacillin and ticarcillin in autodose infusion system bags.
Zhang Y, Trissel LA.
2001
1827 Lehti
J Parenter Sci Technol 1990 ; 44: 332-335.
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM.
1990
1832 Lehti
Pharmazie 2003 ; 6
Stability of fentanyl/ropivacain preparations for epidural application.
Hartmann M, Knoth H, K?ler W, Meissner W.
2003
1833 Lehti
Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792.
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Menard C, Bourguignon C, Schlatter J, Vermerie N.
2003
1834 Lehti
Ann Pharmacotherapy 2003 ; 37, 6: 804-807.
Stability of cefepime hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA.
2003
1835 Lehti
Eur J Pharm Sci 2003 ; 19, 1: 31-36.
Stability of sufentanil and levobupivacain solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes.
Jäppinen A, Turpeinen M, Kokki H, ,Rasi A, Ojanen T, Pelkonen O, Naaranlahti T.
2003
1840 Lehti
J Am Pharm Assoc 2002 ; 42: 428-431.
Stability of three cephalosporin antibiotics in autodose infusion system bags.
Xu QA, Trissel LA, Saenz CA et al.
2002
1842 Lehti
Arzneimittel Forschung 1995 ; 45: 93-98.
Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump.
Sadjack A, Wintersteiger R.
1995
1845 Lehti
EJHP 2003 ; 6: 106-111.
The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container).
Müller HJ, Haker I.
2003
1847 Lehti
J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241.
Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration.
Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.
2003
1851 Lehti
J Pharm Biomed Anal 2001 ; 25, 3-4: 589-597.
Photostability and phototoxicity studies on diltiazem.
Andrisano V, Hrelia P, Gotti R, Leoni A, Cavrini V.
2001
1855 Lehti
J Pharm Biomed Anal 2000 ; 23: 803-817.
Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.
Carla-Broch S, Esteve-Romero J, Garcia-Alvarez-Coque MC.
2000
1857 Lehti
J Pharm Biomed Anal 1999 ; 20-521-530.
Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach.
Farina A, Porra R, Cotichini V, Doldo A.
1999
1858 Lehti
Pharm Acta Helv 1999 ; 74: 1-9.
Stability of L-asparaginase: an enzyme used in leukemia treatment.
Stecher AL, Morgantetti de Deus P, Polikarpov I, Abrahao-Neto J.
1999
1859 Lehti
Il Farmaco 2002 ; 57: 925-930.
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.
2002
1860 Lehti
Int J Pharm 1996 ; 130: 251-255.
Compatibility of propofol diluted in 5% glucose with glass and plastics (polypropylene, molyvinylchloride) containers.
Sautou-Miranda V, Levadoux E, Groueix MT, Chopineau J.
1996
1861 Lehti
Int J Pharm 1996 ; 127: 255-259.
Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture.
Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J.
1996
1863 Lehti
Journal of clinical anesthesia 1996 ; 8: 329-336.
Compatibility of propofol, fentanyl,and vecuronium mixtures designed for potential use in anesthesia and patient transport.
Isert PR, Lee D, Naidoo D, Carasso ML, Kennedy RA.
1996
1864 Lehti
Pain 1998 ; 75: 389-390.
Compatibility of ketamine and morphin injections.
Lau MH, Hackman C, Morgan DJ.
1998
1865 Lehti
Int J Pharm 1999 ; 178: 77-82.
Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions.
Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J.
1999
1866 Lehti
Int J Pharm 1998 ; 174: 157-177.
Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone.
Vermeire A, Remon JP.
1998
1867 Lehti
J Pain Symptom Manage 2001 ; 22, 6: 1042-1047.
Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system.
Hildebrand KR, Elsberry DE, Anderson VC.
2001
1868 Lehti
Nutr Clin Metab 2003 ; 17: 8-14.
Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange.
Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D.
2003
1869 Lehti
J Pain Symptom Manage 2003 ; 25, 5: 464-471.
Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
Hildebrand KR, Elsberry DD, Hassenbusch SJ.
2003
1871 Lehti
Int J Pharm 2002 ; 234: 205-212.
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
2002
1873 Lehti
Clin Ther 2003 ; 25: 1219-1224.
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Laposata M, Johnson SM.
2003
1875 Lehti
Acta Anaesthesiol Scand 2000 ; 44: 864-867.
Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl.
Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W.
2000
1877 Lehti
Br Ophtalmol 2000 ; 84: 117.
Vancomycin and ceftazidime incompatibility upon vitreal injection.
Lifshitz T, Lapid-Gortzak R, Finkelman Y, Klemperer I.
2000
1878 Lehti
Int J Pharm Compound 2004 ; 8, 1: 73-76.
Stability of zidovudine and dobutamine hydrochloride injections in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23±2°C) and 4°C in 50 ml polyvinyl chloride bags up to 24 hours.
Musami P, Stewart JT, Will Taylor E.
2004
1879 Lehti
Clin J Pain 2001 : 17: 239-244.
Stability, compatibility, and safety of intrathecal bupivacaine administered via an implantable delivery system.
Hildebrand KR, Elsberry DE, Deer TR.
2001
1882 Lehti
Ziekenhuisfarmacie 1993 ; 9: 97-101.
Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution.
Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF.
1993
1885 Lehti
Pharm World Sci 1999 ; 21: 144-146.
Long-term stability of morphine and bupivacaine mixture for spinal use.
Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA.
1999
1886 Lehti
Palliative Med 1991 ; 5: 330-333.
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Allwood MC.
1991
1887 Lehti
Int J Pharm 1995 ; 123: 229-235.
Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography.
Andersin R, Tammilehto S.
1995
1888 Lehti
Ziekenhuisfarmacie 1986 ; 2: 45-48.
Compatibility study of midazolam.
Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A.
1986
1889 Lehti
Int J Pharm 2015 ; 492 : 137?140.
Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes.
Briota Th, Vrignaud S, Lagarce F.
2015
1891 Lehti
Int J Pharm Compound 2004 ; 8, 2: 153-155.
Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion.
Gupta VD.
2004
1892 Lehti
Int J Pharm Compound 2004 ; 8, 2: 156-159.
Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags.
Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM.
2004
1893 Lehti
Ann Pharmacotherapy 2004 ; 38: 569-573.
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.
2004
1895 Lehti
J Pharm Biomed Anal 2004 ; 35: 57-64.
Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing.
Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J.
2004
1897 Lehti
EJHP 2001 ; 7, 3: 108-115.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
2001
1898 Lehti
Int J Pharm Compound 2004 ; 8, 3: 228-230.
Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs.
Xu QA, Trissel LA, Pham L.
2004
1899 Lehti
Int J Pharm Compound 2004 ; 8, 3: 231-235.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Trissel LA, Zhang Y.
2004
1900 Lehti
Int J Pharm Compound 2004 ; 8, 3: 236-239.
Stability of zidovudine and ranitidine in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23°C±2°C) and 4°C in 50 ml polyvinylchloride bags up to 24 hours.
Musami P, Stewart JT, Taylor EW.
2004
1901 Lehti
J Pain Symptom Manage 2004 ; 27, 5: 471-475.
The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD, Schneider JJ, Ravenscroft PJ.
2004
1902 Lehti
Can J Hosp Pharm 2004 ; 57, 2: 90-96.
Physical compatibility of pantoprazole with selected medications during simulated Y-site administration.
Walker SE, Wyllie A, Law S.
2004
1903 Lehti
Am J Obstet Gynecol 2002 ; 186: 496-498.
Oxytocin preparation stability in several common obstetric intravenous solutions.
Gard JW, Alexander JM, Bawdon RE, Albrecht JT.
2002
1904 Lehti
Am J Health-Syst Pharm 2003 ; 60: 916-922.
Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents.
Phares KR, Weiser WE, Miller SP, Myers MA, Wade M.
2003
1906 Lehti
Am J Health-Syst Pharm 2004 ; 61: 38-45.
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.
2004
1907 Lehti
Hosp Pharm 2004 ; 39: 554-557.
Sustaining treatment of coccidioidal meningitidis by extending the stability of amphotericin B.
Burger DE, Caldwell JW.
2004
1908 Lehti
J Pain Symptom Manage 2004 ; 28, 1: 4-6.
Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C.
Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.
2004
1909 Lehti
J Pharm Clin 2000 ; 19: 248-251.
Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche.
Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A.
2000
1910 Laboratorio
Baxter 2002
Compatibility of imiglucerase (personal communication)
2002
1911 Laboratorio
Janssen-Cilag Ltd 2016
Bortezomib (Velcade®) - Summary of Product Characteristics
2016
1912 Laboratorio
Merck Sharp Dohme 2016
Ertapenem (Invanz®) - Summary of Product Characteristics
2016
1913 Laboratorio
Pfizer Europe 2020
Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)
2020
1914 Laboratorio
Eli Lilly 2016
Pemetrexed (Alimta®) - Summary of Product Characteristics
2016
1915 Laboratorio
Genzyme 2010
Imiglucerase (Cerezyme®) -Summary of product Characteristics
2010
1917 Lehti
J Pharm Biomed Anal 1997 ; 15: 537- 543.
Analysis of gentamicin sulfate and a study of its degradation in dextrose solution.
Graham AE, Speicher E, Williamson B.
1997
1918 Lehti
J Pharm Sci 1997 ; 86, 12: 1410-1416.
Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition.
Dodds HM, Craik DJ, Rivory LP.
1997
1920 Lehti
Drug Stability 1996 ; 1: 118-122.
Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution.
Akimoto K, Kaway A, Ohya K et al.
1996
1921 Lehti
Drug Stability 1996 ; 1; 141-146.
Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution.
Akimoto K, Kawai A, Ohya K.
1996
1922 Lehti
J Am Pharm Assoc 2002 ; 42: 868-870.
Stability of methylprednisolone sodium succinate in autodose infusion system bags.
Trissel LA, Zhang Y.
2002
1925 Lehti
J Am Pharm Assoc 2000 ; 40: 515-519.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
Trissel LA , Williams KY, Gilbert DL.
2000
1926 Lehti
Am J Health-Syst Pharm 2004 ; 61: 394-396.
Stability of zidovudine with oxytocin in a simulated Y-site injection.
Anderson PL, Miller S, Bushman LR.
2004
1927 Lehti
EJHP 2004 ; 4: 60-63.
Stability of ranitidine hydrochloride in different aqueous solutions.
Ferreira MO, Bahia MF, Costa P.
2004
1928 Lehti
J Pain Symptom Manage 2004 ; 28, 3: 268-272.
Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P.
2004
1929 Lehti
J Pharm Biomed Anal 2004 ; 35: 1251-1256.
Shelf lives of aseptically prepared medicines - stability of netilmicin injection in polypropylene syringes.
Rigge DC, Jones MF.
2004
1931 Lehti
Can J Hosp Pharm 2004 ; 4: 230-235.
Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes.
Donnely RF.
2004
1932 Lehti
Int J Pharm Compound 2004 ; 8,5: 398-403.
Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
Trissel LA, Zhang Y.
2004
1933 Lehti
Int J Pharm Compound 2004 ; 8, 5: 404-406.
Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags.
Gupta VD.
2004
1934 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1438-1445.
Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes.
Ambados F, Brealey J.
2004
1935 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1039-1041.
Stability of lorazepam in 0.9% sodium chloride stored in polyolefin bags.
Norenberg JP, Achusim LE, Steel TH, Anderson TL.
2004
1936 Lehti
Ann Pharmacotherapy 2004 ; 38: 1608-1611.
Physical and chemical stability of palonosetron HCl in 4 infusion solusions.
Trissel LA, Xu QA.
2004
1937 Lehti
Ann Pharmacotherapy 2004 ; 38: 1612-1616.
Physical and chemical stability of daptomycin with nine medications.
Lai JJ, Brodeur SK.
2004
1938 Lehti
Ann Pharmacotherapy 2004 ; 38: 1836-1839.
Stability of sufentanil citrate with levobupivacaine hydrochloride in NaCl 0.9% after microwave freeze-thaw treatment.
Boitquin LP, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM.
2004
1940 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Xu QA, Trissel LA.
2004
1941 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
Potency and stability of frozen urokinase solutions in syringes.
Dedrick SC, Ramirez-Rico J.
2004
1942 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1682-1685.
Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
Smith DL, Bauer SM, Nicolau DP.
2004
1943 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1924-1927.
Compatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injection.
Wang DP, Chiou AHJ, Lee DKT.
2004
1944 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1774.
Visual compatibility of bivalirudin with selected drugs.
Hartman CA, Faria CE, Mago K.
2004
1945 Lehti
Ann Pharmacotherapy 2004 ; 38: 2041-2044.
Stability of cefepime in icodextrin peritoneal dialysis solution.
Elwell RJ, Volino LR, Frye RF.
2004
1946 Lehti
Can J Hosp Pharm 2004 ; 57, 5: 276-282.
Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion.
Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L.
2004
1948 Lehti
J Pain Symptom Manage 2004 ; 28, 6: 603-611.
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
Classen AM, Wimbish GH, Kupiec TC.
2004
1949 Lehti
Clinical Cancer Research 2001 ; 7: 1569-1576.
Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.
2001
1950 Lehti
J Oncol Pharm Practice 2004 ; 10: 191-195.
Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration.
Trissel LA, Yanping Z.
2004
1951 Lehti
Chin Pharm J 2001 ; 53: 185-189.
Stability of sodium cefazolin and tenoxicam in 5% dextrose.
Wang DP, Lee D, Wang CN.
2001
1953 Lehti
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
2004
1955 Lehti
Ann Pharmacotherapy 2005 ; 39: 280-283.
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Trissel LA, Zhang Y.
2005
1956 Laboratorio
Hospira UK Limited 2015
Paclitaxel - Summary of Product Characteristics
2015
1957 Lehti
Int J Pharm Compound 2005 ; 9, 1: 72-74.
Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature.
Gupta VD.
2005
1958 Lehti
EJHP Science 2005 ; 11: 23-25.
Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags.
Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L.
2005
1959 Lehti
Hosp Pharm 2005 ; 40, 2: 154-155.
Precipitate formation after subconjonctival administration of ceftazidime and vancomycin.
Mac Lellan C, Papadopoulos A.
2005
1960 Lehti
J Pharm Biomed Anal 2005 ; 37: 259-264.
Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers.
Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C.
2005
1961 Lehti
Int J Pharm 2005 ; 293: 303-310.
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC.
2005
1962 Lehti
Pharmakon 2004 ; 36, 1: 8-14.
Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C.
Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.
2004
1963 Lehti
Am J Health-Syst Pharm 2004 ; 61: 2415-2418.
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS.
2004
1964 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1784-1785.
Visual compatibility of argatroban with selected drugs.
Hartman CA, Baroletti SA, Churchill WW et al.
2002
1965 Lehti
PDA J Pharm Sci Technol 2004 ; 58, 6: 296-308.
Photostability of sympatomimetic agents in commonly used infusion media in the absence and presence of bisulfite.
Brustugun J, Kristensen S, Tonnesen HH.
2004
1966 Lehti
Support Care Cancer 2005 ; 13, 4: 239-245.
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Barcia E, Reyes R, Azuara L, Sànchez Y, Negro S.
2005
1968 Lehti
Hosp Pharm Pract 1992 ; 2, 9: 597-600.
Stability of morphine and droperidol separately and combined, for use as an infusion.
Williams OA, Middleton M, Henderson P, Reilly CS.
1992
1970 Lehti
Support Care Cancer 2003 ; 11, 2: 107-113.
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S.
2003
1971 Lehti
Support Care Cancer 2001
Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care.
Azuara ML, Sanchez Y, Reyes R, Barcia E.
2001
1972 Lehti
Drug Dev Ind Pharm 2016 ; 42, 1: 166-174.
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method.
Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P.
2016
1974 Lehti
J Pain Symptom Manage 1996 ; 12, 3: 168-171.
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
Chandler SW, Trissel LA, Weinstein SM
1996
1975 Lehti
Int J Pharm Compound 2005 ; 9, 3: 235-237.
Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA.
2005
1976 Lehti
Int J Pharm Compound 2005 ; 9, 3: 238-241.
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA.
2005
1978 Lehti
Clin Ther 1992 ; 14, 2: 192-195.
Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials.
Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A.
1992
1979 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1537-1538.
Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions.
Wu CC, Wang DP, Wong CY, Lin YF.
2002
1980 Lehti
Act Pharm Nord 1991 ; 3, 3: 131-136.
Loss of nitroglycerin during passage through two different infusion sets.
Hansen HC, Spillum A.
1991
1981 Lehti
Am J Health-Syst Pharm 2002 ; 59: 2434-2439.
Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags.
Certain E, Beteta F, Goudou-Sinha C, Darbord JC, Prognon P, Jacquot C.
2002
1982 Lehti
Am J Health-Syst Pharm 2005 ; 62: 834-837.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Trissel LA, Ogundele AB.
2005
1984 Lehti
Am J Health-Syst Pharm 2005 ; 62: 182-188.
Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions.
Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J.
2005
1985 Lehti
Am J Health-Syst Pharm 2005 ; 62: 630-633.
Stability of ibuprofen in injection solutions.
Volonté MG, Valora PD, Congolani A, Ferrara M.
2005
1986 Lehti
Am J Health-Syst Pharm 2005 ; 62: 896-899.
Stability and sterility of dolasetron mesylate in syringes stored at room temperature.
Steiner ME, Lensmeyer G, Vermeulen LC.
2005
1987 Lehti
Am J Health-Syst Pharm 2005 ; 62: 289-291.
Stability of roxatidine acetate in parenteral nutrient solutions containing different amino acid formulations.
Oh J, Gwak H, Moon H, Choi I.
2005
1988 Lehti
Am J Health-Syst Pharm 2005 ; 62: 88-92.
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
Sprandel KA, Styrszula DE, Deyo K, Sibley C, Rodvold KA.
2005
1989 Lehti
Am J Health-Syst Pharm 2005 ; 62: 506-509.
Stability of cidofovir in extemporaneously prepared syringes.
Hennere G, Havard L, Bonan B, Prognon P.
2005
1990 Lehti
Krankenhauspharmazie 2000 ; 11: 576-580.
Treosulfan : chemisch-physikalische stabilität, Hinweise für die pharmazeutisch-onkologische praxis.
Hilger RA, Kredtke S, Barth J.
2000
1992 Lehti
J Pharm Clin 1999 ; 18, 3: 251-257.
Traitement par étoposide oral : présentation adaptée à une meilleure observance pédiatrique hospitalière.
Drouard, VigneronJ, May I.
1999
1993 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1190-1192.
Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Lee DKT, Wang DP, Harsono R, Wong CY.
2005
1995 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA.
2005
1998 Lehti
Am J Health-Syst Pharm 1998 55: 1315-1316.
Fluorouracil precipitate.
Allwood MC.
1998
2000 Lehti
J Pharm Biomed Anal 2005 ; 38: 180-185.
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A.
2005
2001 Lehti
J Pharm Biomed Anal 2005 ; 38: 332-336.
Shelf lives of aseptically prepared medicines - stability of hydrocortisone sodium succinate in PVC and non-PVC bags and in polypropylene syringes.
Rigge DC, Jones MF.
2005
2002 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1299-1302.
Compatibility of tramadol hydrochloride injection with selected drugs and solutions.
Abanmy NO, Zaghloul IY, Radwan MA.
2005
2003 Lehti
EJHP Science 2005 ; 2: 31-36.
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
Paul M, Razzouq N, Tixier G, Astier A.
2005
2004 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1381-1384.
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Patel K, Hursting MJ.
2005
2005 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1347-1348.
Influence of temperature and drug concentration on nafcillin precipitation.
Chan V.
2005
2006 Lehti
Hosp Pharm 2015 ; 50, 7: 609-614.
Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
Gu Z, Wong A, Raquinio E, Nguyen A.
2015
2007 Lehti
J Pharm Biomed Anal 2005 ; 38: 709-713.
Migration of diethylhexyl phtalate from PVC into intravenous cyclosporine solutions.
Gotardo MA, Monteiro M.
2005
2008 Lehti
Ann Pharmacotherapy 2005 ; 39: 1244-1248.
Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.
2005
2009 Lehti
Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Trissel LA, Zhang Y.
2005
2010 Lehti
Ann Pharmacotherapy 2005 ; 39: 1462-1466.
Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial.
André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.
2005
2011 Lehti
Krankenhauspharmazie 2005 ; 26, 6: 206-210.
HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen.
Friess D, Nguyen HC, Lipp HP.
2005
2012 Lehti
Am J Health-Syst Pharm 2005 ; 62: 2001-2005.
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M.
2005
2014 Lehti
J Clin Pharm Ther 2005 ; 30: 455-458.
Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags.
Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.
2005
2015 Lehti
Ann Pharmacotherapy 2005 39: 1654-1658.
Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.
2005
2016 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1998-2000.
Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Xu QA, Trissel LA.
2005
2017 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
Visual compatibility of vasopressin with other injectable drugs.
Barker B, Feddema S, Rusho WJ, Dengg R.
2005
2018 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1968-1969.
Visual compatibility of clonidine with selected drugs.
Veggeland T.
2005
2019 Lehti
Am J Health-Syst Pharm 2005 ; 62: 1548-1550.
Visual compatibility of gentamicin sulfate and 4% sodium citrate solutions.
Wazny L, Walker S, Moist L.
2005
2020 Lehti
Can J Hosp Pharm 2005 ; 58: 65-70.
Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution.
Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C.
2005
2022 Lehti
J Pain Symptom Manage 2005 ; 30: 80-86.
Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
Watson DG, Lin M, Morton A, Cable CG, McArthur DA.
2005
2024 Lehti
J Pain Symptom Manage 2005 ; 30: 192-199.
Stability of tramadol and haloperidol for continuous infusion at home.
Negro S, Martin A, Azuara ML, Sanchez Y, Barcia E.
2005
2026 Lehti
J Pharm Biomed Anal 2005 ; 39: 339-343.
Shelf lives of aseptically prepared medicines - stability of piperacillin/tazobactam in PVC and non-PVC bags.
Rigge D, Jones MF.
2005
2027 Lehti
Can J Hosp Pharm 2005 ; 58: 212-222.
Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers.
Walker SE, Shirley L, Puodziunas A.
2005
2028 Lehti
EJHP Science 2005 ; 11, 4: 88-90.
Sodium nitroprusside stability at 1 µg/ml in aqueous solutions.
Kaisserlian CE, Razzouq N, Astier A, Paul M.
2005
2030 Lehti
Am J Health-Syst Pharm 2005 ; 62: 2410-2412.
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.
Johnson CE.
2005
2031 Lehti
Int J Pharm Compound 2005 ; 9: 482-483.
Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags.
Donnelly RF.
2005
2034 Lehti
EJHP Science 2005 ; 11, 5: 111-113.
Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions.
Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2005
2035 Lehti
EJHP Science 2005 ; 11: 107-110.
The stability of ready-to-use (RTU) ephedrine hydrochloride in polypropylene syringes for use in maternal hypotension.
Griffiths W, Ing H, Fleury-SouverainS, Kern C, Sadeghipour F, Bonnabry P.
2005
2036 Lehti
Ann Pharmacotherapy 2005 ; 39, 12: 2026-2028.
Physical and chemical stability of pemetrexed solutions in plastic syringes.
Zhang Y, Trissel LA.
2005
2037 Lehti
J Antimicrob Chemother 2005 ; 56: 951-953.
Stability of heparin and physical compatibility of heparin/antibiotic solutions ...
Robinson JL, Tawfik G, Saxinger L, Stang L, Etches W, Lee B.
2005
2042 Lehti
Antimicrob Agents Chemother 2002 ; 46: 2327-2332.
Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM.
2002
2043 Lehti
Antimicrob Agents Chemother 1998 ; 42: 762-766.
Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity.
Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE.
1998
2046 Lehti
Antimicrob Agents Chemother 2003 ; 47: 1991-1994.
Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA.
2003
2050 Lehti
Current Ther Res 2000 ; 61: 1-6
Stability of reconstituted urokinase solutions.
Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA.
2000
2051 Lehti
Br J Anaesth 2003 ; 90: 179-182.
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Sanchez del Aguila MJ, Jones MF, Vohra A.
2003
2053 Lehti
Anesth Analg 2003 ; 97: 1646-1651.
Physicochemical compatibility of propofol-lidocaine mixture.
Masaki Y, Tanaka M, Nishikawa T.
2003
2054 Lehti
Int J Pharm Compound 2015 ; 19, 4 : 337-339.
Stability of Prednisone in Oral Mix Suspending Vehicle.
Friciu M, Plourde K, Leclair G, Danapoulos P, Savji T.
2015
2055 Lehti
Int J Pharm 2006 ; 307: 278-284.
Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients.
Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E.
2006
2056 Lehti
J Antimicrob Chemother 2004 ; 53: 675-677.
Stability of benzylpenicillin during continuous home intravenous therapy.
Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.
2004
2057 Lehti
J Antimicrob Chemother 2003 ; 51: 849-855.
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
Droste JC, Jeraj HA, MacDonald A, Farrington K.
2003
2064 Lehti
Int J Pharm Compound 2006 ; 10: 69-73.
Stability of morphine sulfate in polypropylene infusion bags for use in patient-controlled analgesia pumps for postoperative pain management.
Nguyen-Xuan Tho, Griffiths W, Kern C, Van Gessel E, Bonnabry P.
2006
2071 Lehti
Anesth Analg 2002 ; 95: 785.
Precipitation of protamine by cefazolin.
Ng HP, Koh KF.
2002
2073 Lehti
Can J Anesth 1998 ; 45: 347-351.
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Taniguchi T, Yamamoto K, Kobayashi T.
1998
2074 Lehti
Ann Intern Med 1998 ; 128: 1049.
Dissolving phenytoin precipitate in central venous access device.
Tse T, Abdullah R.
1998
2076 Lehti
Ann Emerg Med 2003 ; 42: 9-13.
Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning.
Dribben WH, Porto SM, Jeffords BK.
2003
2077 Lehti
Ann Emerg Med 1990 ; 19: 1242-1244.
Stability of epinephrine in alkalinized solutions.
Bonhomme L, Benhamou D, Comoy E, Preaux N.
1990
2078 Lehti
J Ped Surg 2000 ; 35: 1775-1781.
Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers.
Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL.
2000
2079 Lehti
Can J Anesth 1987 ; 34: 87-89.
The effect of pancuronium on the solubility of aqueous thiopentone.
Morton WD, Lerman J.
1987
2083 Lehti
J Pharm Pract and Res 2002 ; 32: 65-68.
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.
2002
2086 Lehti
J Pharm Pract and Res 2003 ; 33: 279-281.
Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes.
Sharley NA, Burgess NG.
2003
2087 Lehti
Pharmactuel 2004 ; 37: 17-20.
Compatibility of dimenhydrinate injectable by Y administration.
Ferreira E, Forest JM, Hildgen P.
2004
2089 Lehti
Pharmazie 2004 ; 59: 457-463.
Photostability of epinephrine - the influence of bisulfite and degradation products.
Brustugun J, Kristensen S, Tonnesen HH.
2004
2090 Lehti
Pharmactuel 2004 ; 37: 193-196.
Compatibility of injectable pantoprazole in Y-site administration.
Pere H, Chasse V, Forest JM, Hildgen P.
2004
2091 Lehti
J Pharm Pract and Res 2004 ; 34: 11-13.
Stability of insulin aspart in normal saline infusion.
Lim SC, Roberts MJ, Paech MJ, Peng L, Jones A.
2004
2093 Laboratorio
Shionogi B.V. 2020
Cefiderocol (Fetcroja®)- Summary of Product Characteristics
2020
2094 Lehti
EJHP Science 2006 ; 12, 1: 10-12.
Stability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS.
Trittler R.
2006
2095 Lehti
EJHP Science 2006 ; 12, 2: 32-34.
Stability of cefuroxime infusion: the brand-name drug versus a generic product.
Rodenbach, MP, Hecq JD, Vanbeckbergen D, jamart J, Galanti L.
2006
2097 Lehti
Int J Pharm Compound 2006 ; 10: 156-158.
Extended stability of oxytocin in common infusion solutions.
Trissel LA, Zhang Y, Douglass K, Kastango E.
2006
2100 Lehti
Farm Hosp 1995 ; 19: 38-40.
Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100.
Gervas S, Gosalbez F.
1995
2103 Lehti
Farm Hosp 1999 ; 23: 103-108.
Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas.
Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV.
1999
2104 Lehti
Farm Hosp 2000 ; 24: 145-150
Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen.
Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO.
2000
2105 Lehti
Farm Hosp 1999 ; 23: 357-360.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
1999
2107 Lehti
Int J Pharm Compound 2006 ; 10: 234-236.
Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration.
Trissel LA, Zhang Y, Xu QA.
2006
2108 Lehti
Int J Pharm Compound 2006 ; 10: 230-232.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Trusley C, Kupiec TC, Trissel LA.
2006
2109 Lehti
Pharmactuel 2006 ; 39: 71-75.
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pelletier E, Forest JM, Hildgen P.
2006
2110 Lehti
EJHP Science 2006 ; 12, 3: 52-56.
Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C.
Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM.
2006
2111 Lehti
EJHP Science 2006 ; 12, 3: 57-59.
Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C.
Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L.
2006
2113 Lehti
Pharm World Sci 1999 ; 21, 6: 272-274.
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS.
1999
2114 Lehti
Ann Pharmacotherapy 2006 ; 40, 6: 1082-1085.
Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y, Trissel LA.
2006
2115 Lehti
J Pain Symptom Manage 2006 ; 31, 6: 563-567.
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
Schneider JJ, Good Ph, Ravenscroft PJ,.
2006
2116 Lehti
Am J Health-Syst Pharm 2006 ; 63: 906-908.
Visual compatibility of furosemide with phenylephrine and vasopressine.
Faria CE, Fiumara K, Patel N, Tran DC.
2006
2117 Lehti
Ann Pharmacotherapy 2006 ; 40, 7: 1289-1292.
Physical instability of frozen pemetrexed solutions in PVC bags.
Zhang Y, Trissel LA.
2006
2118 Lehti
J Pain Symptom Manage 2006 ; 32, 1: 90-97.
Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems.
Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph.
2006
2119 Lehti
Eur J Anaesthesiol 2003 ; 20: 124-126.
Adsorption of sufentanil to epidural filters and catheters.
Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G.
2003
2120 Lehti
J Pharm Biomed Anal 2006 ; 41: 1363-1366.
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S.
2006
2122 Lehti
EJHP Science 2006 ; 12, 4: 81-84.
Stability and compatibility of paracetamol injection admixed with ketoprofen.
Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.
2006
2123 Lehti
EJHP Science 2006 ; 12, 4: 76-80.
Stability of morphine sulphate in ANAPA Plus ambulatory infusion device and PEGA infusion sets.
Lee G, Sabra K.
2006
2124 Lehti
EJHP Science 2006 ; 12, 4: 72-75.
Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C.
Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L.
2006
2125 Lehti
Hospital Pharmacist 2003 ; 10: 354-361.
Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration.
Gardiner PR.
2003
2128 Lehti
Pharmazie 2006 ; 10: 845-850.
Untersuchungen zur Stabilität der Busulfan-Stammlösung (Busilvex®, Busulfex TM) in B/Braun Injekt® Einmalspritzen.
Karstens A, Krämer I.
2006
2130 Lehti
Bull Cancer 1999 ; 86, 11: 946-954.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
1999
2131 Lehti
Am J Health-Syst Pharm 2006 ; 63: 1423-1426.
Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE.
2006
2132 Lehti
Int J Pharm Compound 2015 ; 19, 4 : 344-347.
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes.
Anderson Collin R, Halford Zachery, MacKay Mark.
2015
2134 Lehti
J Pharm Sci 1998 ; 87, 12: 1572-1576.
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
Fubara JO, Notari RE.
1998
2138 Lehti
Eur J Anaesthesiol 2002 ; 19: 295-297.
Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir.
Brodner G, Ermert T, Van Aken H et al.
2002
2139 Lehti
EJHP Science 2006 ; 12,5: 96-99.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
2006
2140 Lehti
EJHP Science 2006 ; 12, 5: 91-95.
Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion.
Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
2006
2141 Lehti
J Antimicrob Chemother 2003 ; 51: 651-658.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
2003
2143 Lehti
J Pharm Biomed Anal 1998 ; 17: 785-792.
The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry.
Dodds HM, Robert J, Rivory LP.
1998
2145 Lehti
J Clin Pharm Ther 2006 ; 31: 641-643.
Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®).
Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C.
2006
2146 Lehti
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
Drug compatibility with new polyolefin infusion solution containers.
Trissel LA, Xu QA, Baker M.
2006
2147 Lehti
Ann Pharmacotherapy 2006 ; 40, 11: 1950-1954.
Stability of vancomycin in icodextrin peritoneal dialysis solution.
Nornoo AO, Elwell RJ.
2006
2148 Lehti
Anal Biochem 2002 ; 309: 117-126.
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J.
2002
2150 Lehti
J Urology 1998 ; 160; 2: 551-555.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
1998
2151 Lehti
Int J Pharm 1995 ; 115: 113-117.
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.
1995
2155 Lehti
Perit Dial Int 1995 ; 15: 72-74.
Stability of ofloxacin in peritoneal dialysis solutions.
Battista C, Kane MP, Moon DG, Bailie GR.
1995
2156 Lehti
Perit Dial Int 1994 ; 14: 396-398.
Stability of deferoxamine peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I.
1994
2162 Lehti
Perit Dial Int 1990 ; 10: 157-160.
Stability of cotrimoxazole in peritoneal dialysis fluid.
Holmes SE, Aldous S.
1990
2163 Lehti
Perit Dial Int 2002 ; 22: 419-422.
Linezolid stability in peritoneal dialysis solutions.
Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA.
2002
2164 Lehti
Perit Dial Int 2006 ; 26, 4: 498-502.
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials.
Voges M, Divinop-Filho JC, Faict D, Somers F, Vermeulen P.
2006
2165 Lehti
J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365.
Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis.
Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL.
2006
2166 Lehti
J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.
HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine.
Nassr S, Dubuc MC, Lavoie P, Brazier JL.
2003
2167 Lehti
Cancer Chemother Pharmacol 1995 ; 37, 1: 117-124.
Stability of the iv and oral formulations of etoposide in solution.
Joel SP, Clark PI, Slevin ML.
1995
2168 Lehti
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Ozdemir FA, Anilanmert B, Pekin M.
2005
2172 Lehti
J Oncol Pharm Practice 2006 ; 12, 4: 211-222.
Physical and chemical stability of paclitaxel infusions in different container types.
Donyai P, Sewell GJ.
2006
2173 Lehti
EJHP Science 2006 ; 12, 6: 135-139.
Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care.
Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P.
2006
2174 Lehti
EJHP Science 2006 ; 12, 6: 129-134.
Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions.
Kattige A.
2006
2175 Lehti
J Pharm Clin 2006 ; 25, 3: 147-152.
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.
2006
2176 Lehti
Support Care Cancer 2007 ; 15: 57-62.
Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.
Barcia E, Martin A, Azuara ML, Sanchez Y, Negro S.
2007
2178 Lehti
J Pharm Biomed Anal 2007 ; 43: 445-449.
Stability of ertapenem in aqueous solutions.
Zajac M, Cielecka-Piontek J, Jelinska A.
2007
2179 Lehti
Int J Pharm Compound 2007 ; 11, 1: 82-85.
Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA.
2007
2181 Lehti
Bull Cancer 1995 ; 82: 189-195.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Milano G, Renée N.
1995
2183 Lehti
EJHP Science 2007 ; 13, 1: 14-16.
Stability of pemetrexed 25 mg/ml in a glass vial and 5 mg/ml stored in a PVC container after storage for one month at 2-8°C.
Rondelot G, Serrurier C, Vigneron J, Zenier H, May I, Demoré B.
2007
2184 Lehti
J Pain Symptom Manage 2006 ; 32, 4: 297-299.
Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes.
Vranken JH, van Kan HJM, ven der Vegt MH.
2006
2185 Lehti
J Pharm Biomed Anal 2007 ; 43: 1849-1853.
Study on the compatibility of cefotaxime with tinidazole in glucose injection.
Guo P, Li X, Wan J, You A.
2007
2188 Lehti
EJHP Science 2007 ; 13, 2: 40-47
Chemical and physical stability of diluted busulfan infusion solutions.
Karstens A, Krämer I.
2007
2191 Lehti
J Oncol Pharm Practice 2007 ; 13: 33-37
Stability of a heparin-free 50% ethanol lock solution for central venous catheters.
Pomplum M, Johnson JJ, Johnston S, Kolesar JM.
2007
2192 Lehti
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Cochran BG, Sowinski KM, Fausel C, Overholser BR.
2007
2194 Lehti
Am J Health-Syst Pharm 2007 ; 64, 10: 1092-1095.
Stability of phenylephrine hydrochloride injection in polypropylene syringes.
Kiser TH, Oldland AR, Fish DN.
2007
2196 Lehti
Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213.
Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration.
Trissel LA, Trusley C, Ben M, Kupiec TC.
2007
2197 Laboratorio
Medac 2003
Treosulfan injection : details about handling and stability.
2003
2199 Laboratorio
Mundipharma 2007
Chlorhydrate d'oxycodone (Oxynorm®)– Résumé des caractéristiques du produits
2007
2201 Lehti
EJHP Science 2007 ; 13, 3: 55-59.
Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers.
Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B.
2007
2202 Lehti
Investig Clin Farm 2005 ; 2, 4: 195-203.
Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio.
Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E,
2005
2203 Lehti
J Oncol Pharm Practice 2007 ; 13: 119-126.
A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
Kaestner S, Sewell G.
2007
2204 Lehti
J Oncol Pharm Practice 2007 ; 13: 99-103.
Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C.
Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2007
2205 Lehti
Arzneimittel Forschung 2006 ; 56, 10: 714-720.
Compatibility and stability of furosemide and dexamethasone combined in infusion solutions.
Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E.
2006
2206 Lehti
Am J Health-Syst Pharm 2015 ; 72:1292-1297
Stability of chlorothiazide sodium in polypropylene syringes
McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N.
2015
2207 Lehti
Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954.
Stability of oxaliplatin in infusion bags containing 5% dextrose injection.
André A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E.
2007
2209 Lehti
Am J Health-Syst Pharm 2007 ; 64, 22: 2356-2358.
Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days.
Johnson CE, Petrea Cober M.
2007
2210 Lehti
Can J Hosp Pharm 2007 ; 60, 4: 231-237.
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Walker S.E, Charbonneau F, Law S.
2007
2211 Lehti
J Clin Pharm Ther 2007 ; 32: 441-444.
Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B.
2007
2212 Laboratorio
Actavis UK Ltd 2015
Reteplase (Rapilysin®) - Summary of Product Characteristics
2015
2214 Lehti
Int J Pharm Compound 2007 ; 11, 6: 520-524.
Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration.
Ben M, Trusley C,Kupiec T.C, Trissel L.A.
2007
2215 Lehti
Chem Pharm Bull 1984 ; 32, 3: 1113-1119.
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Boehm J.J, Poust R.I.
1984
2216 Lehti
J Pharm Biomed Anal 1998 ; 17: 415-418.
Stability of adenosin infusion.
Proot P, Schepdael A.V, Raymakers A.A, Hoogmartens J.
1998
2217 Lehti
Ziekenhuisfarmacie 1997 ; 13, 1: 21-23.
De stabiliteit van clonazepaminjectievloeistof.
Guchelaar H.J, Hartog M.E.
1997
2220 Laboratorio
Merck Serono 2015
Cétuximab (Erbitux®) - Dossier scientifique
2015
2221 Lehti
Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482.
Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E.
2007
2224 Lehti
Bolletino SIFO 2007 ; 53: 178-180.
Dexrazoxane: Stabilià in soluzione.
Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P.
2007
2225 Lehti
Bolletino SIFO 2006 ; 77:81
Studio di stabilità chimico-fisica di una formulazione per la terapia antalgica a base di levobupivacaina e fentanyl.
Sacco R, Sacchetto G, Francalanci M, Boselli C.
2006
2226 Laboratorio
Pfizer Ltd 2016
Temsirolimus (Torisel®) - Summary of Product Characteristics
2016
2227 Lehti
Int J Pharm Compound 2008 ; 12, 2: 156-160.
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA.
2008
2228 Lehti
Int J Pharm Compound 2008 ; 12,2: 170-173.
Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration.
Kupiec T, Ben M, Trusley C, Trissel LA.
2008
2231 Lehti
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
2008
2232 Lehti
Can J Hosp Pharm 2008 ; 61, 1: 14-20.
Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C)
Walker SE, Milliken D, Law S.
2008
2233 Lehti
Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.
Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery
Condie C.K, Tyler L.S, Barker B, Canann D.M.
2008
2238 Laboratorio
Baxter 2018
Clinomel - Résumé des caractéristiques du produit
2018
2239 Lehti
Chinese J New Drugs 2005 ; 14, 2: 189-191.
Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry.
Wang C, Zhang X, Liu HY.
2005
2240 Laboratorio
Janssen Pharmaceuticals 2019
Décitabine (Dacogen®) - Summary of Product caracteristics
2019
2241 Lehti
J Oncol Pharm Practice 2000 ; 6, 3: 115-121.
Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags.
Thiesen J, Krämer I.
2000
2242 Lehti
Int J Pharm 1998 ; 167, 1-2: 223-228.
A note on the solution chemistry of carboplatin in aqueous solutions.
Lederer M, Leipzig-Pagani E.
1998
2243 Lehti
Int J Pharm 1997 ; 146: 263-269.
Degradation pathway of carboplatin in aqueous solution.
Pujol M, Girona V, Prat J, Munoz M, De Bolos J.
1997
2244 Lehti
J Pharm Biomed Anal 1994 ; 12, 1: 81-84.
Stability of carboplatin in 5% glucose solution in glass, polyethylene and polypropylene containers.
Prat J, Pujol M, Girona V, Munoz M, Sol? L-A.
1994
2245 Lehti
Int J Pharm 1996 ; 129: 275-277.
Stability of carboplatin in 5% glucose solution exposed to light.
Torres F, Girona V, Puiol M, Prat J, de Bolos J.
1996
2247 Lehti
Int J Pharm Compound 2008 ; 12, 3: 276-278.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
2008
2248 Lehti
Neuromodulation 2007 ; 10, 1: 6-11.
Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Shields D, Montenegro R.
2007
2249 Lehti
Neuromodulation 2007 ; 10, 1: 12-17.
Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J.
2007
2250 Lehti
Int J Pharm Compound 2008 ; 12, 6: 558-564.
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System.
Vu N.T, Aloumanis V, Ben MJ, Kupiec T.C, Patterson E K, Radke J, Erickson M A III, Schneider G.
2008
2251 Lehti
Neuromodulation 2005 ; 8, 4: 257-263.
Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration.
Shields D, Montenegro R, Ragusa M.
2005
2252 Lehti
Neuromodulation 2007 ; 10, 1: 1-5.
Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J.
2007
2253 Lehti
J Synchrotron Rad 2001 ; 8: 716-718.
Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.
Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S.
2001
2254 Lehti
New J Chem 2000 ; 24: 1003-1008.
Carboplatin decomposition in aqueous solution with chloride ions monitored by X-ray absorption spectroscopy.
Curis E, Provost K, Nicolis I, Bouvet D, B?nazeth S, Crauste-Manciet S, Brion F, Brossard D.
2000
2255 Laboratorio
Ebewe Pharma 2007
Stability of Alexan "Ebewe" infusion solutions.
2007
2256 Laboratorio
Ebewe Pharma 2007
Stability of doxorubicin "Ebewe" infusion solutions.
2007
2257 Laboratorio
Ebewe Pharma 2007
Stability of epirubicin "Ebewe" infusion solutions.
2007
2258 Laboratorio
Ebewe Pharma 2007
Stability of oxaliplatin "Ebewe" lyophilisate after reconstitution.
2007
2259 Laboratorio
Ebewe Pharma 2007
Stability of oxaliplatin "Ebewe" lyophilisate infusion solutions.
2007
2260 Laboratorio
Ebewe Pharma 2007
Stability of vinorelbin "Ebewe" infusion solutions.
2007
2261 Lehti
Can J Hosp Pharm 2008 ; 61, 3: 191-195.
Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution.
Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R.
2008
2262 Lehti
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
2008
2263 Lehti
Il Farmaco 2005 ; 60: 599-603.
Stability of aztreonam in AZACTAM.
Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I.
2005
2265 Lehti
J Pharm Sci 1990 ; 79, 1: 48-52.
Nefopam hydrochloride degradation kinetics in solution.
Tu YH, Wang DP, Allen LV.
1990
2267 Lehti
Am J Health-Syst Pharm 2008 ; 65, 7: 636-638.
Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Kraft MD, Johnson CE, Chung C, Julian F.
2008
2268 Lehti
Ann Pharmacotherapy 2008 ; 42, 4: 511-515.
AntiXa stability of diluted dalteparin for pediatric use.
Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.
2008
2269 Lehti
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
2008
2270 Lehti
Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251.
Physical and chemical stability of esomeprazole sodium solutions.
Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J.
2008
2271 Laboratorio
Novartis 2006
Daptomycine (Cubicin®) Résumé des caractéristiques du produits
2006
2272 Laboratorio
Genzyme 2006
Clofarabine (Evoltra®) – Résumé des caractéristiques du produits
2006
2275 Lehti
Int J Pharm 1998 ; 173: 221-232.
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Craig Dyar S, Notari RE.
1998
2276 Laboratorio
Pharma Mar SA 2015
Trabectedine (Yondelis®) - Summary of Product Characteristics
2015
2277 Laboratorio
GlaxoSmithKline 2008
Argatroban - Summary of Product Characteristics
2008
2279 Lehti
Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759.
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupiec T, Trusley C, Ben M, Trissel LA.
2008
2280 Lehti
Int J Pharm Compound 2008 ; 12, 5: 463-466.
Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
Shields DE, Aclan J, Szatkowski A.
2008
2281 Lehti
Int J Pharm Compound 2008 ; 12, 5: 460-462.
Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration.
Ben M, Kupiec T, Trusley C, Trisel LA.
2008
2284 Laboratorio
Astra Zenaca 2007
Esomeprazole sodium (Nexium IV®) – Summary of Product Characteristics
2007
2285 Lehti
Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.
2008
2286 Lehti
Int J Pharm Compound 2008 ; 12, 4: 368-371.
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Ben M, Trusley C, Kupiec TC, Trissel LA.
2008
2287 Lehti
EJHP Science 2008 ; 14, 1: 14-18.
Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain.
Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P.
2008
2288 Laboratorio
Cephalon 2008
Bendamustine hydrochloride (Treanda®) – Summary of Product Characteristics
2008
2289 Lehti
Pharmazie 1994 ; 49, 10: 775-777.
Stabilität von bendamustinhydrochloride in infusion lösungen.
Maas B, Huber C, Krämer I.
1994
2291 Lehti
Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
Degradation kinetics of neostigmine in solution.
Yeh MK.
2000
2292 Lehti
EJHP 2016 ;23:22-27
Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability
Philipp E, Braitsch M, Bichsel T, Mühlebach S.
2016
2294 Lehti
Can J Hosp Pharm 2008 ; 61, 5: 356-357.
Stability of magnesium sulfate 20% in Viaflex bags.
Newby B.D, Benes C, Palmer L, Cleve R.
2008
2295 Laboratorio
Merck Sharp Dohme 2013
Fosaprepitant (Emend®) - Summary of Product Characteristics
2013
2296 Laboratorio
Eumedica 2017
Témocilline (Negaban®) - Résumé des caractéristiques du produit
2017
2297 Lehti
Int J Pharm Compound 2008 ; 11, 6: 550-552
Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties.
Donnelly R.F, Corman C.
2008
2298 Lehti
Int J Pharm Compound 2008 ; 12, 6: 553-557.
Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration.
Shields D.E, Aclan J, Szatkowski A.
2008
2302 Laboratorio
Lettre AFFSAPS 30 November 2008 2008 ; 61, 5: 356-357.
Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.
2008
2304 Lehti
Int J Pharm 2005 304; 1-2: 135-144.
The development and stability assessment of extemporaneous pediatric formulations of Accupril.
Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A.
2005
2305 Lehti
Anaesthesia 2008 63, 9: 972-978.
Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F, Ginggen A, Tardy Y.
2008
2306 Lehti
Anaesthesia 2004 ; 59, 10: 979-983.
Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine.
Priston M.J, Hughes J.M, Santillo M, Christie I.W.
2004
2307 Lehti
Palliative Med 1995 ; 9, 4: 315-318.
Epidural diamorphine and bupivacaine stability study.
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
1995
2308 Lehti
Int J Obstet Anesth 2005 ; 14, 4: 284-287.
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.
2005
2310 Lehti
EJHP Science 2008 ; 14, 6: 36-38.
Stability of diluted nadroparin for the treatment of paediatric thrombosis.
Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D.
2008
2311 Lehti
J Clin Pharm Ther 2009 ; 34: 25-31.
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
2009
2312 Lehti
Int J Pharm Compound 2009 ; 13, 1: 78-80.
Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration.
Trissel L.A, Trusley C, Kupiec T.C, Ben M.
2009
2316 Lehti
Clin Ther 2008 ; 30, 11: 2075-2087.
Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas P.A, Kuzmission A, Ikeda K, Yasuo S.
2008
2317 Lehti
EJHP Science 2009 ; 15, 1: 3-5.
Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia.
Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G.
2009
2319 Lehti
EJHP Science 2009 ; 15, 1: 11-14.
Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump.
Janssen K, Wisselo R, Geerlings C, Schouten J.P.
2009
2320 Lehti
EJHP Science 2009 ; 15, 1: 15-19.
Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.
2009
2321 Lehti
Ann Pharmacotherapy 2009 ; 43,2: 390-391.
Stability of Oxaliplatin Solution.
Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R.
2009
2322 Lehti
Can J Hosp Pharm 2009 ; 62, 1
Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes.
Donnelly R.F.
2009
2323 Lehti
Can J Hosp Pharm 2009 ; 62, 1
Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration
Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J.
2009
2324 Lehti
Int J Pharm 2009 ; 369, 1-2 : 30-37
Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application
Treleano A, Wolz G, Brandsch R, Welle F.
2009
2325 Lehti
Pharmazie 2009 ; 64, 2: 94-97.
The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
Nemec K, Germ E, Schulz-Siegmund M, Ortner A.
2009
2328 Laboratorio
Organon 2009
Sugammadex (Bridion®) – Résumé des caractéristiques du produits
2009
2329 Lehti
Can J Hosp Pharm 2008 ; 61, 6: 426-430.
Stability of Ketamine-Propofol mixtures for procedural sedation and analgesia in the emergency department.
Donnely R.F, Willman E, Andolfatto G.
2008
2331 Lehti
Hospital Pharmacy Europe 2009 ; 42 : 30-31.
Stability of 5-fluorouracil and sodium folinate admixture.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.
2009
2332 Laboratorio
Janssen-Cilag 2009
Doripenem (Doribax®) - Laboratoire informations
2009
2334 Lehti
Am J Health-Syst Pharm 2009 ; 66, 9: 860-863.
Stability of fentanyl 5 µg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringes
McCluskey S.V, Graner K.K, Kemp J, Aloumanis V, Ben M, Kupiec T, Nicole Vu N.
2009
2335 Lehti
Am J Health-Syst Pharm 2009 ; 66, 8: 727-729
Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients
Canann D, Tyler L.S, Barker B, Condie C.
2009
2336 Lehti
Can J Hosp Pharm 2009 ; 62, 2: 112-118.
Stability of Hydromorphone–Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use
Ensom M.H.H, Decarie D, Leung K, MontgomeryC
2009
2337 Lehti
Can J Hosp Pharm 2009 ; 62, 2: 135-141.
Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C
Walker S.E, Iazzetta J, Law S.
2009
2339 Lehti
Can J Hosp Pharm 2002 ; 55, 3: 207-211.
Stability of Trimethoprim in Admixtures of Trimethoprim–Sulfamethoxazole Prepared in Polyvinylchloride Bags and Glass Bottles
Curtis J.M, Edwards D.J.
2002
2340 Lehti
Can J Hosp Pharm 2005 ; 58, 4: 212-222.
Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Walker S.E, Law S, Puodziunas A.
2005
2341 Ilmoitus
Poster ESCP Stockholm May 2005
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Bourlon S, Sautou-Miranda V, Dalle M.
2343 Laboratorio
Fresenius Biotech 2009
Catumaxomab (Removab®)
2009
2344 Laboratorio
Ebewe Pharma 2009
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
2009
2345 Lehti
Can J Hosp Pharm 2009 ; 62, 3: 226-231.
Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags.
Donnelly R.F.
2009
2346 Lehti
Am J Health-Syst Pharm 2009 ; 66: 986-987.
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S.
2009
2348 Laboratorio
Alexion Europe SAS 2007
Eculizumab (Soliris®) – Summary of Product Characteristics
2007
2349 Lehti
Am J Health-Syst Pharm 2009 ; 66: 1253-1254.
Incompatibility of imipenem–cilastatin and amoxicillin
Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B.
2009
2350 Lehti
Int J Pharm Compound 2000 ; 4, 3: 225-228.
Stability of morphine-ketamine in 0.9% sodium chloride injection packaged in syringes, plastic bags and MEDICATION CASSETTE Reservoirs.
Roy J.J, Hildgen P.
2000
2352 Lehti
Int J Pharm Compound 2000 ; 4, 6: 480-481.
Stability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V.
2000
2353 Lehti
Int J Pharm Compound 2000 ; 4, 6: 476-479.
Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate.
Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y.
2000
2354 Lehti
Int J Pharm Compound 2000 ; 4, 5: 396-397.
Stability of hydrocortisone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V, Ling J.
2000
2355 Lehti
Int J Pharm Compound 2000 ; 4, 2: 150-153.
Stability of ranitidine hydrochloride with cefazolin sodium, cefbuperazone sodium, cefoxitin sodium nd cephalotin sodium during simulated Y-site administration.
Inagaki K, Miyamoto Y, Kurata N, Nakane S, Gill M.A, Nishida M.
2000
2356 Lehti
Int J Pharm Compound 1998 ; 2, 5: 385-388.
Stability of magnesium sulfate in 0.9% sodium chloride and lactated Ringers solutions.
Sarver J.G, Pryka R, Alexander K.S, Weinstein L, Erhardt P.W.
1998
2358 Lehti
Int J Pharm Compound 2000 ; 4, 6: 482-483.
Stability of levothyroxine sodium injection in polypropylene syringes.
Das Gupta V.
2000
2360 Lehti
Int J Pharm Compound 2008 ; 12, 1: 83-85.
Room temperature stability of injectable succinylcholine dichloride.
Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.
2008
2361 Lehti
J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
2009
2362 Ilmoitus
ADKA Congress 2009 2009
Morphin-Haloperidol mischungen in PCA Pumpen : Kompatibel?
Trittler R, M?ller S, Esteban M.
2009
2363 Ilmoitus
ADKA Congress 2006
Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel?
M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E.
2006
2364 Ilmoitus
PharmSciFair 2009
Hydromorphone and dipyrone in PCA devices: Is still a therapy with hydromorphone?
M?ller S, Trittler R, Schubert R, Strehl E.
2009
2366 Ilmoitus
ADKA Congress 2009
Oxycodon-Metamizol in PCA pumpen : Kompatibel?
M?ller S, Trittler R, Schubert R.
2009
2367 Lehti
Int J Pharm Compound 2005 ; 9, 5: 399-401.
Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion.
Gupta V.D.
2005
2368 Lehti
Am J Hosp Pharm 1992 ; 49: 2956 - 2959.
Stability of ciprofloxacin in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B.
1992
2369 Lehti
Am J Hosp Pharm 1992 ; 49: 1139 - 1142.
Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA.
1992
2370 Lehti
Am J Hosp Pharm 1992 ; 49: 137 - 139.
Stability of vancomycin hydrochloride in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B.
1992
2371 Lehti
Am J Hosp Pharm 1991 ; 48: 1234 - 1237.
Stability of dobutamine hydrochloride in peritoneal dialysis solutions
Gora ML, Seth S, Visconti JA, Shields B, Bay W.
1991
2372 Lehti
Am J Hosp Pharm 1991 ; 48: 291 - 292.
Stability of cefazolin sodium in peritoneal dialysis solutions
Nahata MC, Ahalt PA.
1991
2374 Lehti
Am J Hosp Pharm 1990 ; 47: 147 - 150.
Stability of cefotaxime in two peritoneal dialysis solutions
CM Paap CM, Nahata MC.
1990
2375 Lehti
Am J Hosp Pharm 1989 ; 46: 1832 - 1833.
Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions
Strong DK, Ho W, Nairn JG.
1989
2376 Lehti
J Sep Sci 2007 ; 30, 12: 1233-1238.
Chemical stability of midazolam injection by high performance liquid chromatography.
de Diego M, Godoy G, Mennikent S.
2007
2381 Lehti
Ann Pharmacotherapy 2010 ;44:462-465.
Stability of Extemporaneously Prepared Rufinamide Oral Suspensions .
Hutchinson DJ, Liou Y, Best R, Zhao F.
2010
2382 Lehti
Am J Health-Syst Pharm 1999 ; 56: 547-550.
Stability of fumagillin in an extemporaneously prepared ophthalmic solution
Abdel-Rahman SM, Nahata MC.
1999
2383 Lehti
Am J Health-Syst Pharm 2009 ; 66: 1105-1109.
Stability of zonisamide in extemporaneously compounded oral suspensions
Abobo CV, Wei B, Liang D.
2009
2384 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1267-1270.
Stability of valganciclovir in an extemporaneously compounded oral liquid
Anaizi NH, Dentinger PJ, Swenson CF.
2002
2385 Lehti
Am J Health-Syst Pharm 2002 ; 59: 953-956.
Stability of pantoprazole in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH.
2002
2386 Lehti
Am J Health-Syst Pharm 203 ; 60: 687-690.
Stability of valganciclovir in extemporaneously compounded liquid formulations
Henkin CC, Griener JC, Ten Eick AP.
203
2387 Lehti
Am J Health-Syst Pharm 2003 ; 60: 1268-1270.
Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL.
2003
2388 Lehti
Am J Health-Syst Pharm 2003 ; 60: 75-77.
Stability of tiagabine in two oral liquid vehicles
Nahata MC, Morosco RS.
2003
2389 Lehti
Am J Health-Syst Pharm 2003 ; 60: 69-74.
Characterization of an extemporaneous liquid formulation of lisinopril
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.
2003
2392 Lehti
Am J Health-Syst Pharm 2000 ; 57: 1340-1342.
Stability of famotidine in an extemporaneously compounded oral liquid
Dentinger PJ, Swenson CF, Anaizi NH.
2000
2394 Lehti
Am J Health-Syst Pharm 2009 ; 66: 665-667.
Stability of extemporaneously prepared moxifloxacin oral suspensions
Hutchinson DJ, Johnson CE, Klein KC.
2009
2395 Lehti
Am J Health-Syst Pharm 2008 ; 65: 558-561.
Stability of a flavored formulation of acetylcysteine for oral administration
Siden R, Johnson CE.
2008
2396 Lehti
Am J Health-Syst Pharm 2008 ; 65: 441-447.
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Aliabadi HM, Romanick M, Desai S, Lavasanifar A.
2008
2397 Lehti
Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF.
2007
2399 Lehti
Am J Health-Syst Pharm 2007 ; 64: 1513-1515.
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions
Caruthers RL, Johnson CE.
2007
2400 Lehti
Am J Health-Syst Pharm 2007 ; 64: 762-766.
Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings
Kiser TH, Oldland AR, Fish DN.
2007
2401 Lehti
Am J Health-Syst Pharm 2007 ; 64: 644-646.
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE.
2007
2402 Lehti
Am J Health-Syst Pharm 2006 ; 63: 2240-2247.
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Burnett JE, Balkin ER.
2006
2403 Lehti
Am J Health-Syst Pharm 2004 ; 61: 1493-1496.
Stability of nimodipine solution in oral syringes
Green AE, Banks S, Jay M, Hatton J.
2004
2404 Lehti
Palliative Med 2000 ; 14: 205-208.
The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J.
2000
2405 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1853-1855.
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA.
2002
2406 Lehti
Am J Health-Syst Pharm 2003 ; 60: 1268-1270
Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL.
2003
2407 Lehti
Am J Health-Syst Pharm 2004 ; 61: 54-57.
Stability of tramadol hydrochloride--acetaminophen (Ultracet) in strawberry syrup and in a sugar-free vehicle
Johnson CE, Wagner DS, DeLoach SL, Cichon-Hensley BK.
2004
2408 Lehti
Am J Health-Syst Pharm 2003 ; 60: 1019-1022.
Stability of nifedipine in an extemporaneously compounded oral solution
Dentinger PJ, Swenson CF, Anaizi NH.
2003
2409 Lehti
Am J Health-Syst Pharm 1999 ; 56: 2316-2318.
Stability of levofloxacin in an extemporaneously compounded oral liquid
VandenBussche HL, Johnson CE, Fontana EM, Meram JM.
1999
2410 Lehti
Am J Health-Syst Pharm 2002 ; 59: 361-363.
Stability of oral suspensions of ursodiol made from tablets
Johnson CE, Streetman DD.
2002
2412 Lehti
Am J Health-Syst Pharm 2001 ; 58: 577-579.
Stability of norfloxacin in an extemporaneously prepared oral liquid
Johnson CE, Price J, Hession JM.
2001
2413 Lehti
Am J Health-Syst Pharm 1999 ; 56: 1957-1960
Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids
Fish DN, Vidaurri VA, Deeter RG.
1999
2414 Lehti
Am J Health-Syst Pharm 1999 ; 56: 2224-2226.
Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid
Swenson CF, Dentinger PJ, Anaizi NH.
1999
2415 Lehti
Am J Health-Syst Pharm 2000 ; 57: 1141-1143.
Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C
Nahata MC, Morosco RS, Trowbridge JM.
2000
2416 Lehti
Am J Health-Syst Pharm 1999 ; 56: 240-242.
Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C
Nahata MC, Morosco RS, Hipple TF.
1999
2417 Lehti
Am J Health-Syst Pharm 1999 ; 56: 243-245.
Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C
Abdel-Rahman SM, Nahata MC.
1999
2419 Lehti
Am J Health-Syst Pharm 1999 ; 56: 333-336.
Stability of rifabutin in two extemporaneously compounded oral liquids
Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V.
1999
2420 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1386-1388
Stability of vancomycin in an extemporaneously compounded ophthalmic solution
Fuhrman LC, Jr, RT Stroman
1998
2421 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1804-1809.
Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, MA Erickson
1998
2422 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1915-1920.
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1998
2423 Lehti
Am J Health-Syst Pharm 1998 ; 55: 2511-2513.
Stability of granisetron hydrochloride in two oral suspensions
Nahata MC, Morosco RS, Hipple TF.
1998
2425 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1155-1157.
Stability of enalapril maleate in three extemporaneously prepared oral liquids
Nahata MC, Morosco RS, Hipple TF.
1998
2426 Lehti
Am J Health-Syst Pharm 1997 ; 54: 549-553.
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ.
1997
2427 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1404-1406.
Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid
Quercia RA, Zhang J, Fan C, Chow MS.
1997
2428 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1619-1622
Stability of sumatriptan succinate in extemporaneously prepared oral liquids
Fish DN, Beall HD, Goodwin SD, Fox JL.
1997
2429 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1404-1406.
Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid
Quercia RA, Zhang J, Fan C, Chow MS.
1997
2430 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1833-1836.
Stability of omeprazole in an extemporaneously prepared oral liquid
Quercia RA, Fan C, Liu X, Chow MS.
1997
2431 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2073-2078.
Stability of phenoxybenzamine hydrochloride in various vehicles
Lim LY, Tan LL, Chan EW, Yow KL, Chan SY, Ho PC.
1997
2432 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2483-2487.
Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids
Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC.
1997
2433 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2179-2184.
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
2434 Lehti
Am J Health-Syst Pharm 1996 ; 53: 1944-1949.
Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
2435 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
2436 Lehti
Am J Health-Syst Pharm 1997 ; 54: 178-180.
Stability of tacrolimus in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, West NJ, Foster JA.
1997
2437 Lehti
Am J Health-Syst Pharm 1996 ; 53: 659-662.
Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine
Larson TA, Uden DL, Schilling CG.
1996
2440 Lehti
Am J Health-Syst Pharm 1996 ; 53: 407-409.
Stability of flucytosine in an extemporaneously compounded oral liquid
Wintermeyer SM, Nahata MC.
1996
2441 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2073-2078.
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA,
1996
2442 Lehti
Am J Health-Syst Pharm 1995 ; 52: 189-191.
Stability of itraconazole in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, Walters, JR.
1995
2443 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2433-2436.
Stability of ramipril in water, apple juice, and applesauce
Allen LV, Jr, Stiles ML, Prince SJ, McLaury HJ, Sylvestri MF.
1995
2444 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2204-2207.
Stability of cyclosporine in an extemporaneously compounded paste
Ghnassia LT, Yau DF, Kaye KI, Duggin GG.
1995
2445 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2011-2014.
Stability of ondansetron hydrochloride injection in various beverages
Yamreudeewong W, Danthi SN, Hill RA, Fox JL.
1995
2446 Lehti
Am J Health-Syst Pharm 1998 ; 55: 1299-1301.
Content uniformity and stability of nifedipine in extemporaneously compounded oral powders
Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ.
1998
2447 Lehti
Am J Health-Syst Pharm 1997 ; 54: 2714-2716.
Stability of pyrimethamine in a liquid dosage formulation stored for three months
Nahata MC, Morosco RS, Hipple TF.
1997
2448 Lehti
Am J Health-Syst Pharm 1998 ; 55: 926-929.
Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid
Anaizi NH, Swenson CF, Dentinger PJ.
1998
2449 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
Stability of ursodiol in an extemporaneously compounded oral liquid
Johnson CE, Nesbitt J.
1995
2450 Lehti
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Manduru M, Fariello A, White RL, Fox JL, Bosso JA.
1996
2451 Lehti
Am J Health-Syst Pharm 1995 ; 52: 2022 - 2024.
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions
Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA.
1995
2453 Lehti
Am J Health-Syst Pharm 1997 ; 54: 1301-1303.
Stability of pentoxifylline in an extemporaneously prepared oral suspension
Abdel-Rahman S, Nahata MC.
1997
2454 Lehti
Am J Health-Syst Pharm 1995 ; 52: 1558-1560.
Stability of pyrazinamide in two suspensions
Nahata MC, Morosco RS, Peritore SP.
1995
2455 Lehti
Am J Health-Syst Pharm 2002 ; 59: 1853-1855.
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA.
2002
2463 Lehti
Am J Hosp Pharm 1979 ; 50: 486-488.
Instability of aqueous captopril solutions
Anaizi NH, Swenson C.
1979
2466 Lehti
Am J Hosp Pharm 1981 ; 38: 1750-1753.
Compatibility of lithium citrate syrup with 10 neuroleptic solutions
Theesen KA, Wilson JE, Newton DW, Ueda CT.
1981
2468 Lehti
J Pharm Sci 2023 ; 112: 963-973.
In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
Mohnicke M, Blecher A, Beichert K, Bidlingmaier B, Todt E-J, Dette C, Rotthaeuser B, Mukherjee B.
2023
2469 Lehti
Am J Hosp Pharm 1981 ; 38: 363-364.
Stability of aqueous suspensions of disulfiram
Das Gupta V.
1981
2471 Lehti
Am J Hosp Pharm 1982 ; 39: 309-310.
Stability of disopyramide phosphate in cherry syrup
Mathur LK, Lai PK, Shively CD.
1982
2475 Lehti
Hosp Pharm 2015 ; 50: 376-379.
Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam
Wade J, Cooper M, Ragan R.
2015
2476 Lehti
Am J Hosp Pharm 1986 ; 43: 1489-1491.
Formulation and stability of diazepam suspension compounded from tablets
Strom JG, Jr, Kalu AU.
1986
2477 Lehti
Am J Hosp Pharm 1986 ; 43: 1492-1495.
Stability of propranolol hydrochloride suspension compounded from tablets
Henry DW, Repta AJ, Smith FM, White SJ.
1986
2478 Lehti
Am J Hosp Pharm 1993 ; 50: 2353-2355.
Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM.
1993
2481 Lehti
Am J Hosp Pharm 1993 ; 50: 106-108.
Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions
Graham CL, Dukes GE, Fox JL, Kao CF, Hak LJ.
1993
2482 Lehti
Am J Hosp Pharm 1992 ; 49: 2784-2785.
Stability of etoposide solution for oral use
McLeod HL, Relling MV.
1992
2486 Lehti
Am J Hosp Pharm 1991 ; 48: 992-993.
Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature
Nahata MC, Jackson DS.
1991
2487 Lehti
Am J Hosp Pharm 1991 ; 48: 507-509.
Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C
McBride HA, Martinez DR, Trang JM, Lander RD, Helms HA.
1991
2488 Lehti
Am J Hosp Pharm 1990 ; 47: 1799-1801.
Stability of captopril in powder papers under three storage conditions
Taketomo CK, Chu SA, Cheng MH, Corpuz RP.
1990
2489 Lehti
Am J Hosp Pharm 1989 ; 46: 2040-2042.
Stability of extemporaneously compounded spironolactone suspensions
Mathur LK, Wickman A
1989
2490 Lehti
Am J Hosp Pharm 1989 ; 46: 304-307.
Concentration uniformity of extemporaneously prepared ranitidine suspension
Karnes HT, Harris SR, Garnett WR, March C.
1989
2491 Lehti
Am J Hosp Pharm 1989 ; 46: 256.
Stability of cefuroxime axetil in beverages
St Claire RL, Caudill WL.
1989
2494 Lehti
Am J Hosp Pharm 1986 , 43: 2225-2228.
Stability of 1% rifampin suspensions prepared in five syrups
Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD.
1986
2495 Lehti
Am J Hosp Pharm 1986 ; 43: 380-383.
Long-term stability study of histamine in sterile bronchoprovocation solutions
Marwaha RK, Johnson BF.
1986
2496 Lehti
Am J Hosp Pharm 1986 ; 43: 118-120.
Stability of 5-aminosalicylic acid suspension
Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB.
1986
2499 Lehti
Am J Hosp Pharm 1992 ; 49: 615-618.
Stability of midazolam hydrochloride in a flavored, dye-free oral solution
Steedman SL, Koonce, JR, Wynn JE, Brahen NH.
1992
2500 Lehti
Am J Hosp Pharm 1990 ; 47: 2716-2719.
Stability of nizatidine in extemporaneous oral liquid preparations
Lantz MD, Wozniak TJ.
1990
2501 Lehti
Am J Hosp Pharm 1992 ; 49: 1720-1724.
Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid
Metras JI, Swenson CF, McDermott MP.
1992
2502 Lehti
Am J Hosp Pharm 1992 ; 49: 122-125.
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE.
1992
2503 Lehti
Am J Hosp Pharm 1991 ; 48: 293-295.
Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE.
1991
2504 Lehti
Am J Hosp Pharm 1988 ; 45: 530-531.
Stability of propranolol hydrochloride suspension and solution
Rooney M, Creurer I.
1988
2505 Lehti
Am J Hosp Pharm 1987 ; 44: 2287-2290
Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles
Ahmed I, Day P.
1987
2508 Lehti
Am J Hosp Pharm 1988 ; 45: 1092-1099.
Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes
Tu YH, Stiles ML, Allen LV, Jr, Olsen KM, Barton CI, Greenwood RB.
1988
2511 Lehti
Am J Hosp Pharm 1991 ; 48: 1265-1266.
Stability of oxybutynin chloride syrup after repackaging in unit doses
Van Gansbeke B.
1991
2513 Lehti
Am J Hosp Pharm 1987 ; 44: 360-361.
Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets
Das Gupta V, Stewart KR.
1987
2516 Lehti
Am J Hosp Pharm 1993 ; 50: 691-693.
Stability of famotidine in an extemporaneously prepared oral liquid.
Quercia RA, Jay GT, Fan C.
1993
2517 Lehti
Am J Hosp Pharm 1994 ; 51: 806-809.
Stability of ondansetron hydrochloride in syrups compounded from tablets
Williams CL, Sanders PL, Laizure SC, Stevens RC, Fox JL, Hak LJ.
1994
2522 Lehti
Am J Hosp Pharm 1994 ; 51: 1707-1708.
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate
Nahata MC, Morosco RS, Hipple TF.
1994
2523 Lehti
Am J Hosp Pharm 1994 ; 51: 2409-2411.
Stability of isradipine in an extemporaneously compounded oral liquid
MacDonald JL, Johnson CE, Jacobson P.
1994
2524 Lehti
Am J Hosp Pharm 1994 ; 51: 2955-2957.
Stability of mesalamine in rectal suspension diluted with distilled water
Henderson LM, Johnson CE, Berardi RR.
1994
2527 Lehti
Am J Hosp Pharm 1993 ; 50: 2366-2367.
Stability of fluconazole in an extemporaneously prepared oral liquid
Yamreudeewong W, Lopez-Anaya A, Rappaport H.
1993
2530 Lehti
Int J Pharm Compound 2022 ;26,4:330-335
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes.
Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J.
2022
2531 Lehti
J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
Sanogo S, Silimbani P, Gaggeri R, Masini C.
2021
2534 Lehti
Ann Pharmacotherapy 1993 ;27:1198-1199.
Stability of spironolactone in an extemporaneously prepared suspension at two temperatures
Nahata MC, Morosco RS, Hipple TF.
1993
2538 Lehti
Ann Pharmacotherapy 1995 ;29:987-990.
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Fawcett JP, Boulton DW, Jiang R, Woods DJ.
1995
2541 Lehti
Ann Pharmacotherapy 1997 ;31:851-852.
Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
Nahata MC.
1997
2542 Lehti
Ann Pharmacotherapy 1997 ;31:1291-1295.
Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone.
Fawcett JP, Morgan NC, Woods DJ.
1997
2543 Lehti
Ann Pharmacotherapy 1998 ;32:755-757.
Stability of mycophenolate mofetil as an extemporaneous suspension.
Venkataramanan R, McCombs, JR, Zuckerman S, McGhee B, Pisupati J, Dice JE.
1998
2545 Lehti
Ann Pharmacotherapy 2000 ;34:848-850.
Stability of dapsone in two oral liquid dosage forms.
Nahata MC, Morosco RC, Trowbridge JM.
2000
2546 Lehti
Ann Pharmacotherapy 2000 ;34:600-605.
Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes.
DiGiacinto JL, Olsen KM, BergmanKL, Hoie EB.
2000
2547 Lehti
Ann Pharmacotherapy 2001 ;35:1293-1294.
Stability of extemporaneously prepared gentamicin ophthalmic solutions.
Ho PC, Soh H, Lim SM, Yow KL.
2001
2548 Lehti
Ann Pharmacotherapy 2003 ;37:506-509.
Stability of Sotalol in Two Liquid Formulations at Two Temperatures
Nahata MC, Morosco RS.
2003
2549 Lehti
Ann Pharmacotherapy 2004 ;38:396-399.
Stability of Lisinopril in Two Liquid Dosage Forms
Nahata MC, Morosco RS.
2004
2550 Lehti
Aust J Hosp Pharm 1993 ; 23: 35-37.
Compatibility of nebulizer solutions
Roberts GW, Rossi S.O.P.
1993
2556 Lehti
Aust J Hosp Pharm 1989 ; 19,: 344-346.
Stability of extemporaneously prepared mixtures of metoprolol and spironolactone.
Peterson GM, Meaney MF, Reid CA.
1989
2557 Lehti
Aust J Hosp Pharm 1991 ; 21: 239-241.
Prednisolone stability in a hydroalcoholic prednisolone mixture.
Sullivan JA.
1991
2558 Lehti
Aust J Hosp Pharm 1993 ; 23: 18-21.
The stability of acetylcysteine eyedrops.
Fawcett JP, Woods DJ, Hayes P.
1993
2559 Lehti
Aust J Hosp Pharm 1993 ; 23: 83.
The formulation of spironolactone solution for paediatric use.
Mc Knight DL.
1993
2560 Lehti
Aust J Hosp Pharm 1994 ; 24: 312-316.
A short-term stability study of an oral solution of dexamethasone.
Accordino A, Chambers R, Thomson B.
1994
2561 Lehti
Aust J Hosp Pharm 1994 ; 24: 151-156.
The stability of an enalapril maleate oral solution prepared from tablets.
Boulton DW, Woods DJ, Fawcett JP.
1994
2567 Lehti
Pakistan J Biol Sci 2000 ; 3, 10: 1755-1757.
Preparation and stability study of diclofenac sodium suppositories.
Ahmed M, Jalil R, Islam MA, Shaheen SM.
2000
2570 Lehti
Am J Hosp Pharm 1994 ; 51: 1205-1207.
Degradation of captopril in solutions compounded from tablets and standard powder.
Chan DS, Sato AK, Claybaugh JR.
1994
2575 Lehti
Anest Prog 1997 ; 44, 1: 17-22.
Stability of parenteral midazolam in an oral formulation.
Walker SE, Grad HA, Haas DA, Mayer A.
1997
2586 Lehti
Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1.
Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation.
Martin B, Meunier C, Montels D.
1998
2591 Lehti
Can J Hosp Pharm 1988 ; 41: 121-123.
Stability of a sotalol hydrochloride oral liquid formulation.
Dupuis LL, James G, Bacola G.
1988
2592 Lehti
Can J Hosp Pharm 2005 ; 58, 5: 279-284.
Stability of clozapine stored in oral suspension vehicles at room temperature.
Walker SE, Baker D, Law S.
2005
2593 Lehti
Can J Hosp Pharm 2006 ; 59, 4: 194-200.
Stability of sulfasalazine oral suspension.
Linger-Walsh K, Walker SE, Law S, Abesamis M, Sales P.
2006
2594 Lehti
Can J Hosp Pharm 2007 ; 60, 3: 184-191.
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration.
Ensom MHH, Decarie D, Sheppard I.
2007
2621 Lehti
Eur J Pharm Biopharm 2003 ; 55: 209-213.
Stability of fludrocortisone acetate solutions prepared from tablets and powder.
Cisternino S, Schlatter J, Saulnier JL.
2003
2630 Lehti
Hosp Pharm 1981 ; 16: 486-487.
Incompatibilities with orally administered liquid neuroleptic medication combinations.
Raleigh F.
1981
2634 Lehti
Hosp Pharm 1997 ; 32: 691-693.
Stability of metolazone in a liquid dosage form.
Nahata MC, Morosco RS, Hipple TF.
1997
2635 Lehti
Hosp Pharm 2008 ; 43, 4: 303-306.
Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution.
Yamreudeewoh W, Teixeira G, Mayer GE.
2008
2642 Lehti
Int J Pharm 1982 ; 11, 4: 329-336.
Factors affecting captopril stability in aqueous solution
Timmins P, Jackson IM, Yu-chang John Wang.
1982
2647 Lehti
Int J Pharm 1998 ; 51, 2: 157-160.
Stability of loperamide hydrochloride in aqueous solutions as determined by high performance liquid chromatography
Tu YH, Allen LV, Wang DP.
1998
2648 Lehti
Int J Pharm 1999 ; 190, 1: 103-107.
Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Rieutord A, Arnaud P, Dauphin JF, Brion F.
1999
2649 Lehti
Int J Pharm 2002 ; 234, 1-2: 205-212.
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.
2002
2654 Lehti
Int J Pharm 2007 ; 344, 1-2: 150-153.
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F.
2007
2655 Lehti
Int J Pharm 2008 ; 353, 1-2: 1-7.
Invitro release and stability of an artesunate rectal gel suitable for pediatric use.
Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F.
2008
2657 Lehti
Int J Pharm Compound 1997 : 60-63.
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D.
1997
2659 Lehti
Int J Pharm Compound 2010 ; 14, 2: 160-164.
Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector.
Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK.
2010
2661 Lehti
Eye 2015 ; 29, 6: 820-827.
Storage stability of bevacizumab in polycarbonate and polypropylene syringes
Khalili H, Sharma G, Froome A, Khaw P.T, Brocchini S.
2015
2663 Lehti
Int J Pharm Compound 1997 ; 1: 200-205.
The formulation development and stability of metronidazole suspension.
Alexander KS, Vangala SSKS, Dollimore D.
1997
2665 Lehti
Int J Pharm Compound 1997 ; 1: 352-353.
The stability of lisinopril as an extemporaneous syrup.
Webster AA, English BA, Rose DJ.
1997
2668 Lehti
Int J Pharm Compound 1998 ; 2: 89-91.
Stability of mechlorethamine hydrochloride 0.01% ointment in Aquafor Base.
Zhang Y, Trissel LA, Johansen JF, Kimball CL.
1998
2670 Lehti
Int J Pharm Compound 1998 ; 2: 394-396.
Stability of albuterol in continuous nebulization.
Hunter DA, Yoo SD, Fox JL.
1998
2671 Lehti
J Oncol Pharm Practice 2010 ; 16: 53-61.
Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J, Thiesen J, Krämer I.
2010
2676 Lehti
Int J Pharm Compound 1998 ; 2: 314-317.
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V.
1998
2678 Lehti
Int J Pharm Compound 2000 ; 4: 69-71.
Naratriptan hydrochloride in extemporaneously compounded oral suspensions.
Zhang YP, Trissel LA, Fox JL.
2000
2680 Lehti
Int J Pharm Compound 2000 : 398-399.
Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets.
Rose DJ, Webster AA, English BA.
2000
2682 Lehti
Int J Pharm Pract 1991 ; 1: 19-22.
Formulation and stability of cefuroxime eye-drops.
Oldham GB.
1991
2683 Lehti
Int J Pharm Pract 1993 ; 23: 163-167.
Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations.
Hebron B, Scott H.
1993
2685 Lehti
Int J Pharm Pract 1995 ; 3: 169-173.
Stability of ipratropium bromide and salbutamol nebuliser admixtures.
Jacobson GA, Peterson GM.
1995
2686 Lehti
J Am Acad Dermatol 1989 ; 21: 979-984.
Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
Krochm?al L, Wang JCT, Patel B.
1989
2689 Lehti
J Am Pharm Assoc 1999 ; 39: 375-377.
Stability of amlodipine mesylate in two liquid dosage form.
Nahata MC, Morosco RS, Hipple TF.
1999
2690 Lehti
J Am Pharm Assoc 2000 ; 40: 257-259.
Stability of mexiletine in two extemporaneously liquid formulations stored under refrigeration and et room temperature
Nahata MC, Morosco RS, Hipple TF.
2000
2691 Lehti
J Am Pharm Assoc 2002 ; 42: 865-867.
Stability of nifedipine in two oral suspensions stored at two temperatures.
Nahata MC, Morosco RS, Willhite EA.
2002
2692 Lehti
J Am Pharm Assoc 2007 ; 47, 6; 747-755.
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.
2007
2695 Lehti
Int J Pharm Compound 2015 ; 19, 3: 248-251.
Stability of Metronidazole Suspensions.
Donnelly Ronald F, Ying James.
2015
2697 Lehti
J Clin Pharm Ther 1988 ; 13, 1: 73-76.
The formulation and stability of a unit-dose oral vitamin K1 preparation.
Sewell GJ, Palmer AJ.
1988
2699 Lehti
J Clin Pharm Ther 1991 ; 16, 5: 341-345.
Stability of cefuroxime axetil in suspensions.
Pramar Y, Das Gupta V, Bethea C, Zerai T.
1991
2702 Lehti
J Clin Pharm Ther 1994 ; 19, 1: 31-34.
Stability of metronidazole benzoate in suspensions
Mathew M, Gupta VD, Bethea C.
1994
2704 Lehti
J Clin Pharm Ther 1994 ; 19, 4: 263-265.
Stability of rifampin in two suspensions at room temperature
Nahata MC, Morosco RS, Hippie TF.
1994
2705 Lehti
J Clin Pharm Ther 1994 ; 19, 6: 391-396.
Stability of caffeine oral formulations for neonatal use.
Barnes AR, Hebron BS, Smith J.
1994
2707 Lehti
J Clin Pharm Ther 1998 ; 23, 1: 41-47.
Stability of cefazolin sodium eye drops
How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY.
1998
2708 Lehti
J Clin Pharm Ther 1999 ; 24: 299-302
Stability of ceftazidime in a viscous eye drop formulation
Barnes AR, Nash R.
1999
2717 Lehti
J Liquid Chrom 1995 ; 18: 3117-3128.
Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation.
Barnes AR.
1995
2720 Lehti
J Ocular Pharm Ther 2007 ; 23, 3: 292-303.
Formulation of sirolimus eye drops corneal permeation studies.
Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH.
2007
2721 Lehti
J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337.
Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia
Nahata MC, Morosco RS, Leguire LE.
2000
2723 Lehti
J Ped Hematol Oncol 2004 ; 26: 179-184.
Chemical and functional analysis of hydroxyurea oral solutions.
Heeney MM, Whorton MR, Howard TA.
2004
2729 Lehti
J Pharm Clin 1995 ; 14, 2: 106-111.
Bains de bouche antifongiques: études de stabilité.
Vincent I, Schmit B, Houze S, benhaiem N, Jacques L, Taburet AM.
1995
2730 Lehti
J Pharm Pract and Res 2015 ; 45: 152-158.
Evaluation of the physicochemical compatibility of cyclosporin infusion and parenteral nutrition when intravenously administered via the same central line lumen.
Coutsouvelis J, Yao-Da Dong, Witney K, Li W, Corallo C.
2015
2732 Lehti
J Pharm Clin 1999 ; 18: 183-189.
Stability of vancomycin eye drops.
Barbault S, Aymard G, Feldman D, Pointereau-Bellanger A, Thuillier A.
1999
2733 Lehti
J Pharm Clin 1999 ; 18: 179-182.
Impact of deep-freezing on pefloxacin eye drops stability.
Gellis C, Sautou-Miranda V, Arvouet A.
1999
2737 Lehti
J Pharm Pharmacol 1996 ; 48, 1: 22-26.
Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Batty KT, Ilett KF, Timothy Davis ME.
1996
2759 Lehti
Pediatr Neurol 1999 ; 20: 195-197.
Development of two stable oral suspensions of gabapentin.
Nahata MC.
1999
2760 Lehti
Pharm Hosp et Clin 2007 ; 42, 171 : 171-176.
Etude de stabilité d’un collyre à ,6 mg/ml de ticarciline.
Galvez O,Mullot JU, Mullot H, Simon L, Grippi R, Payen C, Bonneau D, Huart B, Gentes P.
2007
2765 Lehti
Pharm World Sci 1999 ; 21: 275-277.
Stability of dithranol in creams.
Wuis EW, Burger DM, Beelen M.
1999
2770 Lehti
Pharmazie 2007 ; 62, 10: 760-766.
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W.
2007
2771 Lehti
Skin Pharm Appl Skin Physiol 1999 ; 12: 266-270.
Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (Cream PUVA).
Martens-Lobenhoffer J, Rinke M, Losche D.
1999
2772 Lehti
South Med J 1993 ; 86: 771-772.
Stability of midazolam prepared for oral administration
Gragory DF, Koestner JA, Tobias JD.
1993
2773 Lehti
Support Care Cancer 2009 ; 17, 6: 701-706.
Stability of an extemporaneous oral liquid aprepitant formulation.
Dupuis LL, Lingertat-Walsh K, Walker SE.
2009
2774 Lehti
Ann Pharmacotherapy 2004 ; 38: 967-972.
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
McKenzie J.E, Mario Cruz-Rivera M.
2004
2783 Lehti
Int J Pharm 2015 ; 486; 1-2: 367-369.
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.
2015
2785 Lehti
Am J Health-Syst Pharm 2005 ; 62, 11: 1192-1194.
Stability of misoprostol in suppositories.
Hafirassou H, Chaidmi F, Schlatter J, Ratiney R, Fontan JE.
2005
2786 Lehti
Am J Health-Syst Pharm 2005 ; 62, 5: 485-491.
Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus.
Ungphaiboon S, Nittayananta W, Vuddhakul V, Maneenuan D, Kietthubthew S, Wongpoowarak W, Phadoongsombat N.
2005
2787 Lehti
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Lee TY, Chen CM, Lee CN, Chaing YC.
2005
2789 Lehti
Bone Marrow Transplantation 2006 ; 37, 8: 781-784.
Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL.
2006
2790 Lehti
Int J COPD 2007 ; 1, 4: 599-607.
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Kamin W, Schwabe A, Krämer I.
2007
2791 Lehti
Int J Pharm 2015 ; 479 : 23-27.
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J.
2015
2793 Lehti
Hosp Pharm 2015 ; 50, 4 : 296-303.
In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem.
Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A.
2015
2795 Lehti
J Pharm Pharm Sci 2004 ; 7, 1: 84-87.
Stability of sulfadiazine oral liquids prepared from tablets and powder.
Pathmanathan U, Halgrain D, Chiadmi F, Schlmatter J, Vermerie N.
2004
2803 Lehti
Respiratory Care 2008 ; 683, 12: 1716-1722.
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Bonasia PJ, McVicar WK, Williams B, Ong S.
2008
2808 Lehti
Int J Pharm Compound 2015 ; 19, 3: 268-270.
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles.
Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M.
2015
2810 Lehti
Antimicrob Agents Chemother 2009 ; 53, 2: 798-799.
Preparation and stability of voriconazole eye drop solution.
Dupuis A, Tournier N, Le Moal G, Venisse N.
2009
2814 Lehti
Ann Pharm Fr 2009 ; 67: 272-277.
Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C.
Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
2815 Lehti
EJHP 2009 ; 15, 4: 30-32.
Assessment of stability in extemporaneously prepared venlafaxine solutions.
Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE.
2009
2816 Lehti
J Pharm Biomed Anal 1999 ; 25: 269-275.
Photodegradation of folic acid in aqueous solution
Aktar J, Khan A, Ahmad I.
1999
2818 Lehti
J Pharm Biomed Anal 1998 ; 17: 885-890.
Stability of isoniazid in isoniazid syrup: formation of hydrazine
Carlin A, Gregory N, Simmons J.
1998
2820 Lehti
J Pharm Biomed Anal 2006 ; 42: 362-366.
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate
Groeschke J, Solassol I, Bressolle F, Pinguet F.
2006
2824 Lehti
J Clin Pharm Ther 2003 ; 28: 457-463.
Stability of extemporaneously prepared saquinavir formulations
Tan LK, Thenmozhiyal JC, Ho PC.
2003
2825 Lehti
Int J Pharm Compound 2015 ; 19, 3: 261-267.
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials.
Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K.
2015
2827 Lehti
Am J Health-Syst Pharm 2009 ; 66: 1722-1725.
Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles
Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S.
2009
2828 Lehti
J Clin Pharm Ther 2008 ; 33, 3: 263-271.
Evaluation of the stability of morphine sulphate in combination with Instillagel®.
Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E.
2008
2833 Lehti
Int J Pharm Compound 2001 ; 5, 6: 480-481.
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Das Gupta V.
2001
2834 Lehti
Int J Pharm Compound 2003 ; 7, 5: 386-388.
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared With the Use of Powder
Das Gupta V.
2003
2835 Lehti
Int J Pharm Compound 2007 ; 11, 3: 259-261.
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Das Gupta V.
2007
2836 Lehti
Int J Pharm Compound 2003 ; 7, 4: 313-319.
Stability of Hydralazine Hydrochloride in Both Flavored and Nonflavored Extemporaneous Preparations
Okoka CC, Modwick T, Naira G, Khuspo S, Grady LT.
2003
2837 Lehti
Int J Pharm Compound 2005 ; 9, 2: 165-166.
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Das Gupta V, Sood A.
2005
2838 Laboratorio
Pierre Fabre 2010
Vinflunine (Javlor®) – Résumé des caractéristiques du produits
2010
2840 Lehti
Can J Hosp Pharm 2010 ; 63, 1 : 25-30.
Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles.
Donnell RF, Pascuet E, Ma C, Vaillancourt R.
2010
2841 Lehti
Atencion Pharmaceutica 2009 ; 11, 3: 161-166.
Estudio de estabilidad de la mezcla ondansetron-dexametasona en cloruro sodico 0,9%.
Gonzalves Navaro M, Carril Aviles M, Borras Almenar C, Romero Crespo I, Jimenez Torres NV.
2009
2842 Lehti
Int J Pharm Compound 2006 ; 10, 4: 316-317.
Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong W, Teixeira MJ, Mayer GE.
2006
2843 Lehti
Int J Pharm Compound 2004 ; 8, 6: 489-491.
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly R.
2004
2849 Lehti
Int J Pharm Compound 2005 ; 9, 6: 484-486.
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Das Gupta V.
2005
2851 Lehti
Int J Pharm Compound 2005 ; 9, 1: 82-86.
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P.
2005
2852 Lehti
Int J Pharm Compound 2004 ; 8, 6: 486-488.
Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan JP, Tong HHY, Chow AHL.
2004
2854 Lehti
Int J Pharm Compound 1997 ; 1, 3: 195-199.
The Formulation Development and Stability of Spironolactone Suspension
Alexander KS, Sundar S, White DB, Dollimore D.
1997
2855 Lehti
Int J Pharm Compound 2006 ; 10, 5: 396-399.
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel LA, Zhang Y, Koontz SE.
2006
2857 Lehti
Can J Hosp Pharm 2002 ; 55, 1: 63-65.
Stability of Mycophenolate Mofetil in a 1:1 Mixture of Ora-Sweet and Ora-Plus.
Ensom MHH, Decarle D.
2002
2858 Lehti
Int J Pharm Compound 2003 ; 7, 6: 485-489.
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension.
Haase MR, Khan MA, Bonilla J.
2003
2864 Laboratorio
Astellas Pharma 2015
Isavuconazonium (Cresemba®) - Summary of Product Characteristics
2015
2865 Lehti
Int J Pharm 2001 ; 223: 49-54.
Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel
Gebauer MG, McClure AF, Vlahakis TL.
2001
2867 Lehti
Int J Pharm Compound 1999 ; 3, 4: 316-320.
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution.
Peyron F, Elias R, Ibrahim E, Amirat-Combralier V, Bu?s-Charbit M, Balansard G.
1999
2868 Lehti
Int J Pharm Compound 2000 ; 4, 2: 146-149.
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution.
Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT.
2000
2872 Lehti
Int J Pharm Compound 2009 ; 13, 2: 170-174.
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule.
Haywood A, Burrell A, van Breda K, Testa C, Norris R.
2009
2875 Lehti
Can J Hosp Pharm 2004 ; 57, 5: 283.287.
Chemical Stability of 4-Aminopyridine Capsules.
Donnelly RF.
2004
2876 Lehti
Int J Pharm Compound 2009 ; 13, 5: 438-439.
Chemical Stability of Scopolamine Hydrobromide Nasal Solution.
Das Gupta V.
2009
2877 Lehti
Int J Pharm Compound 2009 ; 13, 5: 445-446.
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms.
Das Gupta V.
2009
2878 Lehti
Can J Hosp Pharm 2009 ; 62, 5: 375-380.
Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes.
Pascuet E, Donnelly RF, Garceau D, Vaillancourt R.
2009
2879 Ilmoitus
GSASA Congress - Lucerne - Switzerland 2008
Compatibilité entre amiodarone, catecholamines et/ou nitroprussiate de sodium, administré en continu par voie veineuse aux soins intensifs adultes.
Imesch G., Humbert-Delaloye V., Berger M., Pannatier A.
2008
2881 Ilmoitus
SFPO Congress 2009
Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab.
Jaccoulet E, Guirao S, Morand K, Astier A, Paul M.
2009
2882 Ilmoitus
SFPO Congress 2009
Stabilité de solutions diluées de bévacizumab en fonction de la température.
Morand K, Paul M, Lahlou A, Blanchet B, Astier A.
2009
2883 Lehti
Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.
Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F.
2009
2884 Lehti
Int J Pharm 2015 ; 487 : 270-273.
Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml
Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F.
2015
2886 Lehti
Int J Pharm Compound 2009 ; 13, 3: 250-253.
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S.
2009
2890 Lehti
Acta Pharm 2000 ; 50: 219-228.
Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures.
El-Khawas M, Boraie NA.
2000
2894 Lehti
J Dermatolog Treat 2004 ; 15: 295-302.
A topical azythromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC, Sangha ND, Mc Carty MA et al.
2004
2900 Lehti
EJHP 2009 ; 15, 5: 32-38.
Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration.
Hines S, Pleasance S.
2009
2902 Laboratorio
Forrest Pharmaceuticals 2015
Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics
2015
2904 Lehti
Ann Pharm Fr 2005 ; 63: 162-166.
Development of an oxybutynin chloride solution: from formulation to quality control.
Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G.
2005
2906 Lehti
Farm Hosp 2005 ; 29: 30-36.
Stability study of an aqueous formulation of captopril at 1 mg/ml.
Escribano Garcia MJ, Torrado Duran S, Torrado Duran JJ.
2005
2914 Lehti
Palliative Med 2005 ; 19: 131-136.
Stability of morphine sulphate and diamorphine hydrochloride in Intrasite gel.
Zepetella G, Joel SP, Ribiero MDC.
2005
2925 Lehti
Am J Health-Syst Pharm 2005 ; 62: 2518-2520.
Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E.
2005
2926 Lehti
Am J Health-Syst Pharm 2006 ; 63: 254-257.
Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children.
Nahata MC, Morosco RS, Brady MT.
2006
2928 Lehti
EJHP Science 2005 ; 11: 68-73.
Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations.
Salgado AC, Rosa ML, Duarte MA et al.
2005
2931 Lehti
Hosp Pharm 2006 ; 41: 254-259.
Stability of two extemporaneously prepared oral metoprolol and carvedilol liquids.
Yamreudeewong W, Dolence EK, Pahl D.
2006
2932 Lehti
J Pharm Pract and Res 2005 ; 35: 181-182.
Extemporaneous isoniazid mixture: stability implications.
Haywood A, Mangan M, Grant G et al.
2005
2940 Lehti
Am J Health-Syst Pharm 2001 ; 58: 1021-1024.
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH.
2001
2949 Lehti
Pharmazie 2007 ; 62: 519-521.
Development validation and stability study of pediatric atenolol syrup.
Foppa T, Murakami FS, Silva MAS.
2007
2951 Lehti
J Clin Pharm Ther 1994 ; 19: 313-315.
Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension.
Mehta AC, Hart-Davies S, Payne J, Lacey RW..
1994
2953 Lehti
J Pharm Sci 1982 ; 71: 585-587.
Effect of some formulation adjuncts o the stability of benzoyl peroxide.
Gupta VD.
1982
2960 Lehti
Respiratory Care 1991 ; 36: 1387-1390.
Stability of albuterol and tobramycin when mixed for aerosol administration.
Gooch MD.
1991
2961 Lehti
Can J Hosp Pharm 2001 ; 54: 96-101.
Stability of dexamethasone in extemporaneously prepared oral suspensions.
Wen-Lin Chow J, Decarie D, Dumont RJ.
2001
2970 Lehti
J Pharm Pharm Sci 2005 ; 8: 322-325.
Stability of levamisole oral solutions prepared from tablets and powder.
Chiadmi F, Lyer A, Cisternino S et al.
2005
2975 Ilmoitus
ESCP 2014 2014
In-Use stability of herceptin for subcutaneous injection with different administration materials.
Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C.
2014
2980 Lehti
Ann Pharmacotherapy 2007 ; 41: 1954-1961.
Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
Johnson CE, Cober MP, Ludwig JL.
2007
2982 Lehti
J Ped Pharm Pract 1998 ; 3: 115-118.
Stability of itraconazole in an extemporaneously suspension.
Abdel-Rahman SM, Nahata MC.
1998
2984 Lehti
EJHP Science 2007 ; 13-67-72.
The development of a stable oral solution of captopril for paediatric patients.
Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A.
2007
2986 Lehti
J Clin Pharm Ther 1988 ; 13: 165-169.
Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy.
Gupta VD, Parasrampurian J, Gardner SN.
1988
2988 Lehti
J Clin Pharm Ther 2007 ; 32: 489-496.
Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N, de Beer J, Vervaet C et al.
2007
2990 Laboratorio
Roche 2014
Trastuzumab Emtansine (Kadcyla®) - Summary of Product Characteristics.
2014
2991 Lehti
Drug Dev Ind Pharm 1997 ; 23: 285-291.
Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution.
Tamura T, Takayama K, Satoh H et al.
1997
2998 Lehti
J Pharm Technol 1989 ; 5: 202-205.
Preparation and stability of an oral suspension of dipyridamole.
Ameer B, Callahan RJ, Dragotakes SC et al.
1989
3001 Lehti
Ann Pharm Fr 2015 ; 73: 108-113.
Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name.
Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD.
2015
3002 Lehti
J Ped Pharm Pract 1997 ; 2: 82-84.
Stability of trimethoprim in an extemporaneous liquid dosage form.
Nahata MC.
1997
3006 Lehti
J Am Acad Dermatol 1987 ; 16: 984-988.
Anthralin stability in various vehicles.
Green PG, Kennedy CT, Forbes DR.
1987
3008 Lehti
Pharm J 1987 ; 238: 214-215.
Stability of retinoic acid eye-drops.
Mehta AC, Calvert RT.
1987
3012 Lehti
Hosp Pharm 2015 ; 50, 3: 214-220.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Sullivan T, Forrest J.M, Leclair G.
2015
3017 Lehti
Eur Hosp Pharm 1996 ; 2: 176-180.
Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns.
Rotheli-Simmen B, Martinelli E, Muhlebach S.
1996
3019 Lehti
Curr Med Res Opin 2007 ; 23: 2477-2483.
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Bonasia P, Cook C, Cheng Y et al.
2007
3033 Lehti
Eur Respir J 1998 ; 11: 946-948.
Stability of metacholine chloride solutions under different storage conditions over a 9 months period.
Haynes RD, Beach JR, Rutherford DM et al.
1998
3041 Lehti
Acta Pol Pharm 2006 ; 63: 293-299.
Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A, Zawiswa T, Taberska J , Kukula H.
2006
3052 Lehti
J Pharm Pract and Res 2007 ; 37: 95-97.
Stability of mixtures formulated from warfarin tablets or powder.
Sharley NA, Yu AMC, Williams DB.
2007
3069 Lehti
Eur Hosp Pharm 1997 ; 3: 59-60.
Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al.
1997
3074 Lehti
Int J Pharm 2008 ; 362: 67-73.
Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.
Ritschel WA, Ye W, Buhse L, Reepmeyer JC.
2008
3075 Lehti
EJHP Science 2009 ; 15, 4: 78-82.
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.
2009
3076 Lehti
Ann Pharm Fr 2009 ; 67: 427-432.
Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags.
François JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
3077 Laboratorio
Roche 2019
Trastuzumab (Herceptin®) – Summary of Product Characteristics
2019
3078 Lehti
Can J Hosp Pharm 2009 ; 62, 6: 464-468.
Stability of celecoxib oral suspensions.
Donnelly RF, Pascuet E, Ma C, Vaillancourt R.
2009
3082 Lehti
J Oncol Pharm Practice 2009 ; 15: 195-200.
Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2009
3083 Lehti
Am J Health-Syst Pharm 2009 ; 66: 1478-1483.
Stability of extemporaneously prepared voriconazole ophthalmic solution
Al-Badriyeh D, Li J, Stewart K, Kong DCM, Leung L, Davies GE, Robert Fullinfaw R.
2009
3084 Laboratorio
Bristol Myers Squibb 2009
Ixabepilone (Ixempra®) – Summary of Product Characteristics
2009
3086 Lehti
Anaesthesia 2000 ; 55, 9: 853-858.
Chemical stability of bupivacaine, lidocaine and epinephrine in pH-adjusted solutions.
Robinson, J, Fernando, R, Sun Wai, W.Y., Reynolds, F.
2000
3087 Lehti
BJID 2008 ; 12, 5: 400-404.
Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags.
Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M.
2008
3090 Lehti
Int J Pharm Compound 2010 ; 14, 1: 82-85.
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution).
Voudrie MA, Brett Allen D.
2010
3091 Lehti
Wien Med Wochenschr 2005 ; 155, 13-14: 337-343.
Prüfung von Stabilität und Kompatibilität von Flucloxacillin (Floxapen®) und Ceftazidim (Fortum®) in zwei Infusionslösungen:Relevanz für die klinische Praxis.
Thalhammer F, Maier-Salamon A, Jäger W.
2005
3093 Lehti
J Pharm Sci 2010 ; 99, 3 : 1288-1298.
Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics
Tian J, Stella VJ.
2010
3095 Lehti
Am J Health-Syst Pharm 2010 ; 67: 287-289.
Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP, Johnson CE, Lee J, Currie K.
2010
3096 Lehti
Ann Pharmacotherapy 2010 ;44:295-301.
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF.
2010
3101 Lehti
Perit Dial Int 2002 ; 22: 93-94.
Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use.
Wazny LD, Blake PG.
2002
3109 Laboratorio
Bayer Schering Pharma 2010
Moxifloxacine (Izilox®) -Notice information
2010
3110 Ilmoitus
Poster ADKA Congress May 2010 2010
Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I.
2010
3111 Lehti
Can J Hosp Pharm 2010 ; 63, 2: 113-118.
Stability of Norepinephrine Solutions in Normal Saline and 5% Dextrose in Water.
Walker SE, Law S, Garland J, Fung E, Iazzetta J.
2010
3112 Lehti
J Antimicrob Chemother 2010 ; 65: 1073-1075
Stability of meropenem and doripenem solutions for administration by continuous infusion
Berthoin K, Le Duff, CS , Marchand-Brynaert J, Carryn S, Tulkens PM
2010
3113 Kirja
Compendium Suisse des m?dicaments 2010
Herceptin
2010
3115 Lehti
Ann Pharm Fr 2010 ; 68: 157-162.
Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.
2010
3116 Lehti
Am J Health-Syst Pharm 2010 ;67: 1026-1029.
Stability of sodium bicarbonate solutions in polyolefin bags.
Wear J, McPherson TB, Kolling WM.
2010
3117 Laboratorio
Merck Sharp Dohme 2009
Temozolomide (Temodal ®) - Summary of Product Characteristics
2009
3119 Ilmoitus
Congrès HOPIPHARM 2010
Stabilité de la vincristine sans conservateurs.
Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P.
2010
3120 Ilmoitus
Congrès HOPIPHARM 2010
Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml.
Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J.
2010
3121 Lehti
Am J Health-Syst Pharm 2010 ; 67: 1191-1194.
Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 °C
He J, Figueroa DA, Lim TP, Chow DS, Tam VH.
2010
3122 Lehti
Am J Health-Syst Pharm 2010 ; 67: 1195-1198.
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD.
2010
3124 Lehti
EJHP Science 2010 ; 16, 1: 17-22.
Physicochemical stability of a 1mg/ml dexamethasone acetate oral suspension.
Tiphine T, Armand A, Navas D, Dailly E, Menanteau M, Thomaré P.
2010
3125 Lehti
Int J Pharm Compound 2010 ; 14, 4: 346-349.
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Baker D S, Waldrop Bruce, Arnold John.
2010
3126 Lehti
J Pain Symptom Manage 2010 ; 40, 1: 87-94.
Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems.
Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A.
2010
3128 Laboratorio
Prostrakan 2013
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
2013
3129 Laboratorio
Pfizer 2008
Irinotécan (Campto®) – Résumé des caractéristiques du produits
2008
3130 Laboratorio
Sanofi Avantis France 2009
Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
2009
3131 Lehti
Can J Hosp Pharm 2010 ; 63, 2: 154-155.
Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl.
Donnely RF, Wong K, Spencer J.
2010
3132 Lehti
J Palliat Med 2010 ; 13, 3: 273-277.
Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine.
Negro S, Martin A, Azuara L, Sanchez Y, Barcia E.
2010
3134 Lehti
Enferm Intensiva 2010 ; 21: 96-103.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.
2010
3135 Lehti
Am J Health-Syst Pharm 2010 ; 67, 3: 223-226.
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.
Ikesue H, Vermeulen LC, Hoke R, Kolesar JM.
2010
3137 Lehti
Retina 2010 ; 30, 1: 81-84.
Infliximab stability after reconstitution, dilution, and storage under refrigeration.
Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS.
2010
3138 Laboratorio
GlaxoSmithKline 2009
Ofatumumab (Arzerra®) - Summary of Product Characteristics
2009
3140 Lehti
Int J Pharm Compound 2010 ; 14, 5 : 436-439.
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device.
Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M.
2010
3141 Lehti
Can J Hosp Pharm 2010 ; 63, 4: 304-311.
Stability of Trisodium Citrate and Gentamicin Solution for Catheter Locks after Storage in Plastic Syringes at Room Temperature.
Cote D, Lok CE, Battistella M, Vercaigne L.
2010
3142 Laboratorio
SP Europe 2010
Doxorubicin hydrochloride liposome (Caelyx®) - Summary of Product Characteristics
2010
3143 Laboratorio
Teva Laboratoire 2015
Doxorubicin hydrochloride liposome (Myocet®) - Summary of Product Characteristics
2015
3144 Laboratorio
Ortho Biotech 2010
Doxorubicin liposome (Doxil®) - Product Information
2010
3145 Lehti
Am J Health-Syst Pharm 2010 ; 67: 1539-1544.
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
Crandon JL, Sutherland C, Nicolau DP.
2010
3149 Lehti
Diabetes Tech and Ther 2006 ; 8, 3: 358-368.
In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion.
DeFelippis MR, Bell MA, Heyob JA, Storms SM.
2006
3152 Lehti
Am J Health-Syst Pharm 2010 ; 67: 1640-1644.
Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
Kumar A, Mann HJ.
2010
3153 Lehti
Can J Hosp Pharm 2010 ; 63, 5: 366-372.
Stability of Vancomycin 25 mg/mL in Ora-Sweet and Water in Unit-Dose Cups and Plastic Bottles at 4°C and 25°C.
Ensom M.H.H, Decarie D, Lakhani A.
2010
3154 Lehti
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
Carryn S, Couwenbergh N, Tulkens PM
2010
3155 Lehti
J Ocular Pharm Ther 2010 ; 26, 5: 485-490.
Stability of Fortified Cefazolin Ophthalmic Solutions Prepared in Artificial Tears Containing Surfactant-Based Versus Oxidant-Based Preservatives.
Rojanarata T, Tankul J, Woranaipinich C, Potawanich P, Plianwong S, Sakulma S, Saehuan C.
2010
3157 Laboratorio
Celgene Europe Limited 2015
Paclitaxel albumin (Abraxane®) - Summary of Product Characteristics
2015
3158 Laboratorio
Astellas Pharma GmbH 2014
Bendamustine (Levact®) - Summary of Product Characteristics
2014
3159 Lehti
Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z.
2010
3162 Laboratorio
Bayer HealthCare 2010
Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits
2010
3163 Lehti
EJHP 2010 ; 16, 5: 26-28.
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
Acott SR, Hart M.
2010
3165 Lehti
Am J Health-Syst Pharm 2011 ; 68: 69-72.
Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus
Fohl AL, Johnson CE, Cober P.
2011
3166 Lehti
Can J Hosp Pharm 2011 ; 63, 6: 437-443.
Stability of Levothyroxine in Sodium Chloride for IV Administration.
Strong DK, Decarie D, Ensom MHH.
2011
3167 Lehti
Farm Hosp 2010 ;34:293-7.
Carvedilol stability in paediatric oral liquid formulations.
Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA.
2010
3168 Lehti
Am J Hosp Pharm 1993 ; 50: 683-686.
Stability of hydralazine hydrochloride syrup compounded from tablets.
Alexander KS, Pudipeddi M, Parker GA.
1993
3169 Lehti
Pain Clinic 1999 ; 11: 213-216.
Experimentation about precipitation of pharmacological association: morphine and ketorolac.
Raffaeli W, Pari G, Visani L et al.
1999
3172 Lehti
J Clin Pharm Ther 2011 ; 36, 1: 99-102.
Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion.
Xu F, Xu G, LSu L, Feng E.
2011
3173 Ilmoitus
SNPHPU Congress France 2010
Stability of tetracaine eye-drops
Chaussard M, Bouche V, labat L, Brandely ML, Batista R, Chast F.
2010
3174 Lehti
Ann Pharmacotherapy 2011 ; 45: 130-131.
Stability of Ondansetron and Dexamethasone Infusion upon Refrigeration.
Rolin C, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM.
2011
3176 Ilmoitus
16èmes JFSPH, Sion, 18-19 novembre 2010
Compatibilité du Remifentanil avec d'autres médicaments injectables : influence du soluté.
Humbert Delaloye V, Berger M, Voirol P, Pannatier A.
2010
3177 Ilmoitus
16èmes JFSPH, Sion, 18-19 novembre 2010 2010
Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux.
Humbert-Delaloye V, Berger M, Pannatier A.
2010
3180 Lehti
Int J Pharm Compound 2011 ; 15, 1: 78-80.
Chemical stability of brompheniramine maleate in an oral liquid dosage form.
Gupta VD, Gupta VS.
2011
3181 Lehti
Int J Pharm Compound 2011 ; 15, 1: 81-84.
Stability of venlafaxine immediate-release suspension.
Donnelly RF, Wong K, Goddard R
2011
3182 Lehti
Pharmazie 2011 ; 66, 1: 17-23.
Stability of cefepime in eye drops.
Kodym A, PawLowska M, Ruminski JK, Bartosinska A, Kieliba A.
2011
3183 Lehti
EJOP 2010 ; 4, 3: 11-13.
Physical and chemical stability of cisplatin infusions in PVC containers.
Sewell G
2010
3184 Laboratorio
CP Pharmaceuticals 2005
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
2005
3185 Lehti
Am J Health-Syst Pharm 2011 ; 68:519-521.
Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE, Cober MP, hawkins KA, Julian JD.
2011
3186 Lehti
Am J Health-Syst Pharm 2011 ; 68:377-378.
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
Bryan Dotson B, Churchwell MD.
2011
3187 Lehti
Am J Health-Syst Pharm 2011 ; 68:420-423.
Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E.
2011
3188 Lehti
J Clin Pharm Ther 2011 ; 36, 2: 161-165.
Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions.
Selbach S, Diederich WE, Fett, Fründ SD, Koch T, Eberhart LHJ.
2011
3189 Lehti
J Pharm Pract and Res 2010 ; 40, 2: 101-105.
Stability of intravenous flucloxacillin solutions used for hospital-in-the-home.
Tho T-P, Ching MS, Elis AG, Williams L, Garrett MK.
2010
3190 Lehti
Advance in Haematology 2009 Article ID 704928, 5 page
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions.
Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M,
2009
3195 Lehti
EJHP 2011 ; 17, 2: 39-43.
Physical and chemical stability of docetaxel infusions.
MacLeod S, Sewell G.
2011
3198 Lehti
Farm Hosp 2008 ; 32, 6 : 344-348.
Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas.
Nebot Martinez J, Alos Alminana M, Diez Sales O.
2008
3201 Lehti
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
Dice JE.
2006
3202 Lehti
Am J Health-Syst Pharm 2011 ; 68: 900-908.
Stability of compounded thioguanine oral suspensions
Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A
2011
3203 Lehti
Am J Health-Syst Pharm 2011 ; 68:843-845.
Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP, Johnson CE, Sudekum D, Penprase K
2011
3204 Lehti
Ann Pharmacotherapy 2011 ;45, 4:546.
Stability of Azacitidine Suspensions.
Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.
2011
3205 Lehti
AAPS Pharm Sci 2011 ; 15, 2 : 264-272.
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X.
2011
3206 Lehti
Int J Pharm Compound 2011 ; 15, 2: 166-169.
Nifedpine in Compounded Oral and Topical Preparations.
McCluskey Susan V, Brunn Gregory J.
2011
3207 Lehti
Int J Pharm Compound 2011 ; 15, 2: 170-173.
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes.
McCluskey Susan V, Lovely Jenna K .
2011
3208 Lehti
Int J Pharm Compound 2011 ; 15, 3: 252-254.
Stability of Ertapenem in an Elastomeric Infusion Device.
Phipps Stephen D, Peacock Gina F, Smith Douglas L .
2011
3209 Lehti
Int J Pharm Compound 2011 ; 15, 3: 255-258.
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles.
Voudrie Mark A, Alexander Bridget, Allen D Brett.
2011
3210 Lehti
Int J Pharm Compound 2011 ; 15, 3: 259-261.
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations.
Jasti Bhaskara R, Saraf Poonam.
2011
3212 Lehti
Enferm Intensiva 2011 ;22:78-82.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.
2011
3214 Lehti
EJOP 2011 ; 5,1: 10-14.
Stability of vincristine (TEVA) in original vials after re-use in dilute infusions in polyolefin bags and in polypropylene syringes.
Trittler R, Sewell G.
2011
3215 Lehti
EJOP 2011 ; 5,1: 24-27.
Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution.
Hart MC, Ahmed W.
2011
3216 Lehti
Pharmactuel 2011 ; 44, 1 : 14-18
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G.
2011
3218 Lehti
Perit Dial Int 2011 ; 31: 492?495.
Daptomycin Compatibility in Peritoneal Dialysis Solutions
Peyro Saint Paul L, Albessard F, Gaillard C, Debruyn D, Ryckelynck J Ph, Antoine Coquerel, Lobbedez T
2011
3220 Lehti
Can J Hosp Pharm 2011 , 64, 32: 192-198.
Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes.
Donnelly RF.
2011
3221 Lehti
Can J Hosp Pharm 2011 ; 64, 3: 207-211.
Stability of Levetiracetam in Extemporaneously Compounded Suspensions.
Ensom MHH, Decarie D, Rudolph S.
2011
3222 Lehti
Am J Health-Syst Pharm 2011 ;68:1537-1540.
Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags
Karlage K, Earhart Z, Green-Boesen K, . Myrdal PB
2011
3223 Lehti
Am J Health-Syst Pharm 2011 ;68:1533-1536.
Stability of diluted adenosine solutions in polyvinyl chloride infusion bags
Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F.
2011
3224 Lehti
EJHP Science 2011 ; 1: 3-6.
The stability of soluble insulin in plastic syringes
Fleury-Souverain S, Sigrist T, Griffiths W, Ing H, Matthey B; Sadeghipour F, Bonnabry P.
2011
3225 Lehti
EJHP Science 2011 ; 17, 1: 7-12.
Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I.
2011
3227 Lehti
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Simon B, Hancu G, Gy?resi A.
2014
3228 Lehti
Am J Health-Syst Pharm 2011 ;68:1723-1728.
Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers
Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF
2011
3229 Lehti
Am J Health-Syst Pharm 2011 ;68:1646-1650.
Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes.
Li M, Forest JM, Coursol C, Leclair G.
2011
3230 Lehti
Can J Hosp Pharm 2011 ; 64, 4: 241-245.
Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags
Donnelly RF.
2011
3231 Lehti
Can J Hosp Pharm 2011 ; 64, 4 : 252-256.
Stability of Ciprofloxacin in Polyvinylchloride Minibags.
Donnelly RF.
2011
3235 Ilmoitus
ADKA Congress 2011 2011
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen.
Klemmer A, Krämer I.
2011
3236 Laboratorio
Celgene 2011
Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
2011
3237 Laboratorio
Sanofi Aventis France 2011
Cabazitaxel (Jevtana®) - Résumé des caractéristiques du produit.
2011
3240 Ilmoitus
Congrès SFPO 2011
Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène.
Perissutti M, Vigneron J, Zenier H, May I, Demoré B.
2011
3243 Ilmoitus
ECCO Congress Stockholm 2011
Stability of diluted L-asparaginase in normal saline solution.
Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M.
2011
3244 Ilmoitus
SFPO Congress Mandelieu, France 2011
Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL.
Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM.
2011
3246 Ilmoitus
SFPO Congress Mandelieu, France 2011
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.
2011
3249 Lehti
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
2011
3250 Laboratorio
Eisai Ltd 2011
Eribulin (Halaven®) - Summary of Product Characteristics.
2011
3254 Lehti
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
2011
3255 Lehti
Ann Pharm Fr 2011 ; 69, 6 : 296-301.
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.
2011
3256 Lehti
EJHP 2011 ; 17, 5: 49-56.
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
Burnett B, Radic I.
2011
3258 Lehti
Int J Pharm Compound 2011 ; 15, 6 : 515-520.
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I.
2011
3260 Laboratorio
Astellas Pharma Europe 2011
Telavancin (Vibativ®) - Summary of Products characteristics
2011
3261 Laboratorio
Bristol Myers Squibb 2011
Belatacept (Nulojix®) – Résumé des caractéristiques du produit
2011
3262 Lehti
J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
Conditions causing gemcitabine crystallization.
Manners S, Galettis P, de Souza P.
2011
3263 Lehti
Can J Hosp Pharm 2011 ; 64, 4: 289-290.
Stability of buffered lidocaine in glass vials.
Donnelly R.F.
2011
3264 Ilmoitus
AAPS Congress - Washington, October 2011 2011
Nalbuphine stability at 1 mg/mL concentration.
Hammer C, Perello L, Dory A, Lev?que D, Ubeaud-S?quier G.
2011
3265 Ilmoitus
SFPO Congress, France 2011
Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène.
Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M.
2011
3266 Laboratorio
Lipomed 2011
Dacarbazine solutions: In Use stability of dacarbazine lipomed®
Lipomed Laboratories
2011
3267 Laboratorio
Lipomed 2011
Dacarbazine Lipomed - Summary of Product Characteristics
Lipomed Laboratories
2011
3268 Lehti
Am J Health-Syst Pharm 2012 ;69: 98.
Physical compatibility of calcium gluconate and magnesium sulfate injections.
Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G
2012
3269 Lehti
Am J Health-Syst Pharm 2012 ; 69:56-58.
Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P.
2012
3274 Lehti
Intensice Care Medecine 2011 ; 37, 11: 1899.
Stability of sildenafil (Revatio®) dolutions in dextrose 5%.
Al HadithyF.F.Y, De Goede A.L; Eckhardt M, Hanff L, Koch B.C.P.
2011
3275 Lehti
Am J Health-Syst Pharm 2012 ; 69: 232-240.
Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
D'Hondt M, Vangheluwe E, Van Dorpe S, Boonen J, Bauters T, Pelfrene B, Vandenbroucke J, Robays H, De Spiegeleer B
2012
3277 Lehti
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Yang Z, Cameron S, Paul H.
2012
3278 Lehti
Int J Pharm Compound 2012 ; 16, 1: 80-81.
Chemical Stability of Pentoxifylline in a Topical Cream.
Gupta Vishnu D
2012
3279 Lehti
J Clin Pharm Ther 2012 ; 37, 1: 71-73.
A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care.
Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G
2012
3284 Lehti
Yakugaku Zasshi 2008 ; 128, 8: 1221-1226.
Effect of the Admixture of Tetracycline and Nadifloxacin Ointments on Their Stability and Their Antibacterial Activity.
Kawamoto T, Tayama Y, Sawa A, monde T, Sashima S, Yoshioka M, Miyake K, Morita S, Kihira K.
2008
3285 Lehti
Yakugaku Zasshi 2009 129, 6: 767-771.
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method.
Senoo M, Tajika K, Shimizu H, Hamada M, Dobashi Y, Dan K, Katayama S.
2009
3286 Lehti
Yakugaku Zasshi 2010 ; 130, 10: 1369-1374.
Light-induced Deterioration Test of Carboplatin under Clinical Settings.
Okamoto Y, Tazumi K, Sanada Y, Tsugane M, Uejima E.
2010
3289 Lehti
Acta Pol Pharm 2011 ; 68, 1: 99-107.
Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method.
Kodym A, Hapka-Zmich D, Golab M, Gwizdala M.
2011
3290 Lehti
Acta Pol Pharm 2011 ; 68, 4: 555-564.
Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A, Wisniewski A, Kniola D, Olejniczak M.
2011
3291 Lehti
Acta Pol Pharm 2012 ; 69, 1: 95-105.
Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A.
2012
3293 Lehti
EJHP 2012 ; 19: 52-56.
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service
Patel N, Taki M, Tunstell P, Forsey P, Forbes B.
2012
3294 Lehti
EJHP 2012 ; 19: 57-64.
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A.
2012
3295 Laboratorio
LFB Biom?dicaments 2018
Argatroban - Résumé Caractéristiques du Produit
2018
3296 Lehti
J Chromatographic Sci 2009 ; 47: 1-7.
Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection.
Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F
2009
3297 Lehti
Chromatographia 2008 ; 68, 9-10: 767-772.
Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia.
Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F.
2008
3298 Lehti
Am J Health-Syst Pharm 2012 ; 69: 592-594
Stability of an extemporaneously prepared tadalafil suspension
Pettit R.S, Johnson C.E, Caruthers R.L.
2012
3299 Lehti
Am J Health-Syst Pharm 2012 ; 69:595-597.
Stability of dexmedetomidine 4 µg/mL in polypropylene syringes.
Anderson C.R, Mackay M.W, Holley M, Kay B.A
2012
3300 Lehti
Ann Pharm Fr 2012 ; 70, 2: 88-93.
Stability study of amiodarone hydrochloride in capsules for paediatric patients using a high-performance liquid chromatography method.
Rughoo L, Vigneron J, Zenier H, May I, Demoré B.
2012
3301 Lehti
Hosp Pharm 2012 ; 47, 4: 289-292.
Extended Stability of Magnesium Sulfate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G.
2012
3302 Lehti
Int J Pharm Compound 2012 ; 16, 2 : 164-166.
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted).
Whaley P A, Voudrie M A, Sorenson B.
2012
3303 Lehti
Int J Pharm Compound 2012 ; 16, 2: 167-169.
Stability of Vancomycin in SyrSpend SF.
Whaley P A, Voudrie M.
2012
3306 Lehti
EJOP 2012 ; 6, 1: 1-2.
New stability studies for fludarabine according to the European Pharmacopoeia 7.0
Trittler R.
2012
3307 Lehti
Hosp Pharm 2012 ; 47, 1: 27-30.
Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags.
Kiser T.H, Barber G.R, Robinson A.
2012
3308 Lehti
Antimicrob Agents Chemother 2012 ; 56: 3435-3437;
Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise.
Neoh C.F, Jacob J, Leung L, Li J, Stathopoulos A, Stewart K, Kong D.C.M.
2012
3309 Lehti
EJHP 2012 ;19:378-380
Stability of diluted epinephrine in prefilled syringes for use in neonatology.
Zenoni D, Priori G, Bellan C, Invernizzi R.W.
2012
3310 Lehti
Hosp Pharm 2012 ; 47, 5: 367-370.
Stability of Regular Human Insulin Extemporaneously Prepared in 0.9% Sodium Chloride in a Polyvinyl Chloride Bag.
Greenwood B.C, Chesnick M.A, Szumita P.M, Caryn Belisle C, Cotugno M.
2012
3312 Lehti
Ann Pharm Fr 2012 ; 70, 3: 139-154.
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration.
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A.
2012
3313 Lehti
J Oncol Pharm Practice 2012 ; 18, 2: 218-221.
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J, Krämer I.
2012
3314 Laboratorio
Bristol Myers Squibb 2011
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
2011
3315 Ilmoitus
Communication orale Hopipharm 2012
Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon.
Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E.
2012
3316 Lehti
Chem Pharm Bull 2012 ; 60, 1: 86-93.
A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol.
Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K.
2012
3317 Ilmoitus
APHIF Congress 2009
Stabilité de l'infliximab en solutions diluées.
Guirao S, Paul M, Jaccoulet E, Morand K, Astier A.
2009
3318 Lehti
Ann Pharm Fr 2012 ; 70, 3: 155-162.
Stability of ready-to-use temsirolimus infusion solution (100 mg/L) in polypropylene containers under different storage conditions.
Poujol S, Bressolle F, Solassol I, Pinguet F.
2012
3319 Lehti
Int J Pharm 2012 ; 433, 1-2 : 119-120.
Development and validation of a paediatric oral formulation of clonidine hydrochloride
de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A.
2012
3320 Laboratorio
CTI Life Sciences Limited 2012
Pixantrone (Pixuvri®) - Summary of Product Characteristics
2012
3321 Lehti
Int J Pharm Compound 2012 ; 16, 4: 342-346.
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets.
Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa.
2012
3322 Lehti
Int J Pharm Compound 2012 ; 16, 4 : 347-349.
Stability of Gabapentin in SyrSpend SF.
Sorenson B, Voudrie M, Gehrig D.
2012
3323 Lehti
Int J Pharm 2012 ; 436, 1-2: 282-290.
Long-term stability of diluted solutions of the monoclonal antibody rituximab.
Paul M, Vieillard V, Jaccoulet E, Astier A.
2012
3324 Lehti
J Pharm Pract and Res 2012 ; 42, 2: 115-117.
Stability study of a thalidomide suspension.
Hopkins AM, Sharley NA, Tang CD.
2012
3326 Lehti
J Pharm Pract and Res 2012 ; 42, 2: 106-110.
Chiral stability study of oral liquid clopidrogel formulations for infants.
Mihaila B, Ellis D, Rozek T, Milne R.
2012
3327 Lehti
Am J Health-Syst Pharm 2012 ; 69:1405-1409
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
LaPlante K.L, Woodmansee S, Mermel L.A.
2012
3329 Lehti
Hosp Pharm 2012 ; 47, 7: 538-543.
Extended Stability of Sodium Bicarbonate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G.
2012
3331 Lehti
Ann Pharm Fr 2012 ; 70, 5: 249-255.
Stability of the ready-to-use solutions of eribulin for intravenous infusion.
Poujol S, Dell'ova M, Bekhtari K, Bressolle F, Pinguet F.
2012
3332 Laboratorio
Pfizer 2012
Tigecycline (Tigacyl®) - Summary of Product characteristics
2012
3333 Lehti
Am J Health-Syst Pharm 2012 ; 69:1509-1512.
Stability of infliximab in polyvinyl chloride bags.
Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M.
2012
3334 Lehti
EJHP 2013 ;20:36-41
Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate.
Krämer I, Walz-Jung H, Stanko C, Kamin W.
2013
3336 Lehti
EJHP 2013 ;20:46-49
Stability of an oral ranitidine suspension (15 mg/ml).
Petit-Jean E, Perello L, Hernandez C, Gairard Dory A.C, Gourieux B, Ubeaud-Sequier G.
2013
3337 Lehti
EJHP 2012 ; 19: 428-431.
Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature.
Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z
2012
3341 Lehti
Krankenhauspharmazie 2001 ; 7: 331-333.
Ist teurer immer auch besser? Analytiklabor der Apotheke unterstütz Einkauf sentcheidungen bei Carboplatin-Präparaten.
Trittler R, Jung B, Strehl E.
2001
3342 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:13-21
Stability of Bendamustine Solutions: Influence of Sodium Chloride Concentration, Temperature and Container.
Vigneron J, D'Huart E, Demoré B.
2018
3343 Ilmoitus
ECOP Congress, Budapest, Hungary 2012
Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C.
Vieillard V, da Silva R, Astier A, Paul M.
2012
3344 Ilmoitus
ECOP Congress, Budapest, Hungary 2012
Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL.
Moine M, Vieillard V, Astier A, Paul M.
2012
3345 Lehti
Int J Pharm Compound 2012 ; 16, 5: 428-430.
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date.
Peacock G.F, Sauvageot J.
2012
3346 Lehti
Krankenhauspharmazie 2012 ; 33: 427-431.
Stabilität, Qualität und Analytik individueller Noradrenalin-Zubereitungen.
H?llein L, Bennack E, Holzgrabe U.
2012
3347 Lehti
Drug Discov Ther 2012 ; 6, 1 : 49-54.
Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
Kaushal, G., Sayre, B.E., Prettyman, T.
2012
3348 Laboratorio
Amgen 2016
Carfilzomib (Kyprolis®) - Résumé des caractéristiques du produit
2016
3349 Lehti
Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.
Chemical stability of bortezomib solutions in original manufacturer vials.
Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M.
2012
3350 Lehti
Am J Health-Syst Pharm 2012 ; 69:1999-2001
Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S.
2012
3351 Lehti
Can J Hosp Pharm 2012 ; 65, 5: 352-359
Stability of Azacitidine in Sterile Water for Injection.
Walker S.E, Charbonneau L.F, Law S, Earle C.
2012
3352 Laboratorio
Bristol Myers Squibb 2011
Ipilimumab (Yervoy®) - Summary of Product Characteristics
2011
3356 Lehti
Int J Pharm Compound 2012 ; 16, 6 : 513-515.
Stability of Propranolol Hydrochloride in SyrSpend SF.
Geiger C M, Voudrie M A, Sorenson B.
2012
3360 Lehti
Antimicrob Agents Chemother 2012 ; 56:6432-6433.
Stability of Colistimethate Sodium in Aqueous Solution.
Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.
2012
3361 Lehti
Int J Pharm 2012 ; 423: 360-364.
Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide.
Santovena A, Hernandez-Paiz Z, Farina J.B.
2012
3363 Lehti
J Pharm Pract and Res 2012 ; 42, 3: 213-217.
Stability of Oral Cholecalciferol (Vitamin D3) Liquid Formulations in Olive Oil.
Joseph P.M, Hemmens V.J, Munns C.F.
2012
3364 Lehti
Am J Health-Syst Pharm 2012 ; 69:2130.
Visual compatibility of micafungin sodium and levofloxacin injections.
Fleischbein E, Montgomery P.A, Zhou C.Z.
2012
3365 Lehti
Hosp Pharm 2013 ; 1: 44-47
Y-Site Compatibility of Vancomycin and Piperacillin/Tazobactam at Commonly Utilized Pediatric Concentrations.
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.
2013
3366 Lehti
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.
2012
3369 Laboratorio
MEDAC France 2011
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
2011
3372 Lehti
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
2013
3373 Lehti
J R Soc Med Sh Rep 2011 ; 2: 58.
Precipitation of thiopental with muscle relaxants: a potential hazard.
Khan S, Stannard N, Greijn J.
2011
3374 Lehti
Anaesthesia 2001 ; 56: 494-495.
Precipitation in Manchester: ketorolac/cyclizine
Smith R.P.R, Jones M.
2001
3377 Lehti
Anaesthesia 1983 ; 38: 601-602.
Precipitation betwen meptazinol and thiopentone.
Huddy NC, Durcan JJ.
1983
3378 Lehti
Am J Health-Syst Pharm 2013 ; 70:515-519.
Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection
Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H.
2013
3379 Lehti
Am J Health-Syst Pharm 2013 ;70:520-524.
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Fox L.M, Wilder A.G, Foushee J.A.
2013
3380 Lehti
Ann Pharmacotherapy 2013 ;47:426-427.
Incompatibility of Piritramide with Cephalosporins.
Eckle V-S, Heim E, Hahn M, Grasshoff C.
2013
3381 Lehti
EJHP 2013 ; 20:110-116.
In vitro compatibility of various cardioactive drugs during simulated Y-site administration.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A.
2013
3383 Lehti
Farm Hosp 2013 ;37,1:4-9
Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración.
Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K.
2013
3384 Lehti
Farm Hosp 2013 ;37,1:10-14
Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua.
Otero F.M
2013
3385 Lehti
J Antimicrob Chemother 2013 ; 68: 1179-1182.
Stability and compatibility of vancomycin for administration by continuous infusion.
Raverdi V, Ampe E, Hecq JD, Tulkens PM.
2013
3386 Lehti
Int J Pharm 2013 ; 448: 101-104.
Long-term physico-chemical stability of diluted trastuzumab.
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.
2013
3390 Lehti
Int J Pharm 1993 ; 99: 73-78.
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M.
1993
3397 Ilmoitus
EAHP Congress Paris 2013
Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL.
Heeb R.M, Krämer I.
2013
3398 Laboratorio
Gilead Science (France) 2013
Amphotéricine B (Ambisome®) - Résumé des caractéristiques du produit
2013
3399 Ilmoitus
EAHP Congress Paris 2013
Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children.
Li Y.Y, Postma D.J, Wagenaar H.W.G.
2013
3401 Lehti
J Clin Pharm Ther 2013 ;38, 2: 104-108
Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine.
Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H.
2013
3402 Lehti
J Oncol Pharm Practice 2013 ; 19, 1: 65-74.
Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment.
Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T.
2013
3403 Lehti
Int J Pharm Compound 2013 ; 17 ; 2 : 165-167.
Stability of Minoxidil in Espumil Foam Base
Geiger C.M, Sorenson B, Whaley P.A.
2013
3404 Lehti
Int J Pharm Compound 2013 ; 17, 2 : 162-164.
Stability of Rifampin in SyrSpend SF
Sorenson B, Whaley P
2013
3407 Lehti
Farm Hosp 2013 ; 37, 21: 103-110.
Suspensiones extratemporáneas de clobazam para uso pediátrico preparadas a partir de tabletas disponibles comercialmente y fármaco puro.
Buontempo F, Moretton M.A, E. Quiroga y D. A. Chiappetta.
2013
3408 Lehti
Pharmactuel 2013 ; 46, 1 : 16-21.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Tollec S, Touzin K, Pelletier E, Forest J.M.
2013
3409 Lehti
Am J Health-Syst Pharm 2013 ; 70:894-899.
Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags
Kaushal G, Sayre B.E, Prettyman T.
2013
3410 Lehti
Can J Hosp Pharm 2013 ; 66, 2: 118-124.
Stability of Propranolol in Extemporaneously Compounded Suspensions
Ensom M.H, Kendrick J, Rudolph S, Decarie D.
2013
3413 Lehti
Pharm Res 2004 ; 21, 5: 891-894.
Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H.
2004
3415 Lehti
Pharmaceut Anal Acta 2013 ; 4: 205
Stability-Indicating HPLC Assay and Stability Study Over Two Years of Morphine Hydrochloride Diluted Solutions in Polypropylene Syringes
d?Hayer B, Vieillard V, Astier A, Paul M
2013
3416 Lehti
Am J Health-Syst Pharm 2013 ; 70: 932-937
Physical compatibility of sodium citrate with alcohol and cefepime.
Csaba M, Boddu,S.H.S , Churchwell M.D.
2013
3417 Ilmoitus
ADKA Congress, Dresden, Germany 2013
Aliquotierte Levosimendanlösungen - stabil ?
Trittler R, Hecklinger J.
2013
3418 Lehti
Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.
Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C.
Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C
2013
3420 Lehti
J Oncol Pharm Practice 2014 ; 21, 3: 178-187.
Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology
El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P.
2014
3421 Lehti
Am J Health-Syst Pharm 2013 ;70:1163-1166.
Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions.
Leung E, Venkatesan N, Ly S.C, Scheetz M.H.
2013
3422 Lehti
Hosp Pharm 2013 ; 48, 6: 484-488.
Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags.
Almagambetova E, Hutchinson D, Blais D.M, Zhao F.
2013
3426 Lehti
Journal of Addiction Medicine 2013 ; 7,2:113-115.
Stability of Dilute Oral Morphine Solution for Neonatal Abstinence Syndrome.
Sauberan, Jason; Rossi, Steven; Kim, Jae H.
2013
3428 Lehti
Hosp Pharm 2013 ; 48, 1: 44-47.
Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations.
Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.
2013
3429 Lehti
Am J Health-Syst Pharm 2015 ; 72:483-486
Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration
Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S.
2015
3431 Lehti
Can J Hosp Pharm 2001 ; 54, 3: 214-215.
Stability of preservative-free tobramycin in half-normal saline.
Law S.
2001
3432 Laboratorio
Celgene Corporation 2020
Romidepsin (Istodax®) - Summary of Product Characteristics
2020
3433 Lehti
Am J Health-Syst Pharm 2013 ; 70:1336-1341
Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection.
Preslaski C.R, Mueller S.W, Wempe M.F, Robert MacLaren R.
2013
3434 Lehti
Can J Hosp Pharm 2013 ; 66, 3 : 167-170.
Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection.
Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R.
2013
3435 Lehti
Can J Hosp Pharm 2013 ; 66, 3 : 198.
Stability of Diluted Ketamine Packaged in Glass Vials.
Donnelly R.F.
2013
3436 Lehti
Int J Pharm Compound 2013 ; 17, 4: 336-338.
Stability of Captopril in SyrSPend SF.
Geiger C. M, Sorenson B, Whaley P. A.
2013
3437 Lehti
Int J Pharm Compound 2013 ; 17, 4: 344-346.
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry.
Geiger C.M, Sorenson B, Whaley P.A.
2013
3438 Lehti
J Pharm Biomed Anal 2013 ; 83 : 164-170.
A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids.
Respaud R, Quenum L, Plichon C, Tournamille J.F, Gyan E, Antier D, Viaud-Massuard M.C.
2013
3439 Lehti
Perit Dial Int 2013 ; 33:458-461
Effect of Glucose Concentration on the Stability of Daptomycin in Peritoneal Solutions.
Parra M.A, Campanero M.A, S?daba B, Irigoyen A, Garc?a-L?pez L,Fernandez-Reyes M.J, Ramon Azanza J.
2013
3440 Lehti
Pharmazie 2013 ; 68: 744-748.
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Wollstadt A, Krämer I, Kamin W.
2013
3443 Lehti
J Pharm Pract and Res 2013 ; 43: 112-116.
Stability of Diluted Iron Polymaltose in PVC Infusion Bags.
Patel R.P, Wanandy T, Loring S, Johns C, Hutchinson J, Shastri M.
2013
3445 Lehti
Krankenhauspharmazie 2013 ; 34, 8: 410-411.
Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml.
Heeb R.M, Thiesen J, Krämer I.
2013
3446 Ilmoitus
SFPO Congress, Mandelieu, France 2013
Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois.
Bardo P, Vieillard V, Astier A, Paul M.
2013
3447 Ilmoitus
SFPO Congress, Mandelieu, France 2013
Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière.
Giovanelli M, Vigneron J, May I, Nicolas A.
2013
3448 Lehti
Ann Pharm Fr 2013 ; 71, 5: 358-363.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
2013
3449 Lehti
Ann Pharmacotherapy 2013 ; 47: 1237-1238.
Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles.
Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J.
2013
3455 Lehti
J Drug Deliv Sci Tecnol 2012 ; 22, 4: 347-352.
Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo.
Tous S.S, El Sayed A.M, Abd El Mohsen M.G, Yoissef E.M.K, Agban M.N, Boushra M.F.
2012
3456 Lehti
Curr Med Res Opin 2011 ; 27, 12: 2241-2243.
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D.
2011
3459 Lehti
Cancer Chemother Pharmacol 2013 ; 72: 509-513.
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
Sun S, Schaller J, Placek J, Duersch B.
2013
3463 Lehti
Nursing 2011 ; 29 :62-6
Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad.
Eva Perez Juan, Maria Jos? Arévalo Rubert , Silvia Monica Amoros Cerda , Palau M.M, Nicolau B.R.
2011
3464 Lehti
Enferm Clin 2011 21:25-29.
Compatibilidad física de la amiodarona en perfusión continua
Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.
2011
3465 Lehti
Enferm Intensiva 2010 ;21:96-103.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?.
2010
3466 Lehti
Enferm Intensiva 2011 ;22:78-82.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.
2011
3470 Lehti
Support Care Cancer 2012 ; 20: 2501-2509.
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Destro M, Ottolini L, Vicentini L, Boschetti S.
2012
3472 Lehti
Krankenhauspharmazie 2007 ; 28, 5: 170-178.
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W.
2007
3473 Lehti
Int J Pharm 2015 ; 495, 2: 956-962.
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.
2015
3474 Laboratorio
Accord Healthcare Limited 2009
Fluorouracil - Summary of Product Characteristics
2009
3475 Lehti
Am J Health-Syst Pharm 2013 ;70:1966-1970.
Incompatibility of ciprofloxacin and meropenem injections.
Chen L.Y, Chen J, Waters V, Boodhan S.
2013
3476 Lehti
Am J Health-Syst Pharm 2013 ;70:1970-1972.
Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
Li M, Coursol C, Leclair G.
2013
3485 Lehti
Anaesthesia 2000 ; 55, 10: 1039-1040.
Vancomycin causes dangerous precipitation when infused with gelatin fluid.
Huey-Ping Ng, Kwong-Fah Koh, Lai-San Tham.
2000
3486 Lehti
Cardiovasc Intervent Radiol 2013 ; 36: 237-238.
Incompatibility of contrast medium and trisodium citrate.
Delcour C, Brunnix G.
2013
3488 Lehti
Farm Hosp 1995 ; 19, 1: 41-44.
Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro.
Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F.
1995
3489 Lehti
Farm Hosp 1998 ; 22, 5: 249-251.
Estabilidad de las soluciones orales de clohidrato de metadona al 0,1% y 0,5% en suero fisiologico.
Soy D, Roca M, Deulofeu R, Montes E, Codina C, Ribas J.
1998
3490 Lehti
Ann Pharmacotherapy 2002 ; 36: 423-426.
Stability of furosemide in human albumin solution.
Elwell R.J, Spencer A.P, Barnes J.F, Wynn J.E, Jones C.E.
2002
3495 Laboratorio
Takeda 2013
Brentuximab (Adcetris®) - Summary of Product Characteristics
2013
3496 Laboratorio
Actavis 2009
Gemcitabin Actavis solution - Stability Study
2009
3498 Lehti
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
2008
3501 Laboratorio
Pfizer 2011
Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
2011
3502 Laboratorio
Astra Zeneca 2012
Propofol (Diprivan®) - Summary of Products Characteristics
2012
3503 Laboratorio
Hameln Pharmaceuticals 2012
Fentanyl - Summary of product Characteristics
2012
3504 Laboratorio
Pfizer 2012
Parecoxib (Dynastat®) - Summary of Product Characteristics
2012
3507 Laboratorio
AbbVie 2013
Chirocaine - Summary of Product Characteristics
2013
3508 Laboratorio
Sanofi Aventis Group 2013
Aflibercept (Zaltrap®) - Summary of Product characteristics
2013
3516 Ilmoitus
SFPO Congress, Mandelieu, France. 2013
Stabilité du melphalan à 2 mg/ml dans le chlorure de sodium 0,9% dans des conditions pratiques d'utilisation.
Vigneron J, Zenier H, May I, Nicolas A.
2013
3519 Laboratorio
Glaxo Smith Kline 2011
Remifentanil hydrochloride(Ultiva®) - Summary of Product Characteristics
2011
3520 Laboratorio
Sanofi 2011
Cidomycin - Summary of product Chracteristics.
2011
3521 Laboratorio
Beacon Pharmaceuticals 2012
Tramadol® - Summary of Product Characteristics.
2012
3522 Laboratorio
Actavis 2013
Flucloxacillin - Summary of Product Characteristics.
2013
3523 Laboratorio
Roche 2018
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
2018
3524 Laboratorio
Sanofi 2013
Amiodarone hydrochloride (Cordarone®) - Summary of Product Characteristics.
2013
3525 Laboratorio
AMCO Amdipharm Mercury 2012
Pethidine hydrochloride - Summary of product Characteristics
2012
3526 Laboratorio
Pharmacia 2010
Clindamycin (Dalacin®) - Summary of Product Characteristics
2010
3527 Laboratorio
Glaxo Smith Kline 2018
Amoxicillin (Amoxil®) – Summary of Product Characteristics
2018
3528 Laboratorio
Essential generics 2012
Ampicillin sodium – Summary of Product Characteristics
2012
3529 Laboratorio
Hospira 2013
Ciprofloxacin – Summary of Product Characteristics
2013
3530 Laboratorio
Hospira 2013
Imipenem/Cilastatin – Summary of Product Characteristics
2013
3531 Laboratorio
Wockhardt 2014
Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
2014
3534 Lehti
Am J Health-Syst Pharm 2013 ; 70:2137-2142
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.
2013
3535 Lehti
Int J Pharm Compound 2013 ; 17, 6 : 508-511.
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson T. B, Neumann W L, Kolling W M.
2013
3536 Lehti
Int J Pharm Compound 2013 ; 17, 6: 515-519
Stability of Nitroglycerin 100 mcg/mL Stored in Polypropylene Syringes
McCluskey S V, Vu N, Rueter J.
2013
3537 Lehti
Krankenhauspharmazie 2013 ; 34,11: 500-505.
Bortezomib zur subkutanen Applikation.
Lipp HP, Gfrörer W, Riedmüller S.
2013
3538 Lehti
Krankenhauspharmazie 2013 ; 11: 524-525.
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I.
2013
3539 Laboratorio
The Medecines Company 2013
Bivalirudin (Angiox®) - Summary of Product Characteristics.
2013
3540 Laboratorio
Wockhardt 2010
Heparin sodium - Summary of Product Characteristics.
2010
3541 Laboratorio
Sanofi 2011
Rifampicin (Rifadin®) – Summary of Product Characteristics
2011
3542 Lehti
Am J Health-Syst Pharm 2015 ; 72:390-395
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E.
2015
3543 Laboratorio
Wockhardt 2013
Ceftazidime – Summary of Product Characteristics
2013
3544 Laboratorio
Pfizer 2006
Cefoperazone (Cefobid®) - Summary of Product Characteristics
2006
3545 Laboratorio
Mylan SAS 2009
Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit
2009
3546 Laboratorio
Panpharma SA 2007
Cefamandole Flavelab - Résumé des caractéristiques du produit
2007
3547 Laboratorio
Sanofi-Aventis France 2011
Aztréonam (Azactam®) - Résumé des caractéristiques du produit
2011
3548 Laboratorio
Bristol Myers Squibb 2007
Cefepime (Maxipime®) - Summary of Product caracteristics.
2007
3549 Laboratorio
B Braun 2012
Amikacine B Braun - Résumé des caractéristiques du produit.
2012
3557 Lehti
Can J Hosp Pharm 2013 ; 66, 5: 310-312
Physical Incompatibility between Parenteral Cloxacillin and Vancomycin.
Chan A, Tawfik G, Cheng W.
2013
3558 Lehti
Can J Hosp Pharm 2013 ; 66, 5: 332.
Physical Compatibility of Ranitidine and Metoclopramide in 50-mL Minibags of Normal Saline.
Rowe H, Riley J, Newby B.
2013
3559 Laboratorio
Sanofi Aventis France 2013
Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
2013
3560 Laboratorio
Pharmacia 2013
Linezolid (Zyvox®) - Summary of Product Characteristics
2013
3561 Lehti
Am J Health-Syst Pharm 2015 ; 72:479-482
Stability of frozen 1% voriconazole ophthalmic solution.
Amoros-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, Lopez-Cabezas C.
2015
3562 Laboratorio
Sanofi 2014
Ofloxacin (Tarivid®) - Summary of Product Characteristics
2014
3563 Laboratorio
Sanofi Aventis France 2013
Spiramycine adipate (Rovamycine®) - Résumé des caractéristiques du produit
2013
3564 Laboratorio
B Braun 2012
Rocuronium B Braun - Résumé des caractéristiques du produit.
2012
3565 Laboratorio
Aguettant 2008
Flumazenil Aguettant - Résumé des caractéristiques du produit.
2008
3566 Laboratorio
Pfizer 2013
Voriconazole (Vfend®) - Summary of Product characteristics.
2013
3567 Laboratorio
Pfizer 2020
Anidulafungin (Ecalta®) - Summary of Product Characteristics.
2020
3568 Lehti
Am J Health-Syst Pharm 2014 ;71:219-222
Stability of levetiracetam oral solution repackaged in oral plastic syringes.
Prohotsky D.L, Hughes S.E, Zhao F.
2014
3569 Lehti
EJHP 2014 ;21:34-38
Development of ready-to-use cefuroxime syringes for use in ophthalmology.
Fleury-Souverain S, Sadeghipour F, Bonnabry P.
2014
3571 Lehti
Hosp Pharm 2014 ; 49, 1: 42-47.
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.
2014
3572 Lehti
Int J Pharm Compound 2014 ; 18, 1 : 78-82.
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C.
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L.
2014
3573 Laboratorio
Astellas 2013
Micafungin (Mycamine®) – Summary of Product Characteristics
2013
3574 Laboratorio
Accord Healthcare France SAS 2013
Ondansetron - Résumé des caractéristiques du produit
2013
3575 Laboratorio
Prostrakan 2013
Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
2013
3576 Laboratorio
Prostrakan 2012
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
2012
3577 Laboratorio
Galen Limited
Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
3578 Laboratorio
Accord Healthcare 2011
Cisplatin - Summary of Product Characteristics
2011
3579 Laboratorio
Janssen Cilag 2005
Cladribine Janssen Cilag - Résumé des caractéristiques du produit
2005
3580 Laboratorio
Accord Healthcare France 2016
Cytarabine Accord - Résumé des caractéristiques du produit
2016
3581 Laboratorio
Clinigen Healthcare 2013
Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit
2013
3583 Laboratorio
Roche 2013
Sulfaméthoxazole triméthoprime (Bactrim®) - Résumé des caractéristiques du produit
2013
3584 Laboratorio
Aspen Pharma 2013
Melphalan (Alkéran®) - Résumé des caractéristiques du produit
2013
3585 Laboratorio
Genus Pharmaceuticals 2008
Benzylpenicillin sodium - Summary of Product Characteristics
2008
3586 Laboratorio
Actavis France 2010
Piperacilline tazobactam Actavis® - Résumé des caractéristiques du produit
2010
3587 Laboratorio
GlaxoSmithKline 2014
Ticarcilline/acide clavulanique (Timentin®) - Summary of Product Characteristics
2014
3588 Laboratorio
Sandoz 2011
Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
2011
3589 Laboratorio
PanPharma 2013
Oxacilline PanPharma – Résumé des caractéristiques du produits
2013
3590 Laboratorio
Dakota Pharm 2011
Piperacilline - Résumé des caractéristiques du produit
2011
3591 Laboratorio
Bristol Myers Squibb 2011
Amphotericine B (Fungizone®) - Résumé des caractéristiques du produit
2011
3592 Laboratorio
Sandoz 2008
Cimetidine - Résumé des caractéristiques du produit
2008
3593 Laboratorio
Beacon Pharmaceuticals 2011
Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics
2011
3594 Laboratorio
Zentiva 2013
Metronidazole (Flagyl®) - Summary of Product Characteristics
2013
3595 Laboratorio
Hospira 2009
Aciclovir - Summary of Product Characteristics
2009
3596 Laboratorio
Sanofi 2014
Chlorpromazine (Largactil®) - Summary of Product Characteristics
2014
3597 Laboratorio
AstraZeneca 2013
Terbutaline sulfate (Bricanil®) - Summary of Product Characteristics
2013
3598 Laboratorio
Clinigen Healthcare Ltd 2016
Amifostine (Ethyol®) - Résumé des caractéristiques du produit
2016
3599 Laboratorio
Amco Amdipharm Mercry 2013
Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
2013
3600 Laboratorio
UCB Pharma SA 2009
Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
2009
3601 Laboratorio
Actavis 2012
Cisatracurium Actavis - Résumé des Caractéristiques du Produit
2012
3602 Laboratorio
Baxter SAS 2013
Mesna (Uromitexan®)- Summary of Product Characteristics
2013
3603 Laboratorio
Adienne Pharma Biotech 2011
Thiotepa (Tepadina®) - Summary of Product Characteristics
2011
3604 Laboratorio
Sanofi Aventis France 2012
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
2012
3605 Laboratorio
Lipomed 2010
Dacarbazine (Dacarbazine Lipomed®) - Résumé des caractéristiques du produit
2010
3606 Laboratorio
Wokhardt 2013
Dobutamine - Summary of Product Characteristics
2013
3607 Laboratorio
AOP Orphan Pharmaceuticals AG 2013
Esmolol hydrochloride for injection - Summary of Product Characteristics
2013
3609 Laboratorio
Aspen Pharma 2013
Labetalol (Trandate®) - Summary of Product Characteristics
2013
3610 Lehti
J Oncol Pharm Practice 2014 ; 20, 1: 51-57.
Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K.
2014
3611 Lehti
J Oncol Pharm Practice 2014 ; 20, 1: 58-64.
Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T.
2014
3612 Laboratorio
Amdipharm Mercury Company 2012
Doxapram (Dopram) - Summary of Product Characteristics
2012
3613 Laboratorio
Primius Lab 2013
Dihydralazine (Nepressol®) - Résumé des caractéristiques du produit
2013
3614 Laboratorio
American Regent Inc 2013
Nicardipine Injection - Summary of Product Characteristics
2013
3615 Laboratorio
Archimeded Pharma 2012
Apomorphine (Apomorphine Archimedes®) - Résumé des caractéristiques du produit
2012
3616 Laboratorio
Boehringer Ingelheim 2012
Altéplase (Actilyse®) - Résumé des caractéristiques du produit
2012
3617 Laboratorio
Wockhardt 2011
Hyaluronidase (Hyalase®) - Summary of Product Characteristics
2011
3618 Laboratorio
Amgen 2014
Filgrastim (Neupogen®) - Summary of Product Characteristics
2014
3619 Laboratorio
Wockhardt 2016
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
2016
3620 Laboratorio
Beacon Pharmaceuticals 2012
Phenylephrine - Summary of Product Characteristics
2012
3621 Laboratorio
Renaudin 2008
Phosphate dipotassique - Résumé des caractéristiques du produit
2008
3622 Lehti
Int J Pharm Compound 2014 ; 18, 2 : 152-158.
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride.
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L.
2014
3624 Lehti
Int J Pharm Compound 2014 ; 18, 2 : 169-174.
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets.
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu.
2014
3625 Laboratorio
CSL Behring 2013
Streptokinase (Streptase®) - Summary of Product Characteristics
2013
3626 Laboratorio
Astellas Pharma 2014
Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
2014
3627 Laboratorio
Boeringer Ingelheim 2013
Tenecteplase (Metalyse®) - Summary of Product Characteristics
2013
3629 Laboratorio
Actavis UK 2014
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
2014
3630 Laboratorio
Merck Sharp Dohme 2012
Vecuronium (Norcuron®) - Summary of Product Characteristics
2012
3631 Laboratorio
Aguettant 2016
Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
2016
3632 Laboratorio
Hospira 2017
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
2017
3634 Laboratorio
Accord Healthcare 2011
Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit
2011
3635 Laboratorio
Novartis Pharmaceuticals UK Ltd 2015
Aldesleukine (Proleukin®) - Summary of Product Characteristics
2015
3637 Laboratorio
Hameln Pharmaceuticals 2014
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics
2014
3638 Laboratorio
Hospira 2010
Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics
2010
3639 Laboratorio
Wockhardt 2013
Furosemide - Summary of Product Characteristics
2013
3640 Laboratorio
Hospira 2013
Mitoxantrone - Summary of Product Characteristics
2013
3641 Laboratorio
Pierre Fabre 2011
Vinorelbine (Navelbine®) - Summary of Product Characteristics
2011
3642 Laboratorio
International Medication System (UK) 2013
Epinephrine - Résumé des Caractéristiques du Produit
2013
3643 Laboratorio
Sanofi 2015
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
2015
3644 Laboratorio
Hameln Pharmaceuticals 2010
Calcium gluconate® - Summary of Product Characteristics
2010
3645 Laboratorio
Accord Healthcare 2014
Doxorubicin - Summary of Product Characteristics
2014
3646 Laboratorio
Sanofi Aventis France 2013
Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
2013
3647 Laboratorio
Roche 2019
Trastuzumab (Herceptin® 600 mg for subcutaneous injection) - Summary of Product Characteristics
2019
3648 Lehti
Am J Health-Syst Pharm 2014 ; 71:669-673.
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Hossain M.A, Friciu M, Aubin S, Leclair G.
2014
3649 Lehti
Am J Health-Syst Pharm 2014 ; 71:657-661.
Stability of clonidine suspension in oral plastic syringes.
Ma C, Decarie D, Ensom M.H.H.
2014
3651 Lehti
Perit Dial Int 2014 ; 34:212-218
Stability of the Combination of Ceftazidime and Cephazolin in Icodextrin or pH Neutral Peritoneal Dialysis Solution.
Patel R.P, Shastri M.D, Bakkari M, Wanandy T, Jose M.D.
2014
3653 Laboratorio
Laboratoire Léo 2013
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
2013
3654 Laboratorio
Keocyt 2012
Streptozocine (Zanosar®) - Résumé des caractéristiques du produit
2012
3655 Laboratorio
Bristol Myers Squibb 2016
Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit
2016
3656 Laboratorio
Sanofi Aventis France 2014
Teicoplanine (Targocid®) - Résumé des caractéristiques du produit
2014
3658 Laboratorio
Sandoz 2014
Omeprazole - Summary of Product Characteristics.
2014
3659 Laboratorio
AstraZeneca 2016
Propofol (Diprivan®) - Résumé des caractéristiques du produit
2016
3660 Laboratorio
Hospira 2016
Isoprenaline (Isuprel®) - Résumé des caractéristiques du produit
2016
3661 Laboratorio
Laboratoire L?o 2012
Fusidate de sodium (Fucidine®) - Résumé des caractéristiques du produit
2012
3662 Laboratorio
Clinigen 2014
Foscavir (Foscarnet®) - Summary of Product Characteristics
2014
3663 Laboratorio
Panpharma 2011
Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit
2011
3664 Lehti
Am J Health-Syst Pharm 2014 ; 71:901-902.
Incompatibility of esmolol hydrochloride and furosemide in a central venous access port
Zhao B, Sun W.
2014
3665 Lehti
Am J Health-Syst Pharm 2014 ; 71:956-959
Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C.
Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N.
2014
3666 Lehti
Int J Pharm Compound 2014 ; 18, 3: 248-252.
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A,Khokhlova Kateryna O,Georgiyants Victoriya A,Vyshnevska Liliia I.
2014
3667 Lehti
Int J Pharm Compound 2014 ; 18, 3: 253-255.
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F,Sauvageot Jurgita
2014
3668 Laboratorio
Hospira 2015
Dexamethasone - Summary of Product Characteristics
2015
3669 Lehti
Ann Pharm Fr 2015 ; 73, 1: 31-36.
Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution
Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G.
2015
3670 Lehti
EJOP 2014 ; 8, 3: 26-30.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
Sewell G, Massimini M.
2014
3671 Laboratorio
Teva UK Ltd 2016
Deferoxamine - Résumé des caractéristiques du produit
2016
3672 Laboratorio
Mylan SAS 2016
Nalbuphine Mylan - Résumé des caractéristiques du produit
2016
3674 Laboratorio
PanPharma 2016
Erythromycin lactobionate - Summary of Product Characteristics
2016
3675 Laboratorio
Archimedes Pharma UK Ltd 2015
Thiopental sodium - Summary of Product Characteristics
2015
3676 Laboratorio
Hospira 2014
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
2014
3677 Laboratorio
Sanofi Aventis France 2008
Cefpirome (Cefrom®) - Résumé des caractéristiques du produit
2008
3682 Lehti
EJHP 2016 ;23:33-37
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P.
2016
3683 Laboratorio
Aguettant 2014
Baclofen - Résumé des caractéristiques du produit
2014
3684 Laboratorio
Laboratoire Léo 2012
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
2012
3685 Lehti
EJHP 2017 ; 24:4 : 235-241
A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements.
Pfeifer C, Noll S, Gerecke H, Fassauer G, Jira T, Remane Y , Vogel J, Frontini R, Reinhardt R.
2017
3686 Laboratorio
Eusapharma 2013
L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit
2013
3687 Laboratorio
Stravencon 2013
Cefuroxime sodium - Summary of Product Characteristics
2013
3688 Lehti
Can J Hosp Pharm 2014 ; 67, 2: 102-107
Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C).
Walker S.E, Charbonneau L.F, Law S.
2014
3691 Lehti
J Oncol Pharm Practice 2016 ; 22: 21-25
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer
Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S.
2016
3694 Lehti
Am J Hosp Pharm 1989 ; 46: 985-989.
Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration.
Smith J.A, Morris A, Duafala M.E, Bertino J.R, Markman M, Kleinberg M.
1989
3696 Lehti
Braz J Pharm Sci 2012 ; 48, 4: 691-698.
Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution.
Santos C.A.D, Oliveira-Nascimento L, Knirsch M.C, Stephano M.A, Pessoa J?nior A, Penna T.C.V.
2012
3700 Lehti
Braz J Pharm Sci 2010 ; 46, 1 : 109-114.
Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp.
Salgado A.C.G.B; Silva A.M.N.N; Machado M.C.J.C; Duarte MA.S.C; Ribeiro, Helena M.O.M.
2010
3701 Laboratorio
Gentium SPa 2014
Defibrotide (Defitelio®) - Summary of Product Characteristics
2014
3702 Lehti
J Pharm Pract and Res 2014 ; 44, 1: 26-28.
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
McDougall D.A.J, McWhinney.
2014
3704 Lehti
Can J Hosp Pharm 2014 ; 67, 3:179-202.
Stability of Epinephrine at Standard Concentrations
Carr R.R, Decarie D, Ensom M.H.H
2014
3705 Lehti
EJHP 2014 ;21:161-166
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
Knudsen L, Eisend S, Haake N, Kunze T.
2014
3706 Lehti
Farm Hosp 2014 ;38, 3:154-161
Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia.
Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B.
2014
3707 Lehti
J Oncol Pharm Practice 2014 ; 20: 183-189
Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
Spindeldreier K, Thiesen J, Lipp H.P, Krämer I.
2014
3708 Ilmoitus
ECOP 2 Krakow 2014
Compatibility of epirubicin-loaded DC Beads with different contrast media.
Sarakbi I, Thiesen J, Krämer I.
2014
3711 Laboratorio
Takeda 2015
Vedolizumab (Entyvio®) - Summary of Product Characteristics
2015
3712 Lehti
Pediatr Crit Care Med 2001 ; 2, 4: 315-317.
Stability of dopamine and epinephrine solutions up to 84 hours.
Ghanayem N.S, Lee L, Nelson T, Wong S, Gordon G.B, Markdante K et al.
2001
3713 Lehti
Can J Hosp Pharm 2014 ; 67, 4 : 274-278
Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D.
2014
3714 Lehti
Can J Hosp Pharm 2014 ; 67, 4: 274-280.
Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D.
2014
3715 Lehti
Am J Health-Syst Pharm 2014 ; 71:1534-1535
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D.
2014
3717 Lehti
Am J Health-Syst Pharm 2014 ; 71:1480-1484
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.
2014
3718 Laboratorio
Bayer Healthcare Corporation 2012
Conivaptan (Vaprisol®) - Summary of Product Characteristics
2012
3721 Laboratorio
Spectrum Pharmaceuticals 2014
Belinostat (Beleodaq®) - Summary of Product Characteristics
2014
3722 Lehti
Acta Pol Pharm 2014 ; 71, 4: 661-666.
Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska.
2014
3723 Lehti
Archives de Pédiatrie 1998 ; 5, 10: 1170-1171.
Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal.
Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J.
1998
3725 Lehti
Dysphagia 2014
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D.
2014
3728 Lehti
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
2014
3731 Lehti
J Pharm Sci 1978 ; 67, 4: 526-530.
Thermal and photolytic decomposition of methotrexate in aqueous solutions.
Chatterji D.C, Gallelli J.F.
1978
3743 Lehti
Int J Pharm 1991 ; 69: 197-210.
The degradation of carboplatin in aqueous solutions containing chloride or other selected nucleophiles.
Allsopp M.A, Sewell G.J, Rowland C.G, Riley C.M, Schowen R.L.
1991
3745 Lehti
Am J Hosp Pharm 1979 ; 36: 881.
Sodium chloride residue provides potential for drug incompatibiities.
Kuenhle C, Moore
1979
3752 Laboratorio
Durata Therapeutics Holding 2014
Dalbavancin (Dalvance®) - Summary of Product Characteristics
2014
3753 Laboratorio
Cubist Pharmaceuticals 2014
Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
2014
3754 Lehti
Int J Pharm Compound 2014 ;18, 5: 418-426.
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation.
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H.
2014
3755 Lehti
Int J Pharm Compound 2014 ; 18, 5: 427-431.
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.
2014
3756 Lehti
Int J Pharm Compound 2014 ; 18, 5: 423-437.
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers.
McCluskey S.V, Sztajnkrycer M.D, Jenkins D.A, Zietlow S P, Berns K.S, Park Myung S.
2014
3757 Lehti
Antimicrob Agents Chemother 2014 ; 58 : 2849-2855.
How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis?
Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R
2014
3758 Lehti
J Pharm Pract and Res 2014 ; 44, 89?94
Feasibility and stability of metaraminol in pre-filled syringes.
To T.P, Ching M.S, Booth J.C, Zeglinski P, McGrath A, Elli A.G,Garrett K.
2014
3759 Lehti
Yakugaku Zasshi 2014 ; 134, 2: 293-298.
Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier.
Igarashi K, Kawahara M.
2014
3760 Lehti
J Oncol Pharm Practice 1996 ; 2: 107-112.
An evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion system.
Tivnann H, Gaines-Gas R, Thorpe R et al.
1996
3761 Kirja
Master en pharmacie - University of Geneva 2014
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Chavan E.
2014
3763 Lehti
Can J Hosp Pharm 2014 ; 67, 5:
Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, Décarie D.
2014
3764 Lehti
Am J Health-Syst Pharm 2014 2014; 71: 1831-1832.
Compatibility of argatroban injection with select antiarrhythmic drugs
Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S.
2014
3766 Lehti
Pharmactuel 2014 ; 47, 3 : 161-165.
Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels
Forrest J.M, Hildgen P.
2014
3767 Lehti
Pharmactuel 2014 ; 47, 3 : 167-172.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
2014
3768 Laboratorio
Roche Products Limited 2014
Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
2014
3769 Laboratorio
B Braun laboratoire 2014
Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit
2014
3770 Laboratorio
Eclat Pharmaceuticals 2014
Phenylephrine hydrochloride (Vazculep®) - Summary of Product Characteristics
2014
3771 Laboratorio
Merck Sharp Dohme 2017
Pembrolizumab (Keytruda®) - Summary of Product Characteristics
2017
3772 Laboratorio
Janssen Biotech 2017
Siltuximab (Sylvant®) - Summary of Product Characteristics
2017
3773 Laboratorio
Eli Lilly 2014
Ramicirumab (Cyramza®) - Summary of Product Characteristics
2014
3774 Laboratorio
Amgen 2016
Blinatumomab - (Blincyto®) - Summary of Product Characteristics
2016
3775 Laboratorio
Talon Therapeutics 2014
Vincristine sulfate liposome (Marqibo®) - Summary of Product Characteristics
2014
3776 Laboratorio
Teva Pharmaceuticals 2014
Omecetaxine (Synribo®) - Summary of Product Characteristics
2014
3777 Lehti
Am J Health-Syst Pharm 2015 ; 72:13-14
Stability of ampicillin and amoxicillin in peritoneal dialysis solutions
Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D.
2015
3779 Lehti
Am J Health-Syst Pharm 2014 ; 71:2061-2065
Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
Kintzel P.E, Zhao T, Wen B, Sun D.
2014
3780 Lehti
EJHP 2015 ;22:7-11
Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride
Chen F, Peng L, Zhou B, Fang B, Yang Y.
2015
3781 Lehti
EJHP 2015 ;22:1 56-58
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A
2015
3782 Lehti
Int J Pharm 2014 , 477, 1-2 : 32-38.
­Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a
2014
3785 Lehti
J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370.
Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl
Prohotsky D.L, . Juba K.M, Zhao F.
2014
3786 Lehti
JAMA Ophtalmology 2014 ; 132, 11: 1372-1373.
Stability of Melphalan Solution for Intravitreal Injection for Retinoblastoma
Buitrago E, Lagomarsino E; Mato G; Schaiquevich P.
2014
3787 Laboratorio
The Medicines Company 2016
Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics
2016
3789 Lehti
Int J Pharm Compound 2015 ; 19, 1: 73-77.
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions.
Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V.
2015
3791 Ilmoitus
Apifh Congress, Paris November 2014 2014
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
2014
3792 Lehti
J Ped Pharm Pract 1999 ; 4: 186-189.
Stability of amiodarone in extemporaneous oral suspension prepared from commercially available vehicles.
Nahata M.C, Morosco R.S, Hipple T.F.
1999
3793 Lehti
Drug Intell Clin Pharm 1991 ; 25: 465-469.
Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices.
Nahata M.C.
1991
3794 Lehti
Can J Hosp Pharm 2017 ; 70,3 :247-249
Vancomycin 50 mg/mL Suspension in Oral Syrup: Stability in Plastic Bottles and Syringes at 2 Temperatures.
Smith A.D, Rempel G, Szeitz A, Klassen T.L, Ensom M.H.H.
2017
3796 Lehti
Br Ophtalmol 1995 ; 79: 753-755.
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Morlet N, Young S, Naidoo D et al.
1995
3798 Lehti
Analytical Letter 1994 . 27: 1159-1164.
Stability indicating HPLC assay of zidovudine in extemporaneously syrup.
Radwan M.A.
1994
3800 Lehti
Iranian J Pharm Res 2003 : 157-160.
Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop.
Rahim Bahri Najafi, Soleyman Mohammadi Samania, Nahid Pishvab, Fateme Moheimania.
2003
3802 Lehti
J Clin Pharm Ther 1998 ; 23: 451-456.
Stability of captopril in invert sugar solution
Sam W.J, Ho P.C.
1998
3803 Laboratorio
Laboratoires Merck Sharp & Dohme Chibret 2020
Ceftolozane / tazobactam (Zerbaxa®) - Summary of Product Characteristics
2020
3804 Lehti
EJHP 2014 ;22:150-155.
Physicochemical stability of cabazitaxel and docetaxel solutions.
Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.
2014
3805 Lehti
Am J Health-Syst Pharm 2015 ; 72:1374-1378.
Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.
Chen F.C, Xiong H, Liu H.M, Fang B.X, Li P.
2015
3810 Lehti
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Geiger C M, Sorenson B, Whaley P.
2015
3811 Lehti
Int J Pharm Compound 2015 ; 19, 5 : 428-431.
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Nahata Milap C.
2015
3812 Lehti
Int J Pharm Compound 2015 ; 19, 5 : 432-436.
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Bhattacharya S, Parekh S, Dedhiya M.
2015
3813 Lehti
Hosp Pharm 2015 ; 50, 8: 710-713.
Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
Teibel H.M, Knoderer C.A, Nichols K.R.
2015
3816 Ilmoitus
SFPO Congress, Nantes, France 2015
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.
2015
3817 Ilmoitus
Gerpac Congress, Giens, France 2015
A stability study of 25 mg/mL phenylephrine hydrochloride and 5 mg/mL tropicamide eye drops.
Stordeur F, Chanat C, Brandely M.L, Chast F.
2015
3818 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.
2017
3819 Lehti
J Pharm Biomed Anal 2015 ; 118: 105-112.
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B.
2015
3821 Lehti
Am J Health-Syst Pharm 2015 ; 72:2182-2188
Stability of furosemide and chlorothiazide stored in syringes.
Cies J.J, Moore W.S, Chopra A, Lu G, Mason R.W.
2015
3823 Lehti
Pharmactuel 2015 ; 48, 3 : 146-152.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
2015
3824 Lehti
Pharmactuel 2023 2023;56,3:91-98
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Boudi S, Roy H, Forest JM, Leclair G.
2023
3825 Lehti
J Pharm Pract and Res 2015 ; 496: 421-431.
Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance.
Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G.
2015
3826 Lehti
Can J Hosp Pharm 2015 ; 68, 6: 489-491.
Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D, Lingertat-Walsh K.
2015
3827 Ilmoitus
ASHP Midyear 2015
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
Ghazi I.M, Hamada Y, Nicolau D.P.
2015
3828 Ilmoitus
ASHP Midyear 2015
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
Thabit A.K, Hamada Y, Nicolau D.P.
2015
3829 Ilmoitus
ASHP Midyear 2015
Compatibility of isavunazonium sulfate during simulated Y-site administration.
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
2015
3830 Lehti
J Oncol Pharm Practice 2016 ; 22: 31-36.
Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
Myers A.Ls, Zhang Y-P, Kawedia L, Trinh V.A, Tran H, Smith J.A, Kramer M.A.
2016
3832 Lehti
Ann Pharmacotherapy 2016 ; 50: 155-156.
Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension.
Ei Mon Phyo Lwin, Ellis D, SonY, Turner S, Garg S.
2016
3835 Lehti
Current Ther Res 2015 ; 77: 99-104.
Chemical Stability of Telavancin in Elastomeric Pumps.
Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C.
2015
3837 Lehti
South Asian J Trop Med Pub Health 2003 ; 34: 627-629.
Stability of meropenem in normal saline solution after storage at room temperature.
Jaruratanasirikul S, Sriwiriyajan S.
2003
3838 Laboratorio
Martindale Pharmaceuticals Ltd 2007
Magnesium Sulphate - Summary of Product Characteristics
2007
3839 Lehti
Current Ther Res 2015 ; 77: 105-110.
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T.
2015
3840 Lehti
Acta Pol Pharm 2016 ; 73, 1: 23-27.
Stability of cefpirome sulfate in aqueous solutions.
Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J.
2016
3841 Lehti
Am J Health-Syst Pharm 2016 ; 73:241-246
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations.
Nicholas O?Donnell J, Venkatesan N, Manek M, Rhodes N.J, Scheetz M.H.
2016
3842 Lehti
Am J Health-Syst Pharm 2016 ; 73:137-142.
Stability of tacrolimus solutions in polyolefin containers.
Lee J.H, Goldspiel B.R, Ryu S, Potti G.K.
2016
3843 Lehti
Int J Pharm Compound 2016 ; 20, 1: 81-85
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock G.F, Sauvageot J, Hill A, Killian A.
2016
3844 Lehti
Ann Pharmacotherapy 2016 ; 50: 243-244.
Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates.
Sauberan J.B, Phuong P, Ilog N.D, Rossi S.S.
2016
3845 Lehti
Ann Pharmacotherapy 2016 ; 50: 245-246
Stability of Pentobarbital in Water and Oral Pediatric Suspensions.
Schlatter J, Kabiche S, Balde I-S, Majoul E, Cisternino S, Fontan J.E.
2016
3846 Lehti
Pharmazie 2016 71: 185?191.
Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions.
Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO.
2016
3847 Lehti
J Pain Palliat Care Pharm 2016 ; 29, 4: 370-373.
A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution.
Raphael C.D, Zhao F, Hughes S.E, Juba K.M.
2016
3848 Opinnäytetyö
Thèse de doctorat en pharmacie 2014
Etude de stabilité d'un collyre à l'amphotéricine B 0,5%.
Dermu Marine.
2014
3849 Lehti
Curr Pharm Biotech 2013 ; 14, 2: 220-225.
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
Pabari R.M, Ryan B, Ahmad W, Ramtoola Z.
2013
3850 Lehti
Eur J Cancer 2016 ; 58: 8-16.
Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M.
2016
3851 Lehti
Can J Hosp Pharm 2016 ; 69, 1: 49-51.
Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D.
2016
3854 Lehti
Can J Hosp Pharm 2016 ; 69, 2: 171-173.
Stability of extemporaneously compounded trimethioprim in glass and plastic bottles and plastic syringes.
Ensom M.H.H, Decarie D.
2016
3856 Lehti
Int J Pharm Compound 2016 ; 20, 2:164-166.
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata M.C.
2016
3857 Lehti
Int J Pharm Compound 2016 ; 20, 2: 167-174.
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F.
2016
3859 Lehti
RRJHCP 2016 ; 1, 3: 31-37.
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
Foy G, Poinsignon V, Mercier L, Laurent S, Paci A.
2016
3860 Lehti
J Pharm Pract and Res 2016 ; 46: 10-14.
Stability of trimethoprim in newly formulated liquid dosage form.
Patel R.P, Wanandy T, Zani R, Jose M.D, Shastri M, Zaidi S.T.R.
2016
3861 Lehti
J Pharm Pract and Res 2016 ; 46: 28-33.
Evaluation of stability of melatonin in extemporaneously compounded oral suspensions.
Friciu M , Savji T , Zaraa S, Leclair G.
2016
3862 Lehti
Hosp Pharm 2016 ; 51, 3: 246-251.
Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions.
Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A.
2016
3865 Lehti
Int J Pharm Compound 2016 ; 20, 3 : 236-238.
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration.
Vicky M, Samit S, Jaymin P, Michael C T.
2016
3866 Lehti
Int J Pharm Compound 2016 ; 30, 3 : 247-249.
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children.
Nahata M C.
2016
3868 Lehti
J Oncol Pharm Practice 2016 ; 22: 571-572
Incompatibility of busulfan with 1 ml Luer-Lock syringes.
Loboda C, Lider P, Vigneron J.
2016
3869 Lehti
J Pharm Pharmacol 2016 ; 68: 433-438.
Influence of 5% dextrose volume on amphotericin B deoxycholate preparation
Sun P, Chen J, Zhang Z, Gao X, Chen P, Li X.
2016
3871 Ilmoitus
Synprefh Congress Clermont Ferrand, France 2016
Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ?
Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M.
2016
3872 Lehti
Hosp Pharm 2016 ; 51: 389-395.
Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
Malik A, Gorman G, Coward L ,. Arnold J.J.
2016
3873 Lehti
Am J Health-Syst Pharm 2016 ; 73:755.
Incompatibility between irinotecan and fluorouracil injections
Tan X, Hu J.
2016
3874 Lehti
Ann Pharm Fr 2016 ; 74: 283-287.
Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes
Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L.
2016
3875 Lehti
EJHP 2016 ; 23: 4: 213-218.
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.
Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S.
2016
3879 Lehti
Int J Pharm Compound 2016 ; 20, 4 : 328-332.
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.
2016
3880 Lehti
Int J Pharm Compound 2016 ; 20, 4 : 338-342
Stability of Ampicillin in Normal Saline and Buffered Normal Saline.
Maher M, Jensen Kara J,Lee David, Nix David E
2016
3881 Lehti
Int J Pharm Compound 2016 ; 20, 4 : 343-346
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump.
Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A.
2016
3883 Laboratorio
Arrow 2016
Ceftazidime - Résumé des caractéristiques du produit
2016
3885 Lehti
Int J Pharm 2016 ; 506 : 414-419.
Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method.
Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang.
2016
3886 Lehti
Eur J Pharm Sci 2016 ; 92 : 220-223.
Design and stability study of an oral solution of amlodipine besylate for pediatric patients.
van der Vossen A.C, van der Velde I, Smeets O.S.N.M,. Postma D.J, Vermes A,. Koch B.C.P, Vulto A.G,.Hanff L.M.
2016
3887 Lehti
Perit Dial Int 2016 ; 36:410-414.
Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions.
Robiyanto R, Zaidi S.T.R, . Shastri M.D, Castelino R.L, Wanandy S.T, Jose M.D, . Patel R.P.
2016
3888 Lehti
Perit Dial Int 2016 ; 36:421-426.
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A
2016
3891 Lehti
Can J Hosp Pharm 2015 ; 68, 2: 121-126.
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Walker S.E, Law S, Perks W, Iazzetta J.
2015
3892 Lehti
Can J Hosp Pharm 2016 ; 69, 4 : 329-333.
Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions
Friciu M, Chefson A, Leclair G.
2016
3893 Lehti
Can J Hosp Pharm 2016 ; 69, 4: 327-329.
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions
Friciu M, Zaraa S, Leclair G.
2016
3895 Lehti
Ann Pharmacotherapy 2016 ; 50: 790-792.
Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients
Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L.
2016
3896 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:73-81
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
Kim S.H, Thiesen J, Krämer I.
2016
3897 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:83-89
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials.
Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F.
2016
3898 Lehti
EJHP 2016 ;23:288-293
Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients
Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa
2016
3901 Lehti
Int J Pharm Compound 2016 ; 20, 5 : 421-425.
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A,Mandal Tarun K
2016
3902 Lehti
Int J Pharm Compound 2016 ; 20, 5 : 426-434.
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.
2016
3903 Lehti
Int J Pharm Compound 2016 ; 20, 5 : 435-437.
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light.
Anderson Collin R, Collins D, Laursen T, Arave T, Helm M.
2016
3910 Lehti
EJHP 2016 ; 23: 352-358.
Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O.
2016
3911 Lehti
EJHP 2017 ; 24: 230-234.
Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?
Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L.
2017
3913 Lehti
EJHP 2018 ;25,3:150-156.
Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.
Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O.
2018
3915 Lehti
Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088.
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A.
2016
3916 Lehti
Int J Pharm Compound 2016 ; 20, 6 : 514-516.
Stability of Fentanyl Citrate in Polyolefin Bags.
Donnelly R F.
2016
3917 Lehti
Int J Pharm Compound 2016 ; 20, 6 : 521-525.
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature.
Larson B L, Bushman L R, Casciano M L, Oldland A R, Kiser J J, Kiser T H.
2016
3918 Lehti
J Oncol Pharm Practice 2016 ; 22: 749-756.
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
Sarakbi I, Krämer I.
2016
3919 Lehti
Eur J Pharm Sci 2017 ; 96: 449-455.
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S.
2017
3920 Laboratorio
Fresenius Kabi 2018
Levofloxacine - Résumé Caractéristique du Produit
2018
3921 Lehti
Can J Hosp Pharm 2016 ; 69, 6: 505-507.
Stability of extemporaneously prepared enalapril maleate suspensions in glass bottles and plastic syringes.
Friciu M, Zaraa S, Leclair G.
2016
3922 Lehti
Perit Dial Int 2016 doi:10.3747/pdi.2016.0001
Compatibility of meropenem with different commercial dialysis solutions.
Wiesholzer, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G,Poepp l W.
2016
3923 Lehti
Am J Health-Syst Pharm 2017 ; 74, 1: e64-e71
Stability of sildenafil in combination with heparin and dopamine.
Luu Y, Thigpen J, Brown S.D.
2017
3924 Lehti
Ann Pharm Fr 2016 ; 75, 1 : 17-29.
One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C.
Vieillard V, Astier A, Sauzay C, Paul M.
2016
3925 Lehti
Ann Pharm Fr 2016 ; 75, 1 : 30-39.
Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C.
Simar J, Godet M, Hecq J.-D, Closset M, Gillet P, Langhendries C, Bihin B, Jamart J, Galanti L.
2016
3926 Lehti
Hosp Pharm 2016 ; 51 ; 11 : 915-921.
Stability of Levodopa/Carbidopa Rectal Suspensions.
Donnelly R.F.
2016
3927 Lehti
Int J Pharm Compound 2017 ; 21, 1 : 66-75.
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
Wu G,Yeung S,Chen F.
2017
3928 Lehti
Int J Pharm Compound 2017 ; 21, 1: 76-82.
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
Wu G, Yeung S, Chen F.
2017
3930 Laboratorio
Serb laboratoire 2013
Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit
2013
3931 Laboratorio
Pfizer Laboratoire 2016
Trimébutine (Débridat®) - Résumé des caractéristiques du produit
2016
3932 Laboratorio
Serb Laboratoire 2015
Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
2015
3933 Laboratorio
Teva Laboratoire 2015
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
2015
3934 Laboratorio
GlaxoSmithKline Laboratoire 2016
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
2016
3935 Laboratorio
Sanofi Laboratoire 2016
Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit
2016
3936 Laboratorio
GlaxoSmithKline Laboratoire 2016
Bélimumab (Benlysta®) – Résumé des caractéristiques du produits
2016
3937 Lehti
Biomat Res 2015 ; 19, 2
Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration.
Park K.H, Chung D.J.
2015
3938 Laboratorio
Lilly S.A 2016
Necitumumab (Portrazza®) – Résumé des caractéristiques du produits
2016
3941 Laboratorio
Concordia International 2017
Nicardipine - Summary of Product Characteristics
2017
3942 Lehti
Am J Health-Syst Pharm 2017 ; 74, 5: 280-281.
Physical compatibility of valproate sodium injection with dobutamine and dopamine.
Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D.
2017
3945 Lehti
Can J Hosp Pharm 2017 ; 70,1 : 7-12.
Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags.
Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E.
2017
3946 Lehti
Can J Hosp Pharm 2017 ; 70,1 :51-53.
Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes
Friciu M, Zaraa S, Leclair G.
2017
3948 Lehti
JPEN 2012 ;30. 416?424.
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
2012
3949 Ilmoitus
JFSPH Congress, Bern, Switzerland. 2016
Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité
Brönnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F.
2016
3951 Lehti
Hemodial Int 2009 ; 13, 3: 322-328.
Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Battistella M, Walker S, law S, Lok C.
2009
3952 Lehti
Hemodial Int 2010 ; 14, 3 : 322-326.
Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C.
Battistella M,. Vercaigne L.M, Cote D,. Lok C.E.
2010
3953 Lehti
Hemodial Int 2011 ; 15, 2 : 364-272.
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X.
2011
3956 Lehti
ASAIO Journal 2005 ; 51,6:761-763.
Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique.
Bastani B; Amin K; Herr A.
2005
3958 Lehti
J Infect Dis 1988 ; 157, 3: 600-601.
A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities .
Henrickson K.J; . Powell K.R; . Schwartz C.L.
1988
3960 Lehti
Hosp Pharm 2017 ;52,2:132-137.
Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
Kufel W.D, Miller C.D, Johnson P.R, Reid K., Zahra J.J, Seabury R.W.
2017
3961 Lehti
Int J Pharm Compound 2017 ; 21, 2: 150-153.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
McCluskey S.V,Kirkham K,Munson J.M.
2017
3963 Lehti
Int J Pharm Compound 2017 ; 21, 2: 160-163.
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J.
2017
3964 Lehti
Pharmactuel 2017 ; 50,1 : 27-33.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
2017
3967 Lehti
J Pharm Pharmacol 2017 ;69,7:448-462
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
Staven V, Herra I, Wang S, Grönlie I,Tho I.
2017
3968 Laboratorio
Fresenius Kabi 2015
Ringer lactate - Résumé des Caractéristiques du Produit
2015
3969 Lehti
Neuromodulation 2017
Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems.
Yue B, Brendel R, Lukitsch A, Prentice T, Doty B.
2017
3971 Lehti
Int J Pharm Compound 2017 ; 21, 2 : 164-170.
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
Gorman G, Sokom S, Coward L, Arnold J J.
2017
3974 Lehti
Eur J Pharm Sci 2020
Stability of frozen 1% voriconazole eye drops in glass and in innovative containers.
Roche M, Lannoy D, Bourdon F, Dhorne C, Berneron C, Danel C, G.Fernandez, M.J,Simon N, Odou P.
2020
3975 Ilmoitus
EAHP congress - Cannes 2017
Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C.
Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P.
2017
3976 Lehti
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
2017
3977 Lehti
Drugs R D 2015 ;15:253-259.
Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection.
Desmaris R.P, Mercier L, Paci A.
2015
3978 Lehti
Am J Health-Syst Pharm 2017 ; 74,9: 202-210
Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations.
Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O.
2017
3980 Lehti
Am J Health-Syst Pharm 2017 ; 74,9: e211-e223
Stability study of methotrexate in 0.9% sodium chloride injection and 5% dextrose injection with limit tests for impurities.
Nissen K.B, Jorgensen L.B, Berg D.L, Andersen G.
2017
3981 Lehti
EJHP 2017 ;24:162?166
Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.
2017
3983 Lehti
EJHP 2016 ; 24: 157-161.
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.
Zaid A.N, Assali M, Zalmout S, Basheer A.
2016
3984 Lehti
Hosp Pharm 2017 ,52;3 : 221-228
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Meyer K, Santarossa M, Danziger L.H, Wenzler E.
2017
3985 Ilmoitus
Hopipharm Congress 2017 - Nancy 2017
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.
2017
3986 Lehti
Krankenhauspharmazie 2017 ;38:377-82.
Physikalisch-chemische Stabilität von Carfilzomib (Kyprolis®) im Originalbehältnis nach Erstanbruch und in applikationsfertigen Zubereitungen.
Kim S, Krämer I.
2017
3988 Lehti
Am J Health-Syst Pharm 2017 ; 74:13 : 1002-1006
Stability of tacrolimus ophthalmic solution.
Ezquer-Garin C, Ferriols-Lisart R, Al?s-Almi?ana M.
2017
3989 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017 ; 2,1: 35
Stability of midazolam and noradrenaline stored in cyclic olefin copolymer AT-Closed Vials® and polypropylene syringes during 365 days.
Feutry F, Genay S, Velghe C, Barthélémy C, Décaudin B, Odou, P.
2017
3992 Lehti
Int J Pharm 2016 ; 509 : 279:284.
Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S.
2016
3993 Lehti
Int J Pharm Compound 2017 ; 3: 251-254
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
McHenry A.R,Wempe M.F., Rice P.J.
2017
3994 Lehti
Int J Pharm Compound 2017 ; 3: 255-263
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A.
2017
3996 Lehti
Int J Pharm Compound 2017 ; 21,3 : 240-241.
Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil.
Dijkers E,Nanhekhan V,Thorissen A.
2017
3997 Lehti
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Katip W.
2017
3998 Lehti
Int J Pharm Compound 2017 ; 21:4 :347-351
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
Robert J, Sorrieul J, Rossignol E, Beaussart H, Kieffer H, Folliard C, Dupoiron D, Devys C.
2017
3999 Lehti
Int J Pharm Compound 2017 ; 21:4 :339-346
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A.
2017
4000 Lehti
Int J Pharm Compound 2017 ; 21:4 :334-338
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt.
Graves R, Phan K.V,Bostanian L.A,Mandal T.K, Pramar Y.V.
2017
4001 Lehti
Int J Pharm Compound 2017 ; 21:4 :322-329
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox).
Ip K,Carvalho M,Shan A,Banov D.
2017
4003 Lehti
EJHP 2017 ; 25, 3: 157-164.
Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).
Kim J, Chung J, Park S, Jung S, Kang D.
2017
4004 Lehti
Krankenhauspharmazie 2017 ;38,7:334?340.
Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz.
2017
4007 Ilmoitus
Hopipharm Congress 2017-Nancy 2017
Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P.
2017
4008 Ilmoitus
Hopipharm Congress 2017-Nancy 2017
Formulation et étude de stabilité de crèmes au sirolimus dosées à 0,1, à 0,25 ou à 0,5% m/m.
Vrignaud S, Bougueon G, Briot T, Truffaut C, Martin L, Pailhori?s H, Bastiat G, Clerc M-A, Lagarce F.
2017
4009 Laboratorio
Panpharma 2017
Droperidol - Résumé des Caractéristiques du Produit
2017
4011 Lehti
EJHP 2016 2016;0:1-11
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
Gersonde F, Eisend S, Haake N, Kunze T.
2016
4012 Lehti
EJHP 2018 ; 25, e2
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.
Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R.
2018
4013 Lehti
EJHP 2018 ; 25, e2
Stability of warfarin sodium flavoured preservative-free oral liquid formulations.
Schlatter J, Cisternino S.
2018
4016 Lehti
Ann Pharm Fr 2017 ; 75, 6: 420-435.
Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag.
Vieillard V, Paul M, Ibrahim T, Astier A.
2017
4018 Lehti
Krankenhauspharmazie 2017 ;38:423-429
Physikalisch-chemische Stabilität von rekonstituierten Trabectedin-haltigen Lösungen.
Lipp H-P, Gfrörer W
2017
4020 Lehti
Hosp Pharm 2010 ;45,10:779?784
Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture.
T. Schulz L, J. Elder E, Jones K, Vijayan A, D. Johnson B, E. Medow J, Vermeulen L.
2010
4021 Lehti
J Oncol Pharm Practice 2017 ;25,2: 303-308
Long-term stability of ganciclovir in polypropylene containers at room temperature.
Guichard N, Bonnabry P, Rudaz S, Fleury S.
2017
4022 Lehti
Am J Health-Syst Pharm 2017 ; 74,19: 1579-1583
Stability of extemporaneously prepared rosuvastatin oral suspension.
Zaid A.N, Shtayah R, Qadumi A, Ghanem M, Qedan R, Daibes M, Abu Awwad S, Jaradat N, Kittana N.
2017
4023 Lehti
Hosp Pharm 2017 ; 52,7 : 478-482.
Compounded Apixaban Suspensions for Enteral Feeding Tubes.
Carabello M, Donmez S, Nathan K, Zhao F.
2017
4024 Ilmoitus
SFPO Congress 2017 - Nantes 2017
Pénurie mondiale d'Etopophos et conséquences pratiques : Intérêt des études de stabilité dans le choix d'un générique.
Sadou Yaye H, Rieber Z, HassaniI L, Hoffmann-Martinot C, Babiard M, Aouti H, Bellanger A, Tilleul P.
2017
4025 Ilmoitus
SFPO Congress 2017 - Nantes 2017
Stabilité physico-chimique de solutions de Nivolumab à 1 mois.
Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M.
2017
4026 Lehti
Hosp Pharm 2017 ; 52, 8 : 570-573
Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags.
Van Matre E.T, Ho K.C., Lyda C, Fullmer B.A, Oldlan A.R, Kiser T.H.
2017
4027 Lehti
Hosp Pharm 2017 ;52,10:685-690
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.
Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M.
2017
4028 Lehti
Hosp Pharm 2017 ;52,10 :704-708
Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags.
Donnelly R.
2017
4029 Lehti
Int J Pharm Compound 2017 ; 21, 5: 436-439
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags.
Marquis K, Hohlfelder B, Szumita Paul.
2017
4030 Lehti
Int J Pharm Compound 2017 ; 21, 5 : 430-435
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.
2017
4031 Lehti
Int J Pharm Compound 2017 ;21 , 5 : 426-429
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Kirkham K, Munson J, McCluskey S, Graner K.
2017
4032 Ilmoitus
EAHP Congress - Paris 2013
Stability of frozen ceftazidime in polypropylene syringes for intravitreal injection.
Daul A, Vigneron J, Zenier H, May I, Demor? B.
2013
4033 Lehti
Am J Health-Syst Pharm 2017 ;74,22:1887-1894
Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay.
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S.
2017
4034 Lehti
Afr J Pharm Pharmacol 2012 ;27,6:2055-2060
Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions.
Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y.
2012
4035 Lehti
EJHP 2017 ;0:1-5
Physicochemical stability of voriconazole in elastomeric devices.
Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P.
2017
4036 Lehti
EJHP 2017 ;25,4: 200-203.
Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.
Estan-Cerezo G, Matoses-Chirivella C, Soriano-Iriga L, Murcia-Lopez A.C, Rodrguez-Lucena F.J, Navarro-Ruiz A.
2017
4040 Lehti
J Oncol Pharm Practice 2017 ;25,2: 269-278
The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion.
Lamanna W.C, Heller K, Schneider D, Guerrasio R, Hampl V, Fritsch C, Schiestl M.
2017
4041 Ilmoitus
SNPHPU Congress 12th 2017
Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité.
Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R.
2017
4043 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4: 145-157.
Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen.
Kim S, Heeb R, Krämer I.
2017
4044 Lehti
Pharm Sci Communications 2017 ;9:5:28-35
Quality assessment and stability study of compounded furosemide syrup.
Alfred-Ugbendo D, Zdoryk O.A, Georgiyants V.A.
2017
4045 Lehti
J Pharm Biomed Anal 2016 ;124:365-373
A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor.
Sestak V, Roh J, Klepalova L, Kovarikova P.
2016
4047 Lehti
J Oncol Pharm Practice 2017 ;25,2: 339-350
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
Kim S.H, Krämer I.
2017
4048 Lehti
Hosp Pharm 2017 ;52,11:752-760
In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes.
Reindel K, Zhao F, Hughes S, Dave V.
2017
4049 Lehti
J Pharm Biomed Anal 2018 ; 150 : 386-395
Stability of infliximab solutions in different temperature and dilution conditions.
Tokhadze N, Chennell P, Le Basle Y, Sautou V.
2018
4050 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:193-201
Preparation and physico-chemical stability of dexamethasone oral suspension.
Binson G, Venisse N, Bacle A, Beuzit K, Dupuis A.
2017
4051 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:173-180
Stability study of morphine and baclofen solution in polypropylene syringes.
Robert J, Sorrieul J, Kieffer H, Folliard C, Gibory V, Dupoiron D, Devys C.
2017
4052 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2017
Physicochemical and microbiological stability of a new paediatric oral solution of clonidine.
Verhlac C, Bourdon F, Titecat M, Frealle E, Dhorne C, Berneron C, Odou P.
2017
4053 Lehti
Am J Health-Syst Pharm 2017 ;74,24:2060-2064
Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis P, Cluck D, Huffman J, Ogle A, Brown S.
2017
4054 Lehti
Am J Health-Syst Pharm 2018 , 75, 1: 28-35
Stability of extemporaneously prepared preservative-free prochlorperazine nasal spray.
Yellepeddi V.
2018
4055 Lehti
Am J Health-Syst Pharm 2018 , 75, 1:36-44
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
2018
4056 Lehti
Perit Dial Int 2017
Stability of ceftazidime and heparine in four different types of peritoneal dialysis solutions.
Kandel S, Zaidi S, Wanandy T, Ming L, Castelino R, Sud K, Patel R.
2017
4057 Lehti
Hosp Pharm 2018 ; 53, 2: 125-127.
Physical Compatibility of Micafungin With Sodium Bicarbonate Hydratation Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
Joiner L, Ynes C, Arnold J, Miller R, Gorman G.
2018
4059 Lehti
EJHP 2017 ; 25, e2
Physical and chemical stability of ceftaroline in an elastomeric infusion device.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.
2017
4060 Lehti
EJHP 2018 ;25,3:144-149
Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study.
Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P.
2018
4061 Lehti
Int J Pharm Compound 2018 ; 22,1 :86-94
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K.
2018
4062 Lehti
Int J Pharm Compound 2018 ;22,1:76-85
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K.
2018
4063 Lehti
Int J Pharm Compound 2018 ;22,1:66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Manchanda A, Laracy M, Savji T, Bogner R.
2018
4065 Laboratorio
Mylan 2018
Urapidil (Eupressyl® - résumé des caractéristiques du produit)
2018
4066 Ilmoitus
APHIF 2017 - Congress 2017 2017
Etude de stabilité physico-chimique et microbiologique des collyres de ciclosporine à 0.5 ; 5 et 20 mg/mL conditionnés en flacons de polyéthylène basse densité.
Mordohay A, Chanat C, Bezia C, Fresneau J, Jobard M, Brandely-Piat M.L, Batista R.
2017
4067 Lehti
Pharmazie 2017 ;72:197-199
Caspofungin infusion solutions (50 mg/mL): chemical stability and antifungal activity against Candida spp.
Pinder N, Pelzl L.H; Walther G, Backhaus J, Kurzai O, Hoppe-Ticky T.
2017
4068 Laboratorio
2018 Biogen Idec Ltd
Natalizumab (Tysabri®) - Summary of Product Characteristics
2018
4069 Lehti
EJHP 2018 ; 25, e2
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.
2018
4070 Lehti
Hosp Pharm 2018 ;53, 2: 73-74.
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags.
DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F.
2018
4074 Lehti
EJHP 2018 ; 25: 107-110.
Stability of daptomycin reconstituted vials and infusion solutions.
Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T.
2018
4075 Lehti
Am J Health-Syst Pharm 2018 ;75,5: 309-315
Stability of an extemporaneously compounded minoxidil oral suspension.
Song Y, Whey Chin Z, Ellis D, Mon Phyo Lwin E, Turner S, Williams D, Garg S.
2018
4077 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4.
Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N.
2018
4079 Lehti
J Pharm Anal 2017 ; 7, 4: 237-243.
Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.
Filali S, Bergamelli C, Tall M.L, Salmon D, Laleye D, Dhelens C, Diouf E, Pivot C, Pirot F.
2017
4080 Lehti
Anaesthesia 2017 ;124,3:776-781
Physical Compatibility of Propofol-Sufentanil Mixtures.
Zbytovska J, Gallusova J, Vidlarova L, Prochazkova K, Simek J, Stepanek F.
2017
4082 Lehti
EJHP 2018 ; 25, e2
Stability of mixtures of ondansetron and haloperidol stored in infusors at different temperatures.
Espinosa-Bosch M, Sanchez-Rojas F, Bosche-Ojeda C.
2018
4084 Laboratorio
Accord Health Care 2017
Cisplatine - Résumé des caractéristiques du produits
2017
4085 Lehti
Can J Hosp Pharm 2005 ; 58: 26-30.
Stability of Thiamine in Extemporaneously Compounded Suspensions.
Ensom M, Decarie D
2005
4086 Laboratorio
Novartis Pharma 2017
Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit
2017
4087 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:31-37
Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4.
Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N.
2018
4089 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30
Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units.
Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L.
2018
4090 Lehti
Pharm Dev Technol 2017
Stability study of a clonidine oral solution in a novel vehicle designed for pediatric patients.
Potier A, Voyat J, Nicolas A.
2017
4092 Lehti
Pharm Dev Technol 2016
Stability study of oral paediatric idebenone suspensions.
Schlatter J, Bourguignon E, Majoul E, Kabiche S, Balde I.B, Cisternino S, Fontan J.E.
2016
4096 Lehti
Pharm Dev Technol 2014
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J.
2014
4097 Lehti
Pharm Dev Technol 2013
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M, Alvarez J, Lucero M.
2013
4101 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins.
Ey C, Hosselet C, Villon B, Mar?on F.
2018
4102 Lehti
J Oncol Pharm Practice 2018 ;25,4:831-840.
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.
2018
4103 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Safe use of Dexamethasone in pediatrics: design and evaluation of a novel stable oral suspension.
Santovena--Estevez A, Dorta-Vera D, Gonzelez-Garcia I, Suarez-Gonzalez J, Teigell-Perez N, Farina J.
2018
4104 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T.
2018
4105 Lehti
Ann Pharmacotherapy 2008 ;42:962-966
Stability of Sunitinib in Oral Suspensions.
Navid F, Christensen R, Minkin P, Stewart C, Furman W, Baker S.
2008
4106 Lehti
Can J Hosp Pharm 2018 ;71,2/152-154
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.
Alarie H, Friciu M, Leclair G.
2018
4107 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt.
Ip K, Shan A, Carvalho M, Baker S, Banov D.
2018
4108 Lehti
Am J Health-Syst Pharm 2018 ;75;8:510-512
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu.
2018
4109 Lehti
Am J Health-Syst Pharm 2018 ;75,9:241-245
Stability of milrinone in continuous ambulatory delivery devices.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.
2018
4111 Lehti
Am J Health-Syst Pharm 2018 ;75,9:231-235
Stability of extemporaneously prepared ophtalmic solutions for mydriasis.
Camp N, Nadra J, Hughes S, Gilbert J, Zhao F.
2018
4112 Lehti
Int J Pharm Compound 2018 ;22,2:164-171
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z.
2018
4113 Lehti
Am J Health-Syst Pharm 2018 ; 75, 10: 622-626.
Stability of isoniazid injection in i.v. solutions.
Lee J, Moriyama B, Henning S, Danner R, Walsh T, Penzak S, Grimes G, Gopal K.
2018
4115 Lehti
Drug Design Dev Ther 2016 ;10:3873-3878
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use.
Fang B, Wang L, Gu J, Chen F, Shi X.
2016
4116 Lehti
Drug Design Dev Ther 2016 ;10:1869-1875
Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.
Chen F, Zhu J, Li B, Yuan F, Wang K.
2016
4117 Lehti
Drug Design Dev Ther 2017 ;11:2087-2097
Evaluation of the stability of linezolid in aqueous solution and commonly used intravnous fluids.
Taylor R, Sunderland B, Luna G, Czarniak P.
2017
4118 Lehti
Drug Design Dev Ther 2016 ;10:1029-1034
Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids.
Czarniak P, Boddy M, Sunderland B, Hughes J.
2016
4119 Ilmoitus
Hôpitaux Universitaire de Genève 2004
Stabilité et compatibilité de solutions injectables d'amiodarone (Cordarone®)
Marcoz N, Ing H, Sautter AM, Saadi JF, Roulin JF, Bonnabry P.
2004
4120 Lehti
J Oncol Pharm Practice 2018 25,5:1076?1081
Stability of carboplatin infusion solutions used in desensitization protocol.
Vazquez-Sanchez R, Sanchez-Rubio-Ferrandez J, Cordoba-Diaz D, Cordoba-Diaz M, Molina-Garcia T.
2018
4121 Lehti
Int J Pharm Compound 2018 ;22,3:252-256
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia.
Cote B, Ross B, Fortner J, Rao D.
2018
4122 Lehti
Hosp Pharm 2018 ;54,3:190?196
Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.
Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S.
2018
4123 Lehti
J Oncol Pharm Practice 2018 ;24,3:201-208
Storage and transport of reconstituted omacetaxine mepesuccinate: Considerations for home administration.
Parikh A, Van de Rijn J, Melville C, Sarkari M, Peltier S, McKean R.
2018
4125 Lehti
EJHP 2020 ; 27, 1: 43-48.
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
D'Huart E, Vigneron J, Lider P, Demoré B.
2020
4126 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,3:135-142
Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours.
D'Huart E, Vigneron J, Ranchon F, Vantard N, Rioufol C, Demor2 B
2018
4128 Ilmoitus
GRITA Symposium Perfusion 2017, Lille, France. 2017
Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousselière C, Barthélémy C, Décaudin B, Faure K, Odou P.
2017
4130 Lehti
Pharmaceutics 2021 , 13, 21.
Untersuchungen zur Kompatibilität von Clonidin mit häufig eingesetzen Arzneimittel auf Intensivstationen.
Koller AK, Krebs S, Dörje F.
2021
4131 Lehti
Hosp Pharm 2019 ;54,1:32-36.
Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine.
Fleming K, Donnelly R.
2019
4137 Lehti
Newsletter Stabilis 2018 41;2-6
Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare).
Patel T, Sewell G.
2018
4139 Lehti
Int J Pharm Compound 2018 ;22,4:326-328
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions.
Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J.
2018
4140 Lehti
Int J Pharm Compound 2018 ;22,4:340-344
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G.
2018
4141 Lehti
J Clin Pharm Ther 2018 : 530-535.
Stability of dobutamine in continuous ambulatory delivery devices.
Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P.
2018
4142 Lehti
Can J Hosp Pharm 2018 ;71,3:165-172
Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastinc and Glass Bottles and Plastic Syringes.
Lingertat-Walsh K, Law S, Walker S.E.
2018
4143 Lehti
EJHP 2016 ; 25, 4
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use.
Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R.
2016
4144 Lehti
EJHP 2018 ;75,14:1010-1012
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
Ross A, Boddu S, Mauro V, Churchwell M.
2018
4145 Lehti
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
2018
4147 Lehti
Minerva Anestesiologica 2014 ;81,3:283-287
Stability of generic brands of meropenem reconstituted in isotonic saline.
Carlier M, Stove V, Verstraete A.G, De Waele J.J.
2014
4148 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018
Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5% Infusion Polyolefin Bags at 5+/-3°C after Microwave Freeze-Thaw Treatment.
Huvelle S, Godet M, Galanti L, Closset M, Bihin B, Jamart J, Hecq J.D.
2018
4153 Laboratorio
Orphan Europe (UF) Limited 2014
Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics
2014
4154 Laboratorio
Accord Health Care 2018
Bleomycin sulfate- Summary of Product Characteristics
2018
4157 Lehti
Pediatric Anesthesia 2018
Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia.
Izgi M, Basara B, Muderrisoglu A, Yilbas A.A, Uluer M.S, Celebioglu B.
2018
4160 Lehti
J Pharm Pharmacol 1952 560-565
The Stability of Noradrenaline Solutions.
West G.B.
1952
4162 Lehti
Ann Pharm Fr 2018 ;76,6:444-452
Stability of sufentanil and baclofen mixtures for intrathecal analgesia at different concentrations in polypropylene syringes.
Sorrieul J, Robert J, Gibory V, Kieffer H, Folliard C, Dupoiron D, Devys C.
2018
4163 Lehti
Int J Pharm Compound 2018 22;5:417-423
Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Nalenz H, K?pf E, Dietel E.
2018
4164 Lehti
Int J Pharm Compound 2018 ;22,5:412-416
Stability of Tranexamic Acid Mouth Rinse.
Donnelly R.
2018
4166 Lehti
J Clin Pharm Ther 1978 3:211-214
Stability of heparin in sodium chloride solution.
Bowie H.M, Haylor V.
1978
4170 Lehti
Int J Pharm Compound 2018 22,5:433-439
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F, Dave V.S, Mar M, Perri J.
2018
4173 Laboratorio
Baxalta Innovations GmbH 2018
Pegaspargase (Oncaspar®) - Résumé des Caractéristiques du Produit
2018
4174 Lehti
Int J Pharm Compound 2018 ;22,6:504-511
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
Ip K, Shan A, Yan W, Banov D.
2018
4176 Lehti
Am J Health-Syst Pharm 2018 ;75:1467-1477
Compatibility of linezolid with commercial peritoneal dialysis solutions
Poeppl W, Rainer-Harbach E, Kussmann M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Reznicek G.
2018
4177 Lehti
Int J Pharm Compound 2018 ;22,6:516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
2018
4178 Lehti
EJHP 2017 ; 25, e2
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.
Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.
2017
4179 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:207-218
Validation of an HPLC Assay Method for Routine QC Testing and Stability Study of Compounded Low-Dose Capsules of Acetylsalicylic Acid.
Lonca N, Maillard F, Leguelinel G, Sharkawi T, Soulairol I.
2018
4180 Lehti
Perit Dial Int 2018 ;38,6:430-440
Stability of meropenem and piperacillin/tazobactam with heparin in various peritoneal dialysis solutions.
Mendes K, Harmanjeet H, Sedeeq M, Modi A, Wanandy T, Zaidi S, Ming L, Castelino R, Sud K, Peterson G, Patel R.
2018
4183 Ilmoitus
Professional Practice Conference - the Canadian So 2018
Stability if 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C).
Hook R, Riss V, Scharrer E, Law S, Walker S.E.
2018
4185 Lehti
Hosp Pharm 2019 ; 54, 5: 330-334.
Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures : A New Look at an Old Drug.
Sabins D, Diep T, McCartan P, Patel S, Zhao F
2019
4189 Lehti
Am J Health-Syst Pharm 2022 ;79,12: 1011-1018
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S,
2022
4190 Laboratorio
Janssen 2018
Daratumumab (Darzalex®) - Summary of Product Characteristics.
2018
4191 Lehti
GaBI Journal 2018
Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures.
Vieillard V, Astier A, Paul M.
2018
4192 Lehti
Pediatric Anesthesia 2018
Quality control and stability of ketamine, remifentanil and sufentanil syringes in a pediatric operating theater.
Bourdon F, Simon N, Lannoy D, Berneron C, D?caudin B, Reumaux L, Duhamel A, Richart P, Odou P.
2018
4194 Lehti
Bio Drugs 2018 32;619-625
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y.
2018
4197 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T.
2018
4198 Lehti
Pharmazie 2018 73;196-201
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Uriel M, Gomez-Rincon C, Marro D.
2018
4199 Lehti
EJHP 2018
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.
Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M.
2018
4200 Lehti
EJHP 2018
Stability study of hydromorphone and bupivacaine mixture by HPLC-UV.
Macorigh C, Guibbert V, Casanova M, Haenni C.
2018
4201 Lehti
Am J Health-Syst Pharm 2020 ; 77, 9: 681-689.
Long-term stability of ready-to-use 1-mg/mL midazolam solution.
Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P.
2020
4205 Lehti
J Kor Soc Hosp Pharm 2006 ;23,3:219-224
Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time.
Choi S, O La H, Kim K, Kim S, Hwangbo S.
2006
4211 Lehti
PlosOne 2019
Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A.
2019
4214 Lehti
Int J Pharm Compound 2019 ;23,1:70-76
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.
2019
4215 Lehti
Int J Pharm Compound 2019 ;23,1:82-87
Stability Assessment of Topical Amitriptyline HCl Extemporaneously Compounded with Lipoderm Base and PLO Gel Mediflo 30.
Shakshuki A, Agu R.U.
2019
4216 Ilmoitus
Sunnybrook 2019
Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC).
Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE.
2019
4218 Lehti
EJHP 2020 ; 27, 2: 90-94.
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C,
2020
4223 Ilmoitus
Prof Practice Conference - Canadian Society of PH 2019
Stability of 20,40 and 50 microg/mL Fentanyl Solutions Stored in Syringes at Room Temperature (23°C).
Riss V, Hook R, Neault A, Scharrer E, Law s, Walker S.E.
2019
4227 Ilmoitus
Prof Practice Conference - Canadian Society of PH 2019
Stability of Azacitidine Solutions In Sterile Water for Injection.
Tyono I, Law S, Charbonneau L.F, Walker S.E.
2019
4228 Ilmoitus
Prof Practice Conference - Canadian Society of PH 2017
Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C).
Law S, Perks W, Iazetta J, Walker S.
2017
4229 Lehti
Int J Pharm Compound 2017 ;24,6:519-527
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
Ma N, Perks W, Law S, John I, Walker S.
2017
4230 Ilmoitus
Prof Practice Conference - Canadian Society of PH 2017
Stability of 0.2 and 10 mg/mL Hydromorphone Solutions In CADD reservoirs, PVC and Ethylene/Propylene Co-Polymer (PAB) Bags at Room Temperature (23°C°).
Perls W, Law S, Iazetta J, Walker S.
2017
4231 Ilmoitus
Professional Practice Conference - Canadian Societ 2018
Stability of 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C)
Roxanne Hook, Vera Riss, Erica Scharrer, Shirley Law and Scott E. Walker
2018
4244 Ilmoitus
2019
Chemical Stability of Cloxacillin in Sterile Water for Injection (SWFI) Stored in Polypropylene (PP) Syringes (50 and 100 mg/mL) and Glass Vials (250 mg/mL) at 4°C and 25°C.
Perks W, Marchensano R, Law S, Iazetta J, Walker SE.
2019
4245 Ilmoitus
2019
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
2019
4246 Ilmoitus
2019
Stability of 2.5mg/mL Indocyanine Green (ICG) Solutions Stored in Syringes at 25ºC, 4ºC, -20ºC and -67ºC.
Perks W, Law S, Marchesano R, Walker SE.
2019
4247 Lehti
Clin Ther 2018 ;40,4:664-667
Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices.
Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M.
2018
4248 Lehti
Hosp Pharm 2019 ; 55, 3: 199-193.
Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.
Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L.
2019
4249 Lehti
PeerJ 2018
Stability of an ophtalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multi dose eyedroppers.
Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V.
2018
4250 Lehti
Ann Pharm Fr 2019 ;77,3:212-221.
Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B.
2019
4251 Lehti
Int J Pharm Compound 2019 ;23,2:157-162
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt.
Pramar YV, Mandal TK, Bostanian LA, Nguyen ATQ, Morris TC, Graves RA.
2019
4252 Lehti
Int J Pharm Compound 2019 ;23,2:163-166
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM.
2019
4254 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
D'Huart E, Vigneron J, Demoré B.
2019
4255 Lehti
J Pharm Anal 2013 ;3,6:408-414
Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode-array detection.
Kusters M, Beyer S, Kutschera S, Schlesingera H, Gerhartzb M.
2013
4256 Lehti
Pharmaceutics 2019 ;11,190:
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.
2019
4263 Lehti
Am J Hosp Pharm 1994 ;51:373-377
Stability of ciprofloxacin injection in peritoneal dialysis solutions.
Kane MP, Bailie GR, Moon DG, Siu I.
1994
4264 Lehti
Acta Ophtalmol 2008
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.
2008
4267 Lehti
EJHP 2019
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B.
2019
4268 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2019
Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units.
D'Huart E, Vigneron J, Blaise F, Charmillon A, Demoré B.
2019
4271 Lehti
Adv Ther 2019
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J.
2019
4272 Lehti
Pharm Dev Technol 2019
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
Merino-Bohorquez, Delgado-Valverde M, Garcia-Palomo M, Dàvila- Pousa MC, Canete C, Villaronga M, Rodriguez-Marrodan B, Lopez-Ro
2019
4274 Lehti
J Clin Anesth 2016 ; 35: 551-559.
Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.
Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.
2016
4279 Lehti
Bio Drugs 2019 ; 33: 193–205.
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N.
2019
4280 Lehti
J Pediatr Pharmacol Ther 2019 ; 24, 1: 53-57.
Sterility and Stability Testing of Preservative-free Albuterol.
Gulley, S.L, Baltzley, S.M, Junkins, A.D, Murray, T.D, Simms, S.F, Sullivan, J.E, Al-Ghananeem A.M, O?Hagan A.R.
2019
4282 Lehti
Drugs R D 2017
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.
2017
4283 Lehti
Eur J Pharm Sci 2019
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N.
2019
4284 Lehti
Journal of Chemotherapy 2018 ; 30, 6-8: 371-374.
Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion.
Vercheval C, Streel S, Servais A-C, Fillet M, Van Hees T.
2018
4289 Lehti
Photochemical & Photobiological Sciences 2018
Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood.
Mindt S, Karampinis I, John M, Neumaier M, Nowak K.
2018
4290 Lehti
Microbiology Insights 2018 ; 11, 1-6
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Venugopalan V, Manigaba K, Borgert S.J, Cope J, Peloquin C.A, Klinker K.P.
2018
4292 Lehti
Drugs R D 2019 19: 127–140.
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
Vimpolsek M, Gottar-Guillier M, Rossy E.
2019
4293 Lehti
J Pharm Pract and Res 2019 ;49, 219?223
Validation of the stability of paracetamol in extemporaneously compounded suppositories.
Tianzhi Y, Hae Jung S, Kayla N, Shuhua B.
2019
4298 Lehti
Biomed Chromatogr 2019 ; 33, 4:e4471
Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion.
Fabio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L.
2019
4299 Lehti
Biomed Chromatogr 2019 ; 33, 7: e4529.
Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the EQUASHIELD® closed-system transfer device.
Ezquer-Garin C, Ferriols-Lisart R, Alos-Alminana M.
2019
4301 Lehti
Oncotarget 2017 ;8, 63: 106249-106257.
Stability of azasetron-dexamethasone mixture for chemotherapyinduced nausea and vomiting administration.
Fang B-X, Chen F-C, Zhu D, Guo J, Wang L-H.
2017
4303 Lehti
Pharmacy 2015 3, 379-385.
Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes.
Anderson C, MacKay M.
2015
4304 Lehti
Drugs R D 2014 ; 14:13?23.
Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices.
Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A.
2014
4307 Lehti
J Pediatr Pharmacol Ther 2013 ;18(2):122-127.
Stability of Extemporaneously Prepared Lansoprazole Suspension at Two Temperatures.
Morrison J.T, Lugo R.A, Thigpen J.C, Brown S.D.
2013
4308 Lehti
PlosOne 2017
Stability of gabapentin in extemporaneously compounded oral suspensions.
Friciu M, Roullin G, Leclair G.
2017
4309 Lehti
J Am Pharm Assoc 2013 ; 53, 3: 304-306.
Stability of U-500 regular insulin in prefilled syringes
Lull M.E, Piacentino J.J, Traina A.N.
2013
4310 Lehti
Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.
Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M.
2017
4313 Lehti
PlosOne 2017
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
Friciu M, Zaraa S, Roullin G, Leclair G.
2017
4314 Lehti
J Am Pharm Assoc 2017 ; 56, 4: 457-461.
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.
DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E.
2017
4316 Lehti
J Pharm Technol 2006 ;22:95-98.
Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion.
Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F.
2006
4317 Lehti
J Pharm Technol 2019 ;35,3:105-109
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
Lawson S, Lewis P, Peacock G, Brown S.
2019
4319 Lehti
Hosp Pharm 2020 ; 55, 5: 332-337.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
2020
4323 Ilmoitus
ADKA Kongress 2019
Stabilitätsprüfung von applikationsfertigen Adrenalin- und Noradrenalinverdünningen.
Wethmar U, Hochbrügge H, Strobel HG.
2019
4326 Lehti
Pharmazie 2019 ; 74: 357-362.
Stability studies of antipyocyanic beta-lactam antibiotics used in continuous infusion.
Curti C, Harti Souab K, Lamy E, Mathias F, Bornet C, Guinard B, Fersing C, Primas N, Albanèse J, Vanelle P.
2019
4331 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2019
Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride.
Nilsson N, Nezvalova-Henriksen K, Tho I.
2019
4332 Ilmoitus
JFSPH 2019 2019
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI).
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI)
2019
4334 Lehti
J Oncol Pharm Practice 2020 ; 26, 3: 641-646.
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
Sundaramurthi P, Sean Chadwick S, Narasimhan C.
2020
4341 Lehti
Int J Pharm Compound 2019 ;23,5:414-417
Stability of Furosemide 5 mg/mL in Polypropylene Syringes.
Van der Schaar JAJ, Grouls R, Franssen EJF, Crul M.
2019
4342 Lehti
Int J Pharm Compound 2019 ;23,5:434-437
Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics.
Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L.
2019
4344 Lehti
EJHP 2018
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Yay? HS, Faucheron A, Dupont L, El Kouari F, Fekkar A, Bellanger A, Tilleul P.
2018
4345 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2019
Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study.
Curti C, Mathias F, Savelli M, Garrigue P, Lamy E, Guillet B, Vanelle P.
2019
4348 Lehti
Can J Hosp Pharm 2019 ;72(5):360-8
Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes.
D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B.
2019
4350 Lehti
EJHP 2019 ;0:1-5
Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia.
Beiler B, Barraud D, Vigneron J, Demor? B.
2019
4352 Lehti
J Clin Pharm Ther 2019 ; 44: 875-882.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
2019
4353 Lehti
J Clin Pharm Ther 2019
Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome.
Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R.
2019
4354 Ilmoitus
GERPAC Congress 2019 2019
Compatibilité visuelle du Vyxeos lors d'administration en Y avec une sélection de médicaments injectables.
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
2019
4355 Laboratorio
Jazz Pharmaceuticals UK 2019
Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics
2019
4357 Lehti
Nutrition in clinical Practice 2020 ; 35: 967-972.
Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
Campos-Baeta, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D, Riera P.
2020
4358 Lehti
Ann Fr Anesth Réanim 2014 ; 33, 5: 304-309.
Stabilité physico-chimique des solutions injectables de bésilate de cisatracurium dans les conditions cliniques d'utilisation
Pignard J, Bourdeaux D, Kauffmann S, Constantin J.M, Sautou V.
2014
4360 Lehti
Hosp Pharm 2019
Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients.
Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli.
2019
4362 Lehti
EJHP 2018 Eur J Hosp Pharm 2018;0:1
Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.
Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M.
2018
4366 Lehti
Braz J Pharm Sci 2019 ;55:e17351
Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures.
Estan-Cerezo G, Rodriguez-Lucena F.J, Matoses Chirivella C, Jiminez-Pulido I, Garcia-Monsalve A, Navarro-Ruiz A.
2019
4367 Lehti
J Glaucoma 2016 ; 25, 6: 477-481.
The Degradation of Mitomycin C Under Various Storage Methods.
Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L.
2016
4368 Lehti
J Pharm Health Care Sci 2019 ; 5: 25.
Physical, chemical, and microbiological stability study of diluted atropine eye drops.
Saito J, Imaizumi H, Yamatani A.
2019
4369 Lehti
J Pharm Biomed Anal 2020 ;178:112896
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate
Sadou Yayé H, Hassani L, Secrétan PH, Babiard M, Aouati H, Bellanger A, Tilleul P, Yagoubi N, Do B, Rietveld I.
2020
4370 Lehti
EJHP 2018 2018;0:1-7
Physical stability of an all-in one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs
Staven V, Wang S, Gronlie I, Tho I.
2018
4371 Lehti
Journal of Parenteral and Enteral Nutrition 2018
Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
Mediavilla MM, Molina A, Navarro L, Grau L, Pujol MD, Cardenete J, Cardona D, Riera P.
2018
4373 Lehti
EJHP 2020 ; 27(e1):e87-e92.
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.
Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P.
2020
4374 Lehti
Int J Pharm Compound 2020 ;24,1:64-68
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.
2020
4375 Lehti
Int J Pharm Compound 2020 ;24,1:77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J.
2020
4376 Lehti
Int J Pharm Compound 2020 ;24,1:83-85
Compatibility of Melphalan in Iodinated Contrast Media.
Shi Z, Abruzzo T, Wanasathop A, Li S K.
2020
4377 Lehti
Radiology 1992 ; 184: 385-387.
Ionic lodinated Contrast Medium and Amobarbital Sodium Mixtures: Potential for Precipitation.
Monsein L.H, Miller T.J, Kuwahara S.K, Sostre S, Debrun G.M.
1992
4378 Lehti
Perit Dial Int 2020 ; 40, 5: 470-476.
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
Harmanjeet H, Jani H, Zaidi S.T.R, Wanandy T, Castelino R.L, Sud K, Peterson G.M, Patel R.P.
2020
4380 Laboratorio
Merck Sharp & Dohme Limited 2019
Posaconazole (Noxafil®) - Summary of Product Characteristics
2019
4383 Lehti
Crit Care Resusc 2020 ;22(1):83-85.
Stability of bicarbonate in normal saline: a technical report.
Naorungroj T, Neto AS, Fujii T, Jude B, Udy A, Bellomo R.
2020
4388 Lehti
Int J Pharm Compound 2020 ;24,2:140-147
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D.
2020
4389 Lehti
Pharmactuel 2019 ;52,4:206-213
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
2019
4393 Ilmoitus
Sunnybrook Health Sciences Centre 2020
Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C.
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E.
2020
4395 Ilmoitus
Sunnybrook Health Sciences Centre 2020
Stability of Morphine Solutions of 20, 40, 100 , 200 and 1,000 µg/mL in Syringes Following Dilution with 0.9% Sodium Chloride or D5W at Room Temperature (25°C).
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E.
2020
4396 Lehti
GaBI Journal 2020 ; 9, 1:
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions.
Lueras A, Polozova A, Asbury D, Hippenmeyer J, Litowski J, Goss M, Breslin P, Crampton S.
2020
4397 Lehti
J Oncol Pharm Practice 2021 ;27,1:78–87
Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes.
Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE.
2021
4398 Lehti
J Pharm Pract and Res 2020
Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush.
Smith E. K., Shergold J.A., McWhinney B.C.
2020
4403 Lehti
J Pharm Biomed Anal 2020 ; 179: 112973.
Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL.
2020
4404 Ilmoitus
JFSPH 2019 2019
Compatibility studies of seven commonly used drugs for parenteral administration in palliative care.
Müller U, Haller F, Wiedemeier P, Steuer C.
2019
4405 Lehti
Pharmazie 2020 ; 75: 172-176.
Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures
Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M.
2020
4406 Lehti
Can J Hosp Pharm 2020 2020;73(2):141-4
Stability of Methadone Hydrochloride for Injection in Saline Solution
Friciu M, Alarie H, Beauchemin M, Forest JM, Leclair G.
2020
4407 Lehti
Am J Health-Syst Pharm 2020 ;77,8:649–657.
Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration.
Bustin A, Ramsey Z, Hanna B, Kaushal G.
2020
4408 Lehti
Int J Pharm Compound 2020 ;24,3:252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E.
2020
4411 Lehti
Int J Pharm Compound 2020 ;24,3:238-241.
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions.
Wilder A.G, Foushee J.A, Fox L.M, Navalle J, Wright A.M, Greer M.A.
2020
4412 Lehti
J Pediatr Pharmacol Ther 2014 ;19,1:25–29.
Chiral Stability of an Extemporaneously Prepared Clopidogrel Bisulfate Oral Suspension.
Tynes C.R, Livingston B, Patel H, Arnold J.J.
2014
4413 Lehti
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J.
2016
4416 Lehti
J Pediatr Pharmacol Ther 2015 ; 20, 3: 197-202.
Stability of Hydrocortisone Preservative-Free Oral Solutions.
Chappe J, Osman N, Cisternino S, Fontan J-E, Schlatter J.
2015
4418 Lehti
J Pediatr Pharmacol Ther 2004 ; 9, 4: 254-258.
Chemical Stability of Extemporaneously Prepared Lorazepam Suspension at Two Temperatures.
Ellaria Lee W-M, Lugo R.A, Rusho W.J, MacKay M, Sweeley J.
2004
4419 Lehti
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
Holt R.J, Siegert S.W.K, Krishna A.
2008
4424 Ilmoitus
11ème Recontres Convergences Santé Hôpital 2016
Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique.
Barbazan C, Le Daré, Lester M-A, Boivin P-N.
2016
4426 Lehti
Medicine 2019 98:21(e15747)
Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
Watrobska-Swietlikowska D, Pietka M, Stanislaw Klek S.
2019
4428 Lehti
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
2004
4429 Lehti
Medicine 2016 ; 95:25(e3824)
Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration.
Fang B-X, Li P, Shi X-Y, Chen F.C, Wang L.H.
2016
4430 Lehti
Medicine 2017 96:35(e7979)
Stability study of dezocine in 0.9% sodium chloride solutions for patient-controlled analgesia administration.
Fang B-X, Wang L-H, Liu H-M, Chen F-C, Liu J.
2017
4431 Lehti
Medicine 2018 ; 97:50(e13698)
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.
Chen P, Chen F, Zhou B-H.
2018
4433 Lehti
Clin Ther 2020 ; 42, 3: 475-485.
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
2020
4434 Lehti
Clin Ther 2019 ; 41, 10: 2162-2170.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
2019
4435 Lehti
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Hanifah S, Nugroho B.H, Chabib L.
2020
4436 Lehti
Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225.
Extended compatibility of fentanyl and ketamine in dextrose 5%.
Hanifah S, Kennedy R.A; Ball P.A.
2018
4438 Lehti
Pharmaceutics 2020 ; 12: 292
Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition
Stawny M, Gostyńska A, Nadolna M, Jelińska A.
2020
4439 Lehti
Nutrients 2019 ; 11: 559.
Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition.
Stawny M, Gostynska A, Dettlaff K, Jelinska A, Główka E, Ogrodowczyk M.
2019
4440 Lehti
Ann Nutr Metab 2018 ; 73: 227-233.
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.
2018
4441 Lehti
Pharmaceutics 2020 ; 12, 27
The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures.
Gostynska, A, Stawny M, Dettlaff K, Jelinska A.
2020
4444 Lehti
Clinical Nutrition 1999 ; 19, 3: 159-165.
Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics.
Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.
1999
4445 Lehti
Chemotherapy 1979 ; 25: 336-345.
Antibiotic compatibility and stability in a parenteral nutrition solution.
Reed M.D, Perry E.B, Fennell S.J, Brissie E.O, Ball W.D.
1979
4449 Lehti
J Pharm Pract and Res 2020
Stability assessment of levofloxacin in three different suspension vehicles.
Tardif V.,Lepage O.,Friciu M., St-Jean I., Forest J.M.
2020
4452 Ilmoitus
Congrès Hopipharm 2019
Influence d'un ajout de L-carnitine dans les mélanges de nutrition parentérale destinés aux patients à domicile.
Sémély D, Bello W, Daupin J, Lebland C, Carrez L, Berger M, Sadeghipour F.
2019
4455 Lehti
J Oncol Pharm Practice 2020 online first
Physical and chemical stability of cytarabine in polypropylene syringes.
Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I.
2020
4456 Lehti
Scientific reports 2020 10:1788
Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
Tobudic S, Prager I, Kussmann M, Obermüller M, Ursli M, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G.
2020
4457 Lehti
J Obstet Gynaecol Can 2016 ;38,10:936e944.
Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.
Houlihan, S, Decarie, D, Benes, C, Cleve, R, Vidler M, Magee L.A, Ensom M.H.H, vonDadelszen P.
2016
4458 Lehti
Eur J Clin Microbiol Infec Dis 2017 36:2237–2242.
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G.
2017
4460 Lehti
Scientific reports 2019 9:6512
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
Kussmann M, Ferth A, Obermüller M, Pichler P, Zeitlinger M, Wiesholzer , Burgmann H, Poeppl W, Reznicek G.
2019
4461 Lehti
Molecules 2019 24, 1242.
Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition.
Tomczak S, Stawny M, Dettlaff K, Kieliszek, M, Słominska D, Jelinska A.
2019
4464 Lehti
PlosOne 2018 13(1): e0190577.
Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion.
Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S.
2018
4465 Lehti
Am J Health-Syst Pharm 2020 ;77,14:1144-1148
Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Foushee A, Meredith P, Fox Laura, Wilder A.
2020
4467 Laboratorio
Roche Products Limited 2020
Avastin - Summary of Product Characteristics
2020
4470 Lehti
Critical care 2005 ; 9(Suppl 1) P37
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
2005
4471 Laboratorio
Kyowa Kirin Pharma 2019
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
2019
4472 Lehti
Pharmaceutics 2020 ;12, 781
Stability of Ophthalmic Atropine Solutions for Child Myopia Control.
Berton B, Chennell P, Yessaad M, Bouattour Y, Jouannet M, Wasiak M, Sautou V.
2020
4473 Lehti
Neuromodulation 2020
Study of Physicochemical Stability of Ziconotide in Medication Cassette Reservoir.
Robert J, Sorrieul J, Andrieu A, Mounsef F, Dupoiron D, Devys C.
2020
4474 Laboratorio
Merck 2023
Avelumab (Bavencio®) - Summary of Product Characteristics
2023
4477 Lehti
GaBI Journal 2020 ; 9, 1: 5-13.
Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentration and stress conditions.
Crampton S, Polozoxa A, Asbury D, Lueras A, Breslin P, Hippenmeyer J, Litkowski J,,Goss M.
2020
4478 Lehti
Int J Pharm Compound 2020 ;24,5:413-419
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Graves R.
2020
4479 Lehti
J Oncol Pharm Practice 2020 ;27,6:1328-1332
Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5 +/- 3°C.
Closset M, Goderniaux N, Colsoul M-L, Soumoy L, Bihin B, Jamart J, Odou P, Hecq J-D, galanti L.
2020
4480 Laboratorio
Jazz Pharmaceuticals UK. 2020
Erwinase, Lyophilisate for solution for injection.
2020
4482 Laboratorio
Cipla USA 2020
ZEMDRI (plazomicin) injection, Highlights of Prescribing Information, Cipla USA, Revised: 1/2020
2020
4484 Lehti
Drugs R D 2022 ;22, 95–104
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered.
Bokser A D, Holmes Adegbenle Y, Stoisavljevic V, Norton J C.
2022
4485 Lehti
Can J Hosp Pharm 2021 ;74;1:57-69
Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C)
Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E.
2021
4487 Lehti
Pharmaceutics 2020 ; 12, 786.
Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl- -Cyclodextrins Possess an Extended Physicochemical Stability?
Chennell P, Yessaad M, Abd El Kader F, Jouannet M, Wasiak M, Bouattour Y, Sautou V.
2020
4488 Lehti
Pharmaceutics 2020 ; 12, 677.
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.
Nezvalova-Henriksen K, Niklas Nilsson N, Tomine Østerberg C, Staven Berge V, Tho I.
2020
4490 Lehti
Sci Pharm 2020 ; 88, 25
Medication Safety in Intravenous Therapy: A Compatibility Study and Analysis of Reaction Products of Dihydralazine and Metamizole.
Koller A.K, Fischer O, Krebs S.
2020
4491 Lehti
Eur J Pedia 2020
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
2020
4492 Lehti
Int J Antimicrob Agents 2020
Preparation and physicochemical stability of 50 mg/ml hydroxychloroquine oral suspension in Syrspend pH4 dry.
Binson G, Venisse N , Sauvaget A , Bacle A , Lazaro P , Dupuis A.
2020
4493 Lehti
J Oncol Pharm Practice 2020
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
Le Guyader G, Vieillard V, Paul M.
2020
4496 Lehti
Neuromodulation 2020 ; 24, 7: 1145-1156.
Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes.
Sorrieul J, Robert J, Dupoiron D, Devys, C.
2020
4498 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2020
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.
2020
4499 Lehti
J Pharm Pract and Res 2020
Stability evaluation of an extemporaneously compounded carbimazole oral suspension.
Song Y, Lwin E, Ellis D, Turner S, Williams D, Garg S.
2020
4500 Lehti
J Pediatr Pharmacol Ther 2020 ;25, 8:723-729.
Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures.
Gillium C, Friciu M, Abatzoglou N, Leclair G.
2020
4501 Lehti
BMC Anesthesiology 2020 ;20:283.
The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion.
Henkel E, Vella R, Behan K, Austin D, Kruger P, Fenning A.
2020
4502 Lehti
TH Open 2020 ;4:e354–e361.
Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro.
Takeyama M, Nøhr A.M, Pollard D.
2020
4503 Laboratorio
RIEMSER Pharma GmbH 2018
Ziconotide (Prialt®) - Summary of Product Characteristics
2018
4505 Lehti
Eur J Cancer 2020 ; 135: 192-202.
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion.
Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M.
2020
4506 Lehti
Am J Health-Syst Pharm 2020 ;77,23:1938-1940.
Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C.
2020
4507 Lehti
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Ross E, Salinas A, Petty K, Her C, Carpenter J.
2020
4510 Lehti
J Oncol Pharm Practice 2020 ;26,8:1894–1902
Stability studies of parenteral nutrition with a high dose of vitamin C.
Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.
2020
4512 Lehti
EJHP 2020 2020;0:1-5.
Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements
Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS.
2020
4515 Lehti
Pharmaceutics 2020
Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice.
Tomczak S, Stawny M, Jelinska A.
2020
4516 Lehti
GaBI Journal 2020 ; 9, 4:155-162
Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags.
Seckute J, Castellanos I, Bane S.
2020
4517 Lehti
EJHP 2020
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A.
2020
4518 Lehti
EJHP 2020
In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion.
Mohr A, Krämer I.
2020
4520 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2020
Physicochemical stability of compounded midazolam capsules over a one-year storage period.
Boivin P-N, Legendre P, Bonnaure A-C, M-A.
2020
4521 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2020
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
2020
4522 Lehti
J Pharm Biomed Anal 2020
Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV.
Lin Q, Van Schepdael A, Adams E.
2020
4523 Lehti
Pharm Dev Technol 2021
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
El Mershati S, Thouvenin A , Secretan P-H, De Lonlay P, Tuchmann-Durand C, Cisternino S, Schlatter J.
2021
4524 Ilmoitus
ESCP Symposium, Geneva, Switzerland 2009
Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology.
Stucki C, Sautter A-M, Bonnabry P.
2009
4525 Lehti
Adv Ther 2020 ; 37: 4308–4324.
Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions.
Park D, Kim J, Yun J, Park S.J.
2020
4526 Lehti
EJOP 2021 4: 1.
Stability of mitomycin in polypropylene syringes for use in glaucoma surgery.
Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B.
2021
4528 Lehti
Int J Pharm Compound 2021 ;25,1:52-61
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
2021
4530 Lehti
Int J Pharm Compound 2021 ;25,5:431-439
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.
2021
4532 Laboratorio
Roche Products Limited 2021
Atezolizumab (Tecentriq®) - Summary of Product Characteristics
2021
4533 Lehti
Int J Pharm Compound 2021 ;25,5:427-430
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base.
Lopalco A, Lopedota A, Aurelio F, La Forgia F, Fontana S, Franco M, Denora N.
2021
4534 Lehti
Int J Pharm Compound 2021 ;25,5:422-426
Compatibility of Gestrinone, Nimesulide, and Piroxican in Pentravan for Transdermal and Transmucosal Application.
Polonini H, De Oliveira Ferreira A, Dijkers.
2021
4538 Lehti
Archives of Disease in Childhood 2020 ; 105: 395-397.
Compatibility of pentoxifylline and parenteral medications.
Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K.
2020
4543 Lehti
Archives of Disease in Childhood 2018 ;104:292–295.
Physical compatibility of pentoxifylline and intravenous medications.
Senarathna G, Strunk T, Petrovski M, Batty K.
2018
4544 Lehti
Int J Pharm Compound 2021 ;25,3:236-240
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design.
Lupatini , Sidhu R, Patel H, Bichar K.
2021
4545 Lehti
Journal of Nippon Medical school 2021
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.
2021
4546 Lehti
EJHP 2021
Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags.
Vidal F, Cotteret C, Negbane A, Sebti M, Hinterlang M, Cisternino S, Schlatter J.
2021
4547 Lehti
EJHP 2021
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin Y-S, Lin S-C, Hsieh Y-T,Liu L-Y,Lin C-H, Shen L-J, Huang C-F.
2021
4548 Lehti
Clin Ther 2020 ; 42, 8: 1580-1586.
Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
O'Donnell J.N, Xu A, Lodise T.P.
2020
4550 Lehti
Crit Care Resusc 2013 ;15, 1: 63–66.
The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
Semark, A.J, Venkatesh, K, McWhinney B.C, Pretorius, C, Roberts, J.A, Cohen J, Venkatesh B.
2013
4556 Lehti
J Pharm Technol 2020 ; 36, 4: 126-129.
The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium.
Dobson, S.R, Mauro, V.F, Boddu, S.H.S, Churchwell, M.D.
2020
4558 Lehti
Milit Med 2016 ; 181, 10:1305.
Compatibility of Hydroxyethyl Starch and Tranexamic Acid for Battlefield Co-Administration.
Studer, N.M, Yassin, A.H, Keen, D.E.
2016
4559 Lehti
Drug Design Dev Ther 2020 ;14, 4179-4187.
Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.
Chen P, Chen F, Lei J, Zhou B.
2020
4560 Lehti
J Pediatr Pharmacol Ther 2021 ; 26, 3: 265-270.
Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis.
Cramer J, Bevry M, Handler S, Tillman K, Abourashed E.A.
2021
4561 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20200013.
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study.
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S.
2021
4563 Lehti
Eur J Pharm Sci 2021 ; 160: 105738.
Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children.
Fuss D, Gondé H, Lamoureux F, Pereira T, Colnot M, Buchbinder N, Coquard A, Varin R, Hervouët C.
2021
4567 Lehti
Pharmaceutics 2021 ;13, 458.
Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study.
Henry H, Lannoy D, Maboudou P, Seguy D, Dine T, Pigny P, Odou P.
2021
4568 Lehti
Journal of Chemotherapy 2021
Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump.
Closset M,Onorati S, Colsoul M.L,Goderniaux N,Bihin B, Jamart J, Soumoy L, Hecq J.D, Odou P, Galanti L.
2021
4569 Lehti
Hosp Pharm 2021 ; 56, 4: 282-286.
Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
Lee T.M , Villareal C.L, Meyer L.M.
2021
4570 Lehti
Pharmaceuticals 2019
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Greenhill K, Hornsby E, Gorman G.
2019
4571 Laboratorio
Orion Pharma 2010
Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics
2010
4572 Lehti
Antibiotics 2021 ; 10, 217.
Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures.
Gostynska A, Piwowarczyk L, Nadolna M, Jelinska A, Dettlaff K, Ogrodowczyk M, Popielarz-Brzezinska M, Stawny M.
2021
4573 Lehti
Am J Health-Syst Pharm 2021 ;78, 9:806–812,
Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation.
Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F.
2021
4574 Lehti
Am J Hosp Pharm 2021 ;78,9:825–831
Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions.
Ancedy D, Sebti M, Postaire M, Vidal F, Cisternino S.
2021
4575 Lehti
Int J Pharm Compound 2021 ;25,2:169-175
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Richard A.
2021
4576 Lehti
Int J Pharm Compound 2021 ;25,2:163-168
Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
Walsh A, Ziegler B, Lingertat-Walsh K, Law S, Walker S.
2021
4577 Lehti
Int J Pharm Compound 2021 ;25,2:156-162
Stability of Fagron's Phytobase Cream Compounded with Various Hormones.
Wynn T, Taylor S, Zander C.
2021
4578 Opinnäytetyö
2011
Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques
Respaud R.
2011
4579 Lehti
Processes 2021 , 9, 453.
Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron
Tomczak S, Radwan V, Jelinska A, Stawny M.
2021
4582 Lehti
J Pharm Technol 2021
Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules.
Brun D, Curti C, Lamy E, Jean C, Bertault-Përez P, Broggi J, Tintori G, Vanelle P.
2021
4583 Lehti
Int J Pharm Compound 2021 ;25,3:246-257
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K.
2021
4584 Lehti
EJHP 2023 ; 30, 3: 153-159.
Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials.
Gilliot S, Henry H, Carta N, Genay S, Barthélémy C, Décaudin B, Odou P.
2023
4587 Lehti
J Pediatr Pharmacol Ther 2021 ; 26, 4: 395–404.
Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome.
Rochani A, Nguyen V, Becker R, Kraft W, Kaushal G.
2021
4589 Laboratorio
Mylan 2021
Pemetrexed Mylan - Résumé des caractéristiques du produit
2021
4590 Lehti
J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service.
Smith E.K, McWhinney MPhil B.C.
2021
4592 Lehti
Antibiotics 2021 ; 10: 715.
The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body.
Liebchen U, Rakete S, Vogeser M, Arend F.M, Kinast C, Scharf C, Zoller M, Schönermarck U, Paal M.
2021
4593 Lehti
Int J Pharm Compound 2021 ;78,4:344-351
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases.
Teimouri A, Yeung P, Agu R.
2021
4596 Lehti
Am J Health-Syst Pharm 2021 ;78,15:444–1447
Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.
2021
4598 Lehti
Int J Pharm Compound 2021 ;78,4:336-349
Compatibility of Estradiol, Estriol; Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base.
Polonini H, Dijkers E, Ferreira A, Zander C, Taylor S.
2021
4600 Lehti
EJOP 2021 ; 4: 3.
Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose.
Loeuille G, Vigneron J, D’Huart E, Demoré B.
2021
4602 Lehti
Hosp Pharm 2021 ; 56, 4: 215-220.
Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting.
Buga I, Uzoma J.I, Reindel K, Rashid K, Diep T, McCartan P, Zhao F.
2021
4603 Lehti
Hosp Pharm 2021 ; 56, 4: 228-234.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
2021
4605 Lehti
Ann Allergy 2012 ; 2:28.
Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility.
Foinard A, Décaudin B, Barthélémy C, Debaene B, Odou P.
2012
4606 Lehti
Int J Pharm Compound 2021 ;25,3:258-262
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation.
Odanak K, Kojima H, Nakagawa N.
2021
4607 Lehti
Can J Hosp Pharm 2021 ;74(3):227-34
Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles.
Walker SE, Sachedina H, Bichar K.
2021
4608 Laboratorio
Astra Zeneca 2021
Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021)
2021
4609 Lehti
PlosOne 2021 ; 16(8): e0255963.
The stability of quetiapine oral suspension compounded from commercially available tablets.
Tran J, Gervase M.A, Evans J, Deville R, Dong X.
2021
4611 Lehti
J Pharm Anal 2021 ;10 532e545.
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
Navas N, Hermosilla J, Torrente-Lopez A, Hernandez-Jimenez J, Cabeza J, Perez-Robles R, Salmeron-García A.
2021
4612 Lehti
OFIL 2014 24;2:86-90
Estabilidad de la solución de gentamicina y heparina para sellado de catéter.
Villaba-Moreno AM, Gil-Navarro MV, Cotrina-Luque J, Pérez-Moreno MA, Chamorro-de Vega E.
2014
4616 Lehti
Pharmaceutics 2021 ; 13, 1267.
Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan.
Saito J, Yoshikawa N, Hanawa T, Ozawa A, Matsumoto T, Harada T, Iwahashi K, Nakamura H, Yamatani A.
2021
4617 Laboratorio
Sanofi Genzyme 2021
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021
2021
4619 Laadunvalvontalaboratorio
Quality Control North West, Stockport NHS Foundati 2021
Stability Study for Clindamycin 9.52mg/mL in 5.0% w/v Glucose 50mL Infusion Bags.
Simms D, Roberts J, Rigge D.
2021
4620 Laadunvalvontalaboratorio
Quality Control North West, Stockport NHS Foundati 2021
Stability Study for Piperacillin/Tazobactam 56.9 mg/mL in Sodium Chloride 0.9% w/v in 50mL Infusion Bags.
SimmsD, Roberts J, Rigge D.
2021
4621 Laadunvalvontalaboratorio
Quality Control North West, Stockport NHS Foundati 2021
Stability Study for Piperacillin/Tazobactam 56.9 mg/mL in Glucose 5.0% w/v in 50mL Infusion Bags.
Simms D, Roberts J, Rigge D.
2021
4622 Laadunvalvontalaboratorio
Quality Control North West, Stockport NHS Foundati 2021
Stability Study for Clindamycin 9.52mg/mL in 0.9% w/v Sodium Chloride 50mL Infusion Bags.
Simms D, Roberts J, Rigge D.
2021
4624 Lehti
EJHP 2023 ; 30: e2-e9.
Stability of pemetrexed disodium in sodium chloride 0.9% w/v intravenous Viaflo infusion bags.
Nelson L, Dwier P, Corris M, Santillo M, Davies L, Milligan K, Rahman R, Clarke I.
2023
4627 Lehti
Adv Ther 2019 36:442–450
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ.
2019
4628 Lehti
Pharmaceuticals 2021 ; 14, 943.
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B.
2021
4629 Laboratorio
2021 Sandoz
Pemetrexed Sandoz - Summary of Product Characteristics (SmPc)
2021
4630 Lehti
J Pharm Health Care Sci 2021 ; 7:31
Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan.
Saito J, Hanawa T, Matsumoto T, Yoshikawa N, Harada T, Iwahashi K, Nakamura H, Yamatani A.
2021
4633 Lehti
Pharmaceutics 2021 ; 13, 1447.
Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures.
Reber E, Neyer P, Schönenberger K.A, Saxer C, Bernasconi L, Stanga Z, Huber A, Hammerer-Lercher A, Mühlebach S.
2021
4634 Lehti
Antibiotics 2022 ;11,4: 458
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
2022
4635 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20210005.
Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes.
Mohr A, Erdnüß F, Krämer I.
2021
4636 Lehti
J Oncol Pharm Practice 2022 ;
Design and stability of pediatric oral formulation of imatinib
Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M.
2022
4637 Lehti
Braz J Pharm Sci 2021 ;57: e18896.
Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern.
Gobetti C, da Silva Bitencourt, A, Vinícius Ayres M, Peixoto de Freitas A.L, Loureiro Mendez A.S, Garcia C.V.
2021
4638 Lehti
Can J Hosp Pharm 2021 2021;74(4):327-33
Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes.
St-Jean I, Friciu M, Monfort A, MacMahon J, Forest J-M, Walker S, Leclair G.
2021
4639 Lehti
Can J Hosp Pharm 2021 2021;74(4):344-9
Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions.
Friciu M, Monfort A, Dubé P-A, Leclair G.
2021
4640 Lehti
Hosp Pharm 2021 ; 56, 5: 507–512.
Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation.
Huskey M, Lewis P, Brown S.D.
2021
4641 Lehti
Eur J Pharm Sci 2021 ;167: 106039.
Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies.
Zanon D, Selmin F, Centin G, Maximova N, Casiraghi A, Minghetti P.
2021
4642 Ilmoitus
SEFH Congress (Virtual) October 2021 2021
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner
2021
4643 Lehti
EJHP 2021
Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes.
Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L.
2021
4644 Lehti
Adv Ther 2021 ; 38 : 5609–5622
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A.
2021
4645 Lehti
JAC Antimicrob Resist 2021
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C, Drummond F, Hill T, Ozolina L, Gilchrist M, Seaton R.A, Santillo M, Wilkinson A-S, Allwood M.C.
2021
4646 Lehti
Int J Pharm Compound 2022 ;26,2:150-154
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates).
Brandin T, Wasilewski M, Panuccio C, Bouguergour C, Primas N, Lamy E, Jean C, Bertault-Peres P, Rathelot P, Curti C, Vanelle P.
2022
4648 Lehti
PlosOne 2021 16(11): e0260279.
Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method.
Coache D, Friciu M, Roullin G, Boule M, Forest J-M, Leclair G.
2021
4649 Lehti
GaBI Journal 2021 ; 10, 4
Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices.
Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J.
2021
4650 Laboratorio
Advanz Pharma 2021
Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
2021
4651 Lehti
Eur J Pedia 2021 ;180,1169–1176.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
2021
4652 Laboratorio
Bristol Myers Squibb Pharmaceuticals 2022
Nivolumab (Opdivo®) - Summary of Product Characteristics
2022
4653 Lehti
EJHP 2021 ; 28: 331-335.
Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers.
Jansen MMPM, van Waas VPH, Verzijl JM, Burger D.
2021
4654 Ilmoitus
Communication personnelle 2021
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
2021
4655 Lehti
Am J Health-Syst Pharm 2022 ;79,1:27-33
Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
Holyk A, Lindner A, Lindner S, Shippert B
2022
4661 Lehti
J Pharm Biomed Anal 2022
Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization
Bourcier B, Lagarce R, Lebreton V.
2022
4664 Lehti
Biomed Chromatogr 2022 ;e5340.
Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.
Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M.
2022
4665 Laboratorio
Sanofi Aventis 2021
LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021
2021
4666 Lehti
J Anal Sci Tech 2020 ; 11: 32.
Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron.
Lee C.H, Kim A.R, Lee M.K, Oh J.S, Lee D.K, Choi S.S.
2020
4667 Lehti
Int J Pharm Pharm Sci 2019 ;81(6):1140-114
Stability of Hydromorphone Hydrochloride and Morphine under Different Clinical Infusion Conditions.
Ping L, juan H, Li R-L, Feng Z-Y, Zhou X-J, Liu M-F, Jing B, Jian L.
2019
4669 Lehti
Neuromodulation 2021 : 1-16.
Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.
Robert J, Sorrieul J, Dupoiron D, Jubier-Hamon S, Bienfait F, Visbecq A, Devys C.
2021
4670 Lehti
Molecules 2022 ; 27(3): 1070.
Stability and Formulation of Erlotinib in Skin Creams.
Nguyen D, Secrétan P-H, Cotteret , Jacques-Gustave E, Greco C, Bodemer C, Schlatter J, Cisternino S.
2022
4671 Lehti
Int J Antimicrob Agents 2020 ; 56: 106083.
Voriconazole topical cream formulation: evidence for stability and antifungal activity.
Bouchand C, Nguyen D, Secretan P-H, Vidal F, Guery R, Auvity S, Cohen J.F, Lanternier
2020
4673 Lehti
Pharmaceutics 2022 ;14,1:118
Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases.
Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V.
2022
4675 Lehti
Pharmaceuticals 2021 ;14, 1242.
Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations.
Secretan P-H, Thirion O, Sadou Yayé H, Damy T, Astier A, Paul M, Do B.
2021
4676 Ilmoitus
EAHP Congress Vienna 2022
Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days.
Borišek R, Šmid I.
2022
4677 Ilmoitus
EAHP Congress Vienna 2022
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
Linxweiler H, Thiesen J, Krämer I.
2022
4679 Lehti
PlosOne 2022 17(3): e0262068.
Stability of extemporaneously prepared sitagliptin phosphate solution.
Zaid A.N, Abu Zaaror Y, Kaddumi A , Ghanem M , Jaradat N , Abu Salah T, Siaj S, Omari L.
2022
4681 Lehti
Hosp Pharm 2022 ; 57, 1: 69-75.
An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F.
2022
4683 Lehti
J Pharm Pract and Res 2022 2022; 52, 34-41
Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days
Low M, Singh S, Venkataya B, Pearson J, Ibrahim M, Jarouche M, Khoo C, Rowe J, Li CG.
2022
4686 Laboratorio
Roche Products Ltd. 2022
Pertuzumab (Perjeta®) - Summary of Product Characteristics.
2022
4689 Lehti
Braz J Pharm Sci 2022 ;58: e19175
Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo.
Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M.
2022
4690 Lehti
Hosp Pharm 2022 ; 57, 2: 294-299.
Stability of Compounded Digoxin Solution 0.05mg/mL for Injection.
Friciu M, Marcelin R.B, Bédard P, Forest J.M, Leclair G.
2022
4691 Lehti
Int J Pharm Compound 2022 ;26,3:248-254
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine.
Catry E, Colsoul ML, Closset Me, Hubert J, Soumoy L, Bihin B, Thiry E, Jamart J, Hecq JD, Galanti L.
2022
4692 Lehti
The Scientific World Journal 2022
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J.
2022
4693 Lehti
Drug Design Dev Ther 2022 ;16:1433-1440.
Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection.
Shen H, Fu Y, Chen Y, Xia W, Jia Z, Yu Q, Zhang L, Han L.
2022
4694 Lehti
PlosOne 2022
Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
Coache D, Friciu M, Bernine Marcellin R, Bonnemain L, Viau A, Gaëlle Roullin V, Forest J.M, Leclair G.
2022
4695 Lehti
Int J Pharm Compound 2022 ;24,6:342-351
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T Graves R.
2022
4696 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220005
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
Adoum A, Le P., Faisant S, Legendre P, Lester MA, Boivin PN.
2022
4697 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003
Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage.
Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B.
2022
4698 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2022
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Ayari G, D'Huart E, Vigneron J, Demoré B.
2022
4700 Laboratorio
AS Kalceks 2022
Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
2022
4701 Lehti
Pharm Dev Technol 2018 ; 23, 10: 1024-1029.
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
Singh R, Chen J, Miller T, Bergren M, Mallik R.
2018
4702 Lehti
EJOP 2022 ; 5: 2.
Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags.
Nisse Y-E, Sobalak N, Vigneron J, Demoré B.
2022
4705 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20210010
Stability of voriconazole 10 mg/mL ophthalmic solution during 90 days
Khan A, Venet A, Bernadou J-M, Cresto S, Servant V, Boulestreau H, Xuereb F, Crauste-Manciet S.
2022
4708 Lehti
Drugs R D 2022 ; 22,3: 225–234
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage.
Borišek R, Mischo A, Šmid I.
2022
4709 Laboratorio
Tetraphase Pharmaceuticals. 2021
XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION.
2021
4712 Ilmoitus
GERPAC Congrès - octobre 2022 2022
Développement de formulations buvables de vinorelbine à usage pédiatrique.
Macqueron L, Régnier L, Robinet P, Leroy AM, Lester MA, Boivin PN, Le Corre P.
2022
4714 Ilmoitus
GERPAC Congrès - octobre 2022 2022
Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine.
Vieillard V, Paul M
2022
4716 Lehti
J Pediatr Pharmacol Ther 2022 ;27,7:625-631
Pre-formulation and Stability Study of 20 mcg Clonidine Hydrochloride Pediatric Capsules.
Wasilewski M, Curti C, Panuccio C, Bouguergour C, Primas N, Lamy E, Castera-Ducros C, Jean C, Pirre Bertault-Peres P, Vanelle P
2022
4717 Laboratorio
2022 Daiichi Sankyo Europe Gmb
Enhertu®- Résumé des caractéristiques du produit
2022
4719 Lehti
SAGE Open Medicine 2022 ; 10: 20503121221135568.
Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump.
Bower J, Wright K, Burdette J.
2022
4720 Laboratorio
Paratek Pharmaceuticals 2021
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
2021
4723 Lehti
Am J Health-Syst Pharm 2022 https://doi.org/10.1093/a
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H
2022
4724 Lehti
Int J Pharm Compound 2022 ;26,6:522-526
Intravenous Physical Compatibility of Heparin Sodium and Furosemide.
Maktabi B, Howard MS, Baki G, Churchwell MD
2022
4725 Lehti
J Pharm Biomed Anal 2022
Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers.
Perez-Robles R, Hermosilla J, Navas N, Clemente-Batuista S, Jimenez-Lozano I, Cabanas-Poy MJ, Ruiz-Trave J et al.
2022
4726 Laboratorio
Mylan 2023
Arsenic trioxide Mylan - Résumé des caractéristiques du produit
2023
4727 Lehti
Pharmaceuticals 2023 ;16,72
Stability Study of Parenteral N-Acetylcysteine, and Chemical Inhibition of Its Dimerization
Primas N, Lano G, Brun D, Curti C, Sallée M, Sampol-Manos E, Lamy E, Bornet C, Burtey S, Vanelle P.
2023
4728 Lehti
J Pharm Biomed Anal 2021 ; 203:114209.
Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies.
Hermosilla J, Pérez-Robles R, Salmerón-García A, Casares S, Cabeza J, Navas N.
2021
4729 Lehti
Pharmaceutics 2023 ; 15, 208.
Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study.
Leanpolchareanchai J, Tangteerakoon P, Supapsophon P, Sukavatcharin S, Simaroj P, Suksiriworapong J.
2023
4730 Lehti
Neuromodulation 2022
Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures.
Sorrieul J, Robert J, Vincent L, Andre M, Bourcier B, Bienfait F, Jubier Hamon S, Dupoiron D, Devys C.
2022
4732 Lehti
Am J Health-Syst Pharm 2023 80, 3;164–170
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
Kenneally A, Agbana P, Gardner B, Bae Y, Mitchell T, Beckman E.
2023
4735 Lehti
J Oncol Pharm Practice 2023 ;29,8:1878 - 1883
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags.
Closset M, Onorati S, Colsoul M-L, Goderniaux N, Bihin B, Jamart J, Soumoy L, Hecq J-D, Odou P, Galanti L.
2023
4736 Lehti
J Pharm Biomed Anal 2023
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions.
Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L.
2023
4737 Lehti
Hosp Pharm 2023 ; 58, 2/ 183-187.
Extended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking Bags.
Van Matre E.T, Rice P.J, Wempe M.F, Lyda C, Kiser T.H.
2023
4739 Lehti
PlosOne 2023 18(2): e0282164.
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules.
Thevin P, Curti C, Benech A, Jean C, Lamy E, Castera Ducros C, Primas N, Bertault-Perez P, Vanelle P.
2023
4740 Laboratorio
Roche Products Limited 2021
MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021
2021
4741 Lehti
Int J Pharm Compound 2023 ;27,2:160-168
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R
2023
4742 Lehti
Pharmactuel 2022 ; 55, 4: 247-255.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
2022
4744 Laboratorio
Samsung laboratory 2023
Stability Report of Extended SB8 Opened Vial (400 mg) Stability (personal communication).
2023
4745 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2023
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags.
Vieillard V, Paul M
2023
4746 Ilmoitus
2023
Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C.
Shead K, Derrick H, Lyons D, Law S, Ma N.H.
2023
4747 Lehti
Pharmaceutics 2023 ,15, 957.
Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease.
Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur A-S, Negbane A, Hadchouel A, Schlatter J, Cotteret C.
2023
4748 Lehti
Pharmaceutics 2023 ,15, 309.
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Linxweiler H, Thiesen J, Krämer I.
2023
4750 Lehti
Pharmaceutics 2023 ,15, 755.
Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation.
Lebrat M, Bouattour Y, Gaudet C, Yessaad M, Jouannet M, Wasiak M, Dhifallah I, Beyssac E, Garrait G, Chennell P, Sautou V.
2023
4751 Lehti
Pharmaceutics 2023 https://doi.org/10.3390/
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects.
Polak Y, Jacobs B.A.W, Bouwhuis N, Hollak C.E.M, Kroon M.A.G.M, Kemper E.M.
2023
4754 Lehti
J Oncol Pharm Practice 2023 ;29,3:
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E
2023
4755 Lehti
J Oncol Pharm Practice 2023
Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.
Vieillard V, Le Guyader G, Jallades A, Astier A.
2023
4756 Lehti
J Oncol Pharm Practice 2022 ;29, 5: 1032-1043
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E.
2022
4757 Lehti
Hosp Pharm 2023 ; 58, 3: 304-308.
In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes.
Wojcinski J, Nathan K, Zhaohttps F.
2023
4758 Lehti
Curr Pharm Anal 2023 ; 19, 4: 307-316.
Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine .
Schmidt J.P, Steppe M.
2023
4759 Ilmoitus
Sunnybrook Healt Science Centre 2023
Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers.
Ma NH, Charbonneau LF, Law S, Walker S.
2023
4761 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220009
Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags.
D'Huart E, Sacrez M, Vigneron J, Demoré B.
2023
4762 Lehti
EJHP 2023 ; 30, 1: 11-16.
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
Knoll L, Kraemer I, Thiesen J.
2023
4763 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Almasi J, Erdnuss F, Thiesen J, Krämer I.
2023
4766 Lehti
Int J Pharm Compound 2023 ;27,3:250-255
Stability of omeprazole extemporaneous oral solution in Chopin Base.
Spennacchio A, Assunta Lopedota A, Maria la Forgia F, Fontana S, Denora N, Lopalco A.
2023
4767 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening.
Almasi K, Thiesen J, Krämer I.
2023
4768 Lehti
Journal of Nippon Medical school 2023
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.
Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H.
2023
4769 Lehti
Pharmaceutics 2023 ;15,1404
Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products.
Roche M, Danel C, Simon N, Kouach M, Bouchfaa M, Berneron C, Odou P, Lannoy D.
2023
4770 Lehti
Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220010
Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes.
Cohen A.C, Wiseman L, Al Faraj A, Andreou P, Hall R, Neira V.M.
2023
4772 Lehti
J Pharm Sci 2023 ; 112, 9: 2412-2418.
Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage?
Porlier A, Gagnon P-Y, Chénard V, Michael N-J, Simard C, Drolet B.
2023
4773 Lehti
Eur J Pharm Sci 2023 ; 187: 106464.
Predictive stability, novel HPLC-MS analysis and semi-automatic compounding process for the emergency implementation of a production line of pancuronium in injectable solution.
Merienne C, Filali S, Marchand C, Lapras B, Paillet C, Pirot F.
2023
4776 Lehti
Pharmaceutics 2023 ; 15: 2143.
Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures.
Tomczak S, Chmielewski, M, Szkudlarek J, Jeliinska A.
2023
4777 Lehti
Int J Pharm Compound 2023 ; 27, 4: 330-339.
Physicochemical and microbiological stability of azathioprine suspensions in PCCA base Suspendit.
Pramar Y.V, Mandal T.K, Bostanian L.A, Kader C, Morris T.C, Graves R.A.
2023
4778 Lehti
Int J Pharm Compound 2023 ; 27, 4: 347-351.
Chemical stability of epinephrine 10 µg/mL doluted in 0.9% sodium chloride and stored in polypropylene syringes at 4°C and 25°C.
Hook R, Neault A, Scharer D, Law S, Walker S.E, Ma N.H, Riss V.
2023
4780 Lehti
Int J Pharm Compound 2023 ;27,3:256-262
Extemporaneous Topical Minoxidil Solutions for the treatment of Alopecia : Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base.
Spennacchio A, Lopedota AA, Dibenedetto MT, La Forgia FM, Fontana S, Franco M, Denora N.
2023
4782 Lehti
Drugs R D 2023 ;23,4:363 - 375
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J.
2023
4784 Lehti
EJHP 2023
In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes.
Knoll L, Thiesen J, Klassen .D, Reinders L.M.H, Türk J, Krämer I.
2023
4785 Laboratorio
Janssen-Cilag International NV 2023
Darzalex 1800 mg solution for injection - Summary of Product characteristics.
2023
4786 Ilmoitus
SFPO Congress 2023
Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine .
Avrillon K, Le Guyader G, Doillet H, Jaskowiec C, Paul M, Poullain S.
2023
4802 Laboratorio
Aguettant Laboratory 2021
Glucose-1-Phosphate disodique tétrahydraté (Phocytan®) - Résumé des caractéristiques du produit
2021
2758 résultats

  Mentions Légales